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A  brief  introduction  to  the  practice  of  modern  liquid 
chromatography  is  given,  in  particular  to  its  use  in  the  forensic 
sciences  and  toxicology. 
The  first  compound  examined  was  morphine.·  Its  suitability  for 
analysis  by  HPLC  was  reviewed  and  discussed.  Its  electrochemical 
and  UV  absorbance  properties  were  then  examined  in  detail  in order 
to  assist  with  the  choice  of  a  detection  system.  The 
electrochemical  properties  of  several  other  narcotic  analgesics 
were  examined  for  comparison,  and  some  assessment  of  the 
structure-electrochemical activity relationship was  possible. 
The  selection  of  a  suitable  chromatographic  system  progressed 
through  the  examination  of  binary  solvents  and  varying  conditions 
of  pH  and  ionic  strength.  Results  from  these  studies  suggested 
the  use  of  ion  pairing  techniques.  A  detailed  study  of  the 
effect of  ion  pairing  agents  on  the  retention  of morphine  resulted 
in  the  choice  of  one  particular  system,  which  was  then 
characterised  in  terms  of  interference  from  other  drugs, 
sensitivity and  linearity of response.  This  was  done  for  both  UV 
and  electrochemical  detectors  and  electrochemical  detection  was 
selected  as  the  technique  of  choice  for  further  work.  Nalorphine 
was  selected as  the  internal standard. 
A  technique  described  in'  the  literature  for  the  extraction  of 
morphine  from  biological  fluids  was  examined.  Several 
modifications  were  made  to  the  technique  to  improve  extraction 
efficiency.  This  modified  procedure  was  then  applied  to  the 
analysis of morphine  in blood  samples  from  clinical studies  and 
(11 ) also  post  mortem  sample  in  cases  where  opiate  abuse  was 
suspected.  The  clinical  study  monitored  blood  morphine  levels  in 
patients  under  intensive  care  who  were  receiving  morphine  for 
chronic  pain.  The  effect  of  imparied  renal  function  on  morphine 
metabolism  was  considered,  but  no  conclusive  results  could  be 
drawn  due  to  the  concurrent  use  of  haemofiltration  in  these 
patients. 
The  second  group  of  compounds  cons idered  were  all  local 
anaesthetics.  In  particular  bupivacaine,  procaine  and  cocaine. 
These  were  of  interest  from  the  point  of  view  of  clinical stUdies, 
doping  in  the  racing  greyhound,  and  social drug  abuse  respectively. 
The  electrochemical  and  UV  absorbing  properties  of  these  compounds 
were  examined,  however  the  potentials  required  for  oxidation  of 
the  local  anaesthetics  was  however  too  high  to  permit 
electrochemical  detection  as  a  practical  detection  technique,  and 
UV  detection  was  used  for  further  work.  The  selection  of  ·a 
suitable  chromatographic  system  progressed  through  the  examination 
of  binary  solvents  and  varying  conditions  of  pH  and  ionic 
strength.  Ion  paired  chromatography  was  examined  as  was  the  use 
of  amine  modifiers.  In  order  to  produce  acceptable 
chromatography  for  a  range  of  local  anaesthetics  however,  it 
proved  neccessary  to  use  a  reversed  phase  column  of  low 
lipophilicity.  Using  this  column  with  a  series  of  binary 
solvents  it  proved  possible  to  separate  a  wide  range  of  basic 
compounds, 
efficiency. 
including  several  local  anaesthetics,  wi th  high 
( iii) An  extraction  procedure  was  developed,  based  on  liquid/solid 
extraction  from  an  absorbent  support  (diatomaceous  earth).  This 
procedure  was  applied  to  blood,  plasma  and  urine  samples  and  found 
to  provide  extracts  sui table  for  HPLC  on  the  systems  developed 
above.  Plasma  samples  were  received  from  a  clinical  study  where 
patients  were  receiving  bupivacaine  abdominally  (post-surgery). 
These  were  analysed  by  the  above  techniques  and  it was  shown  that 
the  plasma  levels  obtained  were  high,  in  some  cases  approaching 
the  toxic  range. 
Two  screening  procedures  reconunended  for  the  isolation  of  drugs 
from  greyhound  urine  were  examined  for  their  ability  to  detect 
bupivacaine,  procaine  and  cocaine  in  spiked  urine  samples.  Both 
proved  suitable  and  it  was  noted  that  the  presence  of  local 
anaesthetics  in  a  urine  sample  could  be  detected  by  pre-race 
testing,  and  that  the  identity  of  the  drugs  could  be  confirmed  by 
the  HPLC  technique  developed earlier. 
Greyhounds  were  then  administered  with  the  three  compounds  of 
interest,  and  the  urine  samples  collected  were  tested  for  the 
presence  of  drugs.  Bupi vacaine  was  detected  up  to  twelve  hours 
post  administration,  procaine  up  to  48  hours  post  administration, 
and  cocaine  up  to  twenty  four  hours  post  administation. 
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1 .......  \ CHAPTER  ONE 
INTRODUCTION 
1.1.  HIGH  PRESSURE  LIQUID  CHROMATOGRAPHY 
1.1.1.  Introduction 
High  Pressure  Liquid  Chromatography  (HPLC)  (also  called 
High  Perfo~ance Liquid  Chromatography)  has  been  in  routine  use  as 
an  analytical  and  preparative  technique- for  about  fifteen  years, 
and  its  principles  and  practice  have  been  well  documented  and 
reviewed  (Snyder  and  Kirkland,  1978;  Knox,  1982;  Pryde  and 
Gilbert,  1979;·  Krstulovic  and  Brown,  1982;  Lawrence,  1981, 
Simpson,  1982;  Majors  et al.,  1983). 
Many  applications  have  also 
including  the  analysis  of 
been  described  in 
lipids,  steroids, 
proteins,  vitamins,  pesticides,  environmental 
the  literature 
carbohydrates, 
contaminants, 
pharmaceuticals  and  the  analysis  of  drugs  and  metabolites  in 
biological  fluids.  Examples  of  all  these  applications  are 
included  in  the  above  references. 
Many  of  these  areas  have  applications  in  the  forensic  sciences. 
Analysis  and  characterisation  of  trace  evidence  eg  inks  (Colwell 
and  Karger,  1971),  dyestuffs  (Passarelli  and  Jacobs,  1915)  and 
cosmetics  (Reuland  and  Trinler,  1980). 
There  are  also  applications  in  the  analysis  of  explosives  (Dalton 
at  al.,  1975),  and  analysis  of  hydrocarbons  (Doran  and  HcTagga::-t, 
1974),  and  plastics  and  polymers  (Wheals,  1979). 
-1-The  major  forensic  application  of  HPLC  is  however  in  drug  analysis 
(Wheals,  1976;  Saferstein.  1982). 
This  falls  into  two  categories,  the  identification  of  drugs  in 
questioned  material,  and  the  detection  and  identification  of  drugs 
in  biological material. 
The  former  includes  the  identification  of  the  constituents  of 
cannabis  resin  <Baker  et  a1.,  1980;  Baker  et al.,  1983;  Turner  and 
Mahlberg,  1982),  the  identification  of  drugs,  and  by-products  and 
adulterants  in  street  drugs  notably  cocaine  (Gill  et  a1.,  1984) 
and  heroin  (Trin1er  and  Reuland,  1975).  HPLC  has  also  been  ~sed 
for  the  identification  of  components  of  psilocybe  mushrooms 
(Vanhaelen-Fastre  and  Vanhaelen,  1984;  Kysi1ka  et al.,  1985), 
The  identification  of  drugs  in  biological  fluids  is  a  larger 
field,  as  potentially  any  prescription  drug  and  many  more 
compounds  besides  might  be  present  in  a  sample  submitted  for 
analysis. 
HPLC  has  been  shown  in  the  literature  to  play  an  important  part  in 
this  field.  Many  methods  have  been  reported  for  the 
identification  of  compounds  of  forensic  interest  in  biological 
fluids.  Some  of  these  are  included  in  table  1.1 .. 
HPLC  may  not  be  the  most  gui table  technique  for  the  analy~  is  cf 
all  compounds.  Solvents  for  example  ar~  more  suited  to  analysis 
by  GC  (Ramsey  and  Flanagan,  1982;  Oliver,  1982). 
HPLC  is  of  special  interest  for  those  compounds  which  are  not 
suitable  for  analysis  at  the  temperatures  required  for  GC.  As 
well  as  proteins,  carbohydrates  and  high  molecular  weignt 
compounds,  th is  includes  quaternary  armnon i um  compounds,  and  sorr.e 
esters,  amides  and  anhydrides  which  are  temperature  labile. 
The  option  of  using  stationary  and  mobile  phases  of  different 
-2-Author  Date 
Ray  et  ale  1985 
Levine  and  1985 
Coplan 
I 
w  Uges  and  1984  I 
Bloemhof 
Gill  et  a 1.  1981 
Brodie  et  ale  1978 
Wurst  et  a 1.  1978 
Law  et  ale  1984 
TABLE  1.1. 
HPLC  METHODS  FOR  THE  ANALYSIS  OF  DRUGS 
OF  FORENSIC  INTEREST 
Com12ounds  Class 
propanolol  B  blocker 
fenprofen  non-steroidal 
ibuprofen  anti-
indomethacin  inflammatories 
naproxen 
and  others 
pancuronium  quaternary 
alcuronium  neuromuscular 
pyridostigmine  blocking 
vercuronium  agents 
tubocurarine 
30  barbiturates  sedatives 
benzodiazepines  sedatives 
ergot  alkaloids  hallucinogens 
Cannabinoids  hallucinogens 
Comments 
RP-HPLC  UV 
RP-HPLC  UV 
RP-HPLC  UV 
RP-HPLC  UV 
RP-HPLC  UV 
RP-HPLC  UV 
RP-HPLC 
Off-line 
radioimIllunoassay 
detection polari  ty  also  allows  a  range  of  very  polar  compounds  (such  as 
phenols,  thiols,  sugar  conjugates,  and  free  acids)  to  be  analysed 
directly  without  the  need  for  chemical  alteration  or 
derivatisation. 
1.2.  METHOD  DEVELOPMENT 
The  selection  of  the  appropriate  technique  has  to  be 
carefully considered  for  the  analyte  of  interest. 
Having  decided  on  HPLC  as  the  method  of  choice,  the  process  of 
selecting  suitable  conditions  for  the  assay  is  based  on  a 
consideration  of  the  physical  and  chemical  properties  of  the 
analyte. 
1.2.1.  Detection  systems 
The  detection  system  must  be  sui table  for  measuring  small 
quantities  of  the  analyte.  It  should  be  as  selective  as 
possible,  and  compatible  with  the  solvent  system used. 
The  detection  systems  available  to  this  study  were  ultra 
violet/vi  sible  (UV)  absorbance  detection,  and  electrochemical 
detection  (ED). 
UV  detection  was  one  of  the  first  methods  of  on-line  detection  to 
be  applied  to  liquid  chromatography  (Scott,  1977)  and  its 
principles  and  application  have  been  well  documented  elsewhere 
<Skoog  and  West,  1980).  It  is  a  quantitative  method  by  virtue of 
the  relationship  between  concentration  and  absorption  described  by 
Beer  and  Lambert. 
Electrochemical  detection  is  a  more  recent  innovation. 
-4-1.2.2.  Electrochemical detection  - principles 
This  method  of  detection  is  particularly suited  to  reversed 
phase  HPLC  as  similar  conditions  are  required  for  both,  namely  the 
use  of  an  aqueous  electrolyte-containing solvent. 
The  principle  on  which  the  electrochemical  detector  operates  is  to 
apply  a  potential  difference  across  two  electrodes  lying  in  the 
stream  of  the  eluent  from  the  chromatographic  column.  If  the 
potential  is  sufficient  to  cause  an  electrochemical  reaction  of 
any  eluting  compounds,  the  flow  of  elect:-ons  resulting  from  that 
reaction  can  be  measured  as  a  current,  proportional  to  the  amount 
of material  passing  through  the  flowcell. 
The  basis  of  the  electronics  is  shown  in  figure  1.1..  One 
operational  amplifier  (OA1)  connected  through  the  reference 
electrode  in  a  voltage  follower  circuit,  supplies  a  constant 
potential  relative  to  the  reference  electrode  between  the  working 
electrode  and  the  solution.  A  second  operational  amplifier 
(OA2) ,  in  a  current-voltage  converter  configuration,  rumplifies  any 
current  resulting  from  a  reaction  at  the  working  electrode  (w), 
and  converts  this  to  a  voltage  proportional  to  that  current  which 
can  be  displayed digitally or  connected  to  a  chart recorder. 
1.2.3.  organic  electrochemistry 
A  wide  range  of  compounds  and  functional  groups  can  react 
electrochemically,  both  oxidatively  and  reductively.  The  easiest 
reactions  to  perform  experimentally  are  oxidations,  since  such 
str  i c t  degas sing  and  exper imental  procedures  as  those  for 
reduction  reactions  are  not  required  (Kissinger,  1982;  Ryan,  1984). 
-5-I 
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FIGURE  1.1. 
BASIC  CIRCUIT  DIAGRAM  FOR  ELECTROCHEMICAL  DETECTOR  SHOWING  VOLTAGE  CONTROL  CIRCUIT  (OAl) , 
SIGNAL  PROCESSING  (OA2),  AND  CELL  WITH  REFERENCE  (r),  AUXILIARY  (a)  AND  WORKING  (w)  ELECTRODES. Organic  oxidations  can  be  performed  on  most  electron-rich 
compounds.  Common  reactions  include  phenol  oxidative  coupli:'lgs. 
oxidation  of  primary  and  secondary  alcohols  to  aldehydes  and 
ketones  respectively,  Kolbe  de-carboxylation  of  carboxylic  acids 
oxidation  of  primary  and  secondary  thiols,  hydroquinones,  indoles, 
and  xanthines  (Volke,  1983;  Tomlinov,  1978).  These  two 
references  list  many  more  specialised  and  less  common  reactions 
known  to occur. 
Electrochemical  detection  is  now  being  widely  applied  to  a  variety 
of  compounds  including  drugs,  environmental  cont~inants  and 
biochemicals.  Recent  examples  include  the  analysis  of  platinum 
complexes  used  in  chemotherapy  (Elfrink  et  al.,  1985),  the 
measurement  of  hallucinogenic  indole~ines  (Kysilka  et  al.,  1985), 
Catecholamines,  derivatives  and  metabolites  (De  Jong  et  al., 
1985),  and  the  detection  of  a  wide  range  of  compounds  including 
phenothiazines  (Kauffmann  et  aI,  1985),  analgesics,  local 
anaesthetics,  and  anti-convulsant  drugs,  (Musch  et  al.,  1985). 
Oxidative  electrochemical  detection  has  also  been  reported  for 
benzodiazepines  (Smyth  et al.,  1982). 
Recent  developments  in  the  field  of  electrochemical  detection 
include  the  use  of  electrochemically  induced  fluorescence  in 
aromatic  compounds  to  measure  these  compounds  as  they  elute 
(Blatchford  and  Kalcolme-Lawes,  1985),  and  t~e  use  of 
multifuctional.  detectors,  incorporating  UV,  fluorescence  and 
amperometric  detection  in  a  single  flow  cell  (Schmidt  and  Scott, 
1985) 
-7-1.2.4.  Examination  of electrochemical  properties 
By  applying  a  sufficient potential  to  a  suitable  analyte  in 
an  electrolyte  solution  (to  minimise  mobility  of  the 
electrochemically  generated  intermediates)  an  unstable 
intermediate,  usually  a  radical, can  be  produced.  This  may  react 
with  other  components  of  the  solution  giving  an  hetrogeneou5 
product,  rearrange  itself  to  give  some  new  homogeneous  product  or 
decay  back  to  give  the  starting  material.  The  actual  course  of 
the  reaction  will  depend  on  the  nature  of  the  compound  and  on 
other  components  in  solution.  There  is  no  firm  agreement  as  to 
whether  the  reaction  need  go  to  completion  for  current  to  flow  or 
whether  the  formation  of  a  radical  itself  is  sufficient  (Anderson 
et al.,  1981) 
If  the  potential  applied  to  an  electrolyte  solution  is  gradually 
increased  a  point  will  be  reached  where  the  potential  is 
sufficient  to  cause  the  electrochemical  reaction  to  occur. 
Further  increasing  the  potential  will  give  a  gradual  increase  in 
the  current  up  to  a  point  where  the  reaction  will  equilibrate  and 
the  current  stabilises  at  a  value  dependent  on  the  nature  of  the 
electrode  surface,  the  temperature  of  the  solution  and  upon 
whether  the  solution  is  stirred  (Evans  et al.,  1983). 
The  most  useful  piece  of  information  which  can  be  obtained  from 
this  is  the  voltage  at  which  maximum  curr-ent  is  achieved,  the  E  p 
value  (peak  potential  or  full  wave  potential).  The  Ep  value  i.s 
usually  selected  as  the  working  potential  for  electrochemical 
detection,  as  it  represents  the  point  at  which  the 
current/potential  ratio  is  maximised.  Increas i ng  the  potent  i al 
beyond  E  does  not  give  rise  to  any  further  increase  in  current. 
p 
-8-Another  parameter  often  quoted  is  which  has  no 
thermodynamic  significance,  but  is  useful  in  assessing  the  course 
of  the  reaction. 
There  are  a  number  of  methods  for  obtaining  these  current/voltage 
plots  (Skoog  and  West,  1980). 
One  method  is  to  use  a  developed  chromatographic  system  wi th  an 
electrochemical  detector.  Succesive  injections  of  the  analyte  at 
increasing  potentials  can  be  made  and  the  resulting  detector 
response,  plotted  against  potential  can  be  used  to  construct  a 
Hydrodyn~ic Voltammogr~ (HOV)  (for  an  example  see  figure  2.21.). 
When  there  is  no  suitable  chromatography  developd,  an  alternative 
is  to  use  cyclic  voltammetry  (CV).  This  technique  involves 
applying  a  constantly  changing  potential  to  a  solution  of  the 
compound  of  interest  in  a  three  electrode  cell  similar  to  the 
design  for  the  EO  cell.  At  a  pre-selected  potential  (the 
switching  potential)  the  direction  of  voltage  change  is  reversed 
and  can  be  allowed  to  change  until  it  reaches  a  second  switching 
potential.  This  cycling  of  applied  voltage  will  give  rise  to  a 
cyclic  voltammogram,  (for  an  example,  see  figure  2.6.). 
Oxidations  occur  when  the  voltage  is  changing  in  a  positive 
direction,  reductions  when  the  voltage  change  is  towards  negative 
potentials  (Evans  et al.,  1983). 
Hore  information  about  the  nature  of  the  reaction  taking  place  can 
be  obtained  from  CV  than  from  HOV,  including  the  number  of  steps 
involved  and  whether  the  reaction  is  reversible. 
however  a  value  for  the  full  wave  potential  (Ep) 
obtained. 
-9-
Like  HOV 
can  also  be It  has  been  ~hown  (Anderson  et  al.,  1981;  Kissinger,  1983  (i», 
that  there  is  good  agreement  between  Ep  values  obtained  by  cv 
and  HDV,  providing  the  experiments  are  performed  under  comparable 
conditions  of  solvent,  temperature,  pH,  and  electrode material. 
1.2.5.  Principles  of operation  and  practical considerations 
The  electrochemical  detector  relies  on  the  three  electrode 
design,  used  in  most  electroanalytical  instruments  (Pl~beck. 
1983) .  The  controller  supplies  a  constant  potential  difference 
between  the  working  and  auxilliary  electrodes  measured  with 
respect  to  a  third  reference  electrode.  It  constantly  moni tors 
the  liquid  junction  potential  at  the  working  ele~trode  and  adjusts 
the  potential  applied  accordingly  to  keep  this  at  the  pre-set 
value  on  the  controller. 
The  resulting  current  is  amplified  and  converted  to  an  analog 
voltage  which  can  be  recorded  as  a  graph  of  current  against 
elution  time/volume. 
The  electrochemical  detector  is  selective  to  a  certain  extent. 
other  compounds  present  in  the  eluent  which  react  at  the  applied 
potential  will  also  be  detected,  non  electroactive  compounds  will 
not  be  detected  or  interfere with  the  analyte  of  interest. 
The  potential  provided  must  therefore  be  at  a  low  enough  voltage 
to  exclude  interference  from  co-eluting  compounds,  but  be  high 
enough  to  give  a  measurable  current. 
Two  mcdes  of  electrochemical  detect  ion  are  recogni sed.  One  of 
these,  coulometric  detection,  is  where  complete  conversion  of  the 
analyte  takes  place.  This  is  achieved  using  a  porous  graphite 
-10-electrode  with  a  large  surface  area.  This  high  rate  of 
conversion  is  accompanied  by  an  increase  in  background  current, 
although  a  net  improvement  in  sensitivity  over  the  other  design 
has  been  claimed  (ESA,  1986).  An  additional  advantage  of 
coulometric  detection  is  that  electrode  maintainance  required  is 
minimal. 
The  other  approach  is  amperometric  detection,  wherein  o~ly  a 
fraction  (typically  5-20~,  (BAS,  1980)  of  the  analyte  actually 
reacts  on  an  electrode  of  limited  surface  area,  the  associated 
signal  current  produced  is  lower  than  wi th  cou:!.ometric  detection 
as  is  the  background  current.  The  signal-to-noise  ratio  and 
hence  the  sensitivity is  similar  to  coulometric  detection. 
Glassy  carbon  is  the  material  used  most  widely  as  the  working 
electrode,  however  for  specific  applications  the  use  of  gold, 
mercury/gold or  carbon  paste  electrodes  may  be  advised  (Ryan,  1983) 
Two  designs  of  flow  cell  are  commercially  available  for 
~perometric detectors. 
(a)  Wall  jet electrode. 
Figure  I.2.(b)  shows  the  configuration  of  electrodes  for 
this  design.  The  eluent  from  the  column  tr&vel3  through 
capillary  tubing  and  impinges  onto  the  electrode  surface  as  a 
jet.  The  eluent  and  any  products  formed  in  the  reaction  then 
leave  through  the  auxilliary  electrode.  This  is  designed  to 
increase  the  amount  of  the  compound  which  reacts  (the  conversion 
efficiency).  However,  as  the  flow  of  the  jet  onto  the  electrode 
surface  causes  some  turbulance  in  the  cell  body,  this  leads  to 
increased  noise  on  the  baseline.  Another  suggested  advantage  of 
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FIGURE  1.2. 
(a)  THIN  LAYER  FLOW  CELL  (BAS)  SHOWING  REFERENCE  (R).  WORKING  (W)  AND  AUXILLIARY  (A)  ELECTRODES. 
(b)  WALL-JET  ELECTRODE  FLOW  CELL.  SHOWING  REFERENCE  (R).  WORKING  (W)  AND  AUXILLIARY  (A)  ELECTRODES. this  configuration  is  that  the  continuous  flow  of  liquid  onto  the 
electrode  surface  helps  to  keep  the  electrode clean. 
(b)  Thin  layer  flow cell. 
This  is  shown  in  figure  1.2.(a).  The  principle  behind 
this  design  is  that  the  smooth  flow  of  the  el~ent  over  the 
electrode  surface  will  limit  the  noise  on  the  baseline  and  in  this 
way  lead  to  enhanced  sensitivity.  The  extent  of  the  reaction 
efficiency  however  relies  on  the  diffusion  of  the  analyte  to  the 
electrode  surface where  the  reaction  takes  place. 
This  results  in  a  lower  conversion  efficiency  than  the  wall-jet 
system. 
1.2.6.  Conclusions  and  Selection of  equipment 
The  sensitivity  claimed  for  electrochemical  detection  and 
the  prospect  of  a  selective  detector  suitable  for  the  measurement 
of  some  compounds  of  forensic  interest  prompted  this  investigation 
of  its suitability for  routine  use. 
At  the  outset  of  this  work,  coulometric  detectors  were  not  widely 
available,  and  amperometric  detection  had  been  selected  for 
further  examination. 
There  is  no  agreement  as  to  which  of ,the  two  cell designs  provides 
the  best  sensitivity  or  ease  of  use.  Some  workers  (Law,  1984) 
concluded  that there  was  no  significant difference. 
Two  commerc ially  ava i 1able  flow  cells,  one  of  each  type,  were 
examined  and  found  to  be  comparable  in  sensitivity  and  ease  of 
use.  The  design  of  the  thin  layer  flow  cell  was  prefered  because 
of  its  low  volume  and  its  modular  design  which  could  allow  for 
-13-adaptation  for  microbore  LC  or  for  other  electrode  materials,  eg 
gold,  carbon  paste  if  this  proved  neccessary.  The  control  unit 
selected  (Bioanalytical  Systems,  Anachem,  Luton,  Great  Britain) 
gave  a  constant  display  of  the  current  being  measured  and  readily 
gave  information  about  the  potential  applied  and  the  background 
current.  This  was  useful  for  troubleshooting  purposes.  It  e.lso 
had  a  facility  to  allow  the  use  of  two  or  more  electrodes  in 
series  or  in  parallel,  and  an  electronic  self-test  system.  Its 
ease  of  operation  and  the  wide  range  of  facilitie=s  made  this  the 
unit of  choice,  for  routine  use  and  for  troubleshooting. 
1.3.  SELECTION  OF  COLUMN  AND  SOLVENT 
1.3.1.  Introduction 
Having  examined  the  analyte  and  selected  the  most 
appropriate  detection  system,  the  chromatographic  conditions  may 
be  dictated  to  some  extent.  If  UV  detection  is  being  used, 
certain  solvents  with  chromophores  in  the  same  region  as  the 
analyte may  not  be  used  (Snyder  and  Kirkland,  1978). 
Although  electrochemical  detection  has  been  applied  to  straight 
phase  chromatography  (Gunasingham  and  Fleet,  1983)  the  conditions 
required  for  electrochemical  detection  (aqueous  based  solvent 
system,  high/low  pH,  water  soluble  charge  carriers  are  more 
compatible  with" reversed  phase  HPLC  (Kissinger,  1983  (ii». 
Most  HPLC  methods  for  drug  analysis  are  performed  on  reversed 
phase  materials  (usually  octadecylsilyl  (ODS)  (C-1S»  (see  table 
1.1.).  For  this  work  the  stationary  phase  material  selected  was 
-14-ODS  Hypersil  (Shandon  Southern,  Runcorn,  Cheshire).  This  was 
chosen  as  it  had  been  shown  to  be  one  of  the  most  re liable  i:l 
terms  of  batcb-to-batch  variation  and  quali ty  of  chromatography 
achieved,  by  work  in  this  department  (Eppel,  1980),  and  elsewhere 
(Smith et al.,  1984  (i)  and  (ii)). 
In  addition,  ODS-Hypersil  was  chosen  as  the  stock  reversed-phase 
material  by  the  Home  Office  Forensic  Science  Service,  in  order  to 
ensure  good  column  reproducibility.  It was  considered  convenient 
to  follow  suit  in  this  respect,  as  many  of  the  HPLC  methods  used 
in  this  department  are  based  on  assays  developed  by  the  Home 
Office  Forensic  Science  Service. 
Reversed  phase  HPLC  is  popular  especially  for  the  analysis  of 
basic  drugs,  because  of  the  phenomenon  of  peak  tailing  caused  by 
the  interaction  of  the  basic  nitrogen  atoms  with  the  silica 
packing  material.  This  happens  to  a  lesser  extent  with  residual 
silanol  sites  on  reversed  phase  materials  snd  some  of  the 
techniques  used  to  reduce  thi  s  are  cons idered  in  the  course  of 
this work.  Of  these  the most  widely used  is  ion  pairing. 
1.3.2.  Ion  pairing  technigues 
The  principle  of  ion  pairing  has  been  used  in  conventional 
solvent/solvent  extraction  for  many  years.  If  a  specific  solute 
of  interest  is  polar  or  ionised  and  therefore  insoluble  in  a 
particular  non-polar  solvent,  it  can  be  made  to  dissolve  by 
reducing  the  energy  of  interaction  between  the  polar  and  non-polar 
moieties,  to  a  level  lower  than  the  solvation  energy.  This  can 
be  done  by  adding  to  the  solution  a  counter-ion  of  opposite  charge 
to  the  solute  with  which  it will  form  an  ion  pair which  is  overall 
-15-electrically  neutral  and  effectively  non-polar,  making  this  new 
species  much  more  soluble  in  the  non-polar  solvent. 
Factors  concerning  the  selection  of  the  correct  ion  pairing 
reagent  include  the  steric  si  tuation  and  nature  of  the  charge  in 
the  solute molecule,  how  good  a  nucleophile  or  electrophile  it is, 
the  dissociation  constant  of  the  concommi tant  ion-pair  and  the 
polari  ty of  the  sol  vent'-
The  actual  mechanisms  of  ion  pair  retention  are  still  not  agreed 
upon.  Some  workers  (Horvath  et  al.,  1977  (i);  Horvath  et  al., 
1977  (i)  maintain  that  the  ion-pairs  are  formed  in  solution  and 
then  partition onto  the  organic  stationary phase. 
The  other  popular  mechanism  supported  by  Knox  (1976)  and 
Bidlingmeyer  (1979)  is  an  ion  exchange  type,  in  which  the  ion  pair 
reagent  is  first  adsorbed  onto  the  bonded  phase  thereby  creating  a 
charged  surface,  and  partitioning  of  the  sample  then  takes  place 
between  the  char.ged  surface  and  the mobile  phase. 
This  effect  was  demonstrated  by  Knox  (1976)  by  measuring  how  much 
ion  pairing  agent  from  the  mobile  phase  was  retained  on  the 
column.  He  found  that  a  reversed  phase  packing  material  (SAS 
Silica)  retained  13.0  mg  of  ion  pairing  agent  per  gram  of  packing 
material. 
It  seems  likely  that  the  actual  mechanism  in  most  cases  is  a 
mixture  of  these  two  proposals  and  will  depend  to  a  large  extent 
on  the  concentration  and  composition  of  the  mobile  phase  and  the 
nature  of  the  sample  type  and  choice  of  counter  ion. 
Popular  pairing  reagents  for  cations 
ClO~  and  more  recently  the  sodium  salts  of  pentane  to  nonanp. 
sulphonic  acids. 
-16-Dissociation  of  the  ion-pair  in  a  separation  can  influence  the 
symmetry  of  the  chromatographic  peaks. 
Symmetrical  chromatographic  peaks  are  obtained  if  the  degree  of 
dissociation  of  the  sample  ion-pair  is  kept  low  and  constant. 
This  is  acheived  by  maintaining  a  high  and  constant  concent~&tion 
of  the  counter-ion  in  the mobile  phase. 
One  way  of  maintaining  this  constant  concentration  is  to  add  a 
cation  which  will  bring  about  a  suitable  ion  pair  extraction  of 
the  counter  ion  onto  the  stationary phase. 
This  use  of  ~ine  modifiers  in  the  mobile  phase  has  been 
investigated  by  other  workers  (Gill  et  al.,  1982;  Kie1  et  al., 
1985;  De  Ruyter  et  al.,  1980),  and  it  is  proposed  that  these  may 
improve  the  chromatography  of  basic  compounds  on  reversed  phase 
materials  by  blocking  the  residual  silanol sites on  the  support. 
When  ion  paired  chromatography  is  to  be  used  the  solvent  should 
have  an  aqueous  base  with  an  organic  modifier  to  adjust  its 
polarity  (see  below,  1.3.4.)  to  obtain  the  desired  value  for  the 
extraction constant  and  hence  capacity factor. 
The  pH  must  be  adjusted  to  ensure  dissociation  of  the  sample  ion 
from  its  own  counter  ion,  but  must  not  increase  the  dissociation 
of  the  solute  ion-pair. 
1.3.3.  Optimisation  of  chromatography 
In  this  study,once  the  mode  of  chromatography  and  the 
initial  conditions  had  been  selected,  the  control  of  retention  of 
the  analytes  was  achieved  by  controlling  their  ionisation  through 
the  pH  of  the  solvent,  The  mode  of  chromatography  through  the  use 
of  solvent  additives,  and  the  strength  or  eluting  power  of  the 
-17-solvent  through  control of  the  organic modifier. 
Some  quantitative  measure  of  the  polarity  of  the  solvent  is 
essential  to  the  systematic  optimisation  of  conditions,  and  the 
concept  of  polarity is  therefo~e considered. 
Solvents  are  chosen  for  HPLC  by  considering  both  the  conditions 
enforced  by  the  nature  of  the  technique  and  those  dictated  by  the 
analyte. 
The  former  considerations  include  the  temperature  at  which  the 
separation  takes  place,  the  pressure  required  to  force  the  solvent 
through  the  column  and  the  method  by  which  the  eluting  analyte  is 
to  be  detected.  This  dictates  that  the  solvent  should  be  of  low 
viscosity  to  allow  practical  flow  rates  and  thus  acceptable 
retention  times,  it  must  be  a  liquid  at  the  temperature  and 
pressure  being  used  and  is  normally  a  liquid  at  atmospheric 
pressure  although  there  are  reports  of  carbon  dioxide  being  used 
under  super-critical  conditions  as  an  eluent  for  HPLC  (Haddow  et 
al.,  1985).  Trends  in  these  two  properties  of  viscosity  and 
boiling  point  generally  follow  one  another  for  most  solvents, 
except  where  there  is  a  large  amount  of  hydrogen  bonding,  in 
solvents  like  water  and  the  lower  alcohols,  or  in  compact 
molecules  like  cyclohexanes  and  aromatics,  which  have  higher 
viscosities  than  predicted  from  their boiling points. 
Those  conditions  dictated  by  the  analyte  include  whether  normal  or 
reversed  phase  conditions  should  be  used  (Snyder  and  Kirkland, 
1979),  which  in  turn  dictates  the  choice  of  solvent.  It must  be 
sufficiently  non-reactive  so  that  it  will  not  react  with  the 
analyte  in  the  course  of  the  separation  and  it  must  have  the 
correct  solvency  characteristics  in  order  to  elute  the  analyte 
-18-selectively from  the injected mixture. 
Good  laboratory  practice  alone  imposes  considerations  about  the 
toxicity  and  flammability  of  the  solvents  being  used,  and  makes 
the  use  of  dimethyl  sulphoxide,  acry~onitrile  and  hydrogen 
sulphide undesirable where  there are alternative approaches. 
1.3.4.  THE  CONCEPT  OF  SOLVENT  POLARITY 
1.3.4.1.  Introduction 
In  selecting  a  solvent  for  HPLC  it is  seldom  the  case  that 
one  wishes  to maximiee  the  solubility of  the  analfte  in  the mobile 
phase.  This  would  merely  result  in  eluting it from  the  column  at 
a  very  early  stage,  probably  with  the  solvent  front.  The  usual 
objectiv~  is  to  vary  the  solvent  strength  of  the  mobile  phase  to 
allow  the  analyte  to  be  selectively  partitioned  between  the 
stationary  and  mobile  phases  and  eluted  on  its  own,  separated 
efficiently  from  other  components  in  the  mixture  in  a  reasonable 
time. 
It  is  usually  the  case  that  analysis  time  should  be  as  short  as 
possible,  normally  under  thirty minutes. 
There  are  a  number  of  physico-chemical  parameters  which  dictate 
how  the pure  solvent or  solvent mixture  interact with  the  analyte. 
These  include  dispersion  interactions,  dipolar  interactions  (both 
dipole  induction  and  dipole  orientation),  bydrogen  bonding 
interactions  and  the  Hydrophobic  effect.  Each  of  these  can  bring 
either  a  degree  of  ordering  or  disordering  to  the  solvent  and  thus 
effect  its  interaction with  the  analyte.  Having  to  consider  each 
of  these  processes  in  turn  when  selecting  a  solvent  system  for 
-19-HPLC  would  be  laborious  and  time  consuming.  For  th  is  reason 
several  schemes  have  been  suggested  whereby  the  sum  of  these 
effects  can  be  expressed  in  simple  terms. 
1.3.4.2.  Solvent classification  schemes 
The  polarity  or  strength  of  a  solvent  represents  its 
abili  ty  to  enter  into  all  the  types  of  interactions  cons idered 
above  and  is  defined  as  the  sum  over  all  the  interactions. 
Several  schemes  have  been  proposed  to  do  this.  One  scheme 
(Hildebrand,  1975)  for  classifying  the  solvating  properties  of  a 
solvent  is  based  on  an  empirical  approach  to  the  problem.  Delta, 
the  solubility  parameter  is  related  to  the  enthalpy  of 
vapourisation.  This  arises  from  the  fact  that  the  process  of 
vapourisation  ie  from  liquid  phase  to  gas  phase  is  similar  in 
principle  to  transfer  between  two  liquid  phases. 
calculated  from  boiling point data. 
Delta  is  easily 
Another  scheme  (Rhorschneider,  1973)  for  classifying  the  solvating 
properties  of  a  solvent  is  based  on  experimental  data  rather  than 
theoretical  considerations.  Rohrschneider  measured  the  partition 
coefficients  for  a  number  of  solutes  and  by  doing  so  illustrated 
the  degree  to  which  a  range  of  some  84  solvents  participate  in  the 
various  interactions  described  earlier.  Th is  data  was  exami ned 
by  Snyder  in  1974  and  further  in  1978,  and  simpified  to  allow  its 
application  to  solvent  selection  in  liquid  chromatography. 
Each  solvent  can  be  described  in  terms  of  interactions  with  three 
test solutes. 
The  three  solutes  chosen  were  ethanol,  dioxane  and  ni  tromethan~. 
and  were  des igned  to  5how  the  proton  donor,  proton  acceptor  and 
-20-dipole properties  respectively,  of all the  solvents  examined. 
Since  subdivision  of  P'  into  individual  polarity  contributions  is 
implicit  in  its  derivation  (Snyder,  1978;  Snyder,  1979),  the 
and  X  (chi) 
n  values  represent  the  fractional  polarity 
ascribed  to  proton  acceptor,  proton  donor  and  dipole 
interactions  respectively  for  that  solvent ,assumi  ng  these  to  be 
the major  interactions. 
The  solubility  and  hence  the  relative  partitioning  of  an  analyte 
between  the  stationary  and  mobile  phases  of  a  chromatographic 
system  can  thus  be  controlled  by  varying  the  individual  Xe,  Xn  and 
Xd  values  and  hence  the  polarity of  the  mobile  phase. 
This  may  be  done  mixing  two  solvents  .  The  solvating  properties 
of  the  resulting  mixture  will  be  proportional  to  the  volume 
fractions  of  the  constituent solvents  (Snyder,  1978). 
Where  M  a-i  are  the  mole  fractions  of  solvents  a  to 
P'  i  are  the  respective polarities.  a-
i ,  and 
If  the  mixture  contains  two  solvents,  a  range  of  polarities 
ranging  between  the  polarities  of  the  pure  solvent  components  can 
be  obtained. 
Taking  the  situation dealt  with  in  this  work  where  there  are  three 
solvents,  acefonitrile,  methanol  and  O.OlK  KH2PO"  (assumed  to 
be  equivalent  to  water),  mixtures  of  these  solvents  in  all 
proport  ions  can  be  represented  in  two  d imens ions  as  demonstrated 
in  figure  1.3.,  as  the  mole  fractions  are  interdependant  (ie 
-21-K  +M...  +K  =:  1) .  a  -0  c  Thus  a  range  of  solvents  with  different 
and  values  contributed  from  the  constituent 
solvents,  but  the  same  P'  value  (or  solvent  strength)  can  be 
prepared.  The  use  of  te=nary  rather  than  a  binary  solvent 
mixture  thus  allows  a  greater  degree  of  fine  tuning  in  the 
optimisation  process. 
The  derivation  of  these  parameters  is  found  in  Snyder,  (1974)  and 
(1978),  and  discussed  in detail  in  Snyder,  (1979). 
1.3.5.  TERNARY  SOLVENT  MIXTURES  AND  MIXTURE  DESIGN  STATISTICAL 
TECHNIQUES  IN  LIQUID  CHROMATOGRAPHY. 
1.3.5.1.  Introduction  and  discussion 
The  use  of  three  solvents  in  the  mobile  phase  is  best 
avoided  where  poss ible.  This  is  due  to  the  increase  in 
complexity  in  optimising  the  mobile  phase  conditions  when  there  is 
an  addi tional  degree  of  freedom.  The  strength  of  a  solvent  in 
terms  of  its  position  in  an  elutropic  series  can  be  represented  by 
its  polarity  P'  (Snyder,  1974;  Snyder,  1978).  The  concept  of 
polarity  has  been  discussed  above  (1.3.4.).  In  summary  it  is  a 
single  term  used  to  represent  the  sum  of  the  contributions  to  net 
solvating  properties  of  a  solvent  by  the  major  molecular 
interactions.  These  are  proton  accept ing,  proton  donat ing  and 
dipolar  interactions. 
The  polarity  of  a  solvent  mixture  is  de~ermined  by  the  relative 
proportions  of  its  constituent  pure  solvents.  Thus,  using  three 
pure  solvents,  several  combinations  of  the  substituents  may  have 
-22-the  same  polarity.  Other  properties  of  the  solvent  howeve~, 
namely  contributions  from  proton  accepting  and  proton  donat.ing 
interactions  (Xe,  Xd  and  Xn  respectively),  may  differ. 
Finding  the  optimum  solvent  for  a  particular  separation  when  three 
solvents  are  used  is  considerably  more  complex  than  with  bina=y 
mixtures.  The  advantage  of  ternary  solvent  systems  is  in  the 
broad  range  of  variation  in  selectivity  they  offer  compared  to 
binary mixtures. 
Random  alteration  of  the  solvent  composition  may  provide  a 
sui table  solvent  system,  but  this  is  rather  hi t  and  miss,  and  a 
more  structured  approach  was  cons idered  es sent  i al  if  a  ternary 
system was  to  be  used. 
A  number  of  reports  have  appeared  over  the  last  six  years  on  the 
optimisation  of  ternary  solvent  mixtures,  based  on  statistical 
interpretation  of  a  small  number  of  trial solvents  (Sachok  et al., 
1980;  Glajch  et  al.,  1982;  Berridge,  1982;  De  Smet  et  al.,  1984; 
Weyland  et al.,  1985;  Colley,  1985). 
An  early  report  Glaj ch  et  al.,  1982,  outl  ined  an  approach  to  the 
problem.  A  recent  review  of  this  subject  has  noted  that  this 
early  approach  is  st  i 11  one  of  the  most  rel  i able  (D' Agos t i no  et 
al.,  1985).  In  its  simplest  fornt,  that  is  for  less  than  five 
analytes,  where  the  elution  order  does  not  change,  the  process  is 
described  below.  The  mathematical  basis  for  the  optimisation 
procedure  is  well  established  (Box  and  Wilson,  1951;  Snee, 
1979).  The  process  can  be  considered  in  three  stages. 
Fi rstly  the  three  start  i ng  sol  vent s  are  selected.  These  may  be 
pure  solvents  or  solvent  mixtures.  These  form  the  apices  of  the 
triangle  shown  in  figure  1.3 ..  A  series  of  trial  solvents  {e.g. 
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PLOT  OF  POLARITY  VALUES  FOR  TERNARY  SOLVENT  MIXTURES 
OF  METHANOL,  ACETONITRILE  AND  WATER,  IN  STEPS  OF  lO~. 
-24-7  and  10  have  been  used  (Glajch  et  al,  1982,  Snee,  1979),  8.r-e 
ex~ined experimentally. 
The  chromatograms  produced  are  assessed  in  terms  of  efficiency, 
analysis  time,  capacity  factor,  resolution  and  peak  shape.  In 
order  to  procede  further  with  the  optimisation,  all this  data  must 
be  reduced  to  a  single  number,  known  variously  as  the 
chromatographic  optimisation  factor  (COF) ,  alpha  value  (~), 
chromatographic  response  function  (CRF),  relative  resolution 
product  (RRP)  etc.,  depending  on  the  algorithm  used  to  assess  the 
chromatograms. 
1985. 
These  have  been  reviewed  by  D'Agostino  et  al., 
The  COF  chosen  is  usually  designed  to  have  a  minimum  or  maximum 
value  for  the  solvent  with  the  optimum  chromatographic 
properties.  The  COF  as  described  by  Glajch  et  aI,  1982, 
approaches  zero  from  the negative direction. 
Most  algorithms  can  be  weighted  in  favour  of  one  parameter,  (e.g. 
resolution  or  efficiency)  if  required.  There  is  no  generally 
agreed  algori  thm  for  thi  s  reduct ion,  and  by  the  nature  of  the 
reduction  process  a  lot  of  information  about  the  chromatogram  is 
lost. 
The  COF  calculated  for  each  of  the  trial  points  is  fitted  to  a 
quadratic  or  polynomial  curve  fitting  procedure  which  will  produce 
an  aquation  for  the  response  surface  of  the  solvent map. 
The  final  stage  is  to  solve  the  equation  for  the  desired  or 
opt  imum  value  of  the  COF  used.  This  can  be  done  by  calculating 
the  COF  for  a  number  of  points  on  the  solvent  map  and  plotting  the 
data  (Goldberg  and  Nowakowska,  1984).  Alternatively  it  can  be 
done  by  using  a  simplex  design  (Box  and  Wilson,  1951;  Deming  and 
-25-Morgan,  1973;  Berridge,  1982)  to  solve  the  equation  for  the 
des ired  CCF  value.  This  will  in  theory  give  the  solvent  map 
coordinates  of  the  optimum  solvent composition. 
This  process  requires  an  extensive  number  of  calculations  which 
are  readily  performed  on  a  computer.  A  number  of  commerc i ally 
produced  optimistation  procedures  have  been  produced,  many  wi th 
interactive  HPLC  and  solvent  switching  systems  to  perform  the 
whole  procedure  automatically  (TAMED,  CHEOPS,  PESOS,  ISOOPT,  etc.). 
In  summary,  the  success  of  the  procedure  depends  on  the  selection 
of  the  correct  starting  solvents,  and  the  use  of  an  appropriate 
COF.  Additional  complications  can  arise  from  the  incorrect 
identification  of  peaks  if  the  elution  order  changes  between 
solvents. 
This  procedure  has  also  been  applied  to  the  optimisation  of  other 
mobile  phase  conditions  such  as  electrolyte  concentration, 
ion-pair  concentration  and  pH  (Sachok  et  al.,  1981;  Goldberg  and 
Nowakowska,  1985). 
1.3.5.2.  Conclusion 
The  establ  i shment  of  such  a  system  was  cons idered  to  be 
beyond  the  scope  of  this  study.  However  the  advantages  of 
ternary  solvent  systems  were  still  considered  worthy  of  some 
investigation,  to  determine  if  any  significant  improvement  in  the 
chromatography  could  be  achieved  wi thout  recourse  to  changes  in 
hardware  or  the  use  of  computers. 
-26-1.4.  ASSESSMENT  OF  CHROMATOGRAPHIC  PERFORMANCE 
1.4.1.  Introduction 
The  assessment  of  the  performance  of  HPLC  separations  in 
this  thesis  has  been  made  by  calculating  the  following  para~eters 
and  considering  them  in  the  context  of  each  other.  The  relevent 
parameters  are  shown  in  figure  1.4 .. 
1.4.2.  Capacity factor 
The  capacity  factor,  K',  assesses  the  ability  of  a  column 
with  a  particular  solvent  system  to  retain  the  solute  of  interest, 
with  respect  to  the eluent.  See  figure  1.4 .. 
This  is defined  as 
K'  =  Tr-Tro 
Tro 
(1) 
Wi th  typical  flow  rates  of  l-3ml/min  and  a  dead  volume  of  about 
2ml,  Tro  is  typically  0.6  to  2  minutes.  With  analysis  times  of 
20  minutes  or less,  acceptable  K'  values  are  in  the  range  0-10. 
1.4.3.  Separation 
Where  two  or  more  solutes  are  present  it  is  useful  to  be 
able  to  assess  the  degree  of  separation  between  them.  Thi scan 
be  expressed  by  taking  the  ratio  of  the  relevant  capacity 
factors.  This  is  defined  as  the  selectivity,  a. 
a=  ['2 
['  1 
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o Thus  in  order  for  two  components  to  be  separated,  a  must  be 
greater than  1. 
1.4.4.  Efficiency 
The  efficiency  of  a  separation  relates  to  the  volume  in 
which  a  given  solute  will  elute  with  respect  to  its  retention 
volume.  This  can  be  expressed quantitatively by  the  term 
(3) 
where  N  is  the  efficiency  in  number  of  theoretical  plates.  As 
the  retention  time  increases,  so  also  does  the  longitudinal 
diffus ion  of  the  solute  through  the  column,  and  hence  the  band 
width  increases  also.  As  a  consequence  of  this,  fdr  one 
particular  compound,  minor  changes  in  elutropic  strength  of  the 
solvent  do  not  produce  major  changes  in  the  effic  iency  of  the 
chromatography.  In  order  to  produce  significant  changes  in  the 
efficiency  it  may  be  neccessary  to  change  the  selectivity  of  the 
separation,  say  by  using  a  different  solvent  or  a  solvent 
additive.  It  may  also  be  neccessary  to  change  the  stationary 
phase  or  the  mode  of  chromatography  eg  to  an  ion  paired  separation. 
1.4.5.  Resolution 
The  go~l  of  the  chromatographer  is  to  produce  a  system 
which  will  give  adequate  separation  (a)  of  two  or  more  components 
with  a  reasonable  retention  time  (K')  and  good  peak  shape  (N). 
It  is  useful  to  be  able  to  express  the  quality  of  the  separati')n 
-29-in  one  expression  and  the  term  of  choice  is  the  resolution.  The 
resolution  between  two  adjacent  bands  is  defined  as  the  distance 
between  the  band  centres  divided  by  the  average  band  width 
Rs  =  (T2-Tl) 
which  by  sUbstitution  in  eq  1.  and  3,  gives  rise to 
R = (1/4)  x  (a-I)  x  (~) x  (K'/1+K')  s 
(4) 
(5) 
This  shows  the  empirical  dependence  of  good  chromatography  on  a 
separation  (a)  greater  than  unity,  a  high  efficiency  (N)  and  an 
acceptable  value  of  capac  i ty  factor  (K').  control  of  resolution 
can  be  effected  by  altering  any  of  these  terms. 
1.4.6.  Peak  assymetry 
The  peak  shape  is  determined  by  the  adsorption  isotherm  of 
the  analyte  on  the  column  (Snyder  and  Kirkland,  1978).  If  the 
solubility of  the  analyte  is  substantially different  in  one  of  the 
phases,  then  the  peak  may  be  skew.  wi th  ei  ther  a  long  lead  i ng  or 
trailing  edge.  If  mixed  principles  of  separation  are  involved, 
e. g.,  the  adsorpt ion  of  the  analyte  on  free  s i lanol  sites  of  the 
packing  material,  then  the  peak  will  tail.  A  measure  of  the 
degree  of  tailing  is  to  drop  a  perpendicular  line  from  the  peak  to 
the  base  line  and  measure  the  leading  (Le)  and  trailing  (Te)  edges. 
The  assymetry  factor  A  is  defined  as  the  ratio of  T  IL  . 
9  e  e 
As  should  always  be  considered  in  terms  of  the  peak  width,  since 
a  narrow,  skew  peak  is  usually  prefered  over  a  broad  symmetrical 
peak. 
-30-1.5.  EXTRACTION  OF  DRUGS  FROM  BIOLOGICAL  F~UIDS 
1.5.1.  Introduction 
The  principle  of  selective  extraction  of  compounds  from 
complex  matrices  is well  established. 
The  process  is  based  on  the  partitioning  of  the  analyte  between 
two  immi sc ible  solvents  by  selection  of  appropriate  solvents  and 
conditions  of  pH.  This  is  normally  done  by  shaking  the  two 
phases  together  to  allow  exchange  of  the  analyte  between  phases, 
but  the  practice  of  using  a  solid  phase  in  place  of  one  of  the 
liquid phases  is  also  known  (Harkey  and  Stolowitz,  1984). 
The  selection  of  the  appropriate  conditions  for  the  extraction  is 
specific  to  the  compound  of  interest  (or  compounds  of  ~imilar 
chemical  properties)  and  is  discussed  in  detail  for  each  analyte 
examined  (2.3.  and  3.1.7.). 
Two  methods  of  solid  phase  extraction  (Absorption  and  Adsorption) 
are  also  considered.  These  are  introduced  in  some  detail  at  the 
appropriate  point  in  the  text  (2.3.4.  and  3.1.7.3.). 
1.5.2.  THE  USE  OF  INTERNAL  STANDARDS 
1.5.2.1.  Introduction 
In  an  assay  involving  the  extraction  of  a  particular 
compound  from  some  matrix,  the  accuracy  and  precision  of  the 
method  must  be  considered  before  the  method  can  be  used  to  measure 
the  compound  of  interest  in  samples  containing  unknown  amounts. 
-31-1.5.2.2.  Discussion 
Accuracy  is  the  proximity  of  the  measured  value  to  the  true 
value,  and  precision  is  the  ability  of  the  method  to  produce  the 
same  answer  on  repeated  examinations  of  the  same  sample. 
In  the  assays  developed  in  th is  study,  the  absolute  recovery  of 
the  drug  from  the  sample  is  calculated  by  comparison  of  the  peale 
height  produced  by  a  known  amount  of  drug  (an  unextracted 
standard)  with  the  peak  height  produced  by  a  known  aliquot  of  the 
sample  extract. 
Accuracy  therefore  depends  on  the  sample  and  the  prepared  standard 
behaving  in  the  same  way  during  the  extraction. 
Precision  depends  on  several  extracts  from  the  same  sample  giving 
the  same  answer.  There  is  apparently  a  1 ink  therefore  between 
precision  and  accuracy. 
In  most  cases  the  analysis  was  repeated  four  or  five  times,  and  a 
measurement  of  the  prec  i s ion  was  made.  This  is  given  in  table 
and  text  as  the  standard  deviation  (SO)  and  also  as  the 
coefficient  of  variation  (CoV),  which  is  the  standard  deviation 
expressed  as  a  percentage  of the  absolute  recovery. 
The  accuracy  of  the  extraction  procedure  is  dependent  on  the 
precision,  as  the  level  in  the  sample  is  calculated  from  a 
comparison  of  peak  heights  of  the  standard  with  the  peak  height 
from  the  sample  and  calculated  by  simple  proportion. 
The  assumption  made  is  that  the  sample  and  the  standard  will 
behave  similar.ly  and  the  compound  of  interest will  extract  equally 
well  from  the  sample  and  the  standard. 
Even  when  the  greatest  care  is  taken  with  the  extraction 
procedure,  fundamental  differences  of  the  sample  material  and 
-32-standard  may  make  this  assumption  invalid.  Even  if  both  samples 
are  treated  identically  throughout  the  extraction,  factors  which 
may  effect  the  extraction  efficiency  include  the  nature  of  the 
sample  and  standard  (both  should  be  the  same  med i a  eg  blood  or 
water  or  urine),  the  age  of  the  sample  and  standard,  the 
temperature  at  which  the  sample  or  standard  is  stored  prior  to 
analysis  and  the  initial pH  of the  sample  or  standard. 
It  is  accepted  practice  that  the  inclusion  of  a  known  amount  of  a 
similar  compound  in  the  sample  and  standard  can  be  used  to 
eliminate many  of  these  problems. 
The  properties  requiced  of  an  internal  standard  are  that  it  should 
resemble  the  analyte  as  closely  as  possible  in  all  its  properties, 
and  that  it  should  be  possible  to  measure  it  simultaneously  with 
the  analyte.  Most  importantly  it should  be  extracted  by  the  same 
extraction  procedure.  If  a  su i table  internal  standard  is 
available  and  is  included  in  both  the  sample  and  standard  prior  to 
the  extraction,  any  differences  in  the  treatment  of  the  two 
samples  can  be  accounted  for.  Thus,  whilst  in  replicate 
analys is,  the  extract  ion  effie  iency  between  samples  might  vary, 
the  ratio  of  the  analyte  to  internal  standard  between  assays 
should  be  constant.  Knowing  that  the  amount  of  internal  standard 
added  in  the  first  place  was  the  same,  the  ratio  of  internal 
standard  in  the  sample  to  the  internal  standard  in  the  standard 
will  give  a  measure  of  the  difference  in  extraction  efficiency 
between  the  two  materials.  This  ratio  can  then  be  used  to 
correct  for  differences  in  the  relative  amounts  of  analyte  in  the 
sample  and  standard. 
-33-1.5.2.3.  Conclusion 
The  use  of  an  internal  standard  whilst  not  altering  the 
precision  of  the  extraction  efficiency  should  improve  the 
percieved  precision  (ie  lower  the  CoY)  in  the  ratio  of  drug  to 
internal  standard  compared  to  the  Cov  found  in  the  absolute 
extraction  efficiency.  As  was  shown  above,  an  improvement  in 
precision  will  lead  to  an  improvement  in  accuracy,  therefore  both 
precision  and  accuracy  can  benefit  from  the  use  of  a  suitable 
internal standards. 
1.1.6.  CONCLUSIONS  ON  CHAPTER  ONE 
The  above  review  and  discussion  of  the  current  practice  of 
HPLC  has  shown  that  numerous  applications  exist  in  the  field  of 
the  forensic  sciences.  There  are  a  number  of  areas  in  which  HPLC 
is  the  technique  of  choice,  depending  mostly  on  the  nature  of  the 
analyte. 
The  principles  of  solvent  theory  have  been  outlined  to  illuslrate 
the  use  of  solvent  mixtures  for  the  selective  elution  of  compounds 
from  a  chromatographic  column. 
The  principle  of  the  relatively  new  technique  of  electrochemical 
detection  and  associated  voltammetric  techniques  have  been 
introduced  together with  some  aspects  of  the  theory  involved. 
The  use  of  spec i al  i sed  chromatograph  i c  techn iques  such  as 
ion-pairing  and  automated  or  systematic  methcd  development  have 
also  been  introduced,  as  have  the  parameters  used  in  this  work  for 
the  assessment  of  chromatographic  performance. 
-34-these  factors  are  all  involved  in  the  development  of  HPLC  assays 
for  two  groups  of  compounds  of  forensic  interest  (morphine  and  the 
local anaesthetics),  discussed  in the  following  two  chapters. 
-35-CHAPTER  TWO 
MORPHINE 
2.1.  LITERATURE 
2.1.1.  Introduction 
Opium  (Gr.  'juice'),  the  dried,  compressed  resin  from  the 
seed  case  of  the  poppy  Papaver  Somniferum  (Papaveracaea)  has  been 
recognised  as  a  painkiller  for  over  4000  years.  Its  narcotic  and 
analgesic  properties  were  known  in  early  Egypt,  and  the  practice 
of  smoking  or  eating  opium  for  its  euphoric  effect  has  since 
became  widespread  (Trebach  1982). 
In  1803,  a  German  chemist,  F.W.  Sertilrner  isolated  from  opium  some 
bitter  colourless  crystals,  "a  soporific  and  narcotic  principle  of 
opium"  (Ooenicke,  1983).  Although  the  structure  of  the  material 
was  not  elucidated  until  1925  (Gulland  and  Robinson  1925),  this 
isolation  of  morphine  was  followed  by  attempts  to  manufacture 
derivatives  and  to  test  them  for  thei~  analgesic  properties 
(Sneader,  1985).  The  ultimate  aim  was  to  produce  a  powerful 
narcotic  drug  which  did  not  produce  tolerance  or  dependence  in  the 
user. 
Many  of  these  derivatives  and  structural  analogues  have 
subsequently  been  found  to  be  more  potent  than  the  parent  compound 
and  a  range  of  synthetic  and  semi-synthetic  opiates  are  now 
ava  i lable  (Hart  i ndale,  1984).  The  other  objective  of  producing  a 
narcotic  free  from  addictive  properties  bas  Dot  yet  been  acbieved 
The  synthe sis  in  1874  of  d i acetyl  morph i ne  (hero in)  produced  a 
-36-substance  which  was  discovered  to  have  the  same  effect  as  morphine 
but  with  an  enhanced  (x3-4)  dose-response  relationship,  with  less 
of  the  disagreeable  side  effects  of  morphine  (esp.  nausea, 
vomiting). 
1982) . 
This  made  it  more  popular  with  addicts  (Trebach, 
Both  morphine  and  heroin  are  addictive  substances  and  use:-s  are 
prone  to  psycholog ical  and  physiological  dependence.  Tolerance 
develops  rapidly with  regular  use,  and  can  be  extensive. 
Detoxification  or  withdrawal  from  opiates  can  be  a  distressing  and 
uncomfortable  process  lasting  2-3  days  (De  Ropp,  1958).  Abrupt 
withdrawal  however  is  seldom  used  in  modern  treatment  of  addicts, 
as  methadone  therapy  is  used  to  alleviate  the  unpleasant  symptoms 
(Goodman  and  Gilman,  1980). 
In  the  United  Kingdom,  morphine  is  the  opiate  favoured  by  most 
clinicians  for  severe  pain.  It  is  often  used  in  conjunction  with 
cocaine,  or  alternatively  as  Brompton  Mixture,  a  mixture  of  heroin 
and  cocaine,  in  the  treatment of  chronic  severe  pain. 
Heroin  and  morphine  are  also  used  for  perioperati  ve  and 
postoperative  pain,  and  as  sedatives  (Martindale,  1984). 
however,  is  not  available clinically in  the  United  states. 
Heroin, 
Opiates  are  not  naturally  present  in  the  body  but  h~ve  structural 
similarities  to  a  group  of  endogeneous  peptides  called  endorphins 
and  enkephalins,  discovered  in  1978,  which  play  an  important  role 
in  the  body's  own  control  of  pain  relief  (Blum,  1984).  It  is 
believed  that  morphine  and  its  analogs  act  at  the  receptors  for 
these  compounds  in  the  central  nervous  system. 
The  structures  of  morphine  and  heroin,  its  diacetyl  derivati·.;e, 
are  shown  in  figure  2.1 .. 
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STRUCTURES  OF  MORPHINE  AND  DIAMORPHINE 
-38-2.1.2.  The  increase  in opiate  abuse 
Drug  abuse  as  a  significant  social  problem  has  only 
existed  in  Britain  since  the  early 1960's,  and  drug  use  in Britain 
until  then  was  exceptional  only  for  its  tri  vi al  extent  (Edwards 
and  Busch,  1981). 
The  indicator  used  as  a  measure  of  the  extent  of  the  problem  is 
the  number  of  addicts  known  to  the  Home  Office.  What  percentage 
of  the  actual  number  of  addicts  this  figure  represents  is  widely 
disputed  and  estimates  range  from  96~  to  20~  (Edwards  and  Bus.:h, 
1981),  although  the  current  estimate  accepted  by  the  Home  Office 
is  25~ (Picardie  and  Wade,  1985). 
The  number  of  a.ddicts  known  to  the  Home  Office  over  the  period 
1958  to  1984  is  given  in  table  2.1.,  and  shown  in  figure  2.2. 
(Spear,  1969;  Edwards  and  Busch,  1981;  Home  Office  Statistical 
Bulletin,  1984) 
The  increasing  black  market  availability  of  heroin  reflected  in 
the  number  of  siezures  of  illicit  opiates  (Reports  of  the  Chief 
Constable,  Strathclyde  Region,  1976-84)  and  the  depressed  economic 
climate  are  the  two  factors  generally  held  to  be  responsible  for 
the  current  increasing  trend  in  heroin  abuse.  (C.U.R.R.,  1982; 
Picardie  and  Wade,  1985). 
As  a  result,  there  has  also  been  an  increase  over  the  last  five 
years  in  the  demand  for  analyses  for  morphine  both  in  post-mortem 
casework  and  in  clinical  accident/emergency  admissions. 
-39-TABLE  2.1. 
NARCOTIC  ADDICTS  NOTIFIED  TO  THE 
HOME  OFFICE  BETWEEN  1934  AND  1984. 
Year  Known  addicts 
(UK) 
1934t  300 
1958*  442 
1959  454 
1960  437 
1961  470 
1962  532 
1963  635 
1964  753 
1965  927 
1966  1349 
1967  1729 
1968  2782 
1969  2881 
1970  2657 
1971  2762 
1972  2936 
1973  3023 
1974*  3252 
1975  3425 
1976  3474 
1977  3605 
1978  4116 
1979  4787 
1980  5107 
1981  6157 
1982  7962 
1983  10235 
1984  12489 
t  Spear,  1985 
*  Home  Office statistical Bulletin,  1984  *  Edwards  and  Busch,  1981 
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84 2.1.3.  Ketabolism  and  Toxicity 
Morphine  and  heroin  (also  called  diacetyl  morphine, 
diamorphine)  are  narcotic  analgesic  drugs.  Heroin  itself appears 
to  be  inactive  but  is  immediately  metabolised  in  the  blood  to 
monoacetylmorphine  and  then  to morphine. 
Morphine  acts  as  an  agonist  with  stereospecific  and  saturable 
binding  sites  or  raceptors  in  the  brain  and  other  tissues  (Goodman 
and  Gilman,  1980).  These  sites  are  widely  but  unevenly 
distributed  throughout  the  central  nervous  system.  It  is 
believed  that  morphine,  its  analogs  and  antagonists  occupy  the 
sites  normally  occupi  ed  by  B - endorph i ne  and  the  enkephal  i ns . 
These  are  endogeneous  peptides  which  act  as  neurotransmi tters  or' 
modulators  of  neurotransmission. 
structurally  simi lar  to  morphine. 
They  can  be  shown  to  be 
They  act  by  interfering  with 
the  production  of  cyclic  AMP,  which  in  turn  appears  to  alter  some 
mechanism  fundamental  to neuronal  function  (Blum,  1984). 
In  man  morphine  produces  analgesia,  drowsiness,  changes  in  moed 
and  mental  clouding  without  loss  of  consciousness.  In  seme 
cases,  under  the  correct  condi tions,  users  also  expel." ience 
euphoria  similar  to  sexual  orgasm,  which  is  the  initial attraction 
of  the  drug,  and  the  motivation  behind  psychological  dependence 
(Goodman  and  Gilman,  1980;  Laurie,  1980). 
Other  effects  are  dilation  of  the  pupils  and  dilation  of  the 
surface  capilliaries  causing  flushes.  Side  effects  to 
therapeutic  dosing  include  constipation  through  peristaltic 
depression,  vomiting  and  mild  respiratory  depression  (Goodman  end 
Gilman,  1978;  Martindale,  1984). 
Morphine  levels  in  the  body  fluids  can  be  used  to  indicate  whether 
-42-the  drug  is  present  in  therapeutic  or  harmful  quantities.  Peak 
levels  of  morphine  of  1ug/ml  in  plasma  have  been  reported 
following  bolus  doses  prior  to  surgery  (Vandenberghe  et  aI, 
1983).  The  therapeutic  range  reported  by  Stead  and  Moffat  (1983) 
was  0.04  to  0.5  ug/ml,  whilst  the  therapeutic  range  reported  in 
Moffat  (1986)  is  0.01  to  0.07  ug/ml.  This  wide  range  (0.01  to 
1ug/ml  overall)  is  due  to  the  fact  that  the  body  can  develop 
tolerance  to  morphine  requiring  increased  doses  for  the  same 
effect.  The  estimated  minimum  lethal  dose  in  man  is  20Omg,  but 
addicts  can  tolerate  up  to  ten  times  this  amount.  This  makes  the 
interpretation of  blood  concentrations  of morphine  difficult. 
Patients  recieving  intensive  care  hospital  treatment  can  tolerate 
prolonged  high  doses  by  bolus  and  infusion  if  respiration  is 
applied. 
Toxic  effects  follow  from  therapeutic  effects.  An  increase  in 
respiratory  depression  can  lead  to  coma  and  so  to  death.  An 
increase  in  smooth  muscle  relaxation  can  then  lead  to  muscle  spasm 
and  convulsions. 
Secondary  effects  from  the  drug  include  pneumonia  through  the 
anti-tussive  effects  of  morphine  coupled  with  the  dangers  of 
inhalation  of  gastric  contents.  other  drug  associated  illness  is 
considered  in  2.10.1.1 ..  The  blood  concentrations  which  cause 
toxicity  vary  due  to  tolerance  as  discussed  above.  Toxic 
reactions  have  been  reported  at  blood  levels  of  0.5  to  Sug/ml 
(Stead  and  Moffat,  1983)  and  fatalities  have  occured  at  0.2ug/ml 
(Felby  et al .•  1974). 
Although  the  site  of  action  of  morphine  is  primarily  in  the  eNS, 
only  a  small  amount  actually  crosses  the  blood  brain  barrier. Free  morphine  accumulates  in  the  kidney,  lung,  liver  and  spleen. 
Recent  evidence  suggests  that  it may  persist  in  these  tlssues  for 
up  to  21  days  post withdrawal  (Jones  et aI,  1984). 
Morphine  is  eliminated  from  the  blood  fairly  rapidly.  It  has  a 
half-life  of  2-3  hours  (Goodman  and  Gilma~,  1978).  Absorption  of 
the  drug  will  depend  on  the  route  of  administration.  In  te~s of 
the  onset  and  duration  of  respiratory  depression,  intravenous 
administration  produces  maximum  effect  within  seven  minutes. 
Death  following  intravenous  administration  can  be  rapid,  and  is 
most  conwonly  due  to  pulmonary  eedema  (Polson  et al.,  1983).  The 
reason  for  this  is  not  known. 
The  delay  to  peak  effects  is  30  minutes  following  intramuscular 
injection,  and  up  to  90  following  subcutaneous  administration. 
Adsorption  through  the  mucous  membranes  occurs  rapidly whilst oral 
dosing  can  take  one  to  two  hours  for maximum  effect. 
The  effect  of  a  given  oral  dose  is  less  than  from  an  equivalent 
dose  administered  parentorally,  as  there  is  a  significant amount  of 
first pass  metabolism  in  the  liver. 
The  major  metabolic  pathway  is  well  known  (Boerner  et  al., 
1975) .  Very  little  unchanged  drug  (less  than  1~)  is  excreted  in 
the  urine.  Morphine,  administered  either  as  morphine  or  heroin, 
is  metabolised  to  small  quantities  of  morphine-3-etherea1 
sulphate,  codeine,  norcodeine,  and  normorphine.  Morphine  and  the 
last  three  metabol i tes  mentioned  are  conjugated  through  the  3-0H 
and  6-0H  positions  and  excreted  in  the  urine. 
in  figure  2.3.  (Boerner  et al.,  1975). 
This  is  summarised 
There  is  currently  a  controversy  over- the  role  of  the  kidney  in 
the  e1 ini nat  ion  of  morph i ne.  Recent  studies  in  patients  with 
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MAJOR  PATHWAYS  FOR  THE  METABOLISM 
AND  EXCRETION  OF  MORPHINE 
-45-impaired  renal  function  (McQuay  and  Moore,  1984;  Hoore  et  al .• 
1983)  concluded  that  the  renal  clearance  of  the  drug  is  the 
dominant  route  of  elimination  at  low  concentratio!ls,  and  hepatic 
clearance of more  importance  at higher  blood  concentrations. 
The  immunoassay  methods  used  in  this  study  however  are  c~iticised 
because  of  possible  interference  from  metabolites.  The 
6-glucuronide  which  has  a  reported  cross  reactivity of  1~ with  the 
best  antibody  available  (Moore  et  al.,  1984  (i»  is  often  present 
at  levels  25  times  that  of  morphine  (Svensson  et al.,  1982).  The 
ability  of  the  kidney  tubules  to  transport  morphine  actively  was 
shown  as  early  as  1969  (Watrous  et  al.,  1969).  and  the  gut  wall 
has  been  shown  to  metabolise  morphine  also  (Hanks  and  Aherne, 
1985) . 
2.2.  ANALYTICAL  METHODS 
2.2.1.  Introduction 
In  order  to  mee t  the  demand  for  analys is  of  morph i ne  in 
biological  fluids,  the  various  analytical  methods  currently 
avai lable  were  reviewed.  The  tissue  of  choice  for  analysis  is 
plasma.  In  this  material,  morphine  is  present  in  the 
unconjugated  form,  and  there  is  little  else  in  the  matrix  itself 
likely  to  interfere  wi th  the  isolation  of  the  drug.  although  30T. 
binding  to  ~lasma  proteins  is  reported.  Plasma  is  s~ldom 
available  in  post-mortem  cases  however,  and  the  tissue  most 
commonly  supplied  is  haemolysed,  often  putrified,  blood.  A 
recent  review  of  literature  (Stead  and  Moffat.  1983)  suggests  that 
-46-the  range  of  concentrations  likely  to  be  encountered  are  greater 
than  O.Olug/ml.  The  highest  level  of  morphine  reported  in  the 
blood  of  an  overdose  victim,  is  6ug/ml  following  accidental 
ingestion  whilst  attempting  to  smuggle  heroin  in  balloons  in  the 
stomach  (Connett,  1984).  A  sui table  method  should  therefore  be 
capable  of  detecting  morphine  concentrations  within  this  range. 
Typical  blood  sample  volume  is  1ml,  so  the  method  should  have  an 
absolute  sensitivity of greater  than  lOng. 
2.2.2.  Microchemical  methods 
Quali tati  ve  determination  of  morphine  in  biological 
extracts  by  colour  reactions  and  thin  layer  and  paper 
chromatography  have  been  reviewed  (Mule,  1974(i».  Several 
thin  layer  chromatography  systems  sui table  for  opiates  are  also 
included  in  Moffat,  1986.  Additionally,  Rf  data  for  morphine  is 
included  in  most  TLC  data  collections  (Rentoul  and  Smith,  1973; 
Sunshine"  1974).  The  sensitivities  of  the  methods  are  around 
lug  on  the  TLC  plate,  which  impl ies  that  a  large  sample  volume 
would  be  required  for  sensitive  detection  limits.  Photometric 
methods  involving  a  simple  extraction  of  the  tissue  and  subsequent 
UV  absorbance  measurements  (Mule,  1964;  Goldbaum  and  Williams, 
1.,1964)  were  non-specific.  These  methods  were  also  susceptible 
to  interference  from  natural  decomposition  products  and 
insufficiently  sensitive  for  typically  sized  tissue  samples.  In 
summary,  these· methods  were  found  to  unsuitable  for  reliable  or 
quantitative  analysis  of  small  amounts  of  morphine  in  biological 
extracts. 
-47-2.2.3.  Fluorimetry 
Fluorimetric  methods  based  on  the  oxidative  dimerisation 
of  morphine  to  pseudomorphine  (Kupferberg  et  al.,  1964;  Fry  et 
al.,  1974)  have  been  described.  Extracts  from  tissue  samples 
were  treated  with  potassium  ferricyanide.  Any  phenols  present 
may  form  homogeneous  of  heterogeneous  dimers  by  a  phenolic 
oxidative  coupling  reaction  (Ternay,  1978)  (see  figure  2.8.). 
Pseudomorphine  is  formed  by  this  reaction  and  is  fluorescent  with 
a  strong,  fairly  specific  emission  at  440nm.  The  procedure  has 
the  advantage  of  being  specific  for  opiates  with  a  free  3-0H,  and 
more  selectivity  could  be  achieved  by  first  purifying  the  extract 
by  TLC.  It  is  however  cumbersome  and  the  potential  yield  of  the 
reaction  depends  to  a  large  extent  on 
co-extractives.  Any  other  phenolic  material  in  the  extract 
however  will  lead  to  mixed  dimer  formation  and  may  give  rise  to 
false  negatives. 
2.2.4.  Immunoassay 
Immunoassay  techniques  were  developed  in  the  1960's  to 
measure  insulin  in  human  plasma.  Their  potential  was  quickly 
realised  and  a  radioimmunoassay  (RIA)  for  morphine  was  produced  in 
1971  (Spector  1971). 
1974(i)  and  (ii» 
The  theory  is  well  reviewed  (Mule  et  aI, 
where  several  immunoassay  techniques  for 
morphine  (Radioimmunoassay,  Free  Radical  Assay  Technique,  Enzyme 
Multiplied  Immunoassay  Technique  and  Haemagglutination-Inhibition) 
are  assessed.  The  quality  of  the  assay  and  its  specificity 
depend  on  the  antibodies  available,  but  in  most  cases  RIA  is  the 
method  of  choice.  Although  RIA  is  claimed  to  be  more  sensitive 
-48-than  any  other  technique  (100  femtomole/assay  tube,  Moore  et  al .• 
1984),  it  has  the  disadvantage  of  having  limited  rather  than 
absolute  specificity.  The  antibody  of  choice  in  the  above  study 
(Hoore  et  al.,  1984)  has  10~  cross  reactivity  with  diacetyl 
morphine  and  presumably  wi th  monoacetyl  morphine  and  some  cross 
reactivity with  the  6- and  3-glucuronides  (Hanks  and  Aherne  1985). 
2.2.5.  Gas  Chromatography 
The  advent  of  gas  chromatography  by  James  and  Martin, 
circa  1952,  and  its  subsequent  popularity  in  the  1960's  led 
qu i ckly  to  a  method  of  analys i s  for  morph i ne  (Lloyd  et 
ale ,1960) .  This  involved  a  packed  column  with  poor  efficiency. 
Interference  was  common  and  unavoidable.  Subsequent  improvements 
in  gas  chromatography  and  the  introduction  of  capi llary  columns 
has  led  to  better  resolution  and  improved  sens i ti  vi ty  for  most 
compounds  including  morphine  (Schepers  et  al.,  1982).  A  review 
of  the  development  of  GC  wi th  regard  to  the  analys is  of  morph i ne 
is  given  in Wallace  et al.,  1974. 
Morphine  is  a  polar  compound  by  virtue  of  its  two  hydroxyl 
functions  (figure  2.1.).  These  require  derivatisation  in  order 
to  allow  efficient  chromatography  without  tailing  on  the  type  of 
polar  column  routinely  in  use  (Schepers  et al.,  1982). 
Evidence  has  also  been  published  for  the  transacetylation  of 
morphine  in  the  presence  of  diacetyl  morphine  in  the  injector  zone 
(Brochmann-Hanssen  and  Swendsen,  1962).  Several  ways  of 
preparing  derivatives  have  been  described  in  the  literature. 
including esterification using  the  appropriate  acid  anhydride. 
Trifluoroacetyl  morphine  has  been  produced  in  this  way  and  is 
-49-suitable  for  electron  capture  detection  (Mule,  1974  (i». 
Peralkylation  (Corey,  1965)  and  carbamate  formation  (Hartvig  and 
Vessman,  1974)  have  also  been  described. 
The  most  popular  method  of derivatisation  for  tertiary alcohols  is 
the  formation  of  the  corresponding  silyl ether  (Wilkinson  and  Way, 
1969;  Thenot  &  Horning,  1972;  Clarke  &  Foltz,  1974)  using,  for 
example,  hexamethyldisilazane  in  the  presence  of  a  catalyst,  eg 
pyridine.  The  method  of  detection  can  vary  depending  on  the 
derivative.  Halogenated  derivatives  may  be  suitable  for  electron 
capture  detection.  Flame  ionisation  detection  and 
nitrogen/phosphorus  detection  are  suitable  for  all  derivatives  but 
may  be  too  insensitive  for  the measurement  of  nanogram quantities. 
The  mass  spectrometer  couples  readily  to  a  gas  chromatograph  and 
GCHS  is  the  method  of  choice  when  absolute  identification  is 
required  (Mcnair  and  Bonelli,  1969).  Selecti.ve  ion  monitoring 
can  be  used  to  increase  sensitivity  (Jones  et al.,  1984;  McFadden, 
1973).  The  limited  availability  of  these  instruments  due  to 
their high  cost makes  GCMS  procedures  of  less  general  interest. 
Furthermore,  derivatisation  procedures  must  be  carefully  selected, 
can  be  time  consuming,  and  can  involve  the  use  of  toxic 
reagents.  The  derivatisation  step  can  also  lead  to  sample  loss 
and  poor  reproducibility. 
2.2.6.  High  Pressure  Liquid  Chromatography 
The  wi~e  range  of  columns,  solvent  systems  and  detectors 
available  in  modern  liquid  chromatography  makes  it  a  suitable 
technique  for  the  analysis  of  most  compounds,  particularly  those 
which  are  highly  polar,  non  volatile  or  unstable  at  high 
-50-temperatures.  An  adsorption  extraction  method  for  morphine  from 
biological  fluids  was  published  in  1910  (F~jimoto  et  aI,  1970) 
using  XAD-2  resin  and  eluting  with  organic  solvents.  The  first 
High  Pressure  Liquid  Chromatographic  (HPLC)  method  for  the 
separation  of  morphine  "from  diacetyl  morphine,  and  6-moncacetyl 
morphine  (Cashman  and  Thornton,  1912)  used  an  alumina  column  with 
an  ultra  violet  (UV)  spectrophotometry  detection  system  (254run), 
and  would  separate  the  three  compounds  from  each  oth~r  but  wi th 
poor  efficiency  and  not  without  interference  from  cormnon 
adulterants  like  procaine.  An  HPLC  method  for  the  determination 
of  opiates  in  opium  (Wittner,  1913)  used  an  ion-exchange  column, 
again  with  UV  detection  (254nm).  The  chromatography  was  much 
improved  on  previous  reports,  but  gradient elution was  required. 
A  report  in  1915  (Trin1er  and  Reuland,  1915)  reviewed  methods  for 
the  measurement  of  opiates  by  HPLC.  It  also  described  the  first 
separation  on  reversed  phase  material  (CIS  corasil)  with  an 
isocratic  solvent  system,  of  morphine  in  street  drug  samples. 
Again  UV  detection  (254nm)  was  used. 
The  first  sens i ti  ve  method  for  the  determination  of  morphine  in 
blood  appeared  in  1915  and  used  a  porous  silica  column  (Jane  and 
Taylor  1975).  Morphine  was  derivatised  to  the  fluorescent  dimer 
pseudomorphine  which  was  then  chromatographed  and  monitored  by 
fluorescence  detection  at  400nm.  Compounds  whose  fluorescent 
oxidation  products  may  have  given  false  positives  are 
distinguished  from  morphine  by  their  relative  retention  times. 
The  inclusion  of  an  internal  standard  improves  the  quality of  this 
assay.  The  overall  sensitivity  is  however  dependent  on  the 
condi t ion  of  the  sample  and  the  presence  of  co-extractants.  A 
-51-mixed  d imer  of  the  internal  standard  and  morph ine  wi 11  also  lead 
to  a  decrease  in  sensitivity. 
The  prototype  electrochemical  detector  (Kissinger  et  al.,  1973) 
was  noted  to  be  most  suited  to  the  analaysis  of  phenols,  thiols 
and  primary  amines.  The  first  application  of  electrochemical 
detection  (ED)  to  morphine  analysis  was  reported  by  White  (1979) 
using  a  silica  column  system  and  a  purpose  built  detector  and 
cell.  Morphine  from  blood  extracts  was  oxidised  at  a  potential 
of  0.6  volts  as  it left  the  column.  The  absolute  sens i t i vi ty  of 
the method  was  reported  as  less  than  1ng. 
The  reaction  taking  place  is  assumed  to  be  the  electrochemical 
oxidation  of  morphine  to  pseudomorphine,  and  is  shown  in  figure 
2.8.  (Proksa  &  Molnar  1978).  This  is  the  same  reaction 
accomplished  by  the  use  of  potassium  ferricyanide  in  fluorescence 
methods  described  above  (2.2.3.). 
This  demonstrated  the  potential  use  of  electrochemical  detection 
in  the  sensitive  determination  of  morphine  in  biological  slimples 
without  derivatisation.  It  was  of  simple  design  and  relatively 
low cost  (the detector cost  £100  to  build). 
A  study  in  1982  of  morphine  concentrations  in  the  blood  and 
cerebrospi nal  flu id  (Todd  et  a1.,  1982),  used  a  reversed  phase 
system  (~bondapak  CI8).  A  sens i t i vi ty  of  20pg  on  column  was 
claimed  for  this  method,  wh!ch  makes  it  as  sensitive  as  GC-KS-SIH 
methods  reported  elsewhere  (Jones  ct  al.,  1984).  1"l1li0  subsequent 
studies  on  morphine  used  HPLC  with  electrochemical  detection 
(LCED)  to  examine  the  pharmacokinetics  of  morphine  in  hospital 
patients  (Vandenberghe  et  al  1982,  Hoore  et al.,  1984(ii».  Both 
these  workers  found  it  neccessary  to  use  ion-pa  i ring  agents  to 
-52--attain  efficient  chromatography  of  morphine.  The  detection 
limits  reported  were  3ng/ml  and  O.3ng/ml  respectively. 
other  reports  have  been  made  where  sensitive  detection  using  uv 
has  been  claimed  (Svenson  et  al.,  1982,  Uges  1984),  inc1ud i ng  in 
the  former 
metabolites 
case 
and 
the 
the 
morphine-6-g1ucuronide. 
identification  of  several  conjugated 
tentative  identification  of  the 
UV  detection  is  essential  for  the 
measurement  of  metabolites  as  it  is  believed  that  the  major 
metabolite  morphine-3-g1ucuronide  cannot  be  detected 
electrochemically,  being  conjugated  through  the  3-0H. 
One  report  (Svenson  et  al.,  1982)  also  demonstrates  another 
advantage  of  HPLC  over  GC,  namely  the  chromatography  of  conjugated 
glucuronide  metabolites  without  the  need  for  hydrolysis  and 
subsequent derivatisation prior  to  analysis. 
2.2.7.  Conclusions 
Of  the  quantitative  m~thods  described  above  for  the 
analysis  of  morphine,  GCMS  is  the  method  of  choice,  in  terms  of 
sensitivity  and  absolute  identification  of  the  drug.  Sensitivity 
is  further  enhanced  by  the  use  of  selective  ion  monitoring.  This 
method,  in  use  until  recently  in  this  department,  was  found  to  be 
sensitive,  but  occasional  problems  were  encountered. 
These  included  interference  from  a  column  bleed  peak  of  the  same 
mass  as  the  base  peak  of  the  morphine  derivative,  and  the  presence 
of  silicones  in  the  eluent  presumably  fr:om  the  septum  (Anderson 
1986) . 
The  increasing  demand  for  mor:phine  analysis  has  pr:ompted  the 
development  of  a  complimentary  technique  which  can  be  used 
-53-selectively to measure  morphine  in  a  suitable extract. 
Other  gas  chromatographic  methods  with  flame  ionisation  detection 
(FlO)  and  nitrogen/phosphorus  detection  (NPD)  had  been  examined  as 
alternatives. 
Electron  capture  detection  is  reputedly  more  sensitive  (McFadden, 
1973)  and  this  has  been  investigated,  although  problems  were 
encountered  with  excess  fluorinated  derivatising  agent  in  the 
prepared  sample  contaminating  the  detector  and  causing 
interference  (Anderson,  1986). 
The  use  of  radioimmunoassay  was  considered.  Minimal  sample 
preparation  and  high  sensitivity  makes  RIA  a  useful  screening 
procedure  for  opiates,  where  large  numbers  of  samples  require 
analysis,  as  is  the  case  with  samples  taken  under  the  Road  Traffic 
Act.  In  spite  of  the  high  quality  of  antibodies  currently 
available  for  morphine,  the  still  lack  absolute  specificity, 
particularly  in  their  cross  reaction  with  codeine  and 
dihydrocodeine,  confirmation  of  the  presence  of  morphine  following 
a  positive  RIA  result must  be  made  by  independent  means. 
The  many  degrees  of  freedom  available  from  HPLC  make  it  suitable 
for  the  analysis  of  most  compounds  (Pryde  and  Gilbert,  1979; 
Lawrence  1981).  The  use  of  HPLC  for  the  analysis  of  morphine  has 
the  advantage  that  the  drug  does  not  require  derivatisation  prior 
to  analysis.  HPLC  has  not  been  used  extensively  for  morphine  in 
biolog  i cal  flu ids  in  the  past  due  to  the  lack  of  sens i t i vi ty  of 
the  detectors  available.  Modern  UV  detectors  and  the  development 
of  electrochemical  detectors  hasnow  made  HPLC  more  popular  for 
this  application. 
Reports  in  the  literature,  cited  above,  prompted  the  investigation 
-54-of  LC  as  a  suitable routine method  for  morphine  analysis. 
As  sensitive  procedures  using  both  UV  and  electrochemical 
detection  have  been  described,  these  techniques  merit  further 
comparative  study. 
2.3.  SAMPLE  PREPARATION 
2.3.1.  Direct  analysis 
The  direct  analysis  of  body  fluids  and  tissues, 
particularly  those  of  post  mortem  origin  is  impractical.  These 
samples  usually  require  some  form  of  clean-up  or  preconcentration 
before  chromatographic  methods  can  be  applied.  Radioimmunoassay 
can  be  performed  on  unprepared  samples,  but  a  simple  extract  ion 
into  methanol  is  usually  carried  out  to  el  iminate  interference 
from  the matrix  and  to  increase  sensitivity. 
2.3.2.  Protein precipitation.  ultrafiltration  and  centrifugation 
Following  protein  precipitation  with  tungstic  acid, 
analysis  of  morphine  in  the  supernatant  has  been  reported  by  TLC 
and  paper  chromatography  (Curry,  1969). 
Whilst  this  will  eliminate  some  interference  from  the  matrix, 
protein  precipitation  does  not  concentrate  the  sample.  Simple 
protein  precipitation,  ultrafiltration  and  centrifugation  methods 
were  cons idered  unsu i table  for  th is  study,  because  of  the 
complexity  of  ~he  sample,  and  the  need  to  concentrate  rather  than 
dilute  the  sample.  This  is  important  due  to  the  low 
concentrations  of  morphine  normally  encountered  in  blood 
samples.  Prote  i n  prec ipi tat  ion  has  been  shown  to  be  succes  s ful 
-55-where  the  analyte  is  encountered  in  microgram,  rather  than 
nanogram,  quantities  (Black  and  Sprague,  1978). 
2.3.3.  Liquid/Liquid extraction. 
Liquid/liquid  partition  extraction  is  probably  the  most 
popular  and  widely  used  method  of  sample  preparation  available  i~ 
the  laboratory.  By  correct  choice  of  the  bu~fer  and  extract  i on 
solvent,  a  considerable  degree  of  specificity  can  be  achieved. 
Morphine  is  a  basic  drug  with  a  pKa  of  8.21  (Sunshine  1978). 
Extraction  by  partition  extraction,  following  adjustment  to  a 
suitable  pH,  in  the  most  popular  method  in  published  work  to 
date.  Some  examples  are  contained  in  table  2.2 ..  A  vs.r i ety  of 
solvents  and  buffers  are  cited  and  most  methods  require  multiple 
back extractions. 
The  many  problems  associated  with  putrifying  tissue  are  seldom 
considered  in  clinical  publications.  The  problem  of  material 
co-extracting  when  higher  aliphatic  alcohols  are  present  in  the 
extracting  solvent  has  been  noted  (Horning  at  al.,  1974),  but  the 
degree  of  interference  th is  causes  wi 11  depend  on  the  method  of 
analysis  being  used.  Liquid/liquid  extraction  procedures  are  the 
usual  choice  for  sample  preparation,  as  they  have  been  well 
researched  and  there  is  a  good  understanding  of  the  princi~les 
involved  (Snyder,  1976  (i».  Careful  select  ion  of  buffer  and 
extraction  solvent offer  a  range  of selectivities. 
2.3.4.  Solid  phase  extraction  teChniques. 
The  principle  of  solid  phase  extraction  is  well  known. 
As  appl ied  to  the  removal  of  compounds  from  blood  these  method~ 
-56-TABLE  2.2. 
SUMMARY  OF  SOME  LIQUID/LIQUID  EXTRACTION  TECHNIQUES  REPORTED  TO  BE  SUITABLE  FOR  MORPHINE 
SOURCE  SAMPLE  SOLVENT  RATIO  BUFFER  STEPS  RECOVERY  METHOD  SENSITIVITY 
(~)  (n&/ml) 
Hackett et al  (1975)  aq.  Ref.  CH3Cl  NA  Na2C03  3  It 10  GC  NG* 
Mule  (1969)  general  EtC12/IBA  9:1  base  3  NG  GC  NG 
Jones  et al  (1985)  urine  CH3Cl / IPA  9:1  NH40H/NH4Cl  3  NG  GCMS  NG 
J'lne  & Taylor  (1975)  urine  CH3C1/IPA  9:1  NaOH  3  60-70  LCF  1.2 
K~pferber& et al  (1964)  plasma  CH3C1 /IBA  9:1  Na2C03  1  NG  Fluor.  100 
I  BaRelt  (1980)  plasma  EtoAc  NA  NaOH  1  NG  GC-ECD  1 
V1  Hornin&  et al  (1974)  plasma  EtoAc  NA  (NH4)2C03  3  90  GC  NG  -...J 
I  plasma  CH2C12  NA  (NH4)2C03  3  63  GC  NG 
plasma  C6H6  NA  (NH4)2C03  3  8  GC  NG 
Todd  et al  (1982)  plasma/CSF  CH3CI/IBA  95:5  Borate  pH  8.9  3  78  LCED  1 
Vandenberghe  et al  (1982)  serum  CH3Cl  9:1  phospho  pH  8.9  3  NG  LCED  3 
Hoffat  (1986)  blood/liver  CH3Cl  NA  NH40H  3  NG  UV/TLC  NG 
White  (1979)  Blood  EtoAc/IPA  9:1  Borate  pH  9  3  81  LCED  NG 
*  NG  =  Not  Given fall  into  two  categories,  adsorption  and  absorption. 
ADSORPTION  extraction  relies  on  the  reversible  binding  of  the 
compound  of  interest  to  a  solid phase  material.  Examples  of  this 
include  charcoal  adsorption  and  XAO-2  extraction  procedures. 
More  recently  a  variety  of  adsorbent  phase  materials  have  been 
produced  commercially.  These  include  polar  phases,  silica, 
alumina  and  silica  material  with  bonded  phases  like  cyanide, 
phenol  and  quaternary  atranonium  functions.  There  are  also  some 
non-polar  phases  such  as  C-2,  C-8  and  C-18.  The  principle 
involved  is  as  follows.  The  analyte,  is  prepared  in  a  form  in 
which  it  wi 11  absorb  to  the  stationary  phase.  This  may  be  done 
by  the  use  of  appropriate  conditions  of  solvent,  pH  and  the  phase 
used. 
The  support  is  washed  to  elute  extranaeous  material  and  then  with 
a  suitable  solvent  to  elute  the  compound  of  interest.  There  are 
several  variations  employed. 
of  adsorbent  extraction. 
Table  2.3.  includes  three  examples 
The  reported  recoveries  are  higb 
(84-100'-),  and  extracts  have  been  used  for  GC,  LCUV  and  LCED. 
The  eluates  used  are  aqueous  based  however  and  carryover  of  the 
wash  into  the  eluate  can  arise.  Additionally  the  use  of  an 
inappropriate  wash  solvent  might  lead  to  loss  of  the  analyte  in 
the  wash  step.  In  spi te  of  the  succes  s  of  the  technique  wi th 
plasma  and  urine  samples,  it  has  not  been  widely  appl ied  to  the 
analysis  of  whole  blood  samples  as  these  present  their  own 
problems  with  s~ple handling. 
The  use  of  solid  phase  adsorption  techniques,  in  theory  at  least, 
adds  further  select  i vi ty  to  the  extract  ion  procedure  (Harkey  and 
Stolowitz,  1984),  and  should  make  this  approach  ideal  fOt"  sample 
-58-TABLE  2.3. 
SUKKARY  OF  SOLID  PHASE  EXTRACTION  METHODS  REPORTED  TO  BE  SUITABLE  FOR  MORPHINE 
SOURCE  SAMPLE  SUPPORT  BUFFER  WASH  ELUENT  RECOVERY  ANAL.  SENSITIVITY 
SOLVENT  (,.)  METHOD  (n&/m1~ 
adsorbent 
Mule  (1974)  urine  XAD-2  borax  0.12M  none  CH3C1/IPA  85-100"  GC  NG* 
I  Svenson et a1  (1982)  plasma  sep  pak  C18  NH3  pH9.3  as  buffer  ACN/Phosph.  84  LCUV  5  U1 
\D  Moore  et a1  (1984)  plasma  ODS  bond  e1ut  borate  pH9  water  methanol  100  LCED  0.28 
I 
absorbent 
Breiter  (1976)  blood  extre1ut  pH9.5  none  CH2C12/IPA  100  GC/TLC  300 
Todd  et  a1  (1982)  p1asma/CSF  c1in  e1ut  borate  pH9  none  CH3C1/IPA  NG  LCED  1 
Fritschi et a1  (1985)  urine  extre1ut  NG  none  CH2C12/IPA  NG  GCMSSIM  300 
Derks e t  a1  (1985)  urine  extre1ut  NH4C1  none  CH3C1/IPA  NG  LCUV  2 
*NG  ::  Not  Given preparation  for  LC. 
Methods  for  the  extract  ion  of  whole  blood,  CSF,  plasma  and  ur i ne 
have  been  reported  for  ABSORPTION  extraction.  This  technique 
relies  on  the  absorption  of  one  phase  (the  aqueous  phase)  onto  an 
absorbent  support  usually  wide  pore  kieselguhr,  or  di atomaceous 
earth  (eg.  Extrelut  (Merck)  and  Clin-elut  (Analytichem).  An 
immiscible  solvent  with  a  high  solubility  for  the  analyte  is  then 
passed  down  the  column.  The  technique  is  designed  to  mimic 
liquid/liquid  extraction  but  has  several  advantages.  Problems 
involving  phase  separation  and  emulsion  formation  are  avoided. 
No  wash  step  is  required  so  there  is  less  risk  of  sample  loss. 
Table  2.3.  includes  a  summary  of  four  absorption  procedures  which 
have  been  used  for  the  extraction  of  morphine  from  biological 
fluids.  These  extracts  have  been  analysed  by  LCUV,  TLC,  and  GC. 
Absorption  procedures  add  no  further  selectivity  to  the 
extraction,  but  have  a  high  capacity  for  the  stationary  aqueous 
phase,  and  limit  sample  breakthrough. 
almost  all solvents  and  all  pH  values. 
It  is  also  compatible  with 
Both  the  techniques  have  the  advantage  of  being  modular,  reducing 
the  risk  of  contact  with  potentially  hazardous  biological 
material.  They  may  also  improve  the  reproducibility  of  the 
extraction  procedure  by  avoiding  emulsion  formation.  Their  main 
drawback  is  cost,  the  adsorbent  cartridges  cost  about  £0.50  each, 
and  may  be  used  only  once.  Absorbent  cartridges  can  be  packed  in 
the  laboratory"more  readily  and  cost  around  £0.10  each. 
An  exami nat i on  of  commerc i ally  avai lable  sol  id  phase  extract  i on 
techniques  was  conducted  {Stewart  et  al,  1984).  This  study 
showed  that  for  the  extraction  of  basic  compounds  (procaine  ,  pKa 
-60-8.4  was  used  as  a  model)  from  plasma,  the  most  efficient  approach 
was  with  the  use  of  ODS  cartridges,  diatomaceous  earth  absorbent, 
and  XAO-2  resin.  These  gave  extraction  efficiencies  of  40~,  52~ 
and  61~  respectively.  Methanol  was  used  as  the  elut  ing 
solvent.  Concentrations  were  measured  using  UV  absorbance,  so  no 
indication of  the  selectivity of  the  extraction  procedure  is  given. 
Other  workers  have  ex~ined the  suitability  of  diatomaceous  earth 
and  XAO-2  resin  for  the  extraction  of  several  drugs  (not  including 
morph i ne)  in  post  mortem  blood  (von  Meyer  et  aI,  1980).  The 
extracts  were  ex~ined  by  GC-FIO,  and  the  authors  reported  that 
high  recoveries  were  achieved  from  both  procedures,  with 
marginally  better  recoveries  with  extrelut,  particularly  for  basic 
drugs. 
Although  commercial  automated  sample  preparation  units  are  now 
available  and  several  references  exist  for  on-column  extraction 
(AASP,  WISP,  Ou  Pont  Prep),  very  few  of  these  include  applications 
for  whole  blood. 
2.3.5.  Conclusions 
For  most  analyses  involving  HPLC,  a  clean-up  step  or 
concentration  step  are  required.  In  general,  it is  accepted  that 
sample  clean  up  for  LC  partl 'cularly  wl'th  sensitive  detection  , 
systems  like  electrochemical  detection  (ED)  should  be  more 
selective  than  is  required  for  GC  (Dell,  1976).  It  has  also  been 
shown  that  LC·  column  lifetimes  are  extended  by  the  use  of  more 
rigourous  sample  clean  up  (Kabra  et  al"  1983).  This  applies 
particularly  to  post  mortem  blood  s~p1es,  which  are  among  the 
most  complex  matrices  encountered  in  toxicology  (Oliver,  1984). 
-61-For  these  reasons  direct  analys i s  of  untreated  post  mortem  blood 
was  not  considered. 
Liquid/liquid  extraction  methods  offer  a  wide  variety  of  solvents 
and  the  option  of  :Dultiple  extraction  steps  to  provide  a  clean, 
selective  and  efficient extract. 
The  method  currently  in  use  in  the  department  for  extracting  basic 
drugs  from  blood  and  liver  homogenate  is  based  on  that  described 
by  Horning  et  al.,  (1974).  The  extracts  from  this  procedure  had 
not  been  exwmined  to  assess  their suitability for  LCED. 
Blood  spec imens  wh i ch  requ i re  analys i sin  the  forens i c  can text 
range  from  the  almost  perfect  non-haemolysed  blood,  through 
grossly  haemolysed  and  coagulated  non-pipettable  Gpecimens,  to 
putrid  dark  brown  fluids.  The  presence  of  putrefactive  amines 
common  in  post  mortem  tissue  (Kaempe,  1969;  Oliver  and  Smith, 
1973;  Oliver  et  a1.,  1977)  may  interfere  with  either  the 
extraction or  the  analysis. 
Solid  phase  adsorption  methods  are  in  increasingly  common  use  in 
clinical  applications  for  serum  or  urine  analysis  (Bond  elut 
applications  notes  1985),  but  very  few  applications  for  whole 
blood  samples  have  been  reported. 
It  was  concluded  that  both  absorption  and  adsorption  extraction 
procedures  should  also  be  examined.  with  extraction  procedures 
requiring  several  steps,  clean  up  for  example,  the  cost  would  be 
greater  and  some  of  the  advantage  of  using  solid  phases  lost.  A 
suitable  liquid  extraction  method  may  be  further  improved  by 
adapting  it to  an  absorption/adsorption  procedure. 
-62-2.4.  PHYSICAL  AND  CHEMICAL  PROPERTIES  OF  MORPHINE. 
2.4.1.  Introduction 
Morphine  is  a  plant  alkaloid  with  analgesic  and  narcotic 
properties.  It  occurs  naturally  in  the  opium  poppy  as  a  free 
base  (pKa  8.21)  and  has  a  molecular  weight  of  285.33.  It is  used 
clinically  as  morphine  sulphate  pentahydrate  (MW  758. 76)  and  for 
the  purposes  of  this  work  was  used  as  morphine  hydrochloride 
trihydrate  (MW  375.8). 
As  liquid  chromatography  (LC)  with  two  forms  of  detection  are  to 
be  considered  in  this  study  i.e.  ultra  violet  (UV)  absorbance  and 
electrochemical  detection 
morphine  are  examined. 
(ED) , 
2.4.2.  tN/VISIBLE  SPECTROPHOTOMETRY 
2.4.2.1.  Introduction 
the  relevant  p!"operties  of 
Electrons  in  bonding  and  non-bonding  orbitals  of  saturated 
and  unsaturated  bonds  and  delocalised  systems  can  change  their' 
energy  states  by  the  absorbance  of  electromagnetic  radiation  in 
the  ultraviolet  and  visible  regions.  The  pattern  of  absorbance 
is  specific  to  the  bonds  present  in  the  absorbing  compound  and 
different  compounds  display  different  absorbance  maxima.  The  UV 
absorbance  spectrum  for  morphine  was  measured  to  determine  at 
which  wavelength  it  would  absorb,  this  could  then  be  used  as  a 
selective wavelength  for  monitoring  the  eluent  in  HPLC. 
-63-2.4.2.2.  Method 
A  standard  solution  of  morphine  (2mg/l00ml)  was  prepared 
in  O.IN  H2S04  and  placed  in  a  lcm  quartz  cell.  The  spectrum 
was  scanned  from  190  to  340nm.  O.IN  H2S04  in  a  matched  cell 
was  used  as  a  blank.  The  instrument  used  was  a  scanning  diode 
array  UV/visible  spectrophotometer  (Hewlett  Packard  8451A).  The 
bandwidth  was  2nm. 
2.4.2.3.  Results  and  discussion 
The  spectrum  obtained  is  shown  in  figure  2.4 .. 
Absorbance  maxima  were  found  at  212nm  and  286nm.  The  extinction 
coefficients  (Ai)  were  calculated  and  are  shown  in  table  2.4 .. 
The  selective detection  of  small  amounts  of  morphine  is  difficult. 
as  it does  not  have  a  strong  chromophore  other  than  the  ubiquitous 
*  *  aliphatic  sigma-sigma  and  aromatic  pi-pi  transitions  between 
150  and  220nm  (Williams  and  Fleming.  1980).  As  this  is  the 
region  in  which  many  solvents  used  in  HPLC  also  absorb  (Snyder  and 
Kirkland.  1978)  it  is  inaccessible  on  many  instruments,  and  the 
sensitivity can  be  poor. 
The  other  absorbance  at  28Snm  is  due  to  the  transitions  of 
delocalised  electrons  in  the  aromatic  system.  Thi s  is  more 
spec ific  and  access i ble  wi th  most  spectrphotometers,  however  the 
extinction  coefficient  is 
sensitivity. 
2.4.2.4.  Conclusion 
low  (AI  =  60) 
1 
which  will  limit  the 
The  concentration  of  free  morphine  found  in  blood  is  low 
even  in  overdose  cases  (see  2.1.3.).  In  order  to  use  v~ 
-64-TABLE  2.4. 
UV  ABSORBANCE  DATA  FOR  MORPHINE  SOLUTION  (2mq/lOOml) 
wavelength 
220 
286 
Absorbance 
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~ detection  for  the  measurement  of  morphine  in  blood,  it  would 
probably  be  necessary  to  monitor  at  212nm  and  larger  sample 
volumes  may  be  required. 
2.4.3.  ELECTROCHEMICAL  PROPERTIES 
2.4.3.1.  Introduction 
To  monitor  compounds  electrochemically,  sufficient 
potential  difference  must  be  applied  to  perform  a  reaction,  which 
results  in  the  uptake  or  production  of electrons. 
The  applied  potential  should  not  however  be  so  high  as  to  produce 
a  strong  background  signal  from  the  mobile  phase.  The  optimum 
level  can  be  ascertained  by  performing  hydrodynamic  voltamrnetry 
(HOV)  under  the  chromatographic  conditions  to  be  used  in  the  assay. 
Initially,  as  the  best  conditions  for  chromatography  had  not  been 
developed,  cyclic  voltanunetry  (CV)  was  used  to  determine  a  value 
for  the  E 
P 
and  for  mo~phine  to  allow  the  choice  of  a 
suitable  detector  potential. 
in  chapter  one. 
Both  these  techniques  are  discussed 
2.4.3.2.  Design  of  electrochemical cell - Method 
The  cell  design  shown  in  figure  2.5.(a)  was  constructed  on 
the  principle  cf  classical  cyclic  votammetric  cells.  The 
electrodes  consisted  of  platinum  wire  (22ga.,  7cm),  coiled  to 
allow  the  greatest  surface  area  in  a  small  volume.  These  were 
embedded  in  epoxy  res in.  Connections  to  the  volt-lge  generator 
were  led  from  the  bottom of  the  cell. 
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-68-The  control  unit  was  a  BAS  CV-IA  (Anachem,  Luton,  U.K.)  instrument 
which  provided  the  changing  potential  and  also  amplified  the 
resulting  current  from  the  cell  and  produced  an  analog  voltage  for 
the  chart  recorder. 
A  Ag/AgCl  (SCE)  reference  electrode  (BAS)  with  vs 
standard  hydrogen  electrode  (SHE),  was  dipped  into  the  open  top  of 
the  glass  tube.  Background  scans  were  perfo~ed on  a  variety  of 
solutions  under  different  condition~ of  scan  rate. 
2.4.3.3.  Results  and  discussion 
The  cell  gave  a  suitable  scan  window  (~2.0volts)  in 
aqueous  solutions  and  buffers,  however  in  the  presence  of 
acetonitrile  or  methanol,  anomalous  results  were  obtained  on 
repeat  scans.  This  appeared  to  be  due  to  softening  of  the  epoxy 
resin  by  these  solvents.  Reaction  of  the  res in  components  or 
their  depositing  on  the  electrode  surfaces  may  account  for  this 
behaviour. 
2.4.3.4.  Conclusion 
The  inconsistent  results  obtained  and  the  obvious 
incompatability  of  the  cell  with  some  solvents  often  used  in  HPLC 
and  CV,  meant  that  no  further  work  could  be  done  with  this  cell. 
An  alternative was  sought. 
-69-2.4.4.  MODIFICATION  OF  CELL  DESIGN 
2.4.4.1.  Introduction 
Following  the  incompatability  of  epoxy  resin  an 
alternative  cell  design  was  chosen.  Anderson,  (1981),  noted  that 
the  most  reliable  methods  of  determining  a  working  potential  (WP) 
for  LCEC  by  CV  was  to  use  the  same  electrode  materials  and 
conditions  in  the  CV  cell as  were  found  in  the  HPLC  cell. 
A  second  cell  design  (figure  2.S.(b»  was  considered  based  more 
closely on  the  flow cell used  in  the  BAS-TL-SA  LC  detector cell. 
2.4.4.2.  Method 
The  body  was  made  from  a  PTFE  block  which  was  found  to  be 
inert  to  methanol  and  acetoni tri  Ie.  Th is  was  bored  through  the 
centre  with  a  lOmm  dia.  hole  and  attached  with  four  1/2  ir.ch 
self-tapping  screws  to  a  Smm  dia.  glassy  carbon  electrode  mounted 
in  KEL-F  polymer  (BAS  TL-SA>.  Th is  was  used  as  it  is  reported 
that  electrochemical  mechanisms  are  affected  by  the  nature  of  the 
working  electrode  material  (Albery  and  Hugget,  1984).  A  Ag/AgCl 
(SCE)  reference  electrode  (BAS)  with  E
O=217mV  vs  standard 
hydrogen  electrode  (SHE),  was  dipped  into  the  top  of  the  PTFE 
body.  A  piece  of  platinum  wire  (22ga)  was  sealed  in  glass  with 
the  bottom  ISmm  exposed  and  used  as  the  auxilIary  electrode. 
The  uni t  was  sealed  wi th  a  neoprene  top  to  prevent  atmospheric 
contamination, .or  temperature  fluctuations. 
Background  scans  were  t'un  in  a  series  of  buffer  and  acetoni tri  Ie 
or  methanol  contai  n i ng  solvents.  A  scan  rate  of  lOmV/sec  and 
sensitivity  of  2  and  20  uA/V  were  used  required  (Plambeck,  1982; 
A.nderson  1981). 
-70-2.4.4.3.  Results  and  discussion 
Good  reproducibility  was  obtained  for  repetitive  scanning, 
and  a  window  of  ±  1.5  volts  was  found  for  all  the  solvent 
systems  tested.  The  cell  appeared  to  be  inert  to  all  the 
solvents  used.  The  voltage  window  for  acetonitrile  itself  was  :t 
2.5  volts,  but  for  the  purposes  of  LCEC  where  practical  limits  are 
less  than  1.2  volts,  the  switching  potentials  were  set  at  around 
±  1.5 volts. 
2.4.4.4.  Conclusion 
The  second  cell-design  is  more  suitable  for  examining  the 
electrochemical  proporties  of  drugs,  as  it  is  constructed  of  the 
same  materials  as  the  cell  used  in  the  electrochemical  detector, 
and  is  inert  under  test  conditions. 
for  all further  CV  experiments. 
2.4.5.  CYCLIC  VOLTAHMETRY  OF  MORPHINE 
2.4.5.1.  Introduction 
This  cell  was  therefore  used 
Morphine  has  electrochemical  behaviour  which  has  been 
examined  both  reductively  (Kirkpatrick,  1947)  and  oxidatively 
(Proksa  and  Molnar  1978).  Th e  mo s t  sui tab  1  e  sol  ve n t  for  the 
conduction  of  a  cyclic  voltammetry  (CV)  experiment  is  highly 
purified  and  dried  acetoni trile,  containing  an  inert  electrolyte 
such  as  tetrabutyl  ~onium  tetrafluoroborate  (Evans  et  a1., 
1983),  acting  as  a  charge  carrier.  This  is  essential  where  the 
mechanism  of  the  reaction  is  being  studied  and  reaction  with  water 
-11-or  ions  from  the  electrolyte  might  interfere.  This  solver.t  also 
gives  a  window  with  a  low  background  current  within  the  limits 
-3.5  to  +1.8  volts  (Billon  et  al.,  1982).  In  HPLC,  potentials 
outwith  ~1.5  volts  are  seldom  of  interest,  as  the  associated 
background  current  at  these  values  is  too  high  to  allow  sensitive 
measurements. 
2.4.5.2.  Method 
The  solvent  used,  acetonitrile,  8~,  in  O.OlK  KH2P04, 
at  pH  4.6,  was  based  on  the  results  of  initial  chromatography 
which  had  been  developed  (see  2.5.2.>. 
A  blank  run  was  performed  using  a  solvent  containing  no 
morphine.  This  was  scanned  in  single  fast  scan  mode, 
oxidation-reduction,  at  a  rate  of  lOmV/sec,  and  sensitivities  of 
20  and  200  uA/V  were  used. 
This  was  then  replaced  with  a  solution  of  morphine  (10-3M)  in 
the  same  solvent,  and  scanned  under  the  same  conditions. 
2.4.5.3.  Results  and  discussion 
The  voltammograms  for  the  blank.  solvent  and  the  morphine 
containing  solvent  are  shown  in  figure  2.6 .. 
values  are  +0.87V  and  +0.76V  vs  Ag/AgCl,  respectively.  Th is  is 
in  reasonable  agreement  with  other  reported  values,  noted  in  table 
2.5..  Information  on  the  peak  current  is  also  included  but  this 
is  of  little  practical  use  for  this  application,  as  the  steady 
state  conditions  in  the  CV  cell  differ  greatly  from  the  turbulent 
dynamic  conditions  found  in  the  LCEC  flow  cell. 
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FIGURE  2.6. 
CYCLIC  VOLTAMMOGRAMS  OF  BLANK  SOLUTION 
AND  MORPHINE  CONTAINING  SOLUTION 
-73-TABLE  2.5. 
COMPARISON  OF  RESULTS  WITH 
ELECTROCHEMICAL  DATA  FOR  MORPHINE  REPORTED  ELSEWHERE 
Author  method  Ep  Ep/2  WP 
This  work  CV  0.87  0.76  0.87 
, 
...J 
~ 
White,  1979  HDV  0.83  0.5  0.6 
Hoore  et al.,  1984  1.0 
Vandenberghe  et al.,  1983  HOV  0.70  0.43  0.6 
Todd  et al.,  1982  CV  0.6-0.8  . 
0.79 
Law.  1984(iii)  HOV  no  plateau  0.85 2.4.5.4.  Conclusion 
Cyclic  voltammetry  performed  under  the  conditions 
described  appears  to  be  a  good  method  for  screening  compounds  for 
electrochemical  activity,  and  determining  a  reliable  value  for  the 
and  values.  This  allows  a  reliable  estimate  of 
suitable working  potential for  LCEC. 
2.4.6.  THE  EFFECT  OF  pH  ON  ELECTROCHEMICAL  RESPONSE  OF  MORPHINE 
2.4.6.1.  Introduction 
Factors  such  as  temperature,  supporting  electrolyte  and  pH 
may  have  an  effect  on  the  activation  energy,  rate  and  mechanism of 
the  reaction  (Proksa  and  Molnar  1982). 
The  temperature  is  generally  ambient  for  HPLC  separations  and  was 
not  investigated.  The  effect  of  the  pH  which  is  important  in  the 
development  of  a  suitable  chromatographic  system  is  investigated 
below. 
2.4.6.2.  Method 
A  series  of  solvents  (8~  acetonitrile  in  O.01MKH2P04) 
were  prepared  and  the 
phosphoric  acid  or 
pH  adjusted  either 
60~  KOH  solution 
with 
as 
concentrated 
required. 
Oxidat ion-reduct ion  cycl ic  vol  tanunetry  was  performed  as  before. 
The  electrode was  polished  between  experiments. 
-75-2.4.6.3.  Results  and  discussion 
The  effect  of  altering  the  pH  on  the  E  value  and  on  the 
p 
response  is  shown  in  figure  2.7.  and  table  2.6 .. 
As  the  pH  decrease3,  the  values  increase, 
idicating  that  the  reaction  requires  a  higher  activation  energy  to 
proceed. 
The  peak  current  is  not  signifigantly  changed  between 
experiments.  This  suggests  that  the  peak  current  is  limi ted  by 
the  mass  transport  of  the  analyte  to  the  electrode  surface  and 
diffusion  through  the  helmholtz layer. 
For  a  given  analyte  the  peak  current  will  be  a  function  of  the 
electron  transfer  rate,  electrode  surface  area  and  cell  des ign 
(Anderson  et.  ale  1981;  Evans  et al.,  1983).  As  the  for.mation  of 
a  helmholtz  layer  requires  unperturbed  conditions  (Crow,  1980), 
different  behaviour  may  be  found  in  hydrodynamic  voltammetry, 
where  the  surface  of  the  electrode  is  constantly  being  washed  by 
the  eluting  solvent.  In  the  case  of  HOY  the  limiting  current  is 
a  function  of  mass  transport  to  the  electrode  surface  which  in 
turn  is  a  function  of  the  flow  rate. 
A  study  of  the  usefulness  of  CV  in  estimating  E  (Anderson  et  app. 
al.,  1981)  showed  that,  in  general,  there  was  good  agreement 
between 
confirms 
E 
P 
(CV)  and  E plateau  (HOY)  values. 
that  both  E  and  E  depend  p  plateau 
the  solution  pH  and  the  solution  composition. 
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6 
VARIATION  OF  FULL  AND  HALF  WAVE  POTENTIALS 
FOR  MORPHINE  WITH  pH  OF  SUPPORT  ELECTROLYTE 
TABLE  2.6. 
Ep 
Ep/2 
7 
EFFECT  OF  pH  OF  SUPPORT  ELECTROLYTE  ON  THE  FULL  WAVE 
~p} AND  HALF  WAVE  (Ep/2)  POTENTIALS  OF  MORPHINE 
pH  Ep/2  Ep  Ip(UA) 
3.1  0.89  1.05  3.4 
3.95  0.81  1.05  3.2 
5.2  0.76  0.86  3 . 3 
6.0  0.72  0.84  3 .2 
7.1  0.69  0.80  3 . 5 
-77-2.4.6.4.  Conclusion 
Care  is  required  when  selecting  the  applied  potential  of 
constant  potential  amperometric  detectors  for  LC  applications. 
To  maximise  analytical  response,  and  minimise  background 
interference,  the  applied  potential  should  be  held  at  the  minimum 
value  at  which  current  reaches  the  limiting  current  plateau  of  the 
analyte.  Cyclic  voltammetry  has  been  shown  to  be  a  suitable 
method  for  the  determination  of  electrochemical  acti  vi ty.  The 
Ep/2  value  obtained  for  morphine  is  in  good  agreement  wi th  other 
reported  values.  The  working  potential  chosen  for  initial  LCED 
on  the  basis  of this  experiment  was  0.870  volts. 
It  was  decided  to  use  this  CV  procedure  to  determine  the 
electrochemical  behaviour  of  other  compounds  to  assess  their 
suitability  as  internal  standards  or  potential  interferences  in  an 
LCED  assay  for  morphine. 
2.4.7.  CYCLIC  VOLTAMHETRY  OF  OTHER  NARCOTIC  ANALGESICS 
2.4.7.1.  Introduction 
A  selection  of  narcotic  analges ic  drugs  were  examined  by 
cyclic  voltammetry  in  order  to  assess  any  likely  interference  f~om 
other  drugs  at  the  chosen  working  potential  of  around  0.870  volts, 
and  to  examine  any  structure  activity  relationship  between  the 
compounds  and  their  EC  properties. 
-78-TABLE  2.7. 
FULL  WAVE  AND  HALF  WAVE  POTENTIALS  RECORDED 
FOR  A  SELECTION  OF  NARCOTIC  ANALGESICS 
compound  Ep  Ep/2 
morphine  0.87  0.76 
nalorphine  0.84  0.73 
papaverine  1.94  1.60 
pentazocine  1.10  0.95 
codeine  1.09  0.96 
oxycodone  1.03  0.90 
diamorphine  1.41  1.19 
levorphanol  1.00  0.84 
-79-2.4.7.2.  Method 
The  cell  and  scanning  conditions  were  as  above  (2.4.5.2). 
Solutions  containing  the  compounds  of  interest  were  prepared 
(10-3M )  in  the  support  solution  and  the  voltarr~ograms recorded. 
2.4.7.3.  Results  and  Discussion 
E  values  are  recorded  in  table  2.7 .. 
P  The  structures 
are  shown  in  figures  2.9.  to  2.11 .. 
The  mechanism  proposed  for  the  electrochemical  oxidation  of 
morphine  is  a  phenolic  oxidative  coupling  (see  figure  2.8.) 
(Proksa  and  Molnar,  1976). 
This  involves  the  initial  loss  of  a  proton,  a  one  electron 
oxidation  to  a  phenoxonium  radical  and  subsequent  dimerisation  to 
pseudomorphine.  This  is  a  reaction  of  the  EC  type  (Plambeck, 
1982)  representing  an  electrochemical  step  (E)  followed  by  an 
intermolecular  chemical  step  (C). 
There  is  no  firm  agreement  as  to  whether  a  react  i on  need  go  to 
completion  in  order  for  that  reactant  to  be  detected 
electrochemically.  Some  authors  suggest  that  the  formation  of  a 
short  lived  radical  is  all  that  is  required  (Wilson,  1984). 
There  are  no  reports  in  the  li  terature  of  isolation  of  the  EC 
product  following  amperometric  detection. 
The  reaction  mechanism  for  morphine  shown  in  figure  2.8.,  pertains 
at  pH  13.3  where  the  phenoxide  ion  is  readily  formed,  assisting 
with  the  formation  of  the  radical.  The  reported  E  value  is. 
p 
0.3  volts,  however  the  autho~s  acknowledge  that  the  reaction 
mechanism  in  acidic  media  differs  (Proksa  and  Molnar,  1976), 
al  though  they  do  not  spec i fy  how. 
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FIGURE  2.8. 
REACTION  SCHEME  FOR  PHENOLIC  OXIDATIVE  COUPLING 
IN  ALKALINE  SOLUTION 
-81-has  been  reported  for  morphine  (w'bite,  1979).  This  was  also  in 
alkaline media  (pH  11.2). 
The  E  values  found  in  this  study  were  higher  than  this,  but  all  p 
were  measured  in  acidic  media.  It  was  shown  in  the  section 
above,  (table  2.6.>  that  the  E  value  for  morphine  was  dependent  p 
on  the  pH  of  the  support  scluti  on,  and  that  higher  potentials 
were  required  in  acidic media. 
This  observation  would  support  phenoxide  ion  formation  as  the  rate 
determining  step  (RDS)  for  the  electrochemical  oxidation  of 
morphine  and  its  analog  nalorphine  (figure  2.10.),  as  the 
phenoxide  ion will  be  less  likely to  form  in  acidic media. 
The  analgesics  whose  electrochemical  behaviour  was  exsmined  here 
are  discussed  below  in  terms  of  their structure. 
Deoxycatechols 
Compounds  in  thi  s  group  (figure  2.9.)  have  a  single  free 
phenol  and  hence  phenoxide  ion  formation  is  a  likely  ROS.  It has 
been  suggested  that  phenolic  oxidative  coupling  would  only  occur 
if  the  phenol  function  was  part  of  a  catechol  group  (Petersen  et 
a1,  1980).  The  measurement  of  E  values  of  1.0  and  1.1  volts 
p 
for  1evorphanol  and  pentazocine  respectively  discounts  this 
content ion  as  both  are  deoxycatechols,  having  only  one  phenol ic 
hydroxy  residue. 
Catechols 
Compounds  in  this  group  (figure  2.10.>  have  one  free 
hydroxyl  in  addition  to  the  second  ortho  oxygen  and  therefore 
phenoxide  ion  formation  is  also  a  likely  ROS. 
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STRUCTURES  OF  TWO  NARCOTIC  ANALGESICS 
CONTAINING  DEOXY-CATECHOL  FUNCTION  (PHENOL) 
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STRUCTURES  OF  FOUR  NARCOTIC  ANALGESICS  CONJUGATED  THROUGH  BOTH  CATECHOL  HYDROXYL  GROUPS for  morphine  and  nalorphine  (both  catechols,  although  conjugated 
through  one  hydroxyl)  are  lower  than  for  the  deoxycatechols 
di  scus sed  above,  the  presence  of  the  second  oxygen  may  stabi  1 i se 
the  radical  as  shown  in  figure  2.12 ..  This  increased  stability 
will assist  in  radical  formation. 
Assuming  this  to  be  the  case,  full  catechols  would  be  expected  to 
have  lower  E  values.  p  This  is  indeed  found  to  be  so.  The 
reported  value  of  0.5  volts  for  N-1-propylnorapomorphine 
(Wilson,  1984)  which  has  the  structure  shown  in  figure  2.10., 
containing  an  ortho  biphenyl  (catechol)  is  lower  than  that  for 
either  morphine  or  nalorphine.  This  is  further  confirmed  by  the 
report  of  the  E  for  apomorphine  itself  as  0.52  volts  (Sianchi 
p 
and  Landi,  1985) .  other  catechols  including  dopamine, 
5-hydroxytryptamine,  norepinephrine 
0.5  volts  (Ishikawa et.  al.,  1982) 
Si-conjugated catechols 
also  have  E  values  below 
p 
This  group  of  compounds  (figure  2.11.)  includes  codeine, 
oxycodone  and  d i acetylmorph  i ne.  Code i ne  and  oxycodone  are  both 
methyl  ethers  at  one  hydroxyl  function.  They  are  also 
conjugated  through  the  second  hydroxyl  as  in  morphine.  Formation 
of  a  phenoxide  ion  and  the  subsequent  radical  is  therefore 
unlikely because  of  the  energy  required  to  break  the  CH3-O  bond. 
An  alternative mechanism  is  suggested. 
The  mechanism  proposed  for  the  reaction  of  these  compounds  is 
based  on  the  reported  electrochemical  behaviour  of  ani5yl  alcohol 
(Lund  1957),  where  the  ability of  phenoxy  ethers  to  form  radicals, 
without  involving  initial phenoxide  ion  formation,  was  shown. 
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DELOCALISATION  FOR  RADICAL  RESULTING  FROM  LOSS  OF  ONE  ELECTRON 
Ii'ROM  Tur;  AROMAT I C  SYSTEM  OF  A  PHENYL  ETHER It  was  suggested  there  that  the  primary  step  in  the  reaction  was 
the  loss  of  an  electron  from  the  aromatic  system. 
Cons ideration  of  the  electrons  involved  and  the  mechani sm  shown 
for  POC  (fi  gure  2.8.),  sugges ts  that  in  i t i al  electron  abs tract  ion 
from  the  aromatic  oxygen  is most  likely,  as  shown  in  figure  2.12 .. 
The  presence  of  a  catechol  system  will  make  this  radical  more 
stable  by  the  existance  of  an  additional  resonance  isomer  (figure 
2.12.).  This  increased stability will make  its  formation  easier. 
Any  subsequent  reaction  of  this  radical  is  unlikely,  as  it  would 
involve  breaking  a  C-O+  bond.  This  observation  could  support 
the  contention  that  the  formation  of  a  radical  is  sufficient  for 
electrochemical detection. 
In  the  case  of  diacetylmorphine  and  papaverine,  the  second  phenoxy 
function  is  an  ester  and  an  ether  respectively.  The  same  anisyl 
alcohol  mechanism  can  be  invoked  here.  E  values  have  been 
p 
reported  for  this  compound  (Musch  et  al.,  1985;  Wilson,  1984) 
although  no  mechanism  has  previously  been  proposed.  The  E 
P 
value  for  diacetylmorphine  is  lower  than  for  codeine  or 
oxycodone.  The  additional  delocalisation  through  the  acetyl 
sroup  available to diacetylmorphine may  account  for  this. 
Further  chemical  reaction  is  also  possible  in  the  case  of 
diacetylmorphine,  as  subsequent  acid  catalysed  hydrolys i s  of  the 
ester may  take  place. 
2.4.7.4.  Conclusion 
The  above  study  shows  that  the  widely  held  belief  that  ED 
is  au i table  only  for  free  bydroxyls  (Pryde  and  Gi Ibert  1980)  is 
open  to  question,  and  ED  might  be  more  broadly  applicable  to  druS 
-88-analysis  than  previously  assumed.  The  E  values  for  certain  p 
compounds  can  be  lowered  by  altering  the  pH  or  temperature  of  the 
mobile  phase  (Proksa  and  Molnar  1976;  Anderson  et al.,  1981). 
The  E  values  observed  for  these  opiates  may  represent  the  p 
relative degree  of difficulty  in  forming  the  initial radical. 
These  results  suggest  that  by  judicious  choice  of  potential  and 
mobile  phase  conditions,  many  more  molecules  might  be  suitable  for 
electrochemical  detection.  The  mechanisms  proposed  will  also 
account  for  a  number  of  unexplained  observations  in  the  literature 
(Musch  et al.,  1985,  Wilson;  1984). 
A  further  implication  is  that  morphine  metabolites  conjugated 
through  the  3-0H  (including  codeine,  morphine-3-g1ucuronide  and 
morphine-3-ethereal  sulphate)  might  after  all  be  suitable  for 
sensitive detection  by  ED. 
2.4.8.  CONCLUSIONS  ON  THE  CHOICE  OF  DETECTION  SYSTEMS 
The  above  sections  have  demonstrated  that  morphine  has 
both  electrochemical  and  light  absorbing  properties  which  might  be 
used  to measure  it eluting  from  an  HPLC  column. 
The  electrochemical  properties  of  several  other  narcotic 
analgesics  have  also  been  examined  and  this  information  may  be  of 
use  in  future  assessments  of  the  likely  EC  properties  of  a 
substance,  based  on  consideration of  its structure. 
Because  of  the  difference  in  configuration  of  these  two  methods 
from  the  design  actually  used  in  HPLC  detectors,  an  assessment  of 
the  comparative  sensitivities  has  not  been  possible. 
In  sununary,  the  relative  merits  of  the  UV  and  ED  detection  could 
-89-only  be  properly  compared  when  a  suitable  HPLC  system  was 
developed. 
Initial  chromatographic  development  work  was  done  using  a  UV 
detector  as  no  electrochemical  detector  was  avai lable.  Once  an 
electrochemical detector  was  aquired  it was  decided  to  use  this  at 
a  potential of  0.870  volts  (from  CV  work,  2.4.5.)  in  order to gain 
experience  with  its  use  and  to  assess  i±s  suitability for  routine 
use. 
-90-2.5.  THE  CHROMATOGRAPHIC  BEHAVIOUR  OF  MORPHINE 
2.5.1.  CHROMATOGRAPHY  WITH  METHANOL  AS  THE  ORGANIC  MODIFIER 
2.5.1.1.  Introduction 
The  selection  of  a  chromatographic  system  for  morphine  was 
begun  as  follows.  A  reversed  phase  system  was  chosen  because  of 
the  interest  in  examining  the  suitability  of  EO.  The  initial 
chromatographic  conditions  described  below  were  selected  as  an 
arbitrary  starting  point,  within  reasonable  limits.  The  aim  of 
the  study  was  to  produce  a  simple  binary  solvent  system  for  rapid 
analysis  with  efficient  chromatography  and  high  selectivity  and 
sensitivity.  The  subsequent  alteration  of  the  chromatographic 
conditions  was  then  directed  firstly  towards  finding  an  acceptable 
capacity  factor  (K'),  secondly  improving  peak  shape  (W)  and 
efficiency  (N),  and  lastly optimising  sensitivity and  selectivity. 
2.5.1.2.  Method 
When  this  investigation  was  begun,  the  electrochemical 
detector  was  not  available,  therefore  UV  detection  was  used. 
The  monitoring  wavelength  of  212nm  was  chosen  (see  section 
2.4.2.),  however  in  practice  the  lowest  wavelength  which  could  be 
used  was  220nm.  This  was  the  lowest  wavelength  at  which 
measurements  could  be  made  before  the  cut-off  point  of  the  mobile 
phase  was  reached,  and  was  considered  to  be  a  limit  imposed  by  the 
use  of  the  Cecil  CE  212  detector  being  used  for  this  work.  The 
pump  used  was  a  Constametric  I  (Laboratory  Data  Control, 
Birmingham,  U.K.),  and  sample  introduction  was  through  a  Rheodyne 
-91-7125  six-port  sample  Jntroduction  valve,  fitted  with  a  20ul 
loop.  The  loop  was  filled  from  a  25ul  SGE  syringe. 
Several  mobile  phases  with  different  ratios  of  methanol  as  the 
organic  modifier  in  O.OlM  KH2P04  were  made  up  and  allowed  to 
equilibrate  on  the  column  for  30  minutes.  After  this  time 
reproducible  chromatograms  could  be  obtained.  Methanol/water 
(50/50)  was  pumped  through  the  column  for  twenty  minutes  between 
solvent  changes. 
The  flow  rate  chosen  was  3.0  ml/min.  Injections  of  25ul  were 
made  into  a  Rheodyne  valve  injector  fitted  with  a  20ul  loop. 
This  ensured  thorough 
standard  solution  of 
water/methanol  (99:1)  was 
of 
of 
the  loop 
morphine 
(Eppel 
Hel  in 
1980) .  A 
distilled 
used  unless  otherwise  stated. 
Injecting  distilled  water  between  injections  gave  a  measurement  of 
the  dead  time  of  the  system  as  0.5  mins. 
2.5.1.3.  Results  and  discussion 
All  the  solvents  tested  eluted  morphine  with  such  an  early 
retention  time  that  whilst  the  peaks  were  very  sharp,  they  eluted 
just  beyond  the  solvent  front  which  made  resolution  from  any  other 
components  difficult.  The  retention data are given  in  table  2.8 .. 
Adjusting  the  flow  rate  to  a  lower  level  did  increase  the 
retention  time  but  only  at  the  cost  of  the  peak  shape  and  no 
improvement  in  the  overall  performance  was  noted. 
was  therefore maintained  at  3ml/min. 
-92-
The  flow  rate TABLE  2.8. 
VARIATION  IN  RETENTION  BEHAVIOUR  OF  MORPHINE  AS  A  FUNCTION 
OF  METHANOL  CONTENT  OF  THE  MOBILE  PHASE 
\  MeOH  RT  Pk  W  K'  N 
75  1.60  0.6  2.2  114 
50  1.60  0.8  2.8  64 
25  1.75  0.9  2.6  60 
10  1.80  0.9  3.0  64 
5  2.10  1.5  3.2  31 
Dead  time  = 0.5  mins. 
-93-2.5.1.4.  Conclusion 
None  of  the  broad  range  of  solvents  tested  gave  adequate 
resolution  of  morphine  from  the  solvent  front.  One  possible 
solution  was  to  change  the  selecti  vi ty  of  the  system  by  us ing  a 
modifier with  a  different polarity  and  different selectivity. 
2.5.2.  INITIAL  CHROMATOGRAPHY  USING  ACETONITRILE  AS  THE  ORGANIC 
MODIFIER 
2.5.2.1.  Introduction 
Acetonitrile  (ACN)  is  a  low  boiling,  low  viscosity, 
organic  solvent  commonly  used  in  HPLC.  It  has  a  higher  polarity 
(Snyder  scale  5.8)  and  different  selectivity  (Chi)  values  from 
methanol  (Snyder,  1974  &  1978).  For  th is  reason  it  was  dec ided 
to  test  several  acetonitrile  containing  solvents  for  their 
suitability. 
2.5.2.2.  Method 
The  same  monitoring  wavelength  (220nm)  was  used  as  was  the 
same  buffer,  o. OlM  KH2PO 4.  The  HPLC  equipment  used  was  as  in 
section  2.5.1.2 ..  The  undernoted  solvent  systems  were  allowed  to 
equilbrate  on  the  column  for  30  minutes  as  before  and  the 
retention  behaviour  of  the  morphine  establ  ished.  The  flow  rate 
used  was  3.Oml/min.  A  morphine  HCl  standard  of  -2  10  gil  was 
used  as  before. 
-94-2.5.2.3.  Results  and  discussion 
Retention  data  for  the  various  solvent  systems  is  shown  in 
table  2.9 ..  From  the  data  presented  it  was  apparent  that  the 
retention  time  of  the  drug  on  the  column  was  a  function  of  the 
percentage  of  acetonitrile  in  the  mixture.  The  efficiency  of  the 
separation  was  relatively  poor,  around  100-200  theoretical 
plates. 
tailing. 
Thi s  was  caused  by  poor  peak  shape  wi th  cons iderable 
The  capacity factor  however  was  in  the  desired  region. 
The  chromatography  obtained  using  the  solvent  with  8~ acetonitrile 
was  considered  to  be  the  optimum,  as  it had  a  high  efficiency with 
an  acceptable  retention  time. 
2.5.2.4.  Conclusion 
The  results  indicate  the  best  conditions  so  far  for  the 
chromatography  of  morphine.  The  efficiency  was  however  still 
slightly  lower  than  would  be  suitable  for  the  analysis  of  morphine 
in  a  complex  sample.  Having  examined  the  effect  of  two  of  the 
more  conunon  organic  modifiers,  it was  decided  that  the  effect  of 
pH  should  also  be  investigated. 
2.5.3.  THE  EFFECT  OF  pH  ON  THE  CHROMATOGRAPHIC  BEHAVIOUR  OF 
MORPHINE. 
2.5.3.1.  Introduction 
Since  morphine  is  a  weak  organic  base  (pKa=8.2l)  the  form 
in  which  it exists  in  solution,  either  as  the  uncharged  base  or  as 
the  protonated  conjugate  acid,  will  determine  to  some  extent  its 
chromatographic  behaviour. 
-95-TABLE  2.9. 
VARIATION  IN  RETENTION  BEHAVIOUR  OF  MORPHINE  AS  A  FUNCTION 
OF  ACETONITRILE  CONTENT  OF  THE  MOBILE  PHASE 
\  ACN  RT  Pk  W  K'  N 
15  1.5  0.5  2.0  144 
10  2.15  0.7  3 . 3  151 
8  2.65  0.8  4.3  176 
7  2.95  0.9  4.9  172 
5  4.6  1.5  8.2  151 
2  11.2  4.2  21.4  113 
Dead  Time  =  0.5  mins 
-96-2.5.3.2.  Method 
A  stock  solution  of  the  optimum  mobile  phase  established 
above,  8"  acetonitrile  in  0.01M  KH2
P0
4
,  was  made  up  and 
adjusted  to  the  desired  pH  using  concentrated  orthophosphoric  acid 
or  60"  potassium  hydroxide  solution.  these  solutions  (25Oml) 
were  allowed  to  equilibrate  on  the  column  for  30  minutes  prior  to 
use. 
Injections  of  -2  -1  10  gl  morphine  standard  solution  were  made  as 
before.  Instrumental  conditions  were  as  described  in  section 
2.5.1.2 .. 
2.5.3.3.  Results  and  Discussion 
the  capaci ty  factor  and  efficiency  for  the  morphine  peak 
obtained  wi th  each  of  the  solvents  is  shown  in  table  2.10.  The 
resulting  concentration  of  phosphate  in  the  mobile  phase  is  also 
given.  the  K'  and  N values  are  also  plotted  in  figure  2.13.  as  a 
function  of  the  pH. 
It  was  noted  that  the  capacity  factor  was  fairly  consistent  below 
pH  4.5  t  but  that  the  efficiency  only  began  to  improve  below  pH 
4.5.  the  observed  differences  were  small,  but  the  trend  was 
important  in  assessing  the  optimum  conditions  for  the 
chromatography. 
the  fact  that  orthophosphoric  ac id  was  used  to  adj ust  the  pH  of 
the  mobile  phase  led  to  a  consequent  change  in  the  concentrat  ion 
of  phosphate .. the  use  of  other  acids  to  adjust  the  pH  would  have 
introduced  other  ions  and  complicated  the  interpretation  of 
results.  It  was  noted  that  the  increase  in  efficiency  which  was 
obseved  corresponded  well  with  the  increase  in  phosphate 
-97-pH 
2.5 
3.5 
4.5 
5.5 
6.5 
TABLE  2.10. 
EFFECT  OF  pH  AND  PHOSPHATE  CONCENTRATION 
ON  RETENTION  BEHAVIOUR  OF  MORPHINE 
RT  W  K'  N  [phosphate] 
2.15  0.7  3.78  151  0.024 
2.20  0.9  3.88  95  0.012 
2.20  1.0  3.88  77  0.010 
2.50  1.3  4.56  59  0.010 
2.90  1.5  5.44  60  0.010 
Dead  Time  = 0.45  mins 
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FIGURE  Po.  13. 
VARIATION  IN  Er'l"IClr~NCY  AND  CAPACITY  r'ACTOR  Or'  MORPHIN~ WITH  pH concentration.  This  is  not  shown  in  figure  2.13.,  but  table 
2.10.  shows  that  phosphate  concentrat  ion  was  constant  up  to  pH 
4.5,  wherafter  the  addition  of  orthophosphoric  acid  caused  an 
increase  in  phosphate  concentration.  The  efficiency,  due  mostly 
to  a  drop  in  peak width,  was  seen  to  increase  only  below  pH  4.5. 
This  increase  in  efficiency  suggests  a  hypothesis  that  the  elution 
of  morphine  as  the  morphonium  ion,  may  have  occured  via  the 
formation  of  ion-pairs  between  the  phosphate  ion, 
and  the morphonium  ion,  MH+. 
The  principles  of  ion  paired  chromatography  have  been  discussed  in 
chapter  one,  and  the  use  of  phosphate  as  a  pai ring  ion  has  also 
been  noted  (Wahlund  and  Sokolowski,  1978;  Snyder  and  Kirkland, 
1978) 
If  this  is  the  case,  increased  H2PO~  concentration  would 
increase  k2  (EQ.  1,  below),  and  shift  the  equilibrium  to  the 
right,  by  virtue of  the  conwon  ion  effect. 
EQ.  1 
The  degree  of  ion-pair  dissociation  will  be  less  at  higher 
phosphate  concentrations,  and  should  lead  to  improved  peak  shape 
as  was  observed. 
The  use  of  acidic  pH  could  also  improve  peak  shape  by  ensuring 
that  kl  was  high,  and  most  of  the  morphine  was  present  as 
morphonium  ion. 
From  the  Henderson-Hasselbach  equation,  the  degree  of  protonation 
of  morphine,  can  be  shown  to  vary  only  slightly  from  pH  4.5  to  2.5 
(see  table  2.11.),  and  to  a  greater  extent  above  4.5  by  virtue  of 
its  logarithmic  nature. 
-100-TABLE  2.11. 
VARIATION  IN  DEGREE  OF  PROTONATION  OF  MORPHINE  WITH  pH 
pH 
2.5 
3.5 
4.5 
5.5 
6.5 
7.5 
8.5 
9.0 
9.5 
[Morphine]/[Morphonium  ion] 
1.9SX10-6 
1.95X10-5 
1.95X10-4 
1.95X10-3 
1.95Xl0-2 
1.95X10-1 
1.95 
6.17 
19.5 
Calculated  from  Henderson-Hasselbach  eqn.: 
\  as  MH+ 
100 
100 
100 
99.8 
98.1 
83.6 
33.8 
13.9 
95.1 
pH_pKa+loq[Morphine]/[Morphonium  ion] 
(morphine  pKa  = 8.21) 
-101-The  fall  in  K'  between  pH  6.5  and  4.5,  might  be  due  to  poor 
equilibration  of  the  column  when  using  a  mobile  phase  which  was 
insufficiently  buffered  (Knox,  1978),  as  the  buffer  region  of  this 
O.OlM  KH2P04/H3P04  solution  is either side  of  pH  2.5. 
2.5.3.4.  Conclusion 
The  improvement  in  efficiency  was  shown  to  correlate  to 
both  the  increase  in  protonation  with  pH,  and  to  the  increase  in 
phosphate  concentration.  It  is  most  likely  that  pH,  phosphate 
concentration  and  the  buffer  properties  of  the  solution  all  have 
some  effect  on  the  chromatography  of  morphine.  Of  most  interest 
was  the  effect  of  phosphate  concentration,  as  this  indicated  the 
possible  operation  of  an  ion-paired  effect  which  might  be 
exploited to  improve  the  efficiency of this  separation. 
2.5.4.  THE  EFFECT  OF  PHOSPHATE  CONCENTRATION  ON  RETENTION  OF 
MORPHINE 
2.5.4.1.  Introduction 
In  order  to  investigate  the  possible  existance  of  an  ion 
pairing  effect,  a  series  of  solvents  at  constant  pH  but  varying 
phosphate  concentrations  were  ex~ined. 
2.5.4.2.  Method 
A  series  of  mobile  phases  were  prepared  from  solutions  of 
different  phosphate  concentration;  all  were  however  8'- in 
acetonitrile.  The  pH  was  controlled  by  adding  200mg  of  85'-
-102-orthophosphoric  acid  to  each.  As  volumes  of  250ml  were  used  for 
each  solvent,  this  increased  the  concentration  of  phosphate  in 
each  by  approximately  0.007  molar  with  each  200mg  of  85~ 
orthophosphoric  acid  (H3P04). 
The  mobile  phase  was  allowed  to equilibrate for  1  hour  before  use. 
Other  chromatographic  conditions  were  as  before  (2.5.1.2.). 
2.5.4.3.  Results  and  discussion 
The  buffer  capacity  of  each  solvent  examined  was  sufficient 
to  maintain  the  pH  within  the  range  2.5  - 2.7. 
shown  in  table  2.12 .. 
The  results  are 
There  was  a  trend  showing  an  improvement  in  peak  shape  as 
phosphate  concentration  increased. 
was  noted  above  0.02M  phosphate. 
No  improvement  in  efficiency 
The  retention  time  did  decrease  also,  but  not  sufficiently  to 
account  for  the  apparent  increase  in  efficiency. 
This  gives  qualified  support  to  the  above  hypothesis  that  the 
mechanism  by  which  morphine  was  chromatographed  on  this  system  was 
by  some  form  of  ion-pair  formation. 
At  high  concentration  of  phosphate  however  (greater  than  0.27 
molar),  problems  were  encountered  with  phosphate  crystallising 
around  the  seals  on  the  pump  and  liquid  joints.  Higher  back 
pressures  from  the  column  were  also  noted.  By  reducing  the 
phosphate  concentration  to  0.017M,  these  problems  were  less  severe 
and  no  great  loss  in  efficiency was  noted. 
-103-TABLE  2.12. 
EFFECT  ON  THE  RETENTION  BEHAVIOUR  OF  MORPHINE 
OF  PHOSPHATE  CONCENTRATION 
[Phosphate]  pH  RT  W  K'  N 
0.008  2.51  2.5  1.0  4.0  100 
0.012  2.54  2.3  0.8  3.6  132 
0.017  2.55  2.3  0.7  3.6  172 
0.022  2.55  2.2  0.6  3.4  215 
0.027  2.69  2.2  0.6  3.4  215 
0.107  2.71  * 
Dead  Time  = 0.5  mins 
*  unsuitable  due  to  precipitation of  phosphate 
-104-2.5.4.4.  Conclusion 
The  apparent  increase  in  effic  iency  wi th  increas  i ng 
phosphate  concentration  noted  above  was  confirmed.  This  supports 
a  theory  involving  ion-pair  formation  between  phosphate  and  the 
morphonium  ion.  An  example  of  the  optimum  chromatography 
achieved  using  81.  acetonitrile  in  O.OlK  KH2P04  adjusted  to  pH 
2.5  is  shown  in  figure  2.14 ..  This  shows  a  relatively  sharp  peak 
for  morphine  separated  from  the  solvent  front.  The  efficiency 
was  however  only  172  theoretical  plates,  which  was  low  by  most 
standards  and  the  suitability  of  a  system  like  this  for  the 
analysis  of  biological  extracts  is  not  generally  good.  Before 
further  attempts  were  made  to  improve  the  chromatography  however, 
a  typical  extract  obtained  from  the  procedure  corrently  used 
routinely  for  the  isolation of  morphine  from  post  mortem  blood  was 
examined  for  suitability on  this  system. 
2.5.5.  SUITABILITY  OF  THE  SYSTEM  FOR  THE  MEASUREMENT  OF  MORPHINE 
IN  BIO-EXTRACTS 
2.5.5.1  Introduction 
The  chromatographic  system  developed  above  was  set  up  and 
an  extract  prepared  from  an  expired  transfusion  blood  sample  by 
the  procedure  described  by  Horning  et  ale  1974.  Th i s  procedure 
is  examined  in- detail  later  (2.6.1.),  but  it  was  considered  to  be 
of  assistance  in  the  development  of  the  assay  to  include  this 
experiment  here. 
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CHROMATOGRAPHY  OF  MORPHINE  RESULTING  FROM 
8\ ACETONITRILE  IN  O.OlM  KH2P04  AT  pH2·5 
-106-2.5.5.2.  Method 
A  blank  blood  sample  and  a  sample  spiked  at  a  concentration 
of  10-3  gIl,  morphine  HCl,  were  extracted  by  the  method 
described  in  section 2.6.1 .. 
The  extract  was  reconstituted  in  100ul  and  2Sul  injected  as 
above.  Detection  was  by  UV  monitoring  at  a  wavelength  of  220nm. 
2.5.5.3.  Results  and  discussion 
A  typical  chromatogram  is  shown  in  figure  2.15 .. 
The  amount  of  interference  was  too  great  to  allow  either  definite 
identification  or  sensitive  detection.  The  morphine  peak  is 
hidden  by  the  material  eluting  following  the  injection  peak.  The 
peaks  were  broad  and  badly  tailed.  The  low  acetonitrile 
concentration  led  to  longer  retention  times  for  lipophilic 
material  which  had  co-extracted.  Peaks  resulting  from 
coextracted material  continued  to  elute  for  up  to  24  minutes. 
2.5.5.4  Conclusion 
The  system  as  presented  was  found  to  be  unsuitable  for  the 
examination  of  biological  extracts.  In  addition  to  the  fact  that 
the  morph i ne  peak  was  qu i te  broad,  its  capac i ty  fac tor  on  the 
system  was  short  in  comparison  to  the  later  eluting  peaks 
resulting  from  coextracted  material  in  the  extract.  Ideally  the 
drug  peak  should  be  the  las  t  to  elute  from  the  column.  Th i s 
suggests·  that  a  further  change  in  the  selectivity  of  the 
separation  was  required. 
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FIGURE  2.15. 
AMMONIUM  CARBONATE  EXTRACT  OF  A  SPIKED  BLOOD  SAMPLE 
RUN  ON  A  10cm  ODS  HYPERSIL  COLUMN.  8\ ACETONITRILE. 
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(J)  . 2.5.6.  STRATEGIES  FOR  IMPROVED  CHROMATOGRAPHY 
2.5.6.1.  Introduction 
The  selectivity  of  the  assay  required  improvement,  as  did 
the  peak  shape  and  the  efficiency  the  LC  method.  The 
chromatography  of  ionisable  substances  such  as  amines  often 
presents  problems  with  respect  to  retention,  efficiency  and 
tailing, . when  in  order  to  separate  these  compounds  by  adsorption 
chromatography,  it  is  neccessary  to  use  polar  eluents,  which 
reveal  the  inhomogeneity  of  the  adsorbent  surface  (Snyder  and 
Kirkland,  1978;  Twitchett  and  Moffatt,  1978;  Gill et al.,  1984) 
The  presence  of  heterogeneous  retention  sites  leads  to  mixed 
principles  of  separation.  At  low  sample  concentrations  the 
sites  are  preferentially  combined  with  sample  stronger 
molecules.  When  these  sites  are  not  overloaded,  normal  elution 
of  the  sample  bands  is  observed.  For  more  practical  sample  sizes 
however  these  sites  become  saturated  and  this  overloading  results 
in  band  tailing.  For  later  eluting  compounds  there  is  a  greater 
concentration  of  the  analyte  on  the  stationary  phase  and  therefore 
greater  band  tailing. 
this. 
There  are  several  ways  in  which  to  avoid 
The  high  lipophilic  nature  of  the  C18  chains  means  that  only  a 
low  percentage  covering  of  the  support  material  is  possible 
(typically  5-20~),  and  overloading  can  occur  at  low  analyte 
concentrations.  The  remaining  silanol  groups  can  be  deactivated 
by  reacting  them  with  a  moiety  of  lower  hydrophobicity.  The  most 
common  reagent  is  chloro  trimethyl  silane. 
capping. 
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This  is  known  as Another  approach  is  to  alter  the  selectivity  of  the  solvent  or  to 
change  the  mode  of  chromatography,  for  example  from  reversed  phase 
to  normal  phase,  ion  exchange  or  ion  paired  chromatography. 
As  a  range  of  binary  solvent  mixtures  have  already  been  examined, 
the  use  of  a  deactivated  packing  material  was  considered,  before 
changes  were  made  to  the  mode  of  chromatography. 
At  this  point  the  electrochemical  detector  became  available  and 
was  used  for  the  further  development  of  the  assay.  The  model 
used  was  a  BAS  LC-4B  amperom~tric detector.  It was  operated  with 
a  TL-5A  glassy  carbon  working  electrode  at  a  potential  of  +0.870 
volts  as  determined  by  the  use  of  cyclic  voltammetry  in  2.4.5 .. 
2.5.7.  USE  OF  A CAPPED  PACKING  MATERIAL 
2.5.7.1.  Introduction 
As  ODS  Hypersil  has  no  capping  performed  on  it,  an  ODS 
reversed  phase  material  APEX  ODS  (Jones  chromatography)  was 
considered.  The  product  specifications  state  that  it  is  a  fully 
capped  reversed  phase  material,  absorptive  functions  being 
eliminated  by  reacting  the  residual  sites  silanol  sites  on  the 
C
l8 
material  with  a  small  hydrocarbon  function  to  give  a 
"reproducible,  single  function  separation"  (Applications  notes, 
Jones  chromtography,  Glamorgan,  U.(.) 
2.5.7.2.  Method 
The  ability of  the  packing  material  to  form  a  slurry  in  the 
methanol/sodium  acetate  mixture  described  in  appendix  A  was 
-110-examined.  Th i s  was  found  to  be  su  i table,  and  a  lOcm  column  was 
packed  according  to this  procedure. 
The  8~  acetonitrile  in  O.OlM  KH2P04  at  pH  2.6,  mobile  phase 
was  used.  Detection  was  by  ED  at  a  potential  of  +O.870V  as 
before. 
2.5.1.4.  Results  and  Discussion 
The  results  are  noted  in  table  2.13.,  and  compared  wi th 
results  from  ODS  Hypersil  under  identical conditions. 
This  indicates  that  there  was  no  great  difference  in  the  retention 
properties  of  the  two  materials.  This  could  be  accounted  for  in 
several  ways.  The  limiting  factor  for  the  efficiency  may  be  the 
adsorption  characteristics  of  the  stationary  phase  materials 
themselves.  The  degree  of  capping  of  the  Apex  material  may  have 
been  insufficient  to  accomodate  all  the  analyte  at  the  conditions 
being  examined,  therefore  no  difference  between  the  materials 
would  be  apparent. 
For  practical  purposes,  this  experiment  demonstrates  that  there 
was  no  improvement  in  the  peak  shape  or  overall  performance  using 
a  capped  material.  The  slight  apparent  increase  in  efficiency 
was  attributed to  the  reduced  retention  time. 
Hypersil  ODS  was  initially  selected  for  reasons  outlined  earlier 
in  chapter  one  and  as  there  was  minimal  cost  difference  between 
the  two  materials,  it was  decided  to  continue  using  ODS  Hypersil. 
-111-TABLE  2.13. 
EFFECT  OF  USING  END-CAPPED  STATIONARY  PHASE  ON  THE 
RETENTION  BEHAVIOUR  OF  MORPHINE 
Material 
Hypersil  ODS 
Apex  ODS 
column 
100X4.6 
100x4.6 
capped 
No 
Yes 
TABLE  2.14. 
k' 
3.8 
3.7 
N 
154 
162 
cost/lOg 
£61.00 
£55.00 
EFFECT  OF  PACKING  PROCEDURES  AND  COLUMN  LENGTH 
ON  RETENTION  BEHAVIOUR  OF  MORPHINE 
column  packing  proc.  k'  N 
100x4.6  A  3.8  158 
100x4.6  B  3.80  188 
100x4.6  B  3.20  196 
250x4.6  B  3.13  215 
-112-2.5.8.  REVISED  PACKING  PROCEDURE  FOR  LC  COLUMNS 
2.5.8.1.  Introduction 
The  packing  procedure  used  for  the  HPLC  column  used  in  this 
study  was  that  described  by  Eppel  (1980),  and  was  based  on 
information  supplied  by  the  manufacturers  of  the  packing 
material.  In  an  attempt  to  improve  the  efficiency of  the  columns 
packed  in  the  laboratory,  the  manufacturers  were  contacted  for 
details  of  any  changes  to  the  recommended  packing  procedure.  The 
procedure  currently  recommended  is  given  in full  in  appendix  B. 
In  addition  it was  decided  to  examine  the  effect  of  using  a  250mm 
column  as  a  longer  column  can  give  greater  resol  vi  ng  power  to  a 
separation  (Snyder  and  Kirkland  1978). 
2.5.8.2.  Method 
The  columns  were  packed  according  to  the  full  procedure  as 
outlined  in  appendix  B.  Acetone  was  used  as  the  slurryin& 
solvent  and  also  used  as  the  packing  solvent.  Changing  to  this 
solvent  required  changes  to  the  seals  in  the  packing  pump,  to 
ensure  that  they  were  compatible  with  acetone. 
Other  alterations  to  the  procedure  included  the  practice  of 
inverting  the  column  during  packing. 
Once  the  columns  had  been  packed  and  the  end  fittings  attached, 
they  were  conditioned  with  50/50  methanol/water  (50Oml)  before 
being  washed  with  water  (10Oml)  and  methanol  (10Oml). 
were  left  in  methanol  when  not  in  use. 
Columns 
One  2SOmm  and  two  100mm  columns  were  packed  in  this  manner  and  the 
retention  of  morphine  was  examined  on  each.  The  retention 
-113-behaviour  of  morphine  on  a  column  packed  by  the  procedure  in 
appendix  A is  given  for  comparison. 
2.5.8.3.  Results  and  discussion 
The  capacity  factor  and  efficiency  of  the  chromatography  of 
morphine  on  each  of  the  columns  is  given  in  table  2.14 ..  For  the 
lOOmm  columns  there  was  no  significant  change  in  the  capacity 
factor,  but  there  was  a  slight  change  in  the  efficiency which  was 
marginally  improved. 
For  the  250mm  column  the  increased  length  caused  a  consequently 
higher  back  pressure  and  the  flow  rate was  changed  to  2ml/min. 
The  efficiency  of  the  separation  was  slightly  increased  over  the 
shorter  column,  and  although  there  was  a  small  decrease  in  the 
capacity  factor,  the  retention  time  of  morphine  had  been  increased 
wi thout  any  consequent  loss  of  efficiency.  Th is  was  one  of  the 
aims  of  the  optimisation  and  whether  it  was  due  to  the  greater 
resolving  power  of  the  column  or  the  reduced  flow  rate,  it  was 
cons idered  an  improvement.  This  column  operated  at  2ml/min  was 
used  for all further  developement  work. 
2.5.8.4.  Conclusions 
The  use  of  the  acetone  packing  procedure  (B)  appears  to 
give  improved  chromatography,  and  the  use  of  longer  columns  also 
increases  the  efficiency  with  no  significant  change  in  the 
capacity factor. 
The  efficiency  was  still  relatively  low  and  should  be  improved 
before  the  method  was  suitable  for  the  analysis  of  biological 
extracts.  For  all future  work  procedure  B was  adopted. 
-114-Having  demonstrated  that  the  use  of  the  deactivated  packing 
material  had  not  improved  the  chromatography  of  morphine,  an 
alternative  approach  was  considered. 
The  results  obtained  in  section  2.5.3.  suggested  that  morphine 
might  be  amenable  to  ion-pair  formation,  and  so  the  use  of 
ion-paired  chromatography  was  examined. 
A  number  of  reports  involving  the  use  of  ion  pairing  techniques 
have  appeared  in  the  literature  (Vandenberghe  et  al.,  1984;  Moore 
et  al.,  1984)  and  these  have  demonstrated  acceptable  peak  shape, 
better  than  has  been  achieved  above.  other  pairing  ions  with 
selectivities  considerably  different  from  phosphate  were  therefore 
considered. 
2.5.9.  THE  USE  OF  ION-PAIRING  AGENTS 
2.5.9.1.  Introduction 
A  discussion  of  ion-paired  chromatography  was  given  in 
chapter  1.  Its  use  is  recommended  to  reduce  tailing  of  basic 
compounds  in  reversed  phase  chromatography  (Gloor  and  Johnson, 
1977;  Knox,  1978;  Wahlund  and  Sokolowski,  1978). 
As  morphine  is  a  basic  compound  (pKa=8.21) ,  it will  readily  become 
protonated  in  aqueous  solutions  below  pH  8  (see  table  2.11.). 
The  pH  range  in  which  it  would  be  completely  unprotonated  is 
outwith  the  stability  range  of  the  packing  material  (~reater  than 
pH  11),  therefore  the  complete  or  partial  protonation  of  morphine 
must  be  taken  into  consideration.  The  approach  adopted  for 
ion-pairing  is  to  ensure  complete  protonation  of  the  morphine  by 
-115-using  a  mobile  pbase  of  pH  less  than  3. 
From  the  discussion  in  2.5.3.3.  it  can  be  seen  that  the  region  of 
buffer  activity  is  in  the  pH  range  2.5-2.7 ..  This  pH  will  ensure 
complete  protonation  of  the morphine  (see  table  2.11.). 
Morph i ne  as  the  morphon i um  ion  c an  then  be  pa  i red  wi th  an  an i on 
(figure  2.16.),  and  the  chromatography  of  this  uncharged  moiety 
examined. 
Earlier  results  indicate  that  morphine  may  have  been  pairing  with 
phosphate  to  some  extent  (see  sections  2.5.3.  and  2.5.4.).  Many 
anions  have  been  reported  in  the  li  terature  as  pairing  ions  for 
basic  compounds  including  phosphate,  bromide,  chloride, 
perchlorate,  picrate,  dodecyl  sulphate,  methyl  sulphonate  and 
various  sulphonic  acids  (Snyder  and  Kirkland,  1978;  Gloor  and 
Johnson,  1977). 
It  was  decided  to  examine  the  suitability  of  alkyl  sulphonic 
acids.  These  are  recognised  as  good  ion-pairing  agents  and  their 
hydrophobicity  increases  with  increasing  chain  length,  imparting 
further  selectivity to  the  separation. 
2.5.9.2.  Method 
Heptane  sulphonic  acid  (HSA)  was  added  to  the  optimum 
mobile  phase  developed  above  (8~  acetonitrile  in  0.01H  KH2P04, 
pH2.5),  at  a  concentration  of  0.005K.  This  was  allowed  to 
equilibrate  for  1  hour  before  any  samples  were  introduced.  After 
this  time  reproducible  chromatography  could  be  achieved.  A 
-2  standard  solution of  10  gIl  of morphine  was  used. 
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FIGURE  2.16. 
FORMATION  OF  NEUTRAL  ION-PAIR  BETWEEN 
MORPHONIUM  ION  AND  A  SUITABLE  ANION 
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o 2.5.9.3.  Results  and  discussion 
Morphine  eluted  from  the  column  considerably  later  (25 
minutes,  K'  = 18).  The  efficiency  however  was  400,  a  significant 
improvement  on  before.  The  peak  was  very  broad  (20  minutes)  and 
the  system  as  described  was  of  Ii  ttle  practical  value  for  the 
analysis  of  morphine.  Having  confirmed  however  the  operation  of 
some  ion  paired  effect  in  the  chromatography  of  morphine,  this 
approach  was  considered further. 
2.5.9.4.  Conclusions 
The  presence  of  the  ion-pairing  compound  had  increased  the 
retention  time  of  the  morphine  on  column.  It  was  dec ided  to 
investigate  whether  the  retention  could  be  altered  by  varying  the 
concentration  of  the  organic modifier. 
2.5.10.  OPTIMISATION  OF  ION-PAIRED  CHROMATOGRAPHY  OF  MORPHINE 
2.5.10.1.  Introduction 
The  retention  of  a  moiety  on  column  can  be  altered  by 
changing  the  concentration  or  chain  length  of  the  ion-pairing 
agent  (Bartha  et al.,  1984),  and  also  by  controlling  the  amount  of 
organic modifier. 
The  concentration  of  the  pairing  ion  will  also  effect  the 
retention of  the  analyte  (Gloor  and  Johnson,  1977). 
-118-2.5.10.2.  Method 
Two  ion-pai ring  agents  heptane  sulphonic  ac id  (HSA) ,  and 
octane  sulphonic  acid  (OSA)  were  examined  in  detail.  A series  of 
solvents  with  increasing  acetonitrile  concentrations  were 
prepared.  O.OlM  KH2P04  was  used  and  the  pH  of  the  solvents 
was  kept  at  pH2.S  to  assist  with  the  fOrm.8:tion  of  morphonium  ion 
and  hence  with  ion  pairing.  Detection  was  by  UV  detection 
monitoring  at  220nm,  and  ED  at  a  potential  of  +0.870V  connected  in 
series  in  that  order.  The  large  volume  of  the  reference 
compartment  in  the  electrochemical  cell  would  dilute  the  analyte 
and  prevent  its  detection  in  the  UV  cell.  Further,  the 
electrochemical  detector  wi 11  not  wi thstand  the  pressures  created 
by  attaching further  flow cell after it. 
The  solvent  was  adjusted  to  the  desired  concentration  in 
ion-pairing  agent  by  the  addition  of  a  weighed  amount  of  the 
respective  sodium salt. 
The  mobile  phase  was  allowed  to  equilibrate  for  one  hour,  and  the 
retention  behaviour  of  morphine  investigated  by  the  injection  of 
-3  .  1  20ul  10  gIl morphlne  He  . 
This  was  done  for  a  range  of  pairing  ion  concentrations.  Ion 
pairing  agents  can  be  difficult  to  remove  from  the  column  after 
use.  To  prevent  the  interference  of  ion  pairing  agents  from 
previous  solvents  the  column  were  pumped  through  with  O.OlM 
Ethylenediamine  tetra  acetate  (EDTA)  to  remove  the  ion  pairin& 
agent.  EDTA  is  highly  water  soluble  and  any  residual  material 
was  eluted  with  a  subsequent  water  wash  (20Oml)  when  chan&in& 
between  solvents  with different  ion  pairin&  agents. 
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TABLE  2.15. 
VARIATION  OF  MORPHINE  RETENTION  TIME  WITH  ACETONITRILE  CONTENT 
AND  OSA/HSA  CONCENTRATION 
OSA 
concentration  acetonitrile concentration  (\) 
8\  10\  15\  20\  25\ 
Rt  K'  Rt  K'  Rt  K'  Rt  K'  Rt  K' 
0.005  27.9  17.6  22.8  14.2  14.3  8.5  7.2  3.8  4.4  1.9 
0.01  30.6  19.4  26.0  16.3  16.8  10.2  9.0  5.0  4.7  2.1 
0.02  36.0  23.0  28.4  17.9  19.0  11.7  11.3  6.5  5.7  2.8 
HSA 
concentration  acetonitrile concentration  (\) 
8\  10\  15\  20\  25\ 
Rt  K'  Rt  K'  Rt  K'  Rt  K'  Rt  K' 
0.005  26.3  16.5  16.9  10.3  8.4  5.0  4.6  2.0  3.5  1.4 
0.01  27.8  17.5  18.9  11.6  10.8  6.2  5.4  2.6  4.3  1.9 
0.02  30.0  19.0  21.9  13.6  13.0  7.7  6.7  3.5  4.6  2.0 
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Retention  times  and  capacity  factors  are  shown  in  table 
2.15.,  and  graphically  in  figures  2.17.  and  2.18 .. 
(a)  Heptane  Su1phonic  Acid 
As  the  concentration  of  ion-pair  increases,  so  does 
the  degree  of  retention.  This  could  be  due  to  k2  being  shifted 
further  to  the  right  in  EQ.  1  above  (2.5.3.3.).  As  this  change 
in  retention  follows  the  trend  observed  for  phosphate  in  section 
2.5.4.  above,  it  would  support  the  hypothesis  of  ion-pairing 
between  morphine  and  H2PO~ in  that  case. 
Increasing  the  concentration  of  the  pairing  ion  also  resulted  in 
increased  retention  time/capacity  factor  of  morphine  by  a  small 
amount.  In  the  presence  of  the  ion  pairing  agent  at  any  of  the 
concentrations  examined,  by  far  the  greatest  control  of  retention 
was  ach i eved  by  alter  i ng  the  ace  ton  i tr  i Ie  con ten  t  of  the  mobile 
phase. 
(b)  Octane  Sulphonic  Acid 
The  results  follow  the  pattern  for  HSA.  The 
increase  in  retention  is 
hydrophobicity  of  the 
greater,  due  to 
ion-pair. 
the 
Again 
greater 
higher 
concentrat ions  of  ion  pai ring  agent  increased  the  retent  ion  time 
of  morphine  by  a  small  extent,  however  a  wide  range  of  capacity 
factor  could  be  achieved  by  appropriate  choice  of  the  acetonitrile 
content  of  the mobile  phase. 
-123-The  observed  increase  in  retention  time  with  ion  pair  rea&ent 
. 
concentration  agrees  with  observations  which  show  that  smaller 
pairing  ions  require  very  lar&e  concentrations  before  the  critical 
micelle  concentration  is  reached  (Gloor  and  Johnson,  1977). 
After  that  point  the  retention  decreases  with  increasing  ion-pair 
concentration. 
2.5.10.4.  Conclusion 
The  use  of  ion-pairing  agents  improves  the  peak  shape  for 
morphine.  The  morphine  peak  can  be  retained  on  the  column  for  a 
longer  period  of  time  wi thout  the  spreading  of  the  peak  observed 
when  binary  solvent  mixtures  were  used  (1.5.1.  and  1.5.2.).  The 
alkyl  chain  length  has  a  more  noticeable  effect  on  the  retention 
of  morphine  than  on  the  peak  shape  or  efficiency.  Wi th  the  wi de 
range  of  capaci ty  factors  produced  from  different  concentrations 
of  acetonitrile  it was  expected  that  a  suitable  solvent  could  be 
found  for  the  analysis  of  morphine  in  extracts  from  biological 
samples 
2.5.11.  THE  PRESENCE  OF  SYSTEM  PEAKS  WITH  ELECTROCHEMICAL  DETECTION 
2.5.11.1.  Introduction 
In  the  above  experiments  a  1ar&e  peak  (marked  S)  appeared 
with  every  injection  on  the  trace  from  the  electrochemical 
detector,  and  to  a  sli&ht extent  on  the  UV  detector. 
Sample  ED  traces  are  shown  in  fi&ure  2.19.(a  - c)  for  mobile 
phases  which  were  2~ acetonitrile  in  O.OlK  KH2P04  at  pH  2.5 
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FIGURE  2.19. 
TRACES  SHOWING  THE  POSITION  OF  PEAK  DUE  TO  MORPHINE  (M)  AND  SYSTEM  PEAK  (S) 
FOR  (a)  PENTANE  SULPHONIC  ACID  (10-2M).  (b)  HEPTANE  SULPHONIC  ACID  (10-2M)  AND 
(c)  HEPTANE  SULPHONIC  ACID  (10-2M)  IN  20\  ACETONITRILE  IN  O.OlM  KH2P04  AT  pH3 
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and  10  M  in  pentane,  heptane  and  octane  sulphonic  acids 
respectively. 
This  peak  was  not  immediately  apparent  with  pentane  sulphonic 
acid,  as  it appeared  just  after  the  solvent  front.  Wi th  heptane 
sulphonic  acid,  the  peak  was  very  much  more  apparent  and 
overlapped  to  some  extent  with  the  morphine  peak.  With  octane 
sulphonic  acid  the  peak  appeared  sufficiently  after  the  morphine 
peak  not  to  interfere.  In  order  to  rule  out  the  possibility  of 
contamination,  the  identity of this  peak  was  investigated. 
2.5.11.2.  Method 
The  HPLC  system  was  set  up  with  a  mobile  phase  as 
follows.  20~  acetonitrile  in  O.OH!  KH2
P0
4  at  pH  2.5. 
Sufficient  octane  sulphonic  acid  was  added  to  make  the  resulting 
-2  solution  10  M.  Thi s  mobile  phase  was  chosen  as  it  gave  good 
resolution  of  morphine  from  the  solvent  front,  good  peak  shape  and 
the  fact  that  the  morphine  peak  and  the  system  peak  were  well 
separated. 
A  variety  of  reagent  blanks  and  sample  types  were  examined  by 
injection  into the  sample  loop. 
2.S.11.3.  Results  and  Discussion 
A  peak  in  the  position  shown  in  figure  2.19.(c)  was  found 
after  the  introduction  of  samples  of  water,  mobile  phase,  air, 
helium,  nitrogen,  O.OOlM  NaOH,  O.OlK  HCI.  The  peak  height  was 
not  reproducible,  but  the  peak  was  always  present  to  some 
extent.  It was  assiSDed  as  a  "system peak". 
This  is  the  name  given  to  peaks  which  are  inherent  in  the  system 
-126-and  are  caused  by  equilibration  or  re-equilibration  of  the  mobile 
phase  after  some  disturbance.  Although  these  peaks  are  often 
present  in  published  chromatograms,  they  are  rarely  identified  or 
commented  upon. 
A  separation  of  amino  acids  gave  rise  to  four  peaks  (Levin  and 
Grushka,  1986)  which  were  identified  as  cor~esponding  to  the  four 
const  i tuents  of  the  mobile  phase.  Of  these,  the  latest  eluting 
was  identified  as  heptane  sulphonic  acid,  a  constituent  of  the 
mobile  phase. 
The  mechanism  proposed  here  for  this  phenomenon  is  that  following 
the  injection  of  any  material  onto  the  column,  any  component  of 
the  mobile  phase  which  is  adsorbed  onto  the  top  part  of  the  column 
(all  are  to  a  greater  or  lesser  extent)  will  be  displaced.  The 
equ iIi  bri  urn  concentrat  ions  on  the  top  of  the  column  wi 11 
immediately  be  restored  by  adsorbing  material  out  of  the  mobile 
phase. 
The  displaced  material  will  be  carried  by  the  mobile  phase,  to 
which  it will  be  in  disproportion,  out  of  the  column.  The  degree 
to  which  each  component  is  retained  by  the  column  will  determine 
at  what  time  the  system  peak  elutes.  There  should  be  the  same 
number  of  system  peaks  as  species  present  in  the  mobile  phase. 
Water,  phosphate,  acetonitrile  and  potassium  will  have  negir,lble 
retention  on  the  column  and  these  will  indicate  the  dead  time. 
Alkyl  sulphonic  acids  however  having  hydrophobic  tails  will  be 
significantly  retained  by  the  non-polar  stationary  phase.  The 
degree  of  retention  which  should  increase  with  hydrophobicity  and 
hence  chain  length,  the  shorter  chained  species  being  retained 
less  and  eluting earlier  (Bartha et al.,  1984). 
-127-TAB~E 2.16. 
EFFECT  OF  NATURE  OF  ION-PAIRING  AGENT  ON  THE 
RETENTION  OF  MORPHINE  (M)  AND  THE  SYSTEM  PEAK  (5) 
pairing agent  M/S*  DT  RT  K' 
CSS04H  5  1.3  2.4  0.85 
M  1.3  3.2  1.44 
C7S04H  S  1.3  4.4  2.38 
M  1.3  5.0  2.85 
C8S04H  S  1.3  12.9  8.92 
M  1.3  8.7  5.69 
*  Morphine  or  System  peak 
-128-This  is  confiLmed  in  the  results  shown  in  table  2.16.  fOL  the  Kt 
values  of  the  system  peak  caused  by  pentane,  heptane  and  octane 
sulphonic  acid mobile  phases  shown  in  figuLes  2.l9.(a - c). 
2.5.12.  CONCLUSION  SELECTION  OF  A  SUITABLE  SOLVENT  FOR  THE 
CHROMATOGRAPHY  OF  MORPHINE 
From  the  data  in  the  above  experiments  a  solvent  was  chosen 
for  further  investigation  in  an  attempt  to  find  a  system  suitable 
for  the  sensitive  and  selective  measurement  of  morphine  in 
biological extracts. 
Figures  2.17.  and  2.18.  provide  informat ion  concern i ng  the 
capacity  factor  and  retention  time  of  mOLphine  achieved  using 
various  strengths  of  heptane  and  octane  sulphonic  acids. 
The  solvent  selected  contained  20~ acetonitLile  and  octane 
sulphonic  acid  (10-2M).  This  system  had  a  capacity factor  of 
5.7  for  morphine  and  an  efficiency of  around  N=600. 
Solvents  containing  heptane  sulphonic  acid  were  Lejected  because 
of  the  proximity  of  the  system  peak  to  the  morphine  peak.  An 
example  of  the  chLomatography  achieved  with  this  solvent  is  shown 
in  figure  2.20 ..  Also  shown  in  this  figure  is  nalorphine  which 
was  later  selected  as  an  internal  standard.  This  is  discussed 
below  in  section  2.5.15..  The  other  chLomatogLaphic  conditions 
used  in  further  sections  was  as  follows.  A  Gilson  302  single 
piston  pump  (Smm  pump  head)  opeLated  at  2ml/min.  Sample 
introduction  was  through  a  Rheodyne  7125  six-poLt  injection 
valve.  The  detectoL  was  a  BAS  LC-4B  amperometric  detectoL 
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-130-operated  at  +0.870  volts  (oxidation)  with  the  signal  filter  and 
sensitivity settings set  as  required. 
2.5.13.  HYDRODYNAMIC  VOLTAMMETRY  OF  MORPHINE 
2.5.13.1.  Introduction 
Hydrodynamic  voltammetry  (discussed  in  chapter  one)  is  a 
technique  used  to  study  the  electrochemical  properties  of  a 
substance  when  it can  be  eluted  from  an  HPLC  column. 
Having  selected  a  suitable  solvent  system  for  morphine,  using  a 
potential  +0.870  volts  predicted  by  cyclic  voltammetry  (a  steady 
state  technique)  (see  section  2.4.5.),  the  suitability  of  this 
working  potential  for  morphine  was  examined  under  the  condi tions 
of  the  analysis,  by  recording  hydrodynamic  voltammograms  (HOV's). 
2.5.13.2.  Method 
Two  HOV's  were  conducted  under  the  same  chromatographic 
conditions  but  with  the  voltage  changing  in  opposite  directions  to 
gauge  the  effect  this  might  have  on  the  observed  Ep  value. 
Fresh  solvent  was  prepared  each  time,  and  the  electrode  was 
polished before  each  HOV  was  measured. 
The  first  was  performed  starting  from  1.2  volts  and  decreasing  the 
potential. 
potential. 
The  second  from  0.3  volts  and  increasing  the 
Successive  injections  of  a  10-3g/l  standard  were  made  and  the 
potential  altered  between  each  injection.  The  backsround  current 
was  allowed  to  equ iIi  brate  between  changes  in  potent  i aI,  before 
-131-the  sample  was  injected.  Chromatographic  conditions  were  as 
described  in  section 1.5.12. 
2.5.13.3.  Results  and  discussion 
The  HOV  data  is  shown  as  percentage  of  maximum  response 
(VIR)  (table  2.17.),  as  the  values  for  the  current  produced  were 
not  recorded.  The  data  is  plotted  in  figure  2.21.  and  the  E 
p 
values  are  indicated. 
From  the  two  sets  of  results  it is  evident  that  the  pattern of  the 
voltammetry  changes  considerably  depending  on  the  direction  of 
voltage  sweep. 
With  increasing  potential  the  observed  E  was  0.76  volts 
p 
compared  to  1.05  volts  for  decreasing  potential.  The  implication 
is  that  irreversible  contamination  of  the  working  electrode  occurs 
at  potentials  greater  than  one  volt,  resulting  in  larger 
potentials  being  required  to  ensure  the  adsorption  of  the  ana1yte 
on  to  the  surface.  This  contamination  comes  probably  from 
constituents  or  impurities  in  the mobile  phase. 
It  would  be  reasonable  to  assume  that  more  complex  mobile  phales 
would  contain  more  potential  contaminants  and  this  may  account  for 
the  discrepancy  observed  between  these  values  and  the  value 
obtained  by  CV  (+0.870  volts).  Various  values  of  E  have  been  p 
recorded  for  morphine  by  CV  and  HOV  in  different  solvents  (See 
table  2.5.).  Also  noted  is  the  observation  by  Gill  et  al .• 
(1984)  of  no  plateau. 
-132-RESPONSE  DATA  FOR  HYDRODYNAMIC  VOLTAMMETRY  EXPERIMENTS 
WITH  VOLTAGE  SCAN  UP  AND  VOLTACE  SCAN  DOWN 
HDV  1  HDV2 
potential  scan  down  potential  scan  up 
voltage  %MR  voltage  \MR 
1.20  88  0.30  0 
1.15  97  0.40  0 
1.10  100  0.50  0 
1.00  89  0.55  0 
0.95  66  0.60  7 
0.90  44  0.65  43 
0.85  25  0.70  79 
0.80  11  0.75  96 
0.75  3  0.80  92 
0.70  1  0.85  100 
0.65  0  0.90  99 
0.60  0  0.95  97 
0.55  0  1.00  92 
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.... - ." 2.5.13.4.  Conclusion 
This  experiment  demonstrated  that  the  method  by  which  the 
full  wave  potential  (E  >  of  morphine  is  measured  can  influence  p 
that  measurement.  Contamination  of  the  electrode  is  unavoidable 
in  the  case  of  analys  i s  of  complex  extracts,  and  th ismay  effect 
the  ability  of  the  detector  sensitively  to  detect  the  analyte. 
This  suggests  the  need  for  both  an  internal  standard  of  similar 
electrochemical  properties  to  the  analyte  and  also  regular 
analysis  of  standard  solutions  in  order  to  check  the  sensitivity 
of  the detector. 
As  a  result  of  this  experiment,  the  potential  selected  for  further 
work  was  +0.870  volts,  obtained  by  cyclic  voltammetry  and  used  in 
investigations  up  to this point. 
It  was  noted  in  practice  that  if,  over  a  period  of  several  days 
the  response  of  the  detector  fell,  it  could  be  regained  to  some 
extent  without  polishing  by  increasing  the  applied  potential  to 
+1.000  volt. 
2.5.14.  COMPARISON  OF  SENSITIVITIES  OBTAINED  FROM  UV  AND  ED 
DETECTORS 
2.5.14.1.  Introduction 
The  su  i tabi  I i ty  of  UV  absorbance  and  electrochemical 
detectors  has  been  described  above  (2.2.6.  and  2.4.>.  A 
compari son  was  therefore  made  of  the  two  detect  ion  systems  in 
order  to  assess  which  would  be  most  suitable  for  the  detection of 
low levels  of morphine. 
-135-2.5.14.2  Method 
In  order  to  make  a  val  i d  compar i son  of  two  different  modes 
of  detection,  the  detectors  were  operated  under  i dent i cal 
conditions.  They  were  attached  in  series  and  standards  of 
decreasing  concentration  were  analysed.  The  detec  t i on  1 imi twas 
defined  as  the  settings  at  which  signal  to  noise  ratio  fell  below 
75'-.  Other  parameters  were  set  at  values  normally  used  in  this 
assay.  The  UV  detector  (Kratos  spectroflow)  was  operated  at 
212  nm  as  des  c rib  e din  2. 4 . 2 . .  For  the  electrochemical  detector 
(BAS  LC-4B,  with  TL-5A  thin  layer  flow  cell),  a  potential  of 
+0.870V  was  used.  The  ion-paired  solvent  system  developed  above 
(2.5.12.)  was  used. 
A  series  of  standard  solulions  of  morphine  were  prepared,  ranging 
from  10-2  to  -5  10  gIl.  These  were  analysed  on  the  above 
system. 
2.5.14.3.  Results  and  discuss.!on 
The  linearity  of  response  for  both  detectors  is  shown  in 
table  2.18.  and  figure  2.22.  Because  of  the  wide  range  of 
concentrations  being  examined,  the  units  of  current  are  in  nA  as 
read  from  the  dig  i tal  display.  Absorbances  are  calculated  from 
-3  peak  height  and  presented  as  Abs  x  10  ,(mAbs). 
ED  is  reported  to  have  a  greater  linear  range  than  other  forms  of 
detection.  This  is  not  evident  from  these  results  as  both 
display  a  linear  response  with  correlation  coefficients  greater 
than  0.99  (UV  0.9923,  and  ED  0.9999)  within  the  range  of  interest, 
although  the  final  point  (for  10-2g/L)  did  not  lie  on  t.he  best 
fitted  line  (see  figure  2.22.). 
-136-TABLE  2.1a. 
RESPONSE  OF  UV  AND  ELECTROCHEMICAL  DETECTORS 
TO  A  RANGE  OF  MORPHINE  CONCENTRATIONS 
Concentration 
(gIl) 
10-S 
5x10-S 
10-4 
2x10-4 
5x10-4 
ax10-4 
10-3 
5x10-3 
10-2 
)Ie  Not  detected.  *  omitted 
ng  olc 
0.2 
1.0 
2.0 
4.0 
10.0 
16.0 
20.0 
50.0 
100.0 
$  UV 
(mAbs) 
_)Ie 
_)Ie 
0.2  (SIN  3:1) 
O.S 
1.2 
-*  2.3 
13.4 
21.2 
$  nanograms  of morphine  on  column 
-137-
ED 
(nA) 
0.08  (SIN 
0.30 
0.62 
1.20 
3.0S 
4.48 
6.20 
29.45 
64.30 
4:1) 100 
• 
10
1 
~ 
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C 
'-"'" 
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LINEARITY  OF  RESPONSE  TO  MORPHINE  FROM  UV  AND 
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0 The  poorer  correlation  seen  for  UV  detection  may  result  from 
measuring  error  when  measuring  the  small  peaks  produced  by  the  UV 
detector. 
The  sensitivity  of  the  two  methods  is  also  compared.  The  ED  is 
shown  to  be  ten  times  more  sensitive  (for  a  similar  signal  to 
noise ratio)  than  UV  detection,  under  optimum conditions. 
The  response  of  the  ED  varies  from  day  to  day,  and  the  results 
shown  above  represent  the  opt  imum,  achieved  by  us ing  a  freshly 
polished  electrode,  shortly  after  the  equilibration  of  a  fresh 
solvent.  Typical  day  to  day  variation  is  evident  in  the  study 
discussed  in  section 2.9.3.  (esp.  table 2.27.). 
For  normal  operation,  a  signal  of  o. 5nA  for  a  10-4g/l  standard 
could  be  expected. 
2.4.14.4.  Conclusion 
Because  of  its  greater  sens it  i vi  ty,  the  ED  detector  was 
used  on  its  own  in  this  study  for  the  examination  of  extraction 
procedures,  and  subsequently  for  the  analysis  of  extracts  obtained 
from  authentic  samples. 
2.5.15.  SELECTION  OF  AN  INTERNAL  STANDARD 
2.5.15.1.  Introduction 
A  series  of  drugs  commonly  encountered  in  forensic  casework 
were  analysed  on  the  system  selected  above  in  order  to  check  any 
possible  interference with  the morphine  assay. 
Th •••  drugs  would  have  to  b.  basic  to  pass  the  extraction  step, 
-139-TABLE  2.19. 
RETENTION  BEHAVIOUR  OF  OTHER  DRUGS  ON 
MORPHINE  HPLC  SYSTEM 
Drug  K'  UV220  ED1.000V 
primidone  2.0  +  + 
methyprylon e  3.3  + 
morphine  4.5  +  + 
phenobarbitone  5.5  + 
butabarbitone  6.5  + 
butalbital  6.1  + 
nalorphine  9.0  +  + 
codeine  11.5  + 
phenytoin  15.0  + 
amy1obarbitone  19.0  + 
glutethimide  20.1  + 
oxycodone  22.1  + 
quinalbarbitone  22.3  + 
benzoylecgonine  ne 
bupivacaine  ne 
butacaine  ne 
caffeine  ne 
cannabinol  ne 
cannabidiol  ne 
chlordiazepoxide  ne 
cinchocaine  ne 
cocaine  ne 
cyclizine  ne 
desmethyldiazepam  ne 
diarnorphine  ne 
diazepam  ne 
dihydrocodeine  ne 
dipipanone  ne 
ecgonine  ne 
levorphanol  ne 
lignocaine  ne 
lorazepam  ne 
mepivacaine  ne 
methyldopa  ne 
nicotine  ne 
nitrazepam  ne 
noscapine  ne 
papaverine  ne 
pentazocine  ne 
phena~ocine  ne 
prilocaine  ne 
procaine  ne 
delta  9  THC  ne 
~ne  =  not  eluted with  K'  below  30 
-140-however  a  range  of  basic,  neutral  and  acidic  drugs  were  examined. 
Also  of  interest  was  the  possibility  of  another  compound  having 
suitable  chromatography  on  the  same  system,  such  that  it  might  be 
used  as  an  internal  standard  if  the  extraction  scheme  developed 
had  poor  recovery. 
2.5.15.2.  Method 
Standard  solutions  (10-2g/1)  of  the  drugs  were  prepared 
in  5'- methanol  in  distilled  water.  A  drop  of  Hel  or  KOH  was 
added  to  increase  solubility  as  required.  20ul  of  the  solution 
was  injected  as  before. 
detection. 
The  eluent  was  moni tored  by  UV  and  ED 
2.5.15.3.  Results  and  discussion 
The  traces  for  those  drugs  which  chromatographed  are  shown 
in  figure  2.23 ..  Details  of  all  drugs  tested  for  interference 
are  found  in  table  2.19 ..  It  is  evident  that  the  system 
described  will  be  selective  for  morphine  and  nalorphine,  both  of 
which  chromatograph  with  similar  efficiency,  differing  only  in  the 
character  of  the  side  chain  on  the  basic  nitrogen  atom  (see  figure 
2. 10. ) .  Those  opiates  lacking  a  free  hydroxyl,  have  no 
electrochemical  behaviour  at  this  potential  (+0.870  volts)  as 
demonstrated  previously  (2.4.7.).  They  also  eluted  later  than 
morphine  and  nalorphine  and  had  much  broader  peaks.  The  obvious 
choice  of  compound  for  use  as  an  internal  standard  is 
nalorphine.  It  has  a  good  efficiency,  electrochemical  properties 
at  this  voltage,  and  has  a  similar  pKa  value  to  morphine, 
s u  g g est  i n g  t hat  i tis 1 i ke  1 y  to  ext  r act  from  b i 010  g i cal  rna t ric  e s 
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FIGURE  2.23. 
CHROMATOGRAPHY  OF  A  RANGE  OF  ACIDIC  DRUGS  ON  THE 
HPLC  SYSTEM  DEVELOPED  FOR  MORPHINE 
-142-under  the  same  conditions. 
The  system  as  described  coincidentally  provides  a  good  separation 
for  several  acidic  drugs  (figure  2.23.).  This  separation  is 
possible  on  reversed  phase  material  without  the  use  of  ion-pairing 
agents  (Battah,  1986).  These  acidic  compounds  are  free  from 
interference  wi th  the  s i lanol  sites  on  the  stat  ionary  phase  and 
will  therefore  chromatograph  well  on  reversed  phase  columns  with  a 
very  wide  range  of  solvent  systems  and  without  the  requirement  for 
an  ion  pairing  agent. 
Whilst  these  acidic  drugs  would  be  unlikely  to  extract  under  the 
same  conditions  as  morphine,  and  generally  have  no  electrochemical 
properties,  the  use  of  this  system with  dual  detectors  (ED  and  UV) 
would  provide  a  single  system  for  the  measurement  of  all  those 
compounds  whose  capacity factor  is  quoted  in  table  2.23 .. 
The  one  other  compound  which  appears  to  display  electrochemical 
properties  at  this  potential  is  primidone.  Host  acidic  sedatives 
are  highly  oxidised  and  would  not  be  expected  to  have  further 
oxidative  behaviour.  Primidone  however  can  be  prepared  by  the 
electrolytic  reduction  of  phenobarbital  (Boon  et  al.,  1952;  Bogue 
and  Carrington,  1953). 
The  reverse  process,  shown  in  figure  2.24.,  is  a  likely  mechanism 
to  account  for  this  observation. 
2.5.15.4.  Conclusion 
The  reversed  phase  ion  paired  HPLC  method  for  morphine 
described  above  appears  to  be  quite  selective  for  morphine  and  its 
N-allyl  analogue,  nalorph i ne.  other  simi lar  compounds  (code i ne 
and  oxycodone  have  the  same  skeleton,  but  lack  the  free  hydroxyl, 
-143-prim, done  phenotBr bitone 
FIGURE  2.24. 
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-144-the  reason  both  for  their  poor  chromatography  and  lack  of 
electrochemical  activity at 0.870  volts. 
It has  been  shown  that  electrochemical  detection  has  a  high  degree 
of  selectivity  for  morphine.  Nalorphine  is  the  most  appropriate 
internal  standard  for  this  assay. 
2.5.16.  CONCLUSIONS  ON  MORPHINE  CHROMATOGRAPHY 
The  above  sections  have  illustrated  the  developement  of  a 
suitable  HPLC  system  for  the  chromatography  of  morphine  and  a 
likely candidate  as  an  internal  standard,  nalorphine. 
The  original  aims  (1.5.1.1.>  of  producing  an  efficient,  rapid  and 
sensitive  chromatographic  system  for  morphine  have  been  achieved 
but  only  wi th  the  use  of  an  ion  paired  chromatographic  system. 
This  has  the  dissadvantage  that  it  may  lead  to  lower  detection 
limits  caused  by  electrode  fouling,  and  has  introduced  the 
presence  of  a  system  peak. 
It  has  however  avoided  changing  the  nature  of  the  stationary 
phase,  and  has  produced  a  system  wi th  sens i t i vi ty  in  the  range 
required  to  measure  levels  of  morphine  likely  to  be  encountered  in 
forensic  applications  - particularly  in  biological  fluids. 
-145-2.6.  SAMPLE  PREPARATION  FOR  MORPHINE  ANALYSIS  BY  HPLC 
2.6.1.  AMMONIUM  BICARBONATE  EXTRACTION  PROCEDURE 
2.6.1.1.  Introduction 
Methods  for  the  extraction  of  morphine  from  biological 
fluids  were  reviewed earlier (2.3.). 
For  most  analyses  involving  HPLC,  a  clean-up  and/or  concentration 
step is required. 
The  method  currently  favoured  for  extracting  basic  drugs  from 
blood  and  liver  homogenate  is  based  on  that  described  by  Horning 
et  al.,  (1974).  The  extracts  from  this  procedure  were  examined 
earlier  to  assess  their  suitability  for  LCED  (2.5.5.).  Having 
altered  the  conditions  to  a  system  where  efficient  chromatography 
is  possible  with  a  higher  acetonitrile  content  (2M.  cf.  87.),  the 
suitability of this extract was  examined  again. 
2.6.1.2.  Method 
A  variety  of  samples  were  spiked  wi th  a  known  amount  of 
-4  .  morphine  (10  gIl,  unless  otherWlse  stated). 
The.e  were  water,  plasma  (obtained  from  centrifugation  of  expired 
tran.fusion  blood),  fresh  transfusion  blood  and  a  sample  of  the 
latter  which  had  been  left  exposed  to  the  air,  resealed  and  left 
for  about  two  weeks. 
An  appropriate  blank  was  analysed  in  tandem  wi th  all  samples  to 
cbeck for  interference. 
Tbe.e were  extracted usins  tbe  following  procedure: 
-146-Sample  (Iml)  and  nalorphine  HCl,  -4 
(10  gIl,  Iml)  as  internal 
standard were  added  to  a  15ml  screwcap  tube. 
This  was  saturated  with  freshly  ground  ammonium  carbonate  (approx 
Ig) .  Ethyl  acetate  (8ml)  was  added,  the  tube  was  sealed  wi th  a 
PTFE  lined  cap.  The  contents  were  thoroughly  mixed  on  a  vortex 
mixer  (approx.  20secs),  and  the  tube  centrifuged  at  3000  rpm  until 
two  layers  formed. 
The  ethyl  acetate  was  aspi rated  and  transfered  to  a  second  15ml 
screwcap  tube  containing  3ml  0.1  N H2S04, 
The  contents  were  vortex  mixed  (approx.  20secs)  and  centrifuged  at 
3000  rpm. 
The  ethyl  acetate  layer was  aspirated  and  discarded. 
The  aqueous  residue  was  saturated  with  freshly  ground  ~onium 
carbonate  (approx  Ig).  Ethyl  acetate  (8ml)  was  added  and  the 
contents  vortex mixed  (approx.  20secs). 
The  ethyl  acetate  layer  was  aspirated  and  transfered  to  a  tapered 
centri  fuge  tube.  This  was  evaporated  to  dryness  under  a  stream 
of Oxygen  Free  Nitrogen  (OFN)  at  SOoc. 
The  residue  was  reconstituted  in  100ul  of  the  mobile  phase  and 
20ul  injected  into  the  HPLC. 
HPLC  conditions  were  as  described  in  section  2.5.12 .. 
2.6.1.3.  Results  and  discussion 
Problems  encountered  with  this  extraction  procedure 
included  the  formation  of  an  emulsion  in  the  tube  after  vigourous 
mixing.  This  occured  only  with  blood  samples,  not  with  plasma. 
It  was  unpredictable  and  seemed  to  vary  from  extraction  to 
extraction.  The  formation  of  an  emulsion  may  have  been  due 
-147-either  to  an  excess  of  ammonium  carbonate,  or  to  the  particle size 
of  the  ground  material.  It  was  difficult,  especially  with 
coagulated,  viscous  or  putrified  blood  samples,  to  determine  when 
the  saturation point was  reached. 
Alranonium  carbonate  was  purchased  in  rock  form  as  the  polymer, 
ammon i urn  carbamate 
ammonium  bicarbonate  (Parkes,  1939) .  This  was 
finely  ground  immediately  prior  to  use,  to  exposoe  the  carbamate 
and  added  to  water  where  the  following  reaction  takes  place, 
releasing  ammonium  carbonate,  and  forming  a  buffered  solution. 
The  reagent  must  be  ground  just  before  use,  otherwi se  the  outer 
layer  of  ammonium  bicarbonate  reforms  by  loss  of  ammonia,  and  the 
buffer will not  form. 
The  grinding  of  ammonium  carbonate  was  done  manually  with  a  pestle 
and  mortar.  The  reagent  was  unpleasant  to  use  in  the  open 
laboratory,  due  to  the  release  of  ammonia. 
The  absolute  extraction  efficiencies  for  morphine  (Heff.)  and 
nalorphine  (Neff.)  were  calculated  by  comparison  of  peak  heights 
with  an  unextracted  standard.  The  results  are  given  in  table 
2.20 ..  The  relative  extraction  efficiency  (Heff. INeff.)  is 
also  calculated.  This  is  found  to  be  quite  consistent  for  all 
sample  types,  ranging  from  1.00  ~  0.06  to  0.92  ~  0.09,  for 
aqueous  standards  and  aged  blood  respectively.  The  extraction 
was  performed  five  times. 
-148-TABLE  2.20. 
EXTRACTION  EFFICIENCIES  FOR  MORPHINE  AND  NALORPHINE  FROM 
A VARIETY  OF  MATRICES  USING  THE  PROCEDURE  DESCRIBED 
BY  HORNING  ET  AL,  1974 
sample  type  Keff.  Neff.  ReI.  eff. 
Aqueous  std. 
75  76  0.99 
72  68  1.06 
69  76  0.91 
80  79  1.01 
83  79  1.05 
n=5 
average  (X)  75.8  75.6  1.00 
S.D.  5. 7  4.5  0.06 
CoY  7.5  5.9  6.1 
Plasma  std 
67  69  0.97 
50  52  0.96 
45  44  1.02 
48  53  0.91 
54  58  0.93 
n=5 
average  (X)  52.8  55.2  0.96 
S.D.  8.5  9.2  0.04 
CoY  16.3  16.7  4.2 
Fresh  blood 
45  48  0.94 
49  46  1.06 
27  33  0.82 
37  40  0.93 
40  42  0.95 
D~5 
average  (X)  39.6  41.8  0.94 
S.D.  8.4  5.8  0.09 
CoV  21.2  14.0  9.35 
-149-TABLE  2.20.  contd. 
sample  type  Keff.  Neff.  Rel.  eff. 
Aged  blood 
15  18  0.83 
20  22  0.90 
23  27  0.85 
32  33  0.97 
38  36  1.06 
n=5 
average  (X)  25.6  27.2  0.92 
S.D.  9.2  7.5  0.09 
CoY  36.2  27.4  9.9 
-150-Blank samples 
The  blank  water  and  plasma  samples  were  found  to  contain 
no  interfering  peaks  in  the  region  of  morphine  and  nalorphine. 
Some  of  the  fresh  blood  samples  did  however  produce  late  eluting 
peaks,  and  the  aged  blood  samples  produced  many  more  peaks  in  the 
region of  the  chromatogram of  interest. 
Aqueous  standa~ds 
The  extraction  efficiencies  for  morphine  and  nalorphine 
(Emorph.  and  E nal.  respectively)  for  the  aqueous  standards 
were  75.8'.  ±  5.7,  and  75.67.  ±  4.5  respectively.  The  relati  ve 
recovery  was  1.00  ±  0.06. 
present. 
There  were  no  interfering  peaks 
Plasma 
Extracts  from  the  plasma  samples  were  clean  and  there  were 
few  or  no  other  peaks  in  the  chromatogram. 
extraction  efficiencies  were  K eff.  52.87.  ± 
The  absolute 
8.5,  and  N efr. 
=  5 5 . 27.  ±  9. 2'-.  There  were  no  interfering peaks  present. 
Whole  blood 
In  extracts  from  whole  blood  samples  there  was  some 
interference  from  small  peaks  in  the  same  region  of  the 
chromatogram  as  morphine  was  eluted,  thus making  reliable 
quantitation  difficult.  The  low  extraction  efficiency  ("eff.  ;: 
39.6~  ±  7.5,  Neff.  ;:  41.8  ~  5.3),  meant  that  the  procedure 
had  a  poor  sensitivity. 
-151-Whole  blood  samples  (fresh  and  aged)  were  susceptible  to  emulsion 
formation  by  this  procedure  which  probably  accounts  for  the  low 
absolute  recovery. 
This  was  initially  thought  to  be  caused  by  the  ammonium  carbonate 
not  being  sufficiently  ground.  Whilst  this  was  thought  to  be 
true  in  general,  the  principle  factor  in  emulsion  formation  was 
found  to  the  degree  of  mixing  of  any  blood/ammonium 
carbonate/ethyl acetate mixture. 
Slow mixing  on  a  rocking  rolling mixer  did  not  achieve  homogeneity 
of  the  liquid  part.  Vigourous  mixing  was  required  for  this  and 
emulsification  followed  rapidly. 
Emulsion  formation  was  independent  of  the  volume  of  solvent 
used.  The  emuls ion  could  occas ional1y  be  broken  up  by  st  i rring 
and  recentrifuging  the  sample. 
completely  successful. 
This  was  unreliable  and  never 
As  the  relative  recoveries  for  the  extraction  of  fresh  blood  and 
aged  blood  were  similar  (0.94  ±  0.09,  and  0.90  ±  0.09 
respectively),  the  difference  in  absolute  efficiencies  is  probably 
due  to matrix effects. 
Aged  blood  samples  appeared  to  have  more  coextracted  material  in 
them  (both  from  the  appearance  of  the  extract  and  the  appearance 
of  the  chromatogram). 
It was  difficult  to  consistently  reproduce  the  degree  of  aging  in 
the  blood  samples,  and  th~re  was  cons iderable  sample  to  sample 
variation,  confirming  the  need  for  an  internal  standard. 
-152-2.6.1.4.  Conclusion 
In  spite  of  the  low  recoveries  compared  to  published 
reports  (Horning  et  ale  1974,  see  table  2.2.),  this  was  considered 
a  good  general  method  for  the  analysis  of  morphine  in  a  variety of 
samples.  The  object  of  further  work  would  therefore  be  to 
improve  the  efficiency  and  selecti  vi ty  of  the  procedure,  and  if 
possible to  simplify it. 
In  order  to  avoid  problems  arising  from  inconsistencies  between 
aged  samples,  it was  decided  that  further  developement  work  should 
be  done  on  freshly  prepared  blood  standards,  one  to  three  days 
old,  and  the  optimum  extraction  pr.ocedure  then  applied  to  aged  or 
post mortem  blood  samples. 
2.7.  IMPROVEMENTS  TO  THE  EXTRACTION  PROCEDURE 
2.7.1.  Introduction 
The  main  problems  with  the  above  extraction  procedure  were 
sample  loss  through  emulsion  formation,  poor  recovery  and  carry 
over  of  material  into  the  final  extract.  These  problems  were 
investigated separately.  Firstly  methods  were  examined  to  avoid 
emulsion  formation,  then  attempts  to  improve  the  efficiency  of  the 
extractionby  the  use  of  other  solvents  and  changes  in  solvent 
volume.  Finally  methods  of  keeping  particulate  material  out  of 
the  final extract were  investigated. 
For  the  purposes  of  the  following  study,  fresh  blood  was  used  to 
prepare  standards  shortly before  analysis  (1-2  days). 
-153-2.7.2.  EMULSION  FORMATION 
2.7.2.1.  Introduction 
As  the  ammonium  carbonate  appeared  to  be  the  main  cause  of 
this  problem,  alternative  methods  of  adjusting  the  pH  to  a 
suitable  value  were  sought.  Those  solutio~s examined  were  either 
in  routine  use  in  the  laboratory  or  had  been  used  in  methods 
published  elsewhere  reviewed  in  2.3 .. 
2.7.2.2.  Method 
Various  alkaline  solutions  were  used  to  alter  the  pH  of 
the  sample.  Volumes  of  1m1  were  chosen  to  keep  the  volume  of  the 
aqueous  part  as  small  as  possible  to  improve  the  yield  of  the 
extraction. 
This  investigation  was  carried  out  on  blood  samples  rather  than 
aqueous  standards  or  plasma. 
Sample  (1ml) ,  buffer  (1ml),  nalorphine  (10-"g/1,  1ml)  and  ethyl 
acetate  (8ml)  were  mixed  thoroughly  on  a  vortex  mixer  (approx.  20 
secs).  The  mixture  was  centrifuged  at  3000rpm  unti  1  separated 
(approx.  2  mins).  The  ethyl  acetate  was  aspirated  and  transfered 
to  a  second  tube  containing  3ml  O.lN  H2SO".  The  rest  of  the 
procedure  was  as  before  (2.6.1.2. ) .  Each  extraction  was 
performed  in duplicate  and  the mean  is  given. 
2.7.2.3.  Results  and  discussion 
In  the  absence  of  solid  ammonium  carbonate,  no  emulsions 
were  formed,  even  with  badly  haemolysed  blood. 
The  extraction  efficiency for  morphine  and  nalorphine  are  recorded 
-15"-TABLE  2.21. 
EFFECT  OF  VARIOUS  pH  MODIFIERS  ON  THE  EXTRACTION  EFFICIENCY 
OF  MORPHINE  FROM  FRESH  BLOOD 
Modifier  Meff.  Neff.  MIN 
O.lM  NaOH  24.6  25.2  97.6 
1M  NaOH  42.1  43.1  97.6 
1M  phosphate.  pH9  *  I  I  I 
O.lM  Borate  buffer  pH9  43.4  43.2  100.0 
1M  Borate  buffer  pH9  62.5  64.1  97.5 
1M  Borate  buffer  pH8.5  60.1  62.0  96.9 
1M  Borate  buffer  pH9.5  61.4  61.8  99.3 
*Unsuitable  for  analysis 
-155-in  table  2.21 ..  Phosphate  buffer  was  found  not  to  ~ive very  good 
recovery,  the exact  value  was  not determined  due  to  interference. 
NaOH  on  its  own  did  give  a  relati  vely  clean  extract.  but  the 
efficiency  was  poor.  This  may  be  due  to  deprotonation  of  the 
phenolic  ~roup  on  morphine  by  the  strongly  alkaline  NaOH  solution 
pH  11-12.  This  would  make  the  morphine  negatively  charged  and 
hence  more  soluble  in  the  aqueous  phase.  As  morphine  is 
amphoteric  in  nature  the  pH  range  used  for  the  extraction 
obviously requires  to  be  carefully controlled or buffered. 
Borate  buffers  gave  the  best  extraction  efficiency.  and  of  these 
the more  concentrated worked  notably better. 
There  was  no  appreciable  difference  between  borate  buffers  pH  8.5 
to 9.5. 
2.7.2.4.  Conclusion 
Emulsion  formation  was  successfully  avoided,  and  the 
extraction  efficiency  improved  considerably.  The  buffer  selected 
for  further  work  was  1M  borate  buffer,  pH  9.0,  which  gave  a  mean 
efficiency of  62.S~. 
2.7.3.  SOLVENT  SELECTIVITY 
2.7.3.1.  Introduction 
Some  of  the  interfering  peaks  still  appeared  in  the 
chromatograms.  Whilst  these  appeared  sporadically,  older  samples 
were  notably  worse.  Alternative  extraction  solvents  were  used  in 
an  attempt  to  improve  the  selectivity of  the  extraction. 
-156-2.7.3.2.  Method 
The  extraction  procedure  was  carried  out  as  above. 
Various  solvents  were  used  in  place  of  ethyl  acetate.  Most  of 
these  were  selected  on  the  basis  that  they  had  been  reported  in 
the  literature  as  giving  good  recoveries  for  morphine  (tables  2.2. 
& 2.3.>.  Extractions  were  performed  in  duplicate  and  the  mean  is 
given. 
2.7.3.3.  Results  and  discussion 
The  recoveries  of  morphine  and  nalorphine  are  shown  in 
table  2.22 .. 
Al though  there  is  evidence  of  improved  extract  ion  eff  i c i ency  for 
morphine  with  the  ethyl  acetate/isopropyl  alcohol  solvent  (67.4~), 
it  was  noted  that  a  large  amount  of  co-extracted  material  which, 
whilst  not  interfering  with  the  assay,  increased  the  length  of  the 
run  time  to  about  45  minutes. 
The  coextraction  of  material  other  than  the  analyte  is  a  greater 
problem  when  mixed  solvents  or  salting-out  procedures  are  used. 
This  can  improve  the  efficiency  but  usually  reduces  the 
selectivity of  the  extraction  procedure. 
2.7.3.4.  Conclusion 
The  use  ethyl  acetate  whilst  having  a  lower  apparent 
efficiency  (60.4~>  than  the  mixed  solvents  examined,  gave  a  better 
quality  extract  and  was  therefore  retained,  and  modifications  were 
made  to  the  volume  of  solvent  used  in  the  extraction  procedure. 
-157-TABLE  2.22. 
EFFECT  OF  VARIOUS  EXTRACTION  SOLVENTS 
ON  THE  EXTRACTION  EFFICIENCY  OF  MORPHINE  FROM  FRESH  BLOOD 
Solvent  Meff.  Neff.  MIN 
EtOAc  60.4  62.1  97.1 
CH2Cl2  11.0  10.2  107.8 
CHCl 3:IPA  (9 : 1)  60.4  61.S  98.2 
EtOAc:IPA  ( 9 : 1 }  67.4  69.2  97.4 
-158-2.7.4.  SOLVENT  VOLUME 
2.7.4.1.  Introduction 
No  attempt  had  been  made  to  examine  if  the  extraction 
eff  i c ienc  i es  observed  could  be  improved  by  i ncreas i ng  the  volume 
of  the  extraction  solvent. 
The  transfer  of  a  solute  between  two  media  is  limited  by  its 
partition  coefficient  and  the  relative  volumes  of  the  two 
immiscible  solvents  (Alberty  and  Daniels,  1976).  The  pH  may  also 
play  an  important  part  in  this  partition  if  the  analyte  is 
ionisable.  The  effect of  the  pH  has  been  examined  above. 
Having  shown  that  ethyl  acetate  is  a  suitable  solvent  and  decided 
to  continue  with  its  use,  the  relative  volume  of  the  solvent  was 
changed  to  assess  the  effect  this  might  have  on  the  extraction 
efficiency. 
2.7.4.2.  Hethod 
In  an  effort  to  further  improve  the  extraction  efficiency. 
two  measures  were  taken.  The  volume  of  the  aqueous  part  in  the 
first  step  of  the  extraction  was  reduced  by  using  lOOul  of 
internal  standard  (lO-3g/1),  instead of  Iml. 
The  ethyl  acetate  extraction  was  performed  twice  with  two  volumes 
of  Sml.  These  were  then  combined  in  the  second  tube.  The  rest 
of  the  procedure  was  as  before  (2.7.3.2.). 
-159-2.7.4.3.  Results  and  discussion 
The  results  are  shown  in  table  2.23 ..  The  absolute 
recovery  for  morph i ne  was  found  to  be  64.6"  ±  5.9  (n=5).  Th i s 
represents  an  improvement  on  the  previous  absolute  recovery 
(60.4~)  and  there  was  no  significant  change  in  the  relative 
efficiency which  is  0.94  ±  0.06  (cf.  0.98). 
Performing  two  extractions  did  increase  the  analysis  time,  but  the 
increase  in  extraction  efficiency  could  be  significant  if  only 
small  sample  volumes  were  available,  or  if  low  levels  were  present. 
2.7.4.4.  Conclusion 
Replacing  ammonium  carbonate  with  a  buffer,  in  the  second 
extraction  step  was  considered,  but  this  would  have  involved 
increas ing  the  volume  of  the  aqueous  phase  and  was  cons idered  a 
disadvantage,  so  this  was  not  investigated. 
Using  two  extraction  volumes  in  place  of  one,  and  decreasing  the 
volume  of  the  aqueous  fraction  has  increased  the  efficiency  of  the 
procedure. 
The  use  of  100ul  of  internal  standard  solution  in  place  of  1ml  was 
also  incorporated  into  the  general  procedure. 
2.7.5.  CARRY  OVER  OF  MATERIAL 
2.7.5.1.  Introduction 
The  presence  of  greasy  semi-solid  matter  in  the  dried  down 
residue  caused  some  concern,  as  continually  injecting  this  onto 
the  column  was  found  to  lead  to  8  build-up  in  column  back 
-160-n::5 
TABLE  2.23. 
EFFECT  OF  CHANGES  IN  SOLVENT 
VOLUMES  ON  THE  EXTRACTION  EFFICIENCY  OF  MORPHINE 
FROM  FRESH  BLOOD 
Meff.  Neff.  Re 1.  eff. 
74  72  1.03 
66  73  0.90 
63  68  0.93 
59  65  0.89 
61  65  0.94 
Average  (X)  64.6  68.6  0.94 
S.D.  5 . 9  3.78  0.06 
CoV  9.1  4.8  5 . 5 
-161-pressure.  Some  of  the  extracts  also  appeared  to  contain  a  white 
crystalline  residue,  thought  to  be  ammonium  sulphate  formed  in  the 
final  extraction  step.  This  may  either  be  slightly  soluble  in 
the  ethyl  acetate,  or  result  from  some  of  the  aqueous  layer  being 
carried  over  to  the  evaporation  stage.  Extracts  containing  this 
material  gave  rise  to  a  large  negative  peak  in  the  chromatogram 
just  after  the  system  peak.  The  problems  of  carbonate  in  the 
sample  and  the  presence  of  the  so  called  "carbonate  dip"  peak  have 
been  reported  by  other  workers  (Sunden  et  al.,  1984;  Okada  and 
Kuwamoto,  1984).  Whilst  of  no  real  interest  in  itself,  it  can 
interfere with  the  analyte  peak,  or  in  this  case  with  the  internal 
standard. 
The  optimum  efficiency of  the  morphine  on  this  HPLe  system  was 
found  to  be  N  =  600.  Whilst  an  improvement  on  previous  solvent 
systems  used,  this  is  low  by  most  standards,  but  is  limited  by  the 
interaction  of  basic  compounds  like  morphine  with  the  stationary 
phase.  Any  deterioration  in  efficiency  which  might  be  caused  by 
a  pre-column,  was  cons idered  unacceptable.  Wh i 1 s t  the  use  0 f  a 
pre-column  would  protect  the  analytical  column,  the  build  up  in 
back  pressure  would  not  be  avoided.  In  addition,  as  the  columns 
used  in  this  study  were  packed  in  the  laboratory,  it was  just  as 
easy  to  repack  the  top  of  the  analytical  column  as  to  do  likewise 
to  a  short  precolumn. 
Other  methods  of  preventing  carryover  of  material  were  therefore 
considered.  Three  methods  are  in  general  use  for  preventing 
aqueous  carryover  from 
emulsions  or  organic  liquids  containing  small  amounts  of  water. 
The  first,  freezing  the  residual  water  in  a  dry-ice/acetone  bath 
-162-and  pouring  off  the  solvent,  was  tried  but  was  considered 
uneccessarily  complex  and  the  solvent  still  had  to  be  filtered  to 
remove  particles of  ice. 
The  other  methods  were  therefore  cons i dered.  These  are  the  use 
of  phase  separating  filter  paper  and  filtering  the  organic  solvent 
through  anhydrous  sodium  sulphate.  It  was  expected  that  more  of 
the  solvent  would  be  retained  by  the  second  procedure,  and  that 
this  would  consequently  lower  the  extraction  efficiency.  For 
that  reason  the  use  of  phase  separating  filter  paper  was 
considered. 
Phase  separating  filter  paper  is  prepared  by  treating  ordinary 
filter  paper  with  a  silicone  wax  in  the  presence  of  a  catalyst 
(Whatman  applications  notes,  1984).  This  process  makes  it 
impermeable  to  aqueous  solvents,  but  allows  less  polar  organic 
solvents  to  pass  through.  The  use  of  phase  separat ing  f i 1 ter 
paper  is  avoided  for  some  toxicological  studies,  particularly 
where  GC  and  GCMS  are  being  used.  The  catalysts  used  in  the 
impregnating  process  and  silicones  of  medium  carbon  number  washed 
from  the  paper,  can  give  rise  to  spurious  peaks  on  GC  (Whatman 
produc t  note s,  1982).  The  degree  of  interference  in  LCEO  caused 
by  these  effects  was  ~hecked before  the  phase  separating  paper  was 
used  in  this  assay. 
It was  first  established  that  no  interference  would  arise  from  the 
filter  paper. 
2.7.5.2.  Method 
Ethyl  acetate  (20ml)  was  f i 1 tered  through  fluted  c i rc les 
(10cm)  of  Whatman  PS-l  filter paper,  and  collected. 
-163-This  was  evaporated  to  dryness  at  50
0 C  under  OFN,  and 
reconsti  tuted  in  SOul  of  the  mobile  phase. 
into the  HPLC  as  before. 
20ul  were  injected 
As  no  peaks  with  K'  over  2  were  noted  it was  possible  to  use  the 
phase  separating paper  in  the  extraction procedure. 
Four  blood  samples  were  extracted  as  before  (2.7.4.2.).  The 
final  ethyl  acetate  layers  were  aspirated  and,  prior  to  bein& 
transfered  to  a  tapered  centrifuge  tube,  two  were  first  filtered 
through  pre-wet  PS-1  filter  paper.  The  other  two  samples  were 
not  filtered.  Each  sample  was  evaporated  to  dryness  under  a 
stream of OFN  at  50
0C. 
The  residue  was  reconstituted  in  100ul  of  the  mobile  phase  and 
20ul  injected  into the  HPLC. 
2.7.5.3.  Results  and  discussion 
The  absolute  extraction  efficiency  of  morphine  for  those 
cleaned  up  using  phase-separating  filter  paper  was  50  and  597. 
(54.57.  av.). 
av. ) . 
For  those  without,  this  was  higher  61  and  66  (63.57. 
Some  loss  in  efficiency would  be  expected  due  to  a  small  amount  of 
the  ethyl  acetate  being  retained  in  the  filter  paper. 
Pre-wett ing  the  fi Iter  paper  wi th  ethyl  acetate  should  prevent 
this  to  some  extent. 
The  physical  appearance  of  the  extract  was  improved  and  none  of 
the  waxy  material  or  salt  noted  previously  was  present  in  the 
filtered extracts. 
In  the  chromatogram  there  was  no  evidence  of  the  carbonate  dip. 
and  there was  a  generally better appearance  to the  chromato&raa. 
-164-2.7.S.4.  Conclusion 
As  no  interference  from  the  paper  itself was  encountered, 
it was  decided  that  the  loss  in  efficiency of  the  extraction could 
be  justified  in  terms  of  improved  column  lifetime  and  extract. 
purity when  phase  separating filter paper was  used. 
A  phase  separating  step  was  therefore  incorporat.ed  into  the 
procedure. 
2.7.6.  POSSIBLE  USE  OF  SINGLE  STEP  EXTRACTION 
2.7.6.1.  Introduction 
As  the  extracts  from  the  above  procedure  were  very  clean, 
it was  decided  to  examine  the  quality  of  t.he  extract  proiduced  if 
the  back  extraction  into  O.lN  H2S04  was  ommit.ted  from  the 
extract.ion  procedure. 
2.7.6.2.  Method 
The  procedure  described  below  represents  the  first  part  of 
the  extraction procedure described  in 2.7.S.2 .. 
Sample  (lml,  10-4  gIL  morphine),  1M  pH9  borate  buffer  (lml) , 
internal  standard  (100ul)  and  ethyl  acetate  (8ml)  were  added  to  a 
lSml  screwcap  tube  and  mixed  thoroughly  on  a  vortex  mixer  (approx. 
20  secs).  The  sample  was  then  cent.rifuged  at  3000rpm  and  the 
et.hyl  acetat.e  layer  removed.  This  was  filtered  through  pre-wet 
phase  separating  paper  and  t.hen  evaporated  to  dryness  under  OFN  at. 
SOoC.  The  residue  was  reconstitut.ed  in  100ul  and  20ul  were 
injected. 
-16S-2.7.6.3.  Results  and  discussion 
The  extract was  found  to  be  unsuitable  for  the  analysis  of 
whole  blood  samples  due  to  the  presence  of  a  small  number  of large 
peaks  in  the  early  part  of  the  chromatogram.  Extracts  obtained 
from  plasma  samples  were  however  su  i table  for  analys i s  and  gave 
absolute extraction efficiencies of  84~ ±  5.2  (n=4). 
2.7.6.4.  Conclusion 
The  acidic  back  extraction  was  found  to  be  necessary with 
whole  blood  samples  to  provide  an  extract  sufficiently  clean  for 
LCEC  on  this  system. 
Plasma  samples  were  however  rapidly  and  conveniently  extracted  by 
this  procedure.  Although  plasma  is  rarely  encountered  in 
forensic  applications,  this may  be  of use  for clinical studies. 
2.7.7.  SUMMARY  OF  OPTIMISED  EXTRACTION  PROCEDURE 
2.7.7.1.  Introduction 
The  extraction  procedure  examined  initially  <2.6.1.2.)  bas 
been  substantially  modified,  and  the  absolute  extraction 
efficiency  for  whole  blood  samples  (fresh)  has  been  improved  from 
41.8~ ±  4.1,  to  a  maximum  of  69~ ±  4.0. 
A  compromise  was  accepted  in  the  use  of  phase  separating  filter 
paper  which  gave  cleaner  extracts  and  slowed  the  rate  of  column 
fouling,  but  lowered  the  efficiency of  the extraction. 
The  procedure  chosen  for  routine  use  is  summarised  below. 
Sample  (lml),  pH9  1M  Borate  buffer  (lml)  and  internal  standard 
-166-(100ul)  were  added  to  a  15ml  screwcap  tube.  Ethyl  acetate  (8ml) 
was  added,  the  tube  was  sealed  with  a  PTFE  lined  cap.  The 
contents  were  thoroughly  mixed  on  a  vortex  mixer  (approx.  20secs), 
and  the  tube  centrifuged at  3000  rpm. 
The  ethyl  acetate  was  aspirated  and  transfered  to  a  second  lSml 
screwcap  tube  containing  3ml  0.1  N H
2
S04, 
The  contents  were  vortex  mixed  (approx.  20secs)  and  centrifuged  at 
3000  rpm. 
The  ethyl  acetate  layer was  aspirated  and  discarded. 
The  aqueous  residue  was  saturated  with  freshly  ground  ammonium 
carbonate  (approx  19).  Ethyl  acetate  (8ml)  was  added  and  the 
contents  vortex  mixed  (approx.  20secs).  The  ethyl  acetate  layer 
was  aspirated  and  passed  through  pre-wet  PS-l  filter  paper  into  a 
tapered  centrifuge  tube. 
o  stream of  OFN  at  50  C. 
This  was  evaporated  to  dryness  under  a 
The  residue  was  reconstituted  in  100ul  of  the  mobile  phase  and 
20ul  injected  into  the  HPLC  system described  in  section 1.5.12 .. 
S~ple  chromatograms  obtained  from  a  blank  blood  sample,  a 
standard  sample  (10-4g/L)  and  an  extract  from  an  authentic  post 
mortem  sample,  are  shown  in  figure  2.25. 
The  error  obtained  in  the  calculated  level  in  an  unknown  sample 
when  using  this  extraction  procedure  followed  by  HPLC  is  low  (S.D. 
= 5.5~,  as  measured  in  section 2.7.4.). 
Some  disadvantages  of  the  procedure  are  that  it  is  time  consuming, 
using  three  or  more  successive  extraction  steps,  and  requires  the 
use  of  ~onium bicarbonate  which  is  unpleasant  to  use  in  the  open 
laboratory  and  has  to  be  freshly  ground  before  use. 
The  possibility  of  transferring  this  procedure  to  a  solid  phaae 
extraction method  was  considered. 
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-t 2.8.  OTHER  EXTRACTION  PROCEDURES 
2.8.1.  Introduction 
Examples  in  the  literature  of  rapid  sample  preparation 
using  adsorbent  or  absorbent  materials  and  their  advantages  over 
liquid/liquid  extraction  (reviewed  above  2.3.4.),  prompted 
investigation of  their suitability for  post-mortem blood  samples. 
2.8.2.  ADSORPTION  EXTRACTION  PROCEDURES 
2.8.2.1.  Introduction 
The  use  of  activated  silica  supports  with  a  variety  of 
bonded  phases  of  varying  selectivities,  has  introduced  a  high 
degree  of  selectivity  to  sample  preparation  (Sep  Pak  application 
notes  1984;  Harkey  and  Stolowitz,  1984;  Stewart  et al.,  1984;  Bond 
elut  applications  notes;  1985) .  Methods  reported  for  the 
extraction  of  morphine  were  reviewed  above  (2.3.4.),  and  it  was 
decided  that  the  approach  most  suitable  for  the  extraction  of 
basic  drugs  was  the  use  of  a  C18  cartridge.  It  was  considered 
reasonable  that  the  optimum  conditions  for  the  control  of 
ionisation  and  elution  would  be  similar  to  those  found  for  simple 
liquid/liquid extraction  as  examined  in  section 2.3.3 .. 
These  condi tions  were  therefore  used  as  a  starting  point  for  the 
investigation of  solid phase  adsorbance  procedures. 
2.8.2.2.  Method 
Commercially  prepared  C18  (Sep  Pak)  cartridges  were 
act  i vated  as  recommended  by  the  manufacturers,  by  wash i ng  wi th 
-169-methanol  (4ml)  and  water  (4ml). 
The  sample  (1ml,  -4  10  gIL  morphine)  was  mixed  wi th  1M  pH9  borate 
buffer  (1ml)  and  internal  standard  (lOOul),  in  a  sample  tube. 
This  was  thoroughly  mixed  on  a  vortex  mixer,  and  loaded  onto  the 
cartridge  under  reduced  pressure  from  a  water  suction  pump. 
The  cartridge  was  washed  wi th  a  wash  solvent  and  morph ine  eluted 
in  an  eluting  solvent. 
The  solvent  was  evaporated  to  dryness  under  OFN  and  the  residue 
reconstituted  in 100ul  of  the mobile  phase. 
2.8.2.3.  Results  and  diecussion 
The  chromatograms  were  assessed  for  recovery  of  morphine 
where  possible,  and  for  the  suitability  of  the  extract  for 
analysis  by  LCEC.  This  is  recorded  in  table  2.24 .. 
The  only  extracts  which  were  suitable  for  analysis  were  those  from 
the  plasma  sample,  and  whilst  the  morphine  peak  was  quite  clear at 
this  concentration  (10-4  gIL),  there  were  a  number  of  smaller 
peaks  in  the  same  region  which  may  have  interefered  at  lower 
concentration. 
Some  interference  was  noted  even  in  the  reagent  blanks.  Thorough 
pre-washing  of  the  cartridges  wi th  the  elution  solvent  did  not 
completely  eliminate  this,  although  it did  appear  to  cut  down  the 
interference. 
Having  one  of  the  phases  in  a  sealed  cartridge,  whilst  increasin& 
the  ease  of  sample  handling,  made  it difficult  to  assess  when  all 
the  interstitial  aqueous  phase  had  been  removed,  prior  to  the 
elution  step.  It  was  found  that  the  amount  of  interference  was 
reduced  if  the  cartrid&e  was  thoroughly  dried  under  reduced 
-170-TABLE  2.24. 
RECOVERY  OF  MORPHINE  FROM  SEVERAL  MATRICES  WITH  ADSORBENT 
CARTRIDGES  USING  DIFFERENT  WASH  AND  ELUTING  SOLVENTS 
Sample  Wash  volume  Eluent  Recovery  Suitability 
~ 
Aq.  bIt.  water  2  EtOAc  some  interference. 
1M  pH  9  borate  2  EtOAc  some  interference 
Aq.  Std.  water  2  EtOAc  low  poor 
pH  9  borate  1M  2  EtOAc  84'- !.ood 
Plasma  water  2  EtOAc  low  poor 
:It 
pH  9  borate  1M  2  CH2Cl2 
poor 
pH  9  borate  1M  2  EtOAc  801- ?sood 
Blood  water  2  EtOAc  poor 
pH  9  borate  1M  2  EtOAc  poor 
pH  9  borate  1M  4  EtOAC  poor 
pH  9  borate  1M  2  CHCIJ/IPA  poor 
9:1 
pH  9  borate  1M  2 
then  CHCIJ  2  EtOAC  poor 
:It 
- =  not  suitable  for  LCEC 
-171-pressure,  after  the  wash  step  and  prior  to  elution  of  the 
analytes.  Even  so,  some  aqueous  material  often  appeared  in  the 
eluate  and  this  had  to  be  removed  by  phase  separating  paper. 
This  reduces  the  extraction  efficiency  as  demonstrated  above 
(section 2.7.5.). 
The  fact  that  a  single  extraction  step  is .used  probably  adds  to 
the  poor  suitability of  this method  for  whole  blood. 
One  of  the  advantages  of  these  cartridges  is  their  facility  for 
rapid  sample  preparation.  This  benefit  is  lost  by  the 
requirement  of  a  second  clean  up  extraction. 
The  possibility of  using  a  second  cartridge  for  this  clean  up  step 
was  considered,  but  was  not  investigated. 
2.8.2.4.  Conclusion 
It  had  been  proposed  that  the  increased  selectivity of  the 
adsorbent  might  make  a  single  extraction  sufficient.  This  was 
found  not  to  be  the  case  and  a  subsequent  clean  up  step would  be 
required  for  extracts  from  whole  blood  samples  in  order  for  them 
to  be  suitable  for  LCEC. 
These  extraction  procedures  were  rapid  and  convenient  for  handling 
samples  of  this  type. 
suitable for  LCEC. 
The  extracts  obtained  however  were  not 
-172-2.8.3.  AN  ALTERNATIVE  ADSORPTION  EXTRACTION  PROCEDURE 
2.8.3.1.  Introduction 
The  procedures  used  above  for  the  extraction  of  morphine 
using  bonded  phase  cartridges  gave  poor  results.  It was  as suned 
that  this  was  due  to  the  lack  of  selectivi~y  of  the  process,  as 
when  liquid/liquid  extraction  was  used  a  thorough  clean  up  step 
was  required. 
One  method  of  altering  the  selectivity  is  to  include  an  ion 
pairing  agent  in  the  eluent.  This  was  done  to  some  effect  in 
optimising  the  HPLC  of  morphine  (2.5.9.).  A method  described  for 
the  isolation  of  morphine  from  plasma  using  a  sulphonic  acid 
extraction  procedure  on  ODS  (Bond  elut)  cartridges  (Moore  et  al., 
1984  (ii»  was  investigated. 
2.8.3.2.  Method 
The  procedure  was  followed  directly  from  the  above 
reference.  An  ODS  bond  elute  cartridge  was  attached  to  a  vacumn 
line.  The  cartridge  was  primed  wi th  methanol  (2ml)  and  water 
(2ml) . 
The  s~ple  (1ml,  10-4g/L  morphine),  0.2M  pH9  borate  buffer 
(1ml),  and  0.2M  heptane  sulphonic  acid  (1ml)  were  mixed  thorou&hly 
on  a  vortex  mi xer.  The  mixture  was  applied  to  the  top  of  the 
cartridge  and  sucked  through  under  reduced  pressure. 
the  cartridge  was  washed  through  with  distilled  water  (6ml),  and 
when  dry,  the morphine  was  eluted with methanol  (2ml). 
The  methanol  was  evaporated  to  dryness  under  OFN  at  6S
o
C  and 
reconst  i tuted  in  100ul  of  mobile  phase.  20ul  were  analysed  by 
LeED. 
-173-2.8.3.3.  Results  and  discussion 
The  procedure  was  examined  for  suitability  with  plasma 
samples  and  whole  blood  samples.  As  before,  plasma  samples  gave 
a  su i tably  clean  extract  wi th  an  absolute  extract  ion  effic  iency 
for  morphine  of  74~  ~  6  (n=4). 
This  is  comparable  with  other  methods  described  above  but  the 
recovery  is  short  of  that  reported  in  the  literature  (greater  than 
95~,  Hoore  et al., 1984(ii». 
Blood  samples  analysed  in  this  way  gave  contaminated  extracts 
which  were  unsuitable  for  LCEC. 
2.8.3.4.  Conclusions 
In  the  above  sections  two  adsorbent  phase  cartridges  have 
been  examined  in  normal  operation  and  with  the  use  of  an  ion 
pairing  agent  in  an  attempt  to  improve  the  selectivity  of  the 
extraction  procedure.  Although  neither  proved  suitable  for 
preparing  clean  extracts  from  whole  blood  samples,  the  bond  elut 
cartridges  were  preferred,  as  they  retained  less  of  the  aqueous 
layer  after  drying,  and  none  appeared  to  be  carried  over  in  the 
elut  ing  solvent.  It  appears  that  bonded  phase  cartridges  are  of 
little use  for  the  analysis  of  whole  blood  samples  other  than  wben 
plasma  may  be  obtained. 
A  second  clean  up  step  would  be  required,  offsetting  some  of  the 
advantages  gained  in  their use. 
-174-2.8.4.  ABSORBENT  EXTRACTION  PROCEDURES 
2.8.4.1.  Introduction 
The  literature  includes  two  descriptions  of  the  extraction 
of  basic  drugs  from  blood  (Breiter  et al.,  1975,  von  Meyer  et al., 
1975).  The  material  used  in  these  reports  was  extrelut,  a 
diatomaceous  earth  absorbent. 
suitable for  LCEC  was  examined. 
Its  ability  to  produce  an  extract 
2.8.4.2.  Method 
Short  extrelut  columns  were  prepared  using  glass 
syringes.  A  fri  t  was  formed  wi th  a  plug  of  glass  wool  or  glass 
fibre  matting  at  the  bottom.  The  pipette  was  tap-fi lIed  wi th 
extrelut  material.  The  capaci ty  of  the  columns  was  found  by 
loading  them with  increasing  volumes  of  blood/water  (1:1). 
The  maximum  recommended  loading  is  that  which  leaves  the  bottom 
10~ of  the  packing material  dry  (Christensen,  1984). 
Sample  (lml,  10-4g/L  morphine)  and  buffer  (lml),  were  mixed 
thoroughly  on  a  vortex  mixer  in  a  sterile polypropylene  syringe. 
This  was  then  applied  to  the  top  of  a  prepared  extrelut  column. 
It was  allowed  to  equilibrate  for  10  minutes,  and  then  eluted with 
a  solvent  (2ml).  The  solvent  was  collected  and  evaporated  to 
dryness  under  OFN  at  65
0C. 
The  residue  was  reconstituted  in  100ul  of  the  mobile  phase  and 
20ul  injected.  The  sample  types  and  solvents  used  and 
recoveries  obtained  are  shown  in  table  2.25 .. 
-175-TABLE  2.25. 
RECOVERY  OF  MORPHINE  FROM  SEVERAL  MATRICES  WITH  ABSORBENT 
CARTRIDGES  USING  DIFFERENT  BUFFERS-AND  ELUTING  SOLVENTS 
samEle  buffer  solvent  recovery 
aqueous  standard  O.IM  NaOH  ethyl acetate  74~ 
0.1M  NaOH  CH2C12/IPA  76~ 
(9:1) 
0.1M  Borate  ethyl  acetate  7~ 
(pH  9) 
0.1M  Borate  CH2Cl2/IPA  6~ 
(pH  9)  (9: 1) 
plasma  0.1M  NaOH  ethyl  acetate  69~ 
0.1M  NaOH  CH2C12/IPA  *  -
(9:1) 
O.lM  Borate  ethyl  acetate  7~ 
(pH  9) 
0.1M  Borate  CH2C12/IPA 
(pH  9)  (9:1) 
blood  O.IM  NaOH  ethyl  acetate 
0.1M  NaOH  CH2C12/IPA 
(9:1) 
0.1M  Borate  ethyl  acetate 
(pH  9) 
0.1M  Borate  CH2Cl2/lPA 
(pH  9)  (9:1) 
*  _ unsuitable  for  analysis  by  LCEC 
-176-2.8.4.3.  Results  and  discussion 
The  loading  of  the  columns  was  established  as  2ml  sample 
per  6ml  extrelut  material.  The  wash  step  in  the  adsorbent 
extraction  procedure  examined  above  (sections  2.8.2.  and  2.8.3.). 
is  avoided  here  by  assuming  that  the  water  which  comprises  the 
aqueous  stationary  phase  will  retain  all  material  not  desired  in 
the  extract  by  a  judicious  choice  of  pH  and  solvent.  Recoveries 
of  around  7~  were  attained  for  extraction  of  morphine  from 
aqueous  standards.  Blank  aqueous  samples  produced  no 
interference. 
With  one  combination  of  solvent  and  buffer  (borate  buffer  and 
ethyl  acetate),  it  was  possible  to  measure  morphine  in  a  plasma 
sample  without  interference  (absolute  recovery = 7~). 
One  other  combination  of  solvent  and  buffer  produced  an  extract 
which  was  suitable  for  analysis  by  LCEC,  but  the  presence  of  a 
shoulder  on  the morphine  peak made  quantitation difficult. 
None  of  the  combinations  of  extracting  solvent  and  buffer  produced 
a  suitable  extract  from  whole  blood  samples.  This  confirms 
results  obtained  in  the  single  step  liquid/liquid  extraction 
procedure. 
On  inspection  of  the  results  table  it  was  evident  that  the  mixed 
dichloromethane/isopropyl  alcohol  extraction  solvent  produced 
interfering  peaks  in  all  the  biological  samples  extracted.  As 
little  interference  was  noted  in  the  reagent  blanks  (aqueoul 
standards)  it was  assumed  that  this  had  arisen  from  the  biolo~ical 
material  itself. 
Because  of  the  poor  quality  of  the  extracts  from  whole  blood 
samples,  thi s  procedure  was  not  tested  on  aged  blood  samples  nor 
-177-used  in  routine  analysis. 
The  plasma  extracts  obtained  by  this  procedure  were  relati  vely 
clean. 
2.8.4.4.  Conclusion 
The  interference  noted  in  extracts  from  blood  samples  was 
unfortunately  in  the  region  of  the  morphine  peak,  and  the 
selectivity  of  the  LC  system  would  require  to  be  altered  in  order 
to  make  these  extracts  suitable  for  analysis  without  further 
clean-up. 
2.8.5.  DISCUSSION  AND  CONCLUSIONS  ON  SOLID  PHASE  EXTRACTION 
TECHNIQUES 
below. 
The  results  obtained  in  this  section  are  discussed 
The  attractive  aspects  of  solid  phase  extraction 
techniques  are  the  speed  of  sample  preparation,  the  higb 
efficiencies  reported  for  optimised  extraction  procedures,  and  the 
convenience  for  sample  handling.  These  must  be  balanced  against 
the  cost,  select  i vi ty  of  the  procedure  and  the  qual i ty  of  the 
extract. 
With  samples  of  a  relatively  simple  matrix  (plasma,  serum,  aqueous 
standards),  these  procedures  have  been  shown  above  to  have  a 
generally  suitable  for  LCED.  In  cases  where  the  sample  matrix  i. 
complex,  and  heavily  contaminated  wi tb  a  wide  range  of 
putrefactive  material,  the  selectivity  required  is  much 
narrower.  This  has  not  been  achieved  fo~  single  step  extraction 
in  the  above  study. 
-178-Further  extract  purification  is  required.  Subsequent  class  i cal 
liquid/liquid  extraction  would  nullify  some  of  the  advantages 
gained  from  the  use  of  these  rapid  procedures. 
The  use  of  a  second  adsorbent/absorbent  step  as  a  clean  up 
procedure  is  a  possibility,  but  this  would  increase  the  cost,  and 
would  require  an  extensive  study  to  optimise  this  extraction. 
other  alternatives  would  be  to  incorporate  an  in-line  sample 
step  using  pre-columns,  column  switching  and  purification 
backflushing.  These  were  not  available  for  this  study  and  they 
would  also  require  extensive  optimisation. 
As  a  sui table  liquid/liquid  extraction  procedure  had  been 
optimised  (2.7.7.),  it  was  decided  to  concentrate  on  further 
characteri  sing  thi  s  method,  and  its  exami n ing  its  appl ication  to 
authentic  samples. 
2.9.1.  CONCLUSIONS  ON  THE  EXTRACTION  PROCEDURE  OF  CHOICE 
2.9.1.1.  Introduction 
The  liquid/liquid  extraction  procedure  optimised  in 
section  2.7.  and  summarised  in  2.7.7.,  was  found  to  be  sui table 
for  all  sample  types  examined,  and  was  therefore  used  as  a  general 
method.  For  plasma  samples  which  were  occasionally  supplied,  the 
method  of  choice  was  the  extrelut  procedure  described  in  section 
2.8.4 .. 
-179-2.9.2.  CALIBRATION  CURVE  FOR  PREPARED  MORPHINE  STANDARDS 
2.9.2.1.  Introduction 
An  examination  of  a  series  of  spiked  samples  was  made  to 
establish  whether  the  recovery  using  the  optimised  method, 
described  above,  was  linear over  a  range  of  concentrations. 
2.9.2.2.  Method 
A  standard  solution  of  morphine  (10-2g/l)  was  prepared 
in  expired  transfus ion  blood.  Other  standards  were  prepared  by 
series  dilutions.  These  samples  were  extracted  in  duplicate  and 
-4  the  mean  result  calculated  against  the  10  gIl  standard,  by  peak 
height  ratios. 
2.9.2.3.  Results  and  Discussion 
The  concentration  was  calculated  by  comparison  of  peak 
heights  based  on  the  mean  KIN  level  for  the  0.1ug/ml  standard 
(1.035).  The  calculated  concentrations  are  given  in  table  2.26. 
and  shown  plotted  against  the  prepared  concentration  in  figure 
2.26 .. 
The  correlation  coefficient  is  0.9923  and  the  correlation  is 
linear over  the  range  examined. 
2.9.2.4.  Conclusions 
Most  concentrat  ions  encountered  cl  in ically  or  post-mortem 
would  be  expected  to fall within  this  range  (2.1.3.). 
The  linearity  of  this  correlation  means  that  a  single  point 
calibration  should  be  sufficient  to  allow  an  accurate  measurement 
of morphine  in  an  unknown  sample. 
-180-TABLE  2.26. 
CALIBRATION  CURVE  FOR  MORPHINE  IN  BLOOD  ANALYSED 
USING  THE  DEVELOPED"METHOD 
Sample  cone.  Morphine  Nalorphine  KIN  Cone.  found 
__  ug/ml  nA  nA  ug/ml 
5.0  163.8  3.2  51.2  4.94 
207.4  4.2  49.4  4.77 
189.6  3.8  49.9  4.82 
147.6  2.9  50.9  4.92 
n=4 
Average  (X)  4.86 
S.D.  0.08 
CoV  1.7" 
1.0  35.3  3.5  10.1  0.98 
27.8  2.8  9.9  0.96 
24.6  2.4  10.3  0.99 
44.3  4.0  11.1  1.07 
n=4 
Average  (X)  1.00 
S.D.  0.05 
CoY  4.8" 
0.8  29.8  3.5  8.5  0.82 
17.7  2.1  8.4  0.81 
20.0  2.4  8.3  0.80 
32.7  3.8  8.6  0.83 
n=4 
Average  (X)  0.82 
S.D.  0.013 
CoY  1.6" 
0.5  8.9  1.8  4.9  0.47 
13.4  2.6  5.2  0.50 
15.4  3.1  5.0  0.48 
17.2  3.3  5.2  0.50 
n:4 
Average  (X)  0.49 
S.D.  0.015 
CoY  3.01. 
-181-Sample  conc. 
ug/ml 
0.1 
n=4 
Average  (X) 
S.D. 
CoY 
0.05 
n=4 
Average  (X) 
S.D. 
CoY 
0.01 
D=4 
Average  (X) 
S.D. 
CoY 
n=2B 
Average  (X) 
S.D. 
CoY 
TABLE  2.26.  (contd.) 
Morphine 
nA 
4.3 
3.6 
3.3 
3.B 
1.6 
1.2 
1.7 
1.6 
0.2 
0.2 
0.1 
0.3 
Nalorphine 
nA 
4.0 
3.5 
3.2 
3.B 
3.4 
2.1 
3.0 
2.9 
2.4 
3.4 
1.9 
3.0 
3.0B 
0.6.6 
21.64£. 
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MIN 
1.0B 
1.03 
1.03 
1.00 
0.47 
0.57 
0.57 
0.55 
O.OB 
0.06 
0.05 
0.01 
Cone.  found 
us I JIll 
0.104 
0.099 
0.099 
0.097 
0.100 
0.003 
3.01-
0.045 
0.055 
0.055 
0.053 
0.052 
O.OOB 
15.44£. 
0.007 
0.006 
0.005 
0.009 
0.007 
0.002 
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FIGURE  2.26. 
CALIBRATION  CURVE  FOR  MORPHINE  IN  BLOOD 2.9.3.  EFFECT  OF  SAMPLE  AGE  ON  EXTRACTION  EFFICIENCY 
2.9.3.1.  Introduction 
As  interference  with  badly  haemolysed  samples  had  been 
encountered  throughout  the  work,  and  typical  post  mortem  samples 
are  of  this  type,  the  effect  of  aging  of  a  blood  sample  on  the 
recovery  of morphine  was  investigated. 
2.9.3.2.  Method 
A  sample  of  expired  transfusion  blood  was  obtained  and  a 
standard  of  10-4g/l  was  prepared.  The  sample  was  analysed 
immediately  and  left  open  to  the  atmosphere  for  about  one  day. 
It was  stored at  room  temperature  for  the  duration  of  the  study. 
Using  the  extraction  procedure  developed  above  and  outlined  in 
2.7.7.,  the  sample  was  extracted  at  intervals  for  a  period  of 
three weeks. 
A  qualitative  assessment  of  the  blood  sample  was  made  at 
intervals.  The  blood  sample  used  to  prepare  the  standard  was 
expired  transfusion  blood,  containing  preservative  which  may  limit 
the  decomposition  of  the  blood  to  some  extent. 
As  there  is  some  day-to-day  variation  in  the  response  of  the 
detector,  the  absolute  and  relative  extraction  efficiencies  shown 
in  table  2.27.  were  calculated  by  analysing  unextracted  standards 
of morphine  and  nalorphine  immediately prior  to the  extract. 
The  efficiencies  of  extraction  for  each  sample  was  calculated  by 
comparison  of  the  peak  height  with  an  unextracted  standard.  20ul 
of  10-3g/L  is  equ i valent  to  20ng  on  column.  10~ recovery  from 
Iml  of  10-4g/L  is  equivalent  to  100ng.  This  extract  wa. 
-184-reconstituted  in  lOOul  and  20u1  analysed. 
20ng  on  column  also. 
This  is  equivalent  to 
The  calculation  of  the  concentrations  was  based  on  the  assumption 
that  the  day  to  day  variation  in  the  relative  peak  heights  of 
morphine  and  nalorphine  (see  table 2.27.)  was  significant. 
For  this  reason  the  concentration  was  calculated  on  the  basis  of 
the  recovery  from  the  sample  rather  than  simply  on  peak heights 
The  day  0  sample  was  used  as  a  standard. 
2.9.3.3.  Results  and  discussion 
The  blood  sample  started  as  a  mobile  red  fluid,  free  from 
particulate matter  and  odour. 
By  day  three it was  beginning  to  darken  in  colour. 
By  day  nine  it was  visibly more  viscous  and  was  beginning  to  smell 
characteristically of  amines. 
By  day  fourteen  it  appeared  as  a  dark  redd ish  brown  flu id  wi th 
clumps  of material  present  although  no  large clots. 
By  day  twenty  one  it  was  cons i derably  more  vi scous  and  gas  was 
heard  to  escape  when  the  tube  was  opened.  The  odour  was  much 
stronger  and  the  sample  was  sluggish  and  difficult to  pipette. 
These  changes  in  the  physical  properties  of  the  blood  may  account 
for  the  observed  trends  in  the  extraction  efficiencies  discussed 
below. 
Two  effects  are  noted  in  the  extraction  efficiencies  found  for  the 
sample.  Firstly  the  overall  decrease  in  absolute  extraction 
efficiency  for  morphine  is  considerable  with  sample  a~e,  fallin~ 
from  7  O~  ( day  0)  to  3  6  ~ ( day  21).  A  similar  trend  is  noted  for 
-185-TABLE  2.27. 
EFFECT  OF  SAMPLE  AGE  ON  THE  RECOVERY  OF  MORPHINE 
AND  NALORPHINE  FROM  BLOoD 
10-3g/l  Std  soln.  10-4g/1  extract 
20ng  olc  *100\  =20ng  olc 
Day  * Mht. 
0  101 
1  96 
2  80 
5  85 
7  76 
9  104 
11  94 
14  100 
19  72 
21  88 
n:ll10 
Average  (X) 
S.D. 
CoV(\) 
Nht. 
80 
81 
76 
72 
69 
87 
88 
84 
57 
76 
MIN 
1.26 
1.19 
1.05 
1.18 
1.10 
1.19 
1.07 
1.19 
1.26 
1.16 
1.17 
0.07 
6.18 
Mht.  Nht. 
71  59 
69  57 
53  51 
50  40 
45  42 
56  49 
47  48 
50  46 
32  29 
32  32 
Meff. 
70 
72 
66 
59 
59 
54 
50 
50 
44 
36 
56.0 
11.5 
20.5 
Neff. 
74 
70 
67 
56 
61 
56 
55 
55 
51 
42 
58.7 
9.5 
16.2 
*  100\  recovery  =  lOOng,  reconstituted  in  100ul. 
20/100ul  injected. 
*  Peak  heights  in  mm .•  sensitivity  10nA  fsd. 
$  concentrations  calculated  from  extraction 
efficiencies wrt  Day  0  sample. 
-186-
Conc.$ 
0.100 
0.109 
0.104 
0.112 
0.103 
0.102 
0.096 
0.096 
0.091 
0.091 
0.100 
0.007 
7.04 ~ 
00  ......, 
t 
,-... 
o 
100 
90 
0- 80 
'--"" 
~  10 
(l) 
>  60 
o 
U 
(l)  50 
L 
OJ  40 
+-' 
:J  -- 30 
0 
\J) 
...0  20 
m 
10 
j 
1  234  5  6 
•  • 
•  • 
na I orphine 
morphine 
1  8  9  10  11  12  13  14  15  16  11  18  19  20  21 
sample age (days) 
FIGURE  2.27. 
CHANGES  IN  ABSOLUTE  RECOVERY  OF  MORPHINE  AND  NALORPHINE 
FROM  A  PUTRIFYING  BLOOD  SAMPLE  WITH  SAMPLE  AGE the  recovery  of  nalorphine.  This  is  shown  in  figure  2.28 .. 
The  fact  that  the  recovery  for  both  the  drug  and  the  internal 
standard  drop,  suggested  that  phys ical  changes  to  the  matrix  had 
made  the extraction less efficient. 
Secondly,  whilst  standard  deviation  on  the  calculated  morphine 
level  is  only  ±  7'- throughout  the  three  w.eeks  of  th i s  study,  a 
week-by-week  analysis  shows  that  there  is  a  gradual  decrease  in 
the  measured  morphine  concentration  (calculated  wi th  respect  to 
the  Day  0  sample)  from  O.106g/L  in  the  first  week  to  O.093g/L  in 
the  third week.  This  is  shown  in  table  2.28.  and  figure  2.29 .. 
This  suggests  that  in  addition  to  the  loss  of  efficiency  due  to 
matrix  effects,  the  amount  of  morphine  in  the  sample  is 
decreasing.  The  fall  in  the  relative  recovery  of  morphine  could 
be  ascribed  to microbial degradation. 
It  has  also  been  noted  that  morphine  in  cadavers  can  be  converted 
to  the  dimer,  pseudomorphine,  and  may  be  found  as  this  on 
exhumation  (Curry,  1969).  No  indication  is  given  of  the  rate  of 
this  conversion  but  this  process  may  account  for  some  of  the  loss 
of morphine  observed. 
An  element  of  the  change  might  also  be  accounted  for  by  errors  in 
the  measurement  of  the  blood  al  iquot  for  analys is.  Transfer  of 
the  sample  to  the  extraction  tube  was  done  with  a  Gilson  automatic 
pipette  (lml)  (Scotlab  Instrument  Sales,  Glasgow,  U. K.  ) .  As  the 
blood  became  more  sluggish,  pipetting  became  more  difficult  and 
greater care  had  to  be  taken  with  this  step. 
-188-TABLE  2.28. 
MEAN  WEEKLY  ABSOLUTE  AND  RELATIVE  RECOVERY  OF  MORPHINE  FROM  BLOOD 
relative  recovery  absolute  recovery  (Meff.> 
Age  in  wks  n  X  S.D.  X  S.D. 
1  4  0.106  0.005  66.8  5.7 
I  2  3  0.100  0.004  54.3  4.5  ..... 
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FIGURE  2.28. 
CHANGE  IN  MEASURED  CONCfo;NTRJ\TION  OF  MORPHINE  WITH  AGE  OF  BLOOD  SAMPLE 2.9.3.4.  Conclusion 
It  has  been  shown  that  the  effect  of  the  age  and  degree  of 
putrefaction  of  a  blood  sample  will  have  an  effect  on  the  both  the 
absolute  recovery  and  the  recovery  relati  ve  to  an  added  internal 
standard of morphine  in  a  blood  sample. 
It was  also  noted  that  the  physical  conditipn  of  a  three  week  old 
blood  sample  prepared  from  transfusion  blood  (which  contains 
preservatives)  was  considerably  better  than  many  one  week  old 
post-mortem  specimens.  How  closely  this  prepared  specimen 
resembles  real post mortem  blood  can  only  be  assumed. 
-191-2.10.  APPLICATIONS  OF  THE  METHOD  TO  AUTHENTIC  S~~p~SS 
2.10.1.  POST  MORTEM  ANALYSIS 
2.10.1.1.  Introduction 
As  discussed  earlier,  the  assay  for  morphine  in  post-mortem 
blood  was  developed  to  cope  with  the  increased  demand  for  analysis 
(2.1.2.).  This  increase  is  seen  as  a  direct  result  of  the 
increase  in  drug  use  in  the  UK. 
The  lore  of  drug  culture  has  been  extens i vely  revi  ewed  (Laurie, 
1978;  Trebach,  1982;  Winek,  1974;  Picardie  and  Wade,  1985).  The 
lifestyle  of  a  person  habituated  or  addicted  to  opiates,  generally 
leads  to  contact  with  the  medical  profession  either  in  an  attempt 
to  obtain  drugs,  or  as  a  result  of  drug  related  health  problems 
(Cherubin,  1967). 
These  include  conditions  associated  with  poor  injection  hygeine 
ego  cellulitis,  thrombophlebitis,  septicaemia,  hepatitis,  tetanus, 
malaria  (Doame,  1924;  Louria  et  aI,  1967)  and  more  recently  AIDS 
(Hunsmann,  1985;  Winterton et al.,  1985). 
Other  problems,  common  but  not  associated  with  injection  are 
endocarditis,  pulmonary  complications  and  overdose.  Inhaling  the 
drug  carries  the  same  degree  of  risk  of  these  latter  ailments  as 
injecting. 
Overdose  from  heroin  is  recognised  as  being  of  two  types. 
Immediate  overdose,  resulting  from  a  bolus  injection  of 
morphine/diacetylmorphine  causing  pulmonary  oedema  or  respiratory 
arrest  through  pulmonary  smooth  muscle  spasm,  and  leading  to 
-192-death.  This  occurs  within  five  to  ten  minutes,  and  the  deceased 
is  often  found  with  the  needle  and  syringe  still  in  place.  (Polson 
et al.,  1983). 
The  other  form,  delayed  overdose,  is  a  result  of  heroin 
metabolites,  morphine,  monoacetylmorphine,  methylmorphine,  causing 
CNS  respiratory depression,  coma  and  death.  (Perry,  1975). 
Overdose  is  usually  a  result  of  the  drug  user  buying  drug material 
of  an  unusually  high  purity.  The  purity  of  street  heroin  varies 
between  0  and  100~ (Polson et al.,  1983). 
The  metabolism  of  morphine  and  heroin  have  been  discussed  earlier 
(2.1.3.).  The  detection  of  morphine  in  a  blood  sample  therefore 
can  only  imply  the  use  of  either  morphine  or  heroin. 
Differentiation  between  the  two  would  require  determination  of  the 
specific  heroin  marker,  6-monoacetyl  morphine,  the  initial 
metabolite of diacetyl morphine. 
This  metabolite  is  acetylated  through  the  6-0H  position  of 
morphine. 
Assays  for  this metabolite  have  been  reported  (Christiansen,  1985, 
Derks  et al.,  1985). 
2.10.1.2.  S~ples for  analysis 
Samples  provided  for  this  study  came  from  post-mortem 
examinations  where  the  pathologist  had  reason  to  suspect  opiate 
use.  This  suspicion  may  have  arisen  from  the  police,  the 
deceased's  medical  record,  unusual  pulmonary  changes,  recent 
injection marks  or  lack of  an  adequate  cause  of death. 
Samples  were  generally  received  within  two  to  five  days  of  death, 
and  analysed  as  soon  as  possible  thereafter. 
-193-2.10.1.3.  Limits  of  the  assay 
The  quantitative  cut  off  point  for  the  assay  was  taken  as 
-5 
1X10  gIl,  where  the  CoY  was  found  to  be  25~.(see  section 
2.9.2.>.  Below  this  level,  suspected  positives  could  often  be 
seen  at  -6  5X10  gIl,  and  confirmation  of  this  result  would  be 
required  by  repeating  the  analysis  on  a  larger  sample  or  by  the 
use  of  radioimmunoassay  or  GCMS  procedures. 
As  the  lower  end  of  the  therapeutic  range  is  taken  as  5X10-5g/l 
(Stead  and  Moffat,  1983>,  concentrations  below  th  i s  are  unl ikely 
to  be  encountered  if  morphine  played  a  significant  role  in  the 
cause  of death. 
The  procedure  used  routinely  for  the  assay  was  that  developed  in 
the  first  part  of  this  chapter,  the  chromatographic  conditions  are 
summarised  in  section  2.5.12,  and  the  extraction  procedure  in 
section 2.7.7 .. 
2.10.1.4.  Collection of data 
Over  the  period  between  January  1984  to  December  1985, 
twenty-four  samples  analysed  for  morphine  (by  the  above  method) 
gave  positive  results.  Details  of  many  of  these  cases  are  not 
available,  as  they  came  from  several  different  pathologists  and 
procurators  fiscal  in  Scotland.  Because  of  this  lack  of 
background,  only  limited  conclusions  can  be  drawn  from  the  results. 
In  addition,  the  samples  were  preselected  in  as  much  as  they  came 
from  cases  where  the  pathologist  already  suspected  opiates  were 
involved. 
This  laboratory  was  one  of  the  first  in  Scotland  to  provide  a 
chromatographic  method  for  morphine  in  blood.  As  a  result  in  the 
-194-case 
*  1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
TABLE  2.29. 
BLOOD  MORPHINE  LEVELS  IN  PERSONS  DYING 
MORPHINE  RELATED  DEATHS  AS  ANALYSED  IN  THIS  STUDY 
year  area  sex  level 
(mg/L) 
1984  Glasgow  F  0.1 
Edinburgh  F  0.9 
0.6 
Glasgow  M  0.12 
Glasgow  M  0.26 
Edinburgh  M  0.40 
Edinburgh  F  15.4 
Edinburgh  M  0.7 
Edinburgh  ?  0.01 
Edinburgh  M  0.36 
Edinburgh  F  0.25 
Edinburgh  F  0.31 
Edinburgh  M  0.50 
1985  Glasgow  M  0.25 
Aberdeen  M  0.14 
Glasgow  M  0.017 
Glasgow  M  0.34 
Glasgow  M  0.43 
Glasgow  M  0.51 
Glasgow  M  0.05 
Edinburgh  M  0.6 
Edinburgh  M  0.2 
Glasgow  M  4.7 
Glasgow  M  0.18 
Glasgow  F  0.30 
n=25 
X=1.11 
-195-early  part  of  1984,  almost  all  suspected  opiate  deaths  were  sent 
to  Glagow University  Forensic medicine  department. 
Since  then  other  hospital  laboratories  have  acquired  this 
facility,  and  the  number  of  samples  from  outwith  Strathclyde 
Region  has  declined.  The  Department  of  Forens i c  Hed i cine  and 
Science  at  Glasgow  University  still  provides  the  sole  Forensic 
Toxicology  service for  the  Glasgow  area. 
An  ex~ination of  the  data  (table  2.29.),  shows  that  the  number  of 
positive  results  for  morphine  in  the  Glasgow  area  has  increased 
from  four  cases  in  1984  to  nine  cases  in  1985.  In  the  five 
months  up  until  Kay  1986  however,  only  one  positive  result  had 
been  found. 
An  increase  in  morphine  related  death  would  be  expected  in  1 ine 
with  the  increasing  number  of  people  abusing  the  drug.  The  data 
available  here  does  not  allow  any  conclus ions  to  be  drawn  on  the 
scale  of  the  increase  in  morph ine  related  death.  In  addition, 
the  recent  increase  in  awareness  of  pathologists  to  the  drug 
problem  in  Glasgow,  and  the  availability  of  a  suitable  assay  has 
prompted  an  increase  in  the  number  of  requests  for  morphine 
determination. 
2.10.1.5.  Interpretation of  Results 
The  interpretation  of  blood  concentrations  of  drugs  which 
produce  physiological  dependence  is  difficult.  Tolerance,  that  is 
a  decreased  response  to  the  same  dose,  has  been  seen  to  develop 
soon  after  the  administration  of  the  first  dose  of  morphine  or 
heroin  (Hartin  and  Fraser,  1961). 
This  requires  the  addict  to  increase  his  dose  to  achieve  the  lame 
-196-degree  of  euphoria  as  was  experienced  with  the  first  dosage.  The 
degree  of  tolerance  wi 11  increase  wi th  i ncreas i ng  dose.  As  a 
result  of  this,  concentrations  which  would  be  considered  fatal  in 
the  average  person  are  often  encountered  without  seemingly  ill 
effects  in  those  who  have  acquired  a  tolerance  for  the  drug 
(Goldstein  et  al.,  1974).  There  is  therefore,  considerable 
overlap  in  the  accepted  ranges  of  therapeutic,  toxic  and  fatal 
concentrations  of  morphine  in  blood  (Stead  and  Moffat,  1983). 
The  concentrations  given  for  these  three  ranges  are  0.04  to  0.5, 
0.5  to  5  and  greater  than  0.2mg/L  respectively.  This  infoLmation 
is  in  good  agreement  with  that  reported  elsewhere  (Felby  et  al., 
1974),  where  fatal  concentrations  were  found  above  0.2mg/L.  The 
role  of  morphine  in  the  cause  of  death  may  be  either causitive  or 
. 
subsidiary_  The  toxicological  findings  can  confirm  or  refute 
this  to  some  degree.  High  levels  (above  0.2mg/L>  may  be 
sufficient  to  cause  respiratory  arrest,  but  levels  below  this  may 
lead  to  unconsciousness,  inhalation  of  vomi t  and  suffocation  or 
subsequent  pneumonia.  As  the  survi  val  times  will  be  longer  in 
deaths  resulting  from  pneumonia,  the  morphine  concentration  might 
be  low  or  undetectable.  The  presence  of  morphine  can  however 
give  the  pathologist  a  likely  explanation  for  any  of  the  above 
findings. 
2.10.1.6.  Discussion of results 
The  range  of  morphine  concentrations  found  in  these  samples 
varies  from  0.01  to  15.4  mg/L  (mean  1.12).  This  is  in  agreement 
with  levels  reported  in  the  literature  and  the  findings  in  the 
post  mortem  examination  are  cons i stent  wi th  death  from  mot"ph i ne 
-197-overdose.  The  level  found  in  case  6  is  extremely  high,  and  the 
circumstances  suggest  that  this  arose  from  the  injection  of 
heroin.  In  this  case,  two  of  deceased  were  found  together 
(numbers  5  and  6). 
A  high  blood  morphine  concentration  reported  recently  (Connett. 
1984),  caused  by  the  absorption  of  heroin  from  capsules  in  the 
stomach,  was  still less  than  that  found  in  sample  number  6.  The 
lowest  level  is  just  above  the  cut  off  point  of  the  assay  and  is 
unlikely  to  be  the  sole  cause  of  death.  The  inhalation  of  vomit 
during  unconsciousness  can  lead  to  suffocation  or  if  the  victim 
survives  this,  pneumonia  and  subsequent  death.  Similar  to  the 
behaviour  noted  in  the  case  of  barbiturate  poisoning  (Oliver, 
1986) . 
Two  representative  cases  were  studied. 
2.10.2.  CASE  1 
2.10.2.1.  Medical  and  social history 
A  young  (24)  unemployed  single  male,  was  a  known  drug 
addict  and  had  been  registered  as  such  for  over  two  years. 
Th is  had  first  come  to  light  when  he  was  admi t ted  to  hospi tal 
suffering  from  hepatitis  B. 
He  was  reffered  to  a  drug  clinic  as  an  out  patient,  but  never-
attended. 
2.10.2.2.  Circumstances 
The  man  left  his  girlfr-iend's  house  one  evening  at 
10.45pm.  He  had  been  drinking.  but  not  heavily.  He  gave  no 
-198-indication of  feeling  unwell. 
At  about  12. 4Spm  the  following  day,  he  was  found  dead  in  the 
living  room  of  his  own  flat.  The  police  searched  the  house.  A 
needle  and  a  syringe  containing  traces  of  blood  and  a  white 
substance,  were  found  in  the  ki tchen.  An  empty  blister  pack  (6 
bl  i sters)  marked  "KST  continus  100"  was  also  found. 
vomit  in  the toilet. 
There  was 
The  body  was  removed  to  the  ci  ty  mortuary  where  a  post-mortem 
examination  was  carried out  four  days  later. 
2.10.2.3.  Pathology 
Relevant  features  at  post  mortem  were  the  presence  of  ei&ht 
fresh  needle  punctures  in  the  right  antecubial  fossa,  and  one  on 
the  left side. 
Internally,  both  lungs  were  intensely  congested  and  oedemateous, 
but  there  was  no  evidence  of  inhalation  of  gastric  contents. 
There  were  also  numerous  small  firm  nodules  throughout  both  lungs 
measuring  up  to  O.Scm  in  diameter. 
the  liver  and  spleen. 
Similar  nodules  were  noted  in 
2.10.2.4.  Bacteriology  and  Virology 
Tissue  samples  were  examined 
hepatitis,  but  were  negative  for  both. 
2.10.2.5.  Toxicology 
for  tuberculosis  and 
A  blood  sample  was  screened  for  alcohol,  barbi turates  and 
morphine,  while  a  urine  sample  was  screened  for  alcohol  and  basic 
drugs. 
-199-The  following  results  were  obtained:-
13  milligr~es of  alcohol  per  100m}  of  blood 
43  milligrammes  of  alcohol  per  100ml  of  urine 
4.7  microgrammes  of morphine  per millilitre of  blood. 
All  other  analyses  gave  negative  results. 
The  syringe  and  the  empty  packet  were  also  submitted  for  analysis. 
The  packet  was  identified  as  having  contained  morphine  sulphate 
tablets  (KST,  manufactured  by  NAPP). 
100mg  of morphine  sulphate. 
Each  capsule  would  contain 
The  white  material  was  oily  and  resembled  vaseline  in 
appearance.  Some  of  this  was  dissolved  in  methanol  and  analysed 
by  HPLC  for  the  presence  of  morphine,  and  by  GC-NPO  for  the 
presence  of heroin.  All  analyses  gave  negative  results. 
The  blood  residue  in  the  syringe  was  washed  out  with  distilled 
water  and  extracted  by  the  method  described  in  section  2.5.12 .. 
This  extract  was  analysed  by  HPLC  for  the  presence  of  morphine  t 
and  by  GC-NPD  for  the  presence  of heroin. 
The  extract  was  found  to  contain  0.05  milligrammes  of  morphine. 
No  heroin was  found  in  the  extract. 
2.10.2.6.  Discussion  and  Conclusion 
The  blood  concentration  of  morphine  was  well  within  the 
fatal  range  (Stead  and  Hoffat,  1983)  and  is  sufficient  to  bave 
caused  death  by  CNS  respiratory depression. 
This  morphine  which  was  detected  could  have  come  from  the 
administration  of  morphine  or  heroin.  The  absence  of  any  packet 
-200-of  heroin  in  the  flat,  and  the  presence  of  the  KS1  packa~e. 
together  with  the  finding  of  morphine  in  the  syringe  but  not 
heroin,  suggests  that  the  deceased  may  have  crushed  and  injected 
the  KST  tablets. 
The  nodules  noted  in  the  lungs  and  all  the  other  organs  were 
examined  microscopically  but  their  exact  nature  was  never 
determined.  Although  very  different  from  the  typical  talc 
granulomas  seen  they  were  nevertheless  considered  to  be  somehow 
related  to  chronic  drug  abuse. 
as  morphine  intoxication. 
The  death  was  finally  certified 
2.10.3.  CASE  2 
2.10.3.1.  Medical  and  Social  History 
A  young  (18)  female  had  a  history  of  drug  misuse  and  had 
been  an  in-patient  in  a  psychiatric  hospital  receiving  treatment 
for  this  condition.  She  was  suffering  from  depression  and  had 
been  prescribed  temazep~ tablets  by  her  general  practitioner. 
2.10.3.2.  Circumstances 
In  a  fit of  depression  the  girl  had  taken  a  large  number  of 
temazep~ tablets  and  a  quantity  of  Malibu  liquor,  in  an  apparent 
suicide  attempt.  She  had  been  found  lying  outdoors  in  a 
semi -consc i ous  state  and  was  admi t ted  to  hospi tal  as  a  casual  ty 
patient.  The  next  day  she  discharged  herself.  and  went  to  see 
some  aquaintances  whom  she  had  met  during  a  stay  in  the 
psychiatric  hospital.  Both  these  persons  were  known  dru~ addicts. 
-201-The  circumstances  thereafter  are  vague.  Having  told  the  two 
aquaintances  that  she  wished  to  kill  herself,  they  obtained  a 
quantity  of  heroin  and  one  of  them  injected  her  with  some  of 
this.  She  then  "fell asleep"  and  was  heard  to  be  snoring.  Some 
time  later,  apparently  unconscious,  she  was  removed  from  the  bed 
where  she  had  been  lying  and  was  laid  on  some  cushions.  Later 
that  night  she  was  found  to  be  "blue",  and  unrousable  and  she  was 
taken  to hospital,  where  she  died  shortly after  admission. 
The  cause  for  her  admission  to  hospital  was  stated  to  be  the 
effects of  an  overdose  of  temazep~. 
2.10.3.3.  Pathology 
The  main  findings  at  post  mortem  were  the  precence  of 
several  recent  needle  punctures,  at  the  elbows  and  at  the  wrist. 
Internally there  was  severe  congestion  and  oedema  of  the  lungs. 
2.10.3.4.  Bacteriology  and  Virology 
At  the  request  of  the  pathologist  samples  from  the  deceased 
were  examined  for  hepatitis.  All  samples  were  found  negative. 
2.10.3.5.  Toxicology 
Blood  and  urine  samples  were  retained  by  the  pathologist. 
The  presence  of  morphine  was  detected  in  the  blood  by 
radioimmunoassay.  A  sample  of  the  blood  was  subsequently  sent  to 
this  department  for  confirmation  and  quantification of  this  result. 
The  sample  was  extracted  and  analysed  by  LCED. 
A  concentration  of  0.9  microgr~es of  morphine  per  millilitre  of 
blood  was  found. 
-202-2.10.3.6.  Conclusion 
This  level  is  within  the  overdose  range  and  the  cause  of 
death  was  certified as  morphine  (heroin)  poisoning. 
2.10.3.7.  Discussion 
Police  enquiries  in  this  case  resulted  in  the  apprehension 
for  murder  of  both  of  the  girls  who  allegedly  injected  the 
deceased  with  heroin.  As  a  result,  a  second  postmortem  and 
toxicological  examination  were  carried  out  for 
the  defendants'  solicitors.  The  blood  sample  was  analysed  by 
LCED  for morphine  and  by  GCKS  for  temazep~. 
The  results of this  analysis  were  as  follows:-
0.6 microgrammes  of morphine  per millilitre of  blood 
0.92  microgrammes  of  temazepam  per millilitre of  blood 
The  second  post  mortem  confirmed  the  findings  of  the  first,  but 
also  disclosed  the  presence  of  pneumonia  in  the  lungs,  this  being 
considered  to  be  the  prime  cause  of  death,  it  was  further 
considered  that  the  pneumonia  developed  as  a  result  of  inhalation 
of  vomit  whilst  intoxicated  by  a  combination  of  temazepam  and 
heroin.  The  pathologists  added  that  the  cause  of  death  was 
probably  pneumonia  caused  by  the  combination  of  these  two  drugs. 
80th  the  Crown  and  Defence  analyses  had  been  carried  out  by  the 
same  technique  on  two  different  blood  samples  from  the  deceased. 
The  levels  found  were  0.9  and  0.6  microgrammes  of  morphine  per 
millilitre  of  blood.  Allowing  the  standard  deviation  in  relative 
extraction  efficiency  of  13~,  this  still  leaves  sonlf>  of  the  error 
-203-unaccounted  for.  The  question  of  this  error  was  raised  in 
court.  The  explanation  given  was  that  the  samples  had  been  taken 
one  month  apart,  and  were  respectively  four  weeks  and  eight  weeks 
old  when  taken.  The  advanced  putrefaction  caused  by  pathogens 
present  in  the  mortuary  would  lessen  the  extraction  efficiency  in 
an  older  sample. 
In  addition  it  is  known  that  morphine  is  often  converted  to 
pseudomorphine  in  cadavers,  and  the  amount  of  morphine  in  the 
sample  may  indeed  have  been  less  by  the  time  of  the  second 
analysis. 
It  should  also  be  noted  that  it  was  suggested  in  court  that  the 
second  sample  may  have  been  s imply  scooped  out  of  the  abdominal 
cavity,  as  no  heart  blood  was  available  at  the  time  of  that  post 
mortem.  This  was  however  not  substantiated. 
2.10.3.8.  Conclusion 
It  was  held  by  the  court  that  one  of  the  deciding  factors 
in  the  death  of  the  girl  was  the  administration  of  heroin  in 
sufficient  quantities  to  cause  respiratory  depression  leading  to 
death.  As  a  result,  both  defendants  were  found  gu i I ty  on  the 
reduced  charge  of  culpable  homicide. 
-204-2.10.4.  HOSPITAL  STUDY. 
2.10.4.1.  Introduction 
A  study  was  carried  out  on  critically  ill  patients 
receiving  morphine  for  sedation.  The  object  of  the  study  was  to 
examine  morphine  kinetics  in  the  severely  ill,  and  relate  this  to 
the  level  of  sedation,  analgesia  and  the  severity  of  illness. 
Approval  for  the  study was  given  by  the  local Medical  Ethics  Board. 
Morphine  use  is  becoming  more  prevalent  in  intensive  care  medicine 
since  the  wi thdrawal  of  two  other  popular  agents,  Al thes in  and 
Etomidate,  because  of  side  effects  (Editorial,  Lancet,  1984, 
British National  Formulary,  1985). 
Morphine  kinetics  have  been  well  researched,  but  usually  for 
single  dose  administration  (Moore  et  al.,  1983),  and  there  is 
little  reported  information  on  results  of  infusions  lasting  more 
than  72  hours  (Don  et a1.,  1975). 
The  study  of  critically  ill  patients  receivin~  morphine  by 
infusion,  allows  the  assesment  of  morphine  kinetics  in  relation  to 
the  sedative effect of  the  drug  after long  term administration. 
Many  problems  arise with  the  interpretation  of  results  under  these 
conditions.  The  patients  welfare  must  take  precedence  at  all 
times  and  the  study  cannot  be  allowed  to  influence  the  treatment 
received  by  the  patient.  This  in  turn  means  that  a  great  number 
of  variables  must  be  taken  into  account  when  considering  the 
results. 
Variables  interfering  with  the  steady  state  morphine  levels 
included  ha~modialysis  and  haemofiltration  in  patients  with  Acute 
Renal  Failure  (ARF)  and  occasional  bolus  injections  of  ntorphine  in 
all patients  as  required. 
-205-Problems  involved  in  relating  blood  morphine  levels  to  the  level 
of  sedation,  were  the  additional  administration  of  midazolam  Cby 
bolus  and  infusion)  and  other  sedative  drugs  Cesp.  fentanyl), 
administered  either  for  surgery  or  to  give  the  patient  relief  from 
pain. 
Because  of  the  time  scale  of  the  stud.y,  samples  were  taken 
infrequently  (three  times  daily)  and  were  often  not  laken 
immediately  before  a  change  in  infusion  rate,  when  the  information 
would  have  been  of  most  use.  Lastly,  most  of  the  levels  found  in 
the  study  were  at  the  low  end  of  the  therapeutic  range,  and  hence 
subject  to  larger error. 
2.10.4.2.  Protocol 
Patients  admitted  to  the  Intensive  Therapy  Unit  (ITU)  were 
sedated  using  a  combination  of  opiates  and  benzodiazepines. 
These  are  normally  given  by  infusion,  as  this  causes  less 
ventilatory  depression  than  a  bolus  injection.  Additional  bolus 
injections  however,  were  given  as  required.  Blood  samples  were 
taken  through  an  indwelling  venous  catheter  lwo  or  three  times  a 
day,  and  more  often  when  the  infusion  was  stopped,  to  allow 
o  calculation  of  lhe  hal f  life.  The  samples  were  stored  at  -20  C 
until  analysis. 
At  the  time  the  sa.mp1es  were  taken,  an  assessment  was  made  of  the 
patient's  sedation  level  and  sickness  score. 
~;O.4.3. Sedation  and  ~ickness scoring 
This  was  a  subjective  assesment  by  the  clinician  Call 
assesments  were  made  by  the  same  clinician),  using  a  ten  point 
-206-linear  analogue  scale.  On  this  scale  zero  represented  no 
response  to  verbal  or  tactile  stimuli,  and  ten  represented  full 
alertness  (Bion et al.,  1986). 
The  severity  of  the  illness  was  measured  using  a  sickness  score 
(Bion  et  al.  1985),  based  on  the  APACHE  II  sickness  scoring 
system.  The  higher  the  score,  the  poorer  the  prognosis;  scores 
of  19  and  above  are  usually associated with  subsequent  death. 
The  blood  s~ples were  analysed  as  described  above.  The  analys i s 
was  performed  in duplicate  where  there  was  sufficient  sample. 
2.10.4.4.  Results 
Eleven  patients  were  ex~ined. 
history  are  given  in  table  2.30 .. 
Details  of  their  medical 
A  record  of  the  infusion  rate  of  morphine  over  the  previous  four 
hours,  the  sickness  score  and  the  sedation  score  were  abstracted 
from  the  record  charts  and  are  given  in  appendix  C,  along  with  the 
measured  morphine  concentration.  Elimination  half-lives  were 
calculated  where  suffic  ient  samples  were  taken  during  the  decay 
period.  This  was  done  by  linear  regression  analysis,  using  the 
method  of  least squares. 
2.10.4.5.  Selection of data 
Correlations  were  not  examined  in  cases  where  there  were 
insufficient  data  points  (ie  data  for  less  than  three  infusion 
rates) . 
The  level  of  sedation  would  be  affected  by  the  presence  of  any 
other  sedative  drugs,  and  could  potentially  be  affected  by 
intermittant  dialysis.  For  that  reason  the  sedation  score 
-207-No.  Age 
1  68 
2  61 
3  SS 
4  43 
5  56 
6  S3 
7  38 
8  64 
9  22 
10  24 
1 1  52 
TABLE  2.30. 
MEDICAL  HISTORIES  OF  THE  ELEVEN  HOSPITAL  PATIENTS  IN  THIS  STUDY 
sex  Wt. 
M  80 
M  80 
M  80 
F  55 
F  80 
M  80 
M  68 
F  70 
F  45 
M  75 
M 
Diagnosis 
Post  operative sepsis.  choleostasis.  ARF 
Acute  haemolysis.  ARDS.  ARF 
Road  Traffic Accident.  Head  injury. 
Flail  chest.  ARF 
Septic  shock.  Peritonitis 
Necrotising fasciitis 
Subphrenic  abscess 
Intestinal  infarction 
Road  Traffic Accident.  Ruptured  diaphragm 
and  liver 
ARDS.  Pulmonary  Hodgkins'  disease  .stg.  IV 
Road  Traffic Accident,  Pulmonary  necrosis 
ARDS.  Acute  pancreatitis 
info 
period 
160 
S6 
108 
62 
117 
205 
69 
81 
210 
326 
528 
survived? 
No 
Yes 
No 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
Yes corresponding  to  any  samples  taken  wi th in  the  period  FOUR  HOURS 
after administration of  another  drug  or dialysis,  were  discarded. 
More  data  were  available  to  correlate  the  infusion  rate  with  the 
blood  morphine  concentration,  as  the  latter  was  assumed  to  be 
independent  of  the  presence  of  other  drugs,  whereas  sedation  was 
not. 
2.10.4.6.  Discussion 
The  patients  record  chart  was  examined  and  details  were 
taken  at  points  where  steady  state  morphine  levels  were 
operating.  steady  state  kinetics  were  assumed  to  be  operatin& 
where  the  infusion  rate  had  been  constant  for  four  hours  prior  to 
sampling.  For  patients  receiving  dialysis,  levels  were  not 
considered until  four  hours  after dialysis. 
The  details  of  interest  were  the  patient's  sickness  score,  the 
level  of  sedation,  the  blood  morphine  concentration  and  the 
corresponding  infusion rate. 
Each  patient was  first considered  in  turn. 
The  data  collected  was  examined  to  establish  the  degree  of 
correlation  between  the  following  sets of  parameters; 
Infusion  rate  and  Sedation  level 
Blood  morphine  concentration  and  Sedation  level 
Sickness  score  and  Sedation  level 
Infusion  rate  and  blood  morphine  concentration 
Correlation  coefficients  (r)  were  calculated  usin&  a  best  strai&ht 
-209-TABLE  2.31. 
TEST  OF  CORRELATION  BETWEEN  SEDATION  LEVEL, 
INFUSION  RATE,  BLOOD  MORPHINE  LEVEL  AND  SICKNESS  SCORE 
FOR  EACH  PATIENT 
patient 
number 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
sed./sick. 
+0.19 
+0.67 
-0.49 
-0.76 
Correlation Coefficients 
sed. I I.  R.  sed. ICone.  I . R.  Cone. 
-0.79  -0.48  +0.76 
insufficient data 
-0.65  -0.45  +0.16 
insufficient data 
other  drugs  used 
-0.23  -0.14 
-0.43  -0.54 
insufficient data 
other  drugs  used 
other  drugs  used 
insufficient data 
-210-
+0.92 
+0.96 
+0.94 
+0.87 
+0.86 TABLE  2.32. 
COMPARISON  OF  ELIMINATION  HALF  LIVES  FOR  MORPHINE 
IN  PATIENTS  UNDER  STUDY 
Patient  morphine  highest  blood  corresponding 
number  T/2  concentration  infusion rate 
{mins)  {mg/L)  {mg/hr) 
1  320  0.039  2 
420  0.037  2 
2  65  0.108  5 
3  280  0.078  5 
4  60  0.015  3 
5  113  0.135  7.5 
6  60  0.093  5 
7  50  0.082  5 
8  *  0.046  3 
9  90  0.332  15 
10  90  0.388  15 
11  160  0.077  4 
*  no  data  available 
$  dialysis  performed  during  decay 
-211-line  fit,  linear  regression  analysis  programme,  run  on  a  PET 
microcomputer  (Commodore). 
The  results  of  these  comparisons  are  shown  in  table  2.31 .. 
No  consistent  correlation  is  seen  between  measured  blood  morphine 
level  and  the  degree  of  sedation.  Indeed,  some  patients  appeared 
to  remain  sedated  for  several  days  after -recei  ving  any  sedati  ve 
drug  and  when  there was  no  detectable morphine  in  the  blood. 
This  observation  is  supported  by  a  similarly  low  correlation 
between  infusion rate  and  sedation. 
There  is  evidence  (Martin  and  Fraser,  1961)  that  tolerence  to  the 
euphoriant  effects  of  morphine  can  develop  shortly  after  the  onset 
of  administration  (within  to  2-3  days).  If  the  s arne  app1 i es  to 
the  sedative  effects,  this  would  result  in  a  corresponding  drop  in 
the  level  of  sedation  for  a  given  dose  (or  blood  concentration) 
wi th  time.  The  extent  to  which  to1erence  develops  is  difficult 
to  assess  from  the  data  available  in  this  study.  There  are  many 
variables  which  will  alter  the  sedation  level  of  the  patient, 
including  the  administration  of  other  sedatives  and  the  continuous 
change  in  the  level  of  the  patients  illness,  which  is  later  shown 
to  affect  sedation.  This  made  the  assessment  of  the  de~ree  of 
tolerence  developed  by  the  patients  impossible  on  the  basis  of  the 
results  from  this  study. 
The  only  set  of  data  showing  consistent  correlation  were  infusion 
rate  and  blood  morphine  concentration.  These  showed  a  hi~h 
correlation  r  values  were  greater  than  0.7  for  all  the 
patients.  The  lowest  correlation  (r=  0.71  and  0.80)  for  infusion 
rate  and  blood  morphine  concentration  was  found  in  the  two 
patients  (numbers  one  and  two  respectively)  who  had  Acute  Renal 
failure  (ARF). 
-212-There  was  a  significant difference  in  the  elimination  half-life  of 
the  drug  once  i nfus ion  was  stopped  (table  2.32.),  between  those 
patients with  ARF  and  those  without. 
It  was  proposed  that  these  observations  might  support  the  current 
theory  that  the  kidney  played  a  major  role  in  the  elimination  of 
morphine  (Moore  et  al.,  1983;  Ball  e.t  ale ,  1984) .  The 
differences  between  these  two  groups  (ARF  and  normal)  were 
examined. 
2.10.5.  EFFECTS  OF  ACUTE  RENAL  FAILURE 
2.10.5.1.  Introduction 
The  patients  were  considered  as  two  groups:  those  with  and 
those without  renal  failure. 
Within  these  two  groups  all  the  data  were  then  considered 
collectively,  in  order  to  eliminate  bias  in  mean  blood  levels  for 
infusion  rates  with  a  small  number  of data  points. 
The  degree  of correlation was  calculated as  before. 
2.10.5.2.  Results  and  Discussion 
The  results  are  shown  in  figure  2.29 .. 
The  comparison  of  the  data  was  made  only  up  to  infusion  rates  of 
Smg/hr,  as  this  was  the  highest  rate  of  infusion  administered  to 
patients with  ARF. 
No  weight  correction  was  done,  as  the  patients  were  not  usually  in 
a  suitable  condition  to  be  weighed  when  admitted,  and  only 
approximate  weights  were  known. 
The  data  was  treated  in  the  following  manner.  A  best  strai&ht 
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FOR  (a)  NORMAL  PATIENTS  AND  (b)  THOSE  SUFFERING  FROM  ACUTE  RENAL  FAILURE 
5 line  was  calculated  for  all  the  data  in  each  of  the  groups.  The 
alternative,  to  calculate  the  best  straight  line  for  the  mean 
blood  level  at  each  infusion  rate,  would  not  have  given  sufficient 
weight  for  infusion  rates with  more  data points. 
It  was  shown  that  the  correlation  coefficients  were  0.934  and 
0.803  for  normal  and  ARF  patients  respectively.  A  test  of 
significance,  student's  T-test  (Langley,  1970)  was  done  on  each  of 
the  points  where  there  was  sufficient  data  (table  2.33.).  No 
significant  difference  was  found  for  any  of  these  points  at  a 
probability level of  5~. 
There  was  no  evidence  of  the  accumulation  of  morphine  in  the  blood 
of  those  patients  wi th  ARF,  as  has  been  observed  elsewhere  (Ball 
et  al.,  1985).  The  gradient  of  the  slope  is  actually  less  in 
patients  with  ARF.  The  regression  coefficients  were  0.021  and 
0.012  for  normal  and  ARF  patients  respectively.  This  implies 
that  patients  with  renal  failure  were  eliminating  morphine  more 
rapidly  than  patients  with  normal  renal  function. This  unlikely 
finding  was  ascribed  to  the  fact  that  those  patients  with  ARF 
were,  in  addition  to  receiving  intermittant  dialysis,  also 
receiving  continuous  haemofiltration 
haemoperfusion  unit. 
on  an 
.  r  blcon 
It  was  proposed  that  this  procedure  was  removing  the  sedatives 
from  the  blood.  Other  information  provided  by  this  comparison  is 
that  in  patients  with  normal  renal  function,  no  detectable 
morphine  would  be  found  in  the  blood  at  infusion  rates  below 
O. 5mg/hr,  and  that  infus ion  rates  of  greater  than  2. 5mg/hr  would 
be  required  to  produce  blood  levels  equal  to  that  quoted  a8  being 
the  lower  end  of  the  therapeutic  range  (Stead  and  Moffat,  1983) 
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TABLE  2.33. 
T-TEST  DATA  FOR  THE  RELATIONSHIP  BETWEEN  BLOOD  MORPHINE  CONCENTRATION  AND  INFUSION  RATE 
WITH  RESPECT  TO  STATUS  OF  RENAL  FUNCTION 
ARF 
n 
mean 
SD 
Normals 
n 
Mean 
SD 
DoF 
t 
t(S'> 
0 
5 
8.2E-3 
4.5E-3 
5 
1.8E-3 
2.5E-3 
8 
2.21 
2.36 
1 
2 
0.013 
2.8E-3 
3 
0.036 
5.SE-3 
3 
4.80 
4.3 
2 
10 
0.028 
9.4E-3 
Infusion rate 
3 
2 
0.028 
6.3E-3 
16 
0.033 
0.012 
16 
0.78 
2.13 
4 
7 
0.065 
8.7E-3 
5 
7 
0.067 
0.029 
13 
0.092 
0.025 
18 
1.77 
2.11 
7.5 
4 
0.099 
0.024 
8 
2 
0.134 
0.134 
10 
14 
0.172 
0.051 
15 
8 
0.320 
0.043 2.10.6.  ANALYSIS  OF  RAEMOPERFUSION  FLUID 
2.10.6.1.  Introduction 
To  support  the  above  hypothesis  that  morphine  was  bein& 
removed  from  the  blood  of  anuric  ARF  patients  by  haemofiltration, 
it  would  have  to  be  shown  that  morphine  was  present  in  the 
haemofiltrate. 
2.10.6.2.  Method 
Three  separate  samples  of  amicon  fluid  were  recei  ved  from 
one  of  the  patients  in  the  trial  (number  two).  These  were 
extracted  using  the  general  procedure  described  earlier,  and 
analysed  by  LCEO. 
2.10.6.3.  Results  and  discussion 
All  three  samples  gave  peaks  corresponding  to  morphine. 
The  calculated levels  were  0.015,  0.101  and  0.008ug/ml. 
This  shows  that  haemofiltration  does  remove  some  of  the  morphine 
from  the  blood.  The  haemofiltrate  is  little  different  from 
serum;  the  filter  retaining  only  blood  cell  and  the  larger  plasma 
proteins. 
clearance. 
A  standard  liver  function  test  is  that  of  antipyrine 
When  antipyrine  is  administered  concurrently with  the 
use  of  haemoperfusion  or  dialysis,  misleadingly  low  clearance 
values  will  be  obtained  (Maddocks  et  al.,  1976).  In  this 
connection  it  is  important  to  remember  that  the  clearance  of 
compounds  by  the  Amicon  cannot  be  measured  by  the  product  of  the 
filtrate/blood  concentration  ratio  and  the  filtration  volume  as 
would  be  done  for  urine  (Stevens  1984).  This  is  because  the 
-217-filtrate  in  this  case  is  more  similar  to  serum  and  - unlike  the 
s i tuat  ion  encountered  wi th  renal  clearance  - the  volume  wi 11  not 
effect the  concentration. 
The  observed  increase  in  elimination  half  life  can  be  accounted 
for  by  the  fact  that  the  role  of  the  kidney  in  morphine 
elimination  is  an  active  transport  system,  whereas  the  Amicon 
device  is  a  simple filter. 
2.10.6.4.  Conclusion 
It  is  clear  that  haemoperfus ion  is  removing  morphine  from 
the  circulating  blood  of  those  patients  receiving  this 
treatment.  Although  a  recent  review  has  considered  the  use  of 
haemoperfusion  in  the  treatment  of  poisoning  (de  Broe  et  a1., 
1986),  no  quantitative  study  of  the  removal  of  drugs  by 
haemoperfus ion  has  been  made,  but  such  a  study  would  lead  to  a 
better  understanding  of  the  pharmacological  needs  of  patients  with 
renal  failure.  The  increased  elimination  half  life may  implicate 
the  role  of  the  kidney  in  morphine  metabolism,  but  none  of  the 
patients  meet  the  requirements  of  a  control  experiment,  and  no 
firm  conclusions  can  be  drawn. 
2.10.7.  CONCLUSIONS  ON  THE  CLINICAL  ASPECTS  OF  THE  STUDY 
2.10.7.1.  Introduction 
Further  analysis  of  this  data  was  carried  out  by  the 
Clinical  Shock  Study  Group  and  the  Clinical  Pharmaco10&y  Unit 
where  the  study  was  conducted  (Bion  et  a1. ,1986). 
-218-2.10.7.2.  Discussion 
Whilst  there  was  no  consistent  relationship  between  blood 
morphine  concentration  and  the  level  of  sedation  in  the  patient, 
they  were  able  to  show  that  within  a  given  blood  morphine 
concentration  range  there  was  a  significant  relationship  between 
the  level  of  sedation  and  the  sickness  score  of  the  patient 
(figure 2.30.). 
Not  much  is  known  of  the  effect of  high  morphine  concentrations  on 
the  critically  ill,  but  there  are  fears  that  it  may  lower  their 
resistance  to  infection  (Tubaro  et  al.,  1983).  Cl inic  ians  are 
therefore  anxious  to  keep  the  morphine  concentrations  as  low  as 
absolutely neccessary  for  a  given  level  of  sedation. 
One  major  concern  was  the  high  blood  morphine  concentrations  - up 
to  6.75ug/ml  - reported  in  the  literature  (Ball  et  al.,1985). 
These  levels  above  the  mean  fatal  level  reported  earlier 
(section  2.1.3.  and  2.10.1.4.)  - were  found  in  patients  with 
ARF.  The  highest  level  found  in  this  study  in  patients  with  ARF 
was  0.108ug/ml. 
factors. 
This  large  discrepancy  was  attributed  to  two 
Firstly  the  use  of  continuous  haemoperfusion  in  this  study.  This 
has  been  shown  to  remove  morphine  from  the  blood,  and  the  extent 
to  which  this  operates  will  depend  on  the  volume  of  filtrate 
removed. 
The  other  is  the  method  of  measuring  morphine.  The  hi~h  levels 
reported  in  Ball's  study  were  measured  by  radioimmunoassay  (RIA). 
Recent  reports  suggest  that  the  chronic  administration  of  mo~phine 
may  result  in  a  substantial  increase  in  the  blood  concent~.tionl 
of  morphine  metabolites,  particularly  morphine-6-~lucu~onide  (Joel 
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-220-et  al.,  1985).  High  levels  of  this  metabolite,  which  has  a 
reported  1~  cross  reacti  vi ty  wi th  the  morphine  antibody.  would 
cause  a  significant  amount  of  interference with  an  RIA  assay. 
2.10.7.3.  Conclusions 
The  study  did  not  provide  a  direct  correlation  of  sedation 
to  blood  morphine  concentration  or  infusion  rate,  either  on  the 
same  patient or  between  patients. 
This  finding  leaves  the  appropriate  infusion  rate  for  a  given 
degree  of  sedation  a  matter  for  the  judgement  of  the  clinician. 
This  assesment  should  be  made  on  the  basis  of  the  sickness  of  the 
patient  and  constant  monitoring  of  the  clinical  signs.  The  role 
of  a  morphine  assay  in  therapeutic  drug  monitoring  is  therefore 
limited.  One  possible  application  would  be  to  ensure  that  high 
levels  of  morphine  do  not  accumulate  in  patients  with  metabolic 
disorders  such  as  acute  anuric  renal  failure  or liver dysfunction 
2.11.  CONCLUSIONS  ON  CHAPTER  TWO 
This  chapter  may  been  considered  in  three  main  parts. 
Firstly,  the  consideration  of  appropriate  methods  for  the 
measurement  of  morphine  in  post  mortem  blood  and  the  selection  of 
a  technique  based  on  these  considerations. 
Having  selected  HPLC  as  the  most  appropriate  method  in  terms  of 
convenience,  accessibility  and  ease  of  use,  the  appropriate 
conditions  for  the  analysis  of  morphine  were  selected  by  iterative 
improvements  to  the  conditions  selected  at  each  stase.  In  the 
-221-course  of  this  process  some  consideration  as  to  the  chemical 
processes  taking  place  both  with  respect  to  the  chromatography  and 
to  the  electrochemical  detector  were  made.  This  assisted  with  a 
wider  understanding  of  the  processes  involved  and  gave  an  insight 
into  the  advantages,  dissadvantages  and  limitations  of  the 
technique. 
Secondly,  methods  for  the  isolation  of  morphine  from  complex 
matrices,  in  particular putrified blood,  was  considered. 
Successive  alterations  to  the  extraction  procedure  resulted  in  an 
overall  improvement  in  the  qual  i ty  of  the  extract,  and  made  it 
sui table  for  use  wi th  the  LCED  system  developed.  Alternative 
extraction  procedures  which  had  potential  advantages  in  terms  of 
sample  handling  and  rapid  sample  preparat  ion  were  also  cons idered 
to  some  extent  and  found  to  be  less  compatible  for  use  with 
putrified blood  than  with  plasma. 
Thirdly,  the  application  of  the  method  to  the  analysis  of  samples 
encountered  in  the  field  of  forensic  toxicology  was 
demonstrated.Morphine  was  detected  in  significant  quantities  in 
blood  samples  from  cases  involving  possible  opiate  use.  The 
levels  found  were  within  the  range  expected. 
The  method  was  also  applied  to  the  measurement  of  morphine  in 
intensive  care  patients.  This  showed  that  there  was  considerable 
overlap  between  the  therapeutic  and  fatal  ranges,  as  suggested  by 
the  literature.  No  significant  difference  in  blood  morphine 
level  was  noted  between  patients  with  acute  renal  failure.  this 
may  however  have  been  due  to  the  fact  that  these  patients  were 
receiving  arteriovenous  haemoperfusion  to  remove  body  waste.  It 
was  allo that  the  filtrate  from  thil procedure  contained morphine. 
-222-the  method  was  shown  to  be  suitable  for  the  application  for  which 
it was  developed,  and  has  since  been  incorporated  into  the  routine 
procedures  currently in use. 
-223-CHAPTER  THREE 
LOCAL  ANAESTHETICS 
3.1.  LITERATURE 
3.1.1.  Introduction 
Local  anaesthetics  are  drugs  which  block  nerve  conduction 
when  appl ied  locally  in  the  appropriate  concentrat  ions.  to  nerve 
tissue  (Goodman  and  Gilman,  1980).  Many  compounds  will  do  this 
however  and  those  which  are  clinically  acceptable  must  give 
controlled  reversible  anaesthesia  at  concentrations  which  will  not 
be  toxic  in  the  systemic  circulation. 
Local  anaesthesia  was  first  achieved  througb  hypothermia  by 
applying  crushed  ice  or  volatile  solvents  topically  (Tobin,  1980; 
Sneader,  1985). 
In  1884  Sigmund  Freud  bad  been  examining  tbe  psychotropic  effect 
of  cocaine,  an  alkaloid  found  in  the  plant  erythroxylum  coca. 
His  co-worker,  Carl  Koller,  noticed  the  numbing  effect  this 
compound  had  on  the  tongue  and  shortly  afterwards  publ i shed  the 
first report of  the  use  of  cocaine  as  a  local  anaesthetic. 
The  local  anaesthetic  properties  of  other  natural  products  were 
examined  over  the  ensuing  years.  Kost  were  only  lIli Idly 
anaesthetic  and  either  toxic  at  the  doses  required  to  produce 
anaesthesia  or  had  undesirable  side  effects.  The  discovery  in 
1900  of  the  vasoconstrictor  properties  of  adrenaline  allowed  the 
surgeon  to  local  i se  the  drug  in  the  area  where  surgery  was  to  be 
performed.  This  in  turn  allowed  the  use  of  those  milder 
-224-anaesthetics  whose  use  had  previously  been  avoided  due  to  their 
poor  or  short  acting  analgesic  properties.  One  of  the  more 
popular  of  these  compounds  because  of  its  low  toxicity  was 
procaine  (novocaine),  synthesised  in  1904  by  Einhorn. 
After  the  First  World  War,  several  new  compounds  with  local 
anaesthetic  activity  were  synthesised.  -The  most  effective  of 
these  was  lignocaine  (lidocaine,  xylocaine)  which  is  now  in 
widespread  use  as  a  dental  anaesthetic. 
The  most  recent  advance  in  local  anaesthesia  was  the  synthesis  in 
1957  of  several  lignocaine  analogues,  in  which  part  of  the  side 
chain  was  cyclised.  Two  of  these  new  compounds,  mepivacaine 
(carbocaine)  and  bupivacaine  (marcain),  proved  to  be  longer  actin& 
and  more  powerful  than  any  other  previously  known  agent  and  could 
produce  nerve  blocks  lasting  up  to  eight  hours  (Sneader,  1983). 
The  structures of  the  relevant  compounds are given  in  figure  3.1 .. 
3.1.2.  Hedical  use  of  local  anaesthetics 
The  advantage  of  local,  as  opposed  to  general,  anaesthesia 
is  found  where  the  surgeon  can  best  benefi  t  from  the  pat  ients 
cooperation  and  consciousness.  Examples  include  labour  and 
childbirth,  arthroscopy,  ophthalmology  and  dental  sur&ery.  There 
are  currently  eleven  local  anaesthetics  available  for  various 
applications  in  the  UK  (HHtS,  1986).  Those  applied  systemically 
rather  than  topically  include  procaine,  lignocaine,  bupivacaine 
and  mepivacaine.  Cocaine  is  not  included  in  MIMS. 
Procaine  Hydrochloride  is  available  as  a  local  anaesthetic  and 
also  as  a  substituent  of  the  topical  anti-infective  procaine 
Pen i c i 11 i n  G  ( De po c i 11 in) .  The  role  of  procaine  in  this 
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lignocaine preparation  is  simply  to  form  a  poorly  water  soluble  compound  with 
penicillin  and  thus  to  slow  the  rate  of  dispersion  of  the 
antibiotic  into  the  tissues. 
Lignocaine  is  used  as  a  local  anaesthetic  and  as  an 
anti-arrhythmic  for  treating  cardiac  arrest  or  to  treat  status 
epilepticus  (BNF,  1986). 
poisonings  do  occur. 
As  this  can  be  self  administered, 
Other  local  anaesthetics  wi th  the  exception  of  cocaine  are  used 
almost  exclusively  for  surgical  purposes  and  hence  the  incidence 
of self poisoning with  these  compounds  is  rare. 
Bupivacaine  has  recently  been  used  in  a  project  in  analgesia 
following  abdominal  surgery  (Blyth  et al.,  1985).  The  clinicians 
were  interested  in  assessing  the  degree  of  systemic  absorption  of 
the  drug  from  the  abdominal  cavi ty. 
this  department  for  analysis. 
These  samples  were  sent  to 
3.1.3.  NON  MEDICAL  USE  OF  LOCAL  ANAESTHETICS 
3.1.3.1.  Drug  abuse 
Although  most  local  anaesthetics  can  stimulate  the  CNS  at 
high  dosage,  this  usually  occurs  at  blood  concentrations  in  the 
toxic  range.  For  this  reason  "recreational"  abuse  of  local 
anaesthetics  is  rare.  The  notable  exception  to  this  rule  il 
cocaine,  wh ich  has  a  pronounced  effect  on  the  cerebral  cortex, 
producing  euphoria  even  at  low  concentrations. 
Cocaine  has  a  long  history  of  use  as  a  stimulant  and  euphoriant. 
At  first  thought  to  be  a  cure  for  opiate  addiction,  it loon  became 
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Psychological  dependence  can  develop  and  tolerance  to  the 
convulsant effects  has  been  reported  (Goodman  and  Gilman,  1980). 
The  use  of  cocaine  in  the  UK  has  until  recently  been  small  and 
restricted  to  the  professional  classes  (Henman  et  al.,  1986). 
This  pattern  is  currently  changing  as  the -American  cocaine  market 
is  saturated  and  the  surplus  drug  is  exported  to  Europe.  This  is 
reflected  in  the  increase  in  seizures  of  the  drug  by  the  police 
and  customs  and  excise  (ISDD  report,  1983;  and  supplement,  1984). 
3.1.3.2.  Doping  in  sport 
The  practice  of  affecting  a  competi tors  performance  wi th 
drugs  is  not  new.  Messengers  in  South  America  have  for  centuries 
carried  a  supply  of  coca  leaves  which  were  chewed  to  relieve 
fatigue.  Cocaine  was  one  of  the  most  popular  early  drugs  used  in 
cycling  and  marathon  running  (Woodland,  1980). 
Local  anaesthetics  in  general  can  be  used  to  relieve  pain  thus 
allowing  athletes  to  compete  beyond  limits  where  their  bodies 
would  normally  not  per.mit  them.  Local  anaesthetics  are  listed  as 
proscribed  substances  by  the  International  Olympic  C01IIDittee  (IOC 
report,  1982).  On  medical  grounds  it  is  potentially  dangerous 
for  an  athlete  to  compete  whilst  injured,  as  the  risk  of  further 
injury  is  greater.  various  local  anaesthetic  drugs,  notably 
bupivacaine  (marcain),  are  advertised  in  the  sports  medicine  press 
(Physician  and  Sports  medicine,  1984),  for  the  treatment  of  sporta 
related  injuries.  The  extent  to  which  these  are  used  during 
sporting  events  is  not  known. 
The  above  restrictions  on  local  anaesthetics  apply  in  horse  racing 
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is  forbidden. 
In  the  latter,  the  use  of  all  drugs 
As  the  dose/effect  relationship  of  drugs  in  a  dog  is  not  widely 
known,  it  is  likely  that  the  administration  of  any  drug  could  act 
to  the  detriment  of  the  dogs  performance.  This  may  be  done 
maliciously  or  with  the  intention  of  masking  a  dogs  potential  in 
order  to  improve  its odds  in  subsequent  races. 
For  this  reason  it is  likely that  the  use  of  local  anaesthetics  in 
these  sports  is more  widespread  than  in  human  sport. 
Details  of  the  incidence  of  doping  in  horse  racing  in  the  UK 
between  1970  and  1981  have  been  reported  (Moss  and  Haywood, 
1984).  Local  anaesthetics,  represented  by  procaine  and 
lignocaine,  accounted  for  S.2~ of all doping. 
Greyhound  racing  is  a  major  spectator  sport  in  Great  Britain, 
second  only  to  football.  It  is  also  a  popular  gambl i ng  sport 
accounting  for  approximately  £900M  (18~)  of  the  £S  billion  staked 
each  year.  For  this  reason  it  is  important  that  a  doping  control 
program  should  exist  to  detect  any  attempted  doping  and  to 
discourage  attempts  at  doping.  This  is  done  in  the  United 
Kingdom  by  the  provision  of  a  pre-race  testing  laboratory  at  those 
race  tracks  licenced  by  the  British  administrative  body,  the 
National  Greyhound  Racing  Club  (NGRC).  Thin  Layer  Chromatography 
(TLC)  following  solvent/solvent  extraction  is  used  to  detect 
barbi turates,  neutral  drugs  and  alkaloids  (Bogan  and  Smi th, 
1968).  The  Fujiwara  test  is  used  to  detect  chloral  drugs.  Thi. 
track  side  testing  is  backed  up  by  a  fully  equipped  analytical 
laboratory  at  the  University  of  Glasgow,  Department  of  Forenlic 
Medicine  and  Science  where  confirmatory  analysis  is  carried out. 
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DRUGS  FOUND  IN  THE  URINE  OF  RACING  GREYHOUNDS 
AS  REPORTED  TO  THE  AORC  IN  1984 
Drugs  Times  reported  T- of total 
Caffeine  35  18.9 
Chlorbutanol  2  1.1 
Dexamethasone  1  0.5 
Dimethyl  sulphoxide  4  2.2 
Naproxen  1  0.5 
Nikethamide  10  5.4 
Oxyphenylbutazone  33  17.8 
Phenylbutazone  53  28.6 
Procaine  20  10.8 
Salicylic acid  7  3.7 
Sulphamethoxazole  1  0.5 
Unspecified  18  9.7 
countries  included:  USA,  Australia,  New  Zealand,  Mexico. 
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in  the  UK  are  not  released  by  the  NGRC,  however  figures  provided 
by  the  Association  of  Official  Racing  Chemists  (AORC,  1985)  for 
Canada,  Australia,  New  Zealand  and  America  are  shown  in  Table  3.1. 
In  summary  it can  be  seen  that  local  anaesthetics,  represented  by 
procaine,  accounted  for  10.8~ of  all  dopin~ in  greyhound  racing  in 
1984  in  those  countries  mentioned.  The  NGRC  expressed  an 
interest  in  studying  the  suitability  of  the  current  screening 
procedure  to detect local anaesthetics. 
3.1.3.3.  Conclusions 
From  the  broad  applications  of  local  anaesthetics 
discussed  above,  both  in  sport,  medicine  and  drug  abuse,  it  was 
deemed  to  be  of  interest  to  develop  methods  for  the  isolation, 
detection  and  measurement  of  these  compounds  in  biolo~ical 
fluids.  Those  particularly  of  interest  are  bupivacaine,  procaine 
and  cocaine.  Also  of  interest  is  the  maj or  human  metabol i te  of 
cocaine,  benzoyl  ecgonine. 
3.1.4.  METABOLISM  AND  TOXICITY 
3.1.4.1.  Introduction 
The  structure  activity  relationships  of  local  anaesthetici 
bas  been  reviewed  (Buchi  and  Perlia,  1971).  The  propertiel 
considered  necessary  for  anaesthetic  activity  include  sufficient 
lipid  solubility  to  cross  the  phospholipid  nerve  membrane.  Once 
inside  the  nerve  they  block  the  conduction  of  a  nerve  impulse  by 
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depolarization  (Albert,  1973;  Goodman  and  Gilman,  1980). 
Local  anaesthetics  all  have  certain  similar  structural  features. 
These  include  hydrophobic  and  hydrophilic  domains  separated  by  an 
alkyl  chain.  The  hydrophilic  region  is  a  secondary  or  tertiary 
amine  and  the  hydrophobic  region  is  an  aromatic  residue.  In  most 
cases  the  linkage  between  the  two  includes  an  ester  or  amide 
bond.  The  type  of  bond  involved,  will  determine  to  a  large 
extent  the  pers  i stence  of  the  drug.  In  humans  the  ester  type 
local  anaesthetics  (eg  cocaine,  procaine)  are  short  acting,  the 
ester  being  rapidly  hydrolysed  by  plasma  esterases.  Amide-type 
local  anaesthetics  (lignocaine,  bupivacaine)  are  less  readily 
broken  down  and  are  therefore  longer  acting.  Metabolism  of  these 
compound  proceeds  via  oxidative  dealkylation  and  hydroxylation 
prior  to  excretion  (Bouche  and  Lhoest,  1976).  The  main  toxic 
effect  caused  by  high  doses  of  local  anaesthetic  is  excitation  of 
the  Central  Nervous  System  (CNS)  which  will  produce,  by  degrees, 
yawning,  restlessness,  excitement,  nausea  and  vomiting. 
These  may  be  followed  by  depression,  muscle  twitching, 
convulsions,  respiratory  failure,  coma  and  death  (Martindale, 
1984) . 
This  wide  range  of  effects  illustrates  the  difficulty  in  assessing 
the  correct  dose  of  the  drug  required  for  a  desired  effect.  In 
addition,  certain  individuals  display  hypersensitivity  to  these 
drugs  in  the  form  of  anaphylaxis  or  cardiac  depression  (BNF,  1986). 
The  metabol i sm  and  excret  ion  patterns  of  these  compounds  inman 
were  therefore  considered. 
-232-TABLE  3.2. 
SUMMARY  OF  THERAPEUTIC,  TOXIC  AND  FATAL  CONCENTRATIONS 
OF  SOME  LOCAL  ANAESTHETicst 
therapeutic  toxic  fatal 
compound  body  fluid  <all  concentrations  in  ug/ml) 
cocaine  urine  0  - 3  38  - 118 
blood  0.12  - 0.3  0.25  - 5  gt.  0.9 
procaine  blood  12.7  96  gt.  21 
bupivacaine  blood  0.6  gt.  0.4 
mepivacaine  blood  2-5  gt.  9.8 
lignocaine  blood  gt.  14 
gt.  = greater than. 
t  for  sources,  see  text. 
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table 3.2 .. 
3.1.4.2.  Cocaine 
Cocaine  can  be  taken  orally,  intranasaly  or  injected 
intravenously  or  intramuscularly.  Some  addicts  can  inj ect  up  to 
a  gram  a  day.  Typical  of  ester-type  local  anaesthetics  cocaine 
has  a  short  plasma  half  life  of  0.7  to  1.5  hours.  The  main 
metabolites  are  inactive.  These  include  benzoyl  ecgonine,  methyl 
ecgonine,  ecgonine  and  recent  reports  include  the  isolation  of  an 
active  metabolite,  norcocaine  (Chinn  et  al.,  1982).  4-9~ of  the 
dose  can  be  excreted  unchanged.  This  will  depend  on  the  route  of 
administration,  orally  or  nasally  administered  cocaine  may  be 
hydrolysed  prior  to  absorption.  16-5  5~  is  excreted  as  benz.oyl 
ecgonine  and  30-6~  as  ecgonine  methyl  ester  (Hoffat,  1986). 
Levels  of  cocaine  in  the  urine  following  the  use  of  cocaine 
applied  topically  to  the  nasal  mucosa  of  0  to  3ug/ml  have  been 
recorded  (Wallace  et  al.,  1976).  Concentrations  found  in  urine 
from  fatal  overdose  cases  are  38  to  118ug/ml  for  cocaine  and 
15-185ug/ml  for  benzoyl  ecgonine  (Chinn  et al.,1984).  As  cocaine 
is  psychologically  addictive  and  tolerance  to  the  toxic  effects 
can  develop  there  is  considerable  overlap  between  therapeutic, 
toxic  and  fatal  blood  concentrations,  making  interpretation 
difficult.  The  reported  ranges  are  0.12-0.3ug/ml,  0.25-SuS/ml 
and  greater  than  0.9ug/ml  respectively  (Stead  and  Hoffat,  1984). 
Blood  concentrations  of  benz.oyl  ecgonine  in  5  fatal  cases  ranged 
from  1.0  - 7.4us/ml  (Chinn  et  al.,  1984).  The  wide  variation 
reported  in  the  ~ount of  drus  excreted  uncbanged  in  the  urine  mAJ 
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been  shown  to  be  significant,  and  precautions  should  be  taken  to 
guard  against  it. 
A  qualitative  study  of  cocaine  in  the  racing  greyhound  (Lewis, 
1984)  showed  that  most  of  the  dose  was  excreted  as  benzoyl 
ecgonine  and  could  be  detected  for  up.  to  eight  hours  post 
administration.  No  cocaine  was  found  in  the  urine. 
3.1.4.3.  Procaine 
Procaine  is  a  short  acting  ester  type  local  anaesthetic 
with  a  half-life  of  around  0.1  hours.  It  i.s  rapidly  hydrolysed 
in  man  to  p-aminobenzoic  acid.  Only  about  ~ is  excreted 
unchanged  in  the  urine.  Procaine  has  a  relatively  low  toxicity 
and  steady  state  blood  concentrations  12.7ug/ml  have  been  reported 
for  therapeutic  treatment.  Following  accidental  administration 
of  4g  of  the  drug  to  a  patient  a  plasma  concentration  of  96u&/ml 
was  recorded.  The  patient  survived  (Wikinski  et  al.,  1970). 
Fatali  ties  have  however  been  recorded  above  21ug/ml  (Stead  and 
Moffat,  1984). 
Toxic  effects  in  the  horse  have  been  reported  as  eNS  stimulation 
excitability  and  pawing  at  the  ground  (Dunlop  et  aI,  1935; 
Reidenberg  1972). 
3.1.4.3.  Bupivacaine,  mepivacaine  and  lignocaine 
These  compounds  are  amide  type  local  anaesthetics  (see 
figure  3.1)  wi th  correspond  ingly  longer  hal  f  1 i ves  of  1-3  bours, 
1-2bours  and  2-3  hours  respectively  (Moffat,  1986).  Metabolism 
of  these  compounds  in  man  proceeds  by  oxidat  i ve  dealkylat ion  and 
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sufficiently  polar  to  be  excreted  without  conjugation  (Bouche  and 
Lhoest,  1976). 
With  bupivacaine,  less  than  1~  of  the  dose  is  excreted 
unchanged.  Therapeutic  blood  concentrations  of  1.lu&/ml  have 
been  reported  (Wilkinson  and  Lund,  1970), - and  concentrations  of 
0.6ug/m1  were  found  in  maternal  blood  during  labour.  Toxic 
reactions  including  muscular  rigidi  ty  and  convuls ions  have  been 
reported  at  concentrations  of  &reater  than  4u&/ml.  No 
information  has  been  found  for  fatal  levels.  Mepivacaine  has  a 
similar  toxicity  to  bupivacaine,  and  similarly,  less  than  1M.  is 
excreted  unchanged.  Therapeutic  blood  levels  of  2-5u&/ml  have 
been  reported  and  fatali ties  have  occured  at  levels  &reater  than 
9.8u&/ml.  (Stead  and  Moffat,  1984). 
Li&nocaine  has  given  rise  to  toxic  reactions  at  6ug/ml  and 
fatalities  have  occurred  at  concentrations  of  &reater  than 
14u&/ml.  Less  than  5~ of  the  dose  is  excreted  unchanged. 3.1.5.  ANALYTICAL  METHODS 
3.1.5.1.  Introduction 
Ideally  when  screening  samples  for  the  presence  of  local 
anaesthetics,  it  would  be  possible  to  detect  or  confirm  the 
presence  of  several of  the  drugs  using  one  assay. 
The  literature  however  shows  that  most  analytical  methods  are 
developed  for  the  measurement  of  one  drug  and  possibly  its 
metabolites. 
3.1.5.2.  Chemical  and  Colorimetric Tests 
Various  presumptive  tests  have  been  developed  for  the 
rapid  identification  of  cocaine  in  questioned  material  (Baker  and 
Gough,  1979).  Generally  however,  these  are  not  sufficiently 
sensitive  to  be  applied  to biological materials. 
3.1.5.3.  Thin  layer  chromatography 
Thin  layer  chromatography  (TLC)  has  been  applied  to  the 
identification  of  local  anaesthetics  in  biological  extracts. 
Comprehensive  data  collections  for  the  identification  of  drugs  by 
TLC  normally  include  Rf  values  for  local  anaesthetics.  Stead  et 
a1.  (1982)  investigated  the  TLC  behaviour  of  794  drugs  in  eight 
TLC  systems.  This  improves  the  chances  of  correct  identification 
by  allowing  comparison  of  Rf  values  of  an  unknown  compound  on 
different  systems.  The  above  study  included  Rf  data  for  20  local 
anaesthetics, 
bupivacaine. 
among  them  procaine, 
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cocaine.  lignocaine  and A  recent  publication  (Koffat,  1986)  includes  a  review  of  TLC 
systems  for  local  anaesthetics  and  recommends  a  system  from  stead 
et  aI,  (1982),  of  silica gel  plates,  sprayed  with  IOH  in methanol 
and  dried.  The  plates  are  developed  in  acetone.  A  number  of 
locating  agents,  including  acidified  potassium  iodoplatinate 
(PIP),  are  recommended. 
The  Handbook  of  Analytical  Toxicology  (Sunshine,  1969)  also 
includes  Rf  data for these  compounds  on  several  systems. 
An  earlier  study  of  TLC  for  a  large  range  of  basic  drugs  (Rentoul 
and  Smith,  1973;  Oliver  1971)  recommended  silica  gel  plates, 
developed  in  chloroform:methanol,  3:1.  These  studies  include  Rf 
data  for  procaine,  cocaine  and  lignocaine.  All  Rf  values  are  in 
the  acceptable  range,  however  no  Rf  data  are given  for  benzoyl 
ecgonine,  bupivacaine  or  mepivacaine.  Procaine,  cocaine  and 
lignocaine  all  gave  positive  reactions  with  acidified  potassium 
iodoplatinate  as  the  locating  agent.  This  TLC  system  is  used  in 
the  screening  procedures  for  local  anaesthetic  drugs  in  greyhound 
urine  (Bogan  and  Smith,  1968). 
In  addition  there  are  reports  of  various  TLC  systems  used  in  the 
investigation  of  one  drug  in  particular,  notably  for  cocaine  in 
biological fluids  (Wallace  et al.,  1975;  Lewis,  1980). 
All  the  above  TLC  systems  provide  sui  table  methods  for  screening 
for  the  presence  of  most  local  anaesthetic  drugs.  Detection 
limits  are  around  one  microgram  on  the  plate  when  a  suitable 
locating reagent  is used. 
The  Rf  values  may  be  affected  by  the  presence  of  other material  in 
the  extract  and  the  colour  produced  with  the  locating  reagent  may 
depend  on  the  amount  of  material  on  the  plate.  TLC  is  best  used 
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Ai  .sa therefore,  to  detect  the  presence  of  a  compound  whose  identity  can 
then  be  confirmed  by  other means. 
3.1.5.4.  Immunoassay 
Several  immunoassay  methods  have  been  reported  for  cocaine 
in  a  variety  of  samples  including  hair  (Valente  et  al.,  1981), 
blood,  plasma  and  urine  (Roche,  1978).  An  RIA  method  for  the 
measurement  of  procainamide  in  serum  has  also  been  reported 
(Gallagher et al.,  1980). 
Immunoassay  methods  have  the  advantage  that  they  can  be  applied 
directly  to  biological  samples  and  require  Ii  ttle  or  no  sample 
preparation.  Occasionally  a  methanol  extraction  is  used  in  order 
to  assist  with  sample  handling  and  to  reduce  matrix 
interference.  The  disadvantage  of  the  method  is  the  high  de&ree 
of  cross  reactivity  of  some  antisera  with  metabolites  and 
structural  analogs  and  the  complete  lack  of  cross  reactivity  with 
other  major  metabolites  (eg  methyl  ecgonine,  ecgonine,  Budd, 
1981).  RIA  methods  for  other  local  anaesthetics  have  not  been 
developed. 
Radioimmunoassay  techniques  are  among  the  most  sensitive  reported 
(Hule,  1974,  Moffat,  1986).  The  fact  that  they  are  not 
absolutely  specific  can  be  an  advantage  as  this  allows  RIA  to  be 
used  as  a  screening  procedure  for  the  drug  and  its  metabolitel. 
The  operator  should  however  be  aware  that  the  method  is  not 
specific  and  that  some  confirmatory  anaytical  technique  should  be 
applied. 
For  any  method  other  than  RIA,  where  the  sample  contains  material 
either  from  a  biolo&ical  extract  or  adulterants,  lome 
chromato&raphic  technique  should  be  applied. 
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Gas  chromatography  (GC)  has  been  extensively  used  to 
measure  local  anaesthetics  in  a  variety  of  samples  (Gudzinowicz 
and  Gudzinowicz,  1979).  A number  are  summarised  in  table  3.3 .. 
Modern  capillary  columns  giving  high  resolution  allow  the  analysis 
of  a  large  range  of  compounds  on  a  single  column  (Ardrey  and 
Mo f fat,  1981). 
volatile,  heat 
GC  is  best  sui  ted  to  the  analysis  of  non-polar, 
stable  compounds.  Local  anaesthetics  are 
generally  amides  or  esters,  and  as  such  are  prone  to  dissociation 
at  temperatures  often  encountered  in  GC  injectors  or  detectors. 
Decomposition  of  the  drug  may  lead  to  multiple  peaks  or  reduced 
sensitivity  (Gudzinowicz  and  Gudzinowicz,  1979).  Additionally 
when  using  GC  care  must  be  taken  that  the  analyte  is  in  the 
correct  form  for  analysis,  and  that  an  appropriate  solvent  is 
used.  As  is  shown  later,  one  of  the  extraction  procedures 
cons idered  leaves  any  base  in  the  extract  in  the  form  of  the 
hydrochloride  salt.  It  has  been  shown  that  only  a  narrow 
temperature  range  will  permit  the  dissociation  of  this  to  the  free 
base  without  the  hydrolysis  of  the  amide  or ester. 
A  review  of  GC  methods  for  the  analysis  of  cocaine  and  its 
metaboli tes  in  biological  fluids  (Lindgren  et  al.,  1981)  shows 
that  the  analysis  of  cocaine  is  popular  by  GC,  but  simultaneous 
determination  of  its  major  metabolite,  benzoyl  ecgonine,  is  not 
possible,  as  this  is  an  amino  acid  which  requires  derivatisation, 
usually  methylation,  back  to  cocaine,  before  GC  analysis. 
Conversion  to  the  propyl  ester  has  also  been  reported  (Wallace  et 
al.,  1976;  Von  Minden  and  D'Amato,  1977). 
GCMS  is  the  method  of  choice  for  absolute  identification.  Both 
-239-TABLE  3.3. 
GC  METHODS  FOR  THE  IDENTIFICATION  OF  LOCAL  ANAESTHETICS 
Refe'rence  date  com~ounds examined  sam(!le  technigue 
Nelson et ale  1959  Lignocaine  plasma/urine  GC-CI-MS 
and  metabolites 
Beckett  and  Moffat  1968  procaine  urine  GC-FID 
prilocaine 
lignocaine 
benzocaine 
I  cocaine 
N  •  0  Wallace  et ale  1976  cocaine  urine  GC-FID  I 
benzoyl  ecgonine 
von  Minden  1977  cocaine  urine  GC-FID 
and  D'Amato  benzoyl  ecgonine 
Kogan  et al.  1977  cocaine  plasma/urine  GC-NPD/ECD 
benzoyl  ecgonine 
Naito  et ale  1977  lignocaine  brain/liver/  GC-FID 
mepivacaine  muscle 
Park  et  ale  1980  mepivacaine  plasma  GC-NPD 
tetracaine 
bupivacaine 
etidocaine 
lignocaine I 
N  •  ... 
I 
Reference 
Chinn et al. 
Gettinqs et al.  . 
Ardrey  & Moffat 
Baselt 
Liu  et ale 
Matsubaru  et ale 
Marko  et ale 
date 
1980 
1981 
1981 
1982 
1983 
1984 
1985 
TABLE  3.3.  CONTINUED 
compounds  examined  sample  t~chll.i_que 
cocaine 
and  metabolites 
tocainide 
lignocaine 
1318  drugs  inc. 
20  locals 
cocaine 
cocaine 
benzoyl  ecgonine 
lignocaine 
cocaine 
benzoyl  ecgonine 
methyl  ecgonine 
pentocaine 
plasma 
plasma/serum 
plasma 
urine 
blood/urine 
blood/urine 
serum 
GC-CI-MS 
GC-FID 
GC-FID/NPD 
GC-NPD 
GC-FID 
GC-CI-MS 
GC-CI-SIM 
GC-FID electron  impact  (EI)  and  chemical  ionisation  (CI)  mass 
spectrometry  have  been  reported  for  cocaine  (Chinn  et  al,  1982; 
Matsubara  et  al.,  1984).  Mass  spectrometry  is  not  widely 
available  however  and  when  it  is,  it  is  more  efficient  to  use  it 
for difficult one-off  analyses  rather  than  for  routine  screening. 
3.1.5.6.  High  Pressure  Liquid  Chromatography 
HPLC  is  well  suited  to  the  analysis  of  non-volatile  or 
thermally  labile  compounds.  Compounds  containing  low  energy 
bonds,  such  as  amides  or  esters  in  local  anaesthetics  and  C-N+ 
bonds  in  quaternary  ~ines,  are  particularly  suited  to  this 
technique.  As  a  result,  many  procedures  have  been  developed  for 
the  LC  assay  of  individual  local  anaesthetics. 
summarised  in  table 3.4 .. 
A  number  are 
Most  of  the  methods  examined  use  reversed  phase  columns.  These 
are  well  suited  to  the  analysis  of  biological  extracts,  retaining 
any  highly  lipophilic  material  irreversibly  and  allowing  the 
chromatography  of  smaller  ionised  or  ionisable  molecules.  In 
addition,  reversed  phase  columns  are  compatible  with  a  wide  range 
of  aqueous  based  solvent  systems  and  are  relatively  stable  between 
pH  2  and  9  (Snyder  and  Kirkland,  1978). 
The  use  of  highly  contaminated  extracts  can  shorten  the  Ii  fet  ime 
of  a  column,  and  pre-columns  should  be  used  for  these  samples. 
Local  anaesthetics  are  basic  by  virtue  of  their  secondary  or 
tertiary  amine  functions.  Examples  from  the  literature  and 
experience  with  morphine  chromatography  (see  chapter  2)  has  shown 
that  peak  tailing  problems  associated  with  hydrophilic 
interactions  can  be  overcome  wi th  the  use  of  the  correct  mode  of 
-242-chromatography,  eg  ion  pairing. 
Most  of  the  reports  in  table  3.4.  which  include  ex~ples  of 
chromatography  exhibit  either  broad  peaks  (Width)  or  asymmetrical 
peaks.  Various  approaches  have  been  adopted  to  overcome  this, 
for  ex~ple the  use  of  ion  pairing  agents  which  has  been  reviewed 
earlier  (1.3.2.>. 
Gill  et  al.,  (1982)  have  described  a  method  for  modifying  the 
chromatography  by  including  an  alkyl  amine  in  the  mobile  phase. 
They  suggest  that  the  amine  competi ti  vely  occupies  the  res idual 
silanol  sites  on  the  stationary  phase  surface  and  thus  reduces 
peak  tailing. 
chromatography 
This  was  then  used  to  good  effect  in  improvin&  the 
of  phenyl  ethylamines.  The  inclusion  of 
N-hexylamine  in  the  mobile  phase  has  been  applied  to  the  analysis 
of  some  35  local  anaesthetic  compounds  (Gill  et  al.,  1984).  The 
authors  noted  however  that  the  range  of  polari ties  encountered 
made  it  impract ical  to  analyse  all  the  drugs  wi th  one  solvent 
system. 
UV  absorption  detection  is  the  method  chosen  in  most  cases  for 
monitoring  local  anaesthetics.  The  advent  of  linear  diode  array 
and  multiple  wavelength  detectors  also  improves  the  selectivity of 
UV  detection  (Fell  et  al.,  1983)  through  complete  capture  of 
spectra  or  absorption  ratioing  at  selected  wavelengths. 
not  been  applied  specifically to  local  anaesthetics. 
This  hal 
Although  the  electrochemical  properties  of  local  anaesthetics  have 
not  been  investigated  in  great detail,  a  report  on  the  measurement 
of  lignocaine  in  biological  fluids  by  HPLC  with  electrochemical 
detection  (Halbert  and  Baldwin,  1984)  did  include  some  cyclic 
Yoltammetry  on  lignocaine  and  bupivacaine.  The  full  wave 
-243-TABLE  3.4. 
HPLC  METHODS  FOR  THE  IDENTIFICATION  OF  LOCAL  ANAESTHETICS 
compounds 
Reference  date  examined  sample  column  Detection 
Trinler  and  Reuland  1975  .  street drugs  ODS  LCUV  @ 254nm  cocalne 
Khalil  and  Shelver  1976  procaine  pharmac~uticals  ODS  LCUV  @ 254nm 
Jatlow et ale  1978  cocaine  urine  ODS  LCUV  @ 235nm 
and  metabolites 
I 
N  Evans  and  Morarity  1980  lignocaine  plasma/tissue  ODS  LCUV  @ 235nm  •  •  cocaine  I 
and  metabolites 
Warsaszkiewicz  et ale  1981  lignocaine  pharmaceuticals  CN  LCUV  @ 254nm 
Jane et ale  1981  cocaine  street drugs  RP-2  LCUV  @ 279 
and  others 
Nachtmann  1982  procaine  pharmaceuticals  RP-8  LCUV  @ 220nm 
and  Gatrein 
N09gle  and  Clarke  1983  procaine  street drugs  ODS  LCUV  @ 254nm 
cocaine 
mepivacaine 
lignocaine 
and  others TABLE  3.4.  CONTINUED 
compounds 
Reference  date  examined  sample  column  Detection 
Ohtake  et ale  1983  procaine  urine  0-814  LCRI/UV  @ 270nm 
Lindberg  1984  bupivacaine  serum  RP-8  LCUV  @ 210nm 
and  Pihlajamaki 
Wiegand  and  Chou  1984  bupivacaine  plasma  ODS  LCUV  @ 254nm 
I 
N 
Halbert  and  Baldwin  1984  lignocaine  blood/serum  silica  LCED  @ 1.2V  •  Ut 
I  bupivacaine 
Gill et ale  1984  data  for  street drugs  ODS  LCUV  @ 230nm 
30  locals potentials  (E)  recorded  were  high  (greater  than  1  volt)  and  p 
were  found  to  be  dependent  on  the  pH  and  the  acetonitrile  content 
of  the  support  solution.  They  did  show  that  ED  might  be  suitable 
for  these  compounds  under  the  correct mobile  phase  conditions,  but 
the  authors  concluded  that  the  high  potentials  recommended  (1.2 
volts)  meant  that  these  compounds  were  not  ideal  candidates  for 
LCED. 
A  recent  report  (Kusch  et  al,  1985),  has  indicated  that  a  number 
of  local  anaesthetics,  including  procaine  and  lignocaine,  were 
detectable  by  ED,  but  the  potential  required  was  1.2V.  The 
method  was  not  applied  to  the  analysis  of  biological extracts. 
An  examination  of  the  structures  of  local  anaesthetics  suggests 
that  the  aromatic  amine  function  might  be  responsible  for  the 
electrochemical  activity.  Reactions  of  primary  and  secondary 
aromatic  amines  have  been  reviewed  (Adams,  1969;  Ryan,  1984). 
They  all  involve  radical  formation  at  the  anilinium  nitrogen  and 
subsequent  delocalisation  and  dimerisation.  Examples  of 
reactions  for  para  substituted  anilines  (eg  procaine)  and 
secondary  aromatic  amines  (eg  bupivacaine,  lignocaine)  are  shown 
in  figures  3.2.  and  3.3 .. 
Isocratic  liquid  chromatography  appears  to  be  a  rapid  method  of 
analysis  which  might  be  applied  to  a  range  of  local  anaesthetic 
compounds. 
The  literature  suggests  that  at  least  two  detection  methods  mi&ht 
be  suitable  also. I 
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ELECTROCHEMICAL  OXIDATION  OF  SECONDARY  AROMATIC  AMINES 3.1.5.7.  Conclusions 
The  above  techn  iques  have  been  cons idered  wi th  a  vi  ew  to 
selecting  a  screening  method  for  the  presence  of  drugs  in 
biological  fluids,  and  to  consider  appropriate  confirmatory 
techniques. 
Immunoassay  is  sensitive  but  has  not "generally  been  applied  to  the 
detection  of  local  anaesthetics.  The  use  of  mixed  antisera  would 
provide  a  specific  screening  procedure  for  local  anaesthetics. 
This  however  would  prevent  the  detection  of  other  drugs  in  a 
sample  unless  a  comprehens i ve  series  of  RIA  screens  was  used. 
TLC  is  cheap,  rapid  and  a  much  more  general  method  for  screening 
biological  extracts  for  the  presence  of  exogeneous  compounds. 
For  this  reason  it  was  prefered  to  RIA  and  the  TLC  system 
described  by  Rentoul  and  smith  (1973)  was  selected  for  use  in  this 
work  as  it is  currently  in  routine  use  in  the  department.  It has 
been  shown  over  many  years  to  be  sui table  for  the  detection  of 
most  common  drugs  (Smith,  1972;  Smith  1978). 
For  confirmatory  analysis,  an  isocratic  HPLC  method  may  offer  a 
suitable  assay  in  terms  of  selectivity,  convenience  and  speed. 
Individual  properties  of  the  solvent,  column  or  solvent  additives 
can  be  altered  to  allow  the  separation  of  a  range  of  analytes  from 
each  other  and  from  other  material  in  an  extract.  For  this 
reason  the  development  of  an  HPLC  assay  for  these  compounds  was 
cons idered.  The  compounds  of  most  interest  (see  3.1.3.)  were 
procaine,  for  its  doping  applications,  bupivacaine  from  a  clinical 
point  of  view  and  cocaine  and  its  metabolite  ben~oyl  eCloDine. 
from  the  point  of  view  of  drug  abuse.  The  ideal  HPLC  method 
should  therefore  be  suitable at  least for  these  compounds. 
-249-3.1.6.  SAMPLES  ANO  SAMPLE  PREPARATION 
3.1.6.1.  Introduction 
The  samples  most  commonly  submitted  for  toxicological 
analysis  for  local  anaesthetics  are  of  biological  origin  - blood, 
urine  or  plasma.  These  arise  from  cases  where  the  drugs  may  have 
been  administered  either  in  therapeutic,  toxic  or  overdose  levels 
in  any  of  the  circumstances  discussed earlier  (see  3.1.3.) 
3.1.6.2.  Blood  and  Plasma 
Plasma  as  a  medium  is  preferred  to  whole  blood,  as  whole 
blood  is  prone  to  decomposition  and  changes  in  its  gross 
properties  which  make  analysis  more  difficult  .  Information  on 
protein  binding  is  available  for  bupivacaine  and  mepivacaine, 
suggesting  that  90~  and  77~  respectively  are  bound  to  plasma 
proteins  (Moffat,  1986). 
This  suggests  tha"t  the  drug  is  not  concentrated  in  the 
erythrocytes,  and  that  blood  concentrations  and  plasma 
concentrations  should  not  differ  greatly.  The  degree  of  protein 
binding  will  not  neccessarily  prevent  the  extraction  of  the  drug· 
from  the  sample,  as  the  extent  of  binding  is  likely  to  change  with 
pH  and  the  solvent conditions. 
Plasma  samples  also  contain  less  material  likely  to  interfere  in 
the  assay  than  does  whole  blood. 
Therapeutic  concentrations  of  the  drug  in  blood  or  pla8ma  will 
often  be  quite  low.  For  clinical  purposes,  with  respect  to 
therapeutic  drug  monitoring  (TOM),  it  is  important  to  monito~ 
blood  or  plasma  concentrat  ions  to  ensure  that  the  drug  level  i. 
-250-sufficient  for  therapeutic  effect,  but  is  not  allowed  to 
accumulate  to  toxic  levels. 
3.1.6.3.  Urine 
Urine  is  the  sample  of  choice  in  dope  testing.  This  il 
due  to  the  ease  of  collection  and  also  the.relatively  large  volume 
available.  In  clinical  and  post  mortem  situations  urine  is  often 
not  available or difficult to collect. 
Unchanged  drug  is  often  found  in  the  urine  in  addi tion  to  the 
metabolites.  In  the  case  of  cocaine,  Chinn  et  al.,  (1984), 
reported  several  cases  where  high  levels  of  cocaine  were  found  in 
the  urine,  but  cocaine  was  not  detected  in  the  blood.  Hydrolysis 
of  cocaine  in  stored  urine  samples  has  also  been  noted  however 
(Baselt,  1983;  Fletcher  and  Hancock,  1983). 
One  problem  with  urinalysis  is  that  metabolites  are  often 
converted  to  the  conjugated  form  in  order  to  improve  their  water 
solubi Ii  ty  prior  to  excretion.  In  order  to  extract  and  measure 
these  conjugated  metabolites,  the  sample  must  be  hydrolysed  usin& 
for  example  acid/base  hydrolysis,  Helix  Pomaciea  or  subtilisin 
Carlsberg  prior to analysis. 
Local  anaesthetics  and  their  metabolites  are  generally 
sufficiently polar  to  be  excreted without  conjugation. 
Quantitation  of  drug  concentrations  in  urine  is  done  relatively 
easily  by  the  addition  of  an  internal  standard  prior  to 
extraction.  The  results  obtained  however  are  of little practical 
use,  unless  the  total  volume  of  urine  over  the  excretion  period  il 
known,  or  the  dru&  concentration  is  related  to  lome  internal 
marker  such  as  creatinine clearance  (Duarte,  1980). 
-251-In  metabolism  studies  where  the  total  volume  of  urine  is  not 
known,  the  concentration  of  the  drug  is  oIten  normal i sed  wi tb 
respect  to  the  creatinine  concentration  of  the  urine.  Lactate 
and  creatinine  are  the  products  of  anaerobic  activity  in  the 
muscles.  They  are  normally  present  in  low  but  constant 
concentration  in  human  blood,  when  normal  renal  function  is 
present.  Creatinine  is  excreted  by  the  renal  tubules  at  a 
constant  rate,  independent  of  the  glomerular  filtration  rate 
(GFR).  Relating  the  urinary  drug  concentration  to  the  creatinine 
concentration  gives  an  accurate  indication  of  the  blood  dru& 
concentration.  In  the  dog  however,  creatinine  is  excreted  by  a 
weak  proximal  tubule  secretory  mechan ism.  Studies  on  creatinine 
clearance  in  the  dog  have  shown  that  a  very  wide  range  exists, 
making  creatinine  clearance  an  unreliable marker  (Bovee  and  Joyce, 
1979).  This  is  further  complicated  in  the  racing  greyhound,  as 
blood  creatinine  is  likely  to  vary  considerably  during  bursts  of 
anaerobic  activity such  as  racing. 
3.1.7.  SAMPLE  PREPARATION 
3.1.7.1.  Introduction 
Direct  analysis  is  suitable  only  for  immunoassay  methods 
where  the  technique  is  sensitive  enou&h  not  to  require 
preconcentration  of  the  analyte,  and  not  susceptible  to 
interference  from  the  sample  matrix.  Preconcentration  of  the 
drug  improves  the  sensitivity  of  the  assay,  and  the  removal  of 
extraneous  material  from  the  sample  improves  the  selectivity. 
-252-Centrifugation  or  ultra  filtration  are  occasionally  used  prior  to 
an  extraction  step to assist with  sample  handling. 
Extractions  are  generally  of  two  types,  liquid/solid  or 
liquid/liquid.  The  application  of  these  to  the  isolation  of 
local  anaesthetics  is  considered  below. 
3.1.7.2.  Liquid/Liquid  partition extraction 
As  wi th  extraction  procedures  for  morphine  reviewed 
earlier, most  reports  favour  liquid liquid extraction. 
Local  anaesthetics  are  basic  drugs  and  are  therefore  extracted 
from  aqueous  alkaline  samples  into  organic  solvents.  They  are 
Some  of  likely  to  be  extracted  in  most  basic  drug 
these,  both  general  and  specific  procedures 
screens. 
are  summarised  in 
table  3.5 ..  In  general,  alkaline  pH  is  used  with  chloroform 
based  solvents.  The  pH  of  the  extraction  should  be  carefully 
controlled  and  the  extraction  procedure  should  be  as  rapid  as 
possible  as  some  of  the  ester  type  local  anaesthetics  are  prone  to 
hydrolys i s  even  on  short  exposure  to  base  (Fletcher  and  Hancock, 
1981;  Baselt et al.,  1983). 
Hany  methods  have  been  described  for  the  isolation  of  cocaine  and 
in  some  cases  its  metaboli tes.  As  benzoylecgonine  is  a  water 
soluble  amino  acid,  it is  not  extracted  well  into  pure  solvents. 
Salting  out  procedures  have  been  used  (Koontz  et  aI,  1973)  but 
were  shown  to  cause  coextraction  of  other  endogeneous  material 
from  the  urine  (Wallace  et  aI,  1976).  This  suggests  that  mixed 
solvents  would  be  require  for  the  extraction of  benzoylecgonine. 
A  thorough  study  (Wallace  et  al.,  1975;  Wallace  et  al.,  1976) 
conducted  on  the  extraction  of  cocaine  and  benzoyl  ecgonine  from 
-253-TABLE  3.5. 
EXTRACTION  PROCEDURES  SUITABLE  FOR  LOCAL  ANAESTHETICS 
Reference  date  compound/s  sample  buffer  solvent  recovery  (t.) 
Beckett  1968  basic drugs  urine  CH2C12 
and  Moffat  diethyl ether 
Bogan  and  saith  1968  basic drugs  urine  NH40H  EtOAc  NG 
Asling et al.  1969  bupivacaine  plasma  NaOH  diethyl ether  NG 
mepivacaine 
I 
N  Wallace et al.  1975  cocaine  urine  none  CHC13:EtOH  90-95 
\It  ..  benzoyl  ecgonine  8:2  65-70 
I 
Hornlng et al.  1976  basic drugs  urine  NH4(C03)2  EtOAc  87-104 
blood 
Linberg  1978  bupivacaine  p1aslla  NaOH  Hezane/IPA/CHC13  92 
and  Plhlaj ..  aki  3/6/1 
Jatlov at al  1978  cocaine  urine  9.5  CHC13:EtOH 
and metabolites  8:2 
Park .t a1.  1980  lIeplvacalne  pla  ••  a  NaOH  diethyl ether  NG 
buplvacaine  CSP' 
etidocaine  blood 
lignocaine 
tetracaine TABLE  3. 5.  CONTINUED 
aefereDce  date  compound/s  sample  buffer  solvent  recovery  (1.) 
Chinn at al.  1980  cocaine  blood  ItH 2  POle  to1uene/heptane/IAA  NG 
and metabolites  brain 
liver 
urine 
Itidney 
Lewis  1980  cocaine  urine  pH3-Ie  CHC13  NG 
benzoyl  eClonine  urine  pH9-10  CHC13/IPA  NG 
I  95:5 
N 
\It 
\It  Hill at a1.  1982  basic/acidic  urine  ion-paired  CHC13/IPA  NG  I 
dru,s  3:1 
Sundlof et al.  1982  procaine  urine  NH40H  ether/hexane/IAA  80 
Da1belte  et a1.  1983  basic/acidic  urine  various  benzene 
dru,s  cyclohexane 
Wie,and et a1.  1984  bupivacaine  p1a ••  a  NaOH  hexane  95 biological  fluids  showed  that  the  recovery  of  cocaine  and  benzoyl 
ecgonine  were  relatively  pH  independent  over  the  range  pH  5.5  to 
9.5.  The  recovery  of  cocaine  fell  at  pH  above  10.  Various 
solvents  were  examined  and  an  optimum  solvent  of  201.  ethanol  in 
chloroform  was  found.  This  gave  recoveries  of  90-95~ for  cocaine 
and  6S-70~  for  benzoyl  ecgonine.  other  workers  have  reported 
this  solvent  mixture  to  work  very  well  (von  Minden  and  0' Amato, 
1977;  Jatlow  et  al.,  1978).  The  solubility  of  cocaine  and 
benzoyl  ecgonine  in other  solvents  has  been  shown  to  be  poor. 
A study  in  1980  (Lewis,  1980)  of  cocaine  in  the  ~.CiD'  greyhound 
used  separate  extraction  procedures  for  cocaine  and  benzoyl 
ecgonine.  These  are discussed later. 
Two  methods  are  reported  for  the  isolation  of  procaine  from  the 
urine  of  the  racing  greyhound  (Sundlof  et  ale  (1984).  These 
involve  back  extractions  and  the  use  of  benzene  as  the  extracting 
solvent which  was  unacceptable  on  grounds  of toxicity. 
Extraction  procedures  for  bupivacaine  include  those  described  by 
Wiegand  et  ale  (1978)  and  Lindberg  and  Pihlajamaki  (1984).  Both 
are  performed  at alkaline  pH  using  HaOH  to  adjust  the  pH. 
A  small  number  of  purpose  designed  extraction  schemes  for  drug 
screening  in  urine  have  been  described.  The  method  developed  by 
Bogan  and  Smith  (1968)  for  the  analysis  of  acidic,  neutral  and 
basic  drugs  in  greyhound  urine  uses  an  initial extraction  at  basic 
pH  into  ethyl  acetate,  to  remove  basic  compounds  from  the 
sample.  A  s'ubsequent  extraction  at  low  pH  removes  neutral  and 
weakly  acidic  drugs.  Some  of  the  interfering  compounds 
encountered  in  these  extracts  have  been  characterised  and 
identified  (Oliver  et  al.,  1978).  Th is  procedure  does  however 
-256-use  a  large  amount  of  solvent  (200ml/sample)  and  requires  several 
subsequent  extraction  steps  which  might  reduce  the  efficiency  of 
the  procedure.  No  specific  details  of  the  recovery  of  local 
anaesthetics  are  given. 
A  more  recent  report  (Hill  et  al.,  1982)  describes  a  single  step 
extraction  procedure  for  the  analysis  of  ~asic  neutral  and  weakly 
acidic  drugs  in  greyhound  urine.  This  is  performed  at  pH7  and 
the  basic  drugs  are  extracted  by  formation  of  an  ion  pair  complex 
with  dioctyl  sulphosuccinate  (DOSS).  This  appears  to  be  a  very 
rapid  method  and  requires  only  Sml  of  extracting  solvent.  It has 
been  shown  to  recover  cocaine,  but  no  information  is  given 
regarding  procaine,  bupivacaine or benzoyl  ecgonine. 
3.1.7.3.  Liquid/solid extraction 
A  small  number  of  applications  of  liquid/solid  extraction 
procedures  which  are  or  may  be  suitable  for  the  analysis  of  local 
anaesthetics  have  been  reported  (table 3.6.).  Of  these,  most  are 
for  plasma  samples  and  are  for  one  drug  in  particular rather  than 
a  range. 
Two  of  these  procedures  use  Extrelut,  a  diatomaceous  earth 
absorbent.  One  is  a  general  extraction method  for  drugs  in  blood 
or  urine  (Breiter  et  aI,  1978)  and  no  data  is  given  specifically 
for  local anaesthetics. 
The  other  is  designed  specifically  for  the  extraction  of  cocaine 
and  its metabolites  from  urine.  High  recoveries  are  reported. 
Another  two  procedures  use  bonded  phase  extraction  cartrid,  ••. 
On.  of  these  procedures  (Ohtake  et al.,  1983)  is  desi,ned  for dru, 
screening  in  urine  from  racehorses.  No  information  is  liven 
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TABLE  3.6. 
SOLID  PHASE  EXTRACTION  PROCEDURES  SUITABLE  FOR  LOCAL  ANAESTHETICS 
Reference  date  compound/s  sample  buffer  solvent  recovery 
Absorption  on  extrelut diatomaceous  earth 
Breiter et al.  1976  basic/acidic drugs 
Katsubara et al.  1984  cocaine 
methyl  ecgonine 
benzoyl  ecgonine 
Stewart et al.  1984  procaine 
~dsorption extraction on  C-18  cartridge. 
Ohtake et al.  1983  basic/acidic drugs 
Halberl et al.  1984  bupivacaine 
lignocaine 
Stewart et al.  1984  procaine 
Hie  - not  known 
blood 
urine 
urine 
plasma 
urine 
serum 
plasma 
pH  9 
pH9 
NaOH 
neutral 
NH40H 
NaOH 
IP ether 
MeOAc  (7:3) 
CHCI3:IPA 
9:1 
CH2CL2 
CHC13 
acetonitrile 
CH2C12 
86-102 
83 
38 
51 
NK 
76 
40 regarding  recoveries,  but  the  procedure  is  reported  to  be  suitable 
for  the detection of  procaine. 
The  other  procedure  (Halbert  and  Baldwin,  1984)  gave  a  recovery  of 
76~ and  the extract was  analysed  by  HPLC. 
In  addition  to  these  specific  reports,  a  review  (stewart  et  aI, 
1984)  ex~ined six  solid  phase  extraction  ~ethods of  both  types. 
several  basic  and  acidic  drugs  were  extracted  from  plasma  and 
aqueous  standards  and  the  recoveries  measured  by  uv 
spectrophotometry.  Among  those  drugs  examined  was  procaine,  and 
the  recoveries  ranged  from  15~ on  a  silica adsorbent  phase  through 
16~  on  a  cyano  phase  and  39~  on  a  C-18  phase,  to  51~  on  an 
absorbent  stationary  phase 
demonstrated  the  different 
and  61~  on  XAO-2.  This  work  also 
recoveries  observed  when  the  drug  was 
present  in different matrices. 
Automated  preconcentration  methods  such  as  direct  injection  of  a 
large  volume  of  urine  onto 
adsorption/elution  using  column 
a  precolumn  and  subsequent 
switching  have  been  reported. 
These  are  still in  the  development  stage,  expensive  and  unsuitable 
for  routine  analysis  as  yet. 
3.1.7.4.  Conclusions 
For  clinical  studies  or  post  mortem  analyses,  blood  or 
plasma  are  the  most  suitable  samples,  whilst  urinalysis  providel  a 
lood  indicator of drug  administration  in  sport. 
AI  all  these  applications  are  of  interest  in  the  present  study. 
two  approaches  are  required.  Firstly,  a  drug  screening  procedure 
suitable  for  the  extraction  of  a  broad  range  of  drugs  from  a  large 
lample.  probably  urine.  Secondly  an  extraction  procedure 
-259-applicable  to  smaller  samples,  typically  blood  end  plasma,  but 
ideally  suitable  for  confirmatory  analysis  on  small  volume  urine 
samples. 
For  screening  urine  samples  two  procedures  were  cons idered  for 
further  study.  The  first  is  that  used  routinely  for  the  analysis 
of  drugs  in  greyhound  urine,  based  on  the. procedure  described  by 
Bogan  and  Smith  (1968).  This  study  will  examine  the  suitability 
of  that  method  for  the  detection  of  local  anaesthet ic  drugs  in 
urine.  Secondly,  a  procedure  descri  bed  by  Hi 11  et  a1.  (1982), 
using  ion-pair  extraction  to  provide  a  single  step  extraction 
procedure  for  acidic,  basic  and  neutral  drugs  is  examined  as  it is 
reportedly  very  rapid,  cheap  and  efficient. 
For  blood  and  plasma  samples,  it  was  decided  to  investigate  the 
method  described  by  Lindberg  and  Pihlajamaki  (1984).  This  had 
been  used  effectively  for  bupivacaine  (recovery  =  92~)  I  but  has 
not  been  assessed  for  other  local  anaesthetics. 
Experience  gained  in  the  extraction  of  morphine  and  the  reports 
cited  above  (Matsubara  et  al.,  1984;  Stewart  et  al.,  1984) 
suggested  that  liquid/solid  extraction  on  diatomaceous  earth  might 
be  suitable  for  the  extraction  of  at  least  some  of  the  compounds 
of  interest  from  all  sample  types. 
-260-3.2.  UV  ABSORBANCE  AND  ELECTROCHEMICAL  PROPERTIES  OF  LOCAL 
ANAESTHETICS 
3.2.1.  Introduction 
In  order  to  select  an  appropriate  detection  system, 
suitable  for  a  range  of  local  anaesthetics~  the  UV  absorbance  and 
electrochemical  properties  of  some  of  the  local  anaesthetics  were 
considered. 
3.2.2.  UV/visible  spectrophotometry 
Examination  of  the  UV  visible  spectra  of  the  local 
anaesthetics  wi 11  show  wavelengths  at  which  these  compounds  wi 11 
absorb  most  strongly.  This  was  done  for  the  compounds  of 
interest  in  the  hope  of  finding  a  strong  chromophore  common  to 
all.  Other  local  anaesthetics  were  also  cons idered  for  their 
possible use  as  internal standards. 
3.2.2.1.  Method 
Standard  solutions  of  between  2  and  4  mg/100ml  were 
prepared  in  O. 01N  H 2S04 .  The  UV  spectra  of  each  was  recorded 
in  turn.  The  absorbance  maxima  were  noted  and  the  gravimetric 
absorbance  coefficient  for  a  1mg/10Oml  standard  solution  in  a  lcm 
cell  at  these  maxima  calculated  (Moffat,  1986).  The 
spectra  were  recorded  against  a  0.01N  H 2S04  blank  in  a  lcm 
&lass  cell.  The  instrument  used  was  an  HP8451A  scannlng  diode 
array spectrophotometer,  scanning  from  190  to 400nm.  bandwidth  2nm. 
-261-3.2.2.2.  Results  and  Discussion 
The  absorbance  maxima  are  listed  in  table  3.7.,  wi th  the 
calculated  A~ values. 
The  UV  spectra  are  shown  superimposed  in  figure  3.4.  This 
demonstrates  that  all  the  compounds  examined  have  absorbance 
maxima  below  220nm  and  that  the  greatest  number  have  maximum 
absorbance  at  200nm.  Absorbance  at  this  wavelength  is  caused  by 
sigma-sigmall\'  transitions  and  is  common  to  most  organic 
molecules.  This  wavelength  is  best  avoided  if  alternati  ves  are 
available  as  this  region  of  the  spectrum  is  inaccessible  to  some 
UV  detectors,  and  with  some  mobile  phase  solvents  and  additives. 
Further  examination  of  the  spectra  shows  that  most  of  the 
compounds  demonstrate  a  second  absorbance  maximum  at  around 
230nm.  Exceptions  to  this  however  are  cinchocaine,  bupivacaine, 
mepivacaine  and  lignocaine which  have  no  maximum  in this  region. 
Further  maxima  are  also  seen  in  the  region  260  to  280nm  and 
above.  The  absorbances  are  poor  however  and  are  not 
coincident.  Cinchocaine,  for  example,  peaks  at 322nm. 
In  selecting  an  appropriate  wavelength  for  UV  monitoring,  the 
maximum  number  of  compounds  should  be  detectable  with  the  highest 
extinction  coefficient.  This  suggests  the  use  of  monitorin&  at 
200nm.  If  this  were  not  possible,  monitorin&  at  230nm  would 
provide greater selectivity and  similar sensitivity. 
Bupivacaine  however  has  poor  absorbance  at  this  wavelength 
(230~ •  75). 
It  was  decided  that  if  UV  detection  was  to  be  used,  a  wavelength 
of  230nm  should  be  used  to  monitor  the  eluent.  This  would 
however  reduce  the  sensitivity  towards  bupivacaine,  mepivacaine, 
-262-TABLE  3.7. 
UV  ABSORBANCE  MAXIMA  FOR  VARIOUS  LOCAL  ANAESTHETICS. 
compound  Lambda  Max.  Ai  230Ai 
amethocaine  200  467  431 
230  431 
312  68 
282  55 
amylocaine  236  451  427 
202  375 
276  47 
benzocaine  200  733  693 
228  697 
274  92 
bupivacaine  200  408  75 
264  5 
butacaine  200  351  319 
230  319 
280  59 
cinchocaine  206  934  297 
248  637 
322  224 
cocaine  236  379  360 
202  368 
276  37 
lignocaine  210  394  60 
264  14 
mepivacaine  202  614  125 
pE'ocaine  230  425  425 
200  388 
280  95 2 
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FIGURE  3.4. 
SUPERIMPOSED  UV  SPECTRA  FOR  THOSE  LOCAL  ANAESTHETICS  LISTED  IN  TABLE  3.7. lignocaine  and  cinchocaine,  as  suggested  by  the 
in  table  3.7 ..  If  these  compounds  were  of  spec ial  interest, 
reducing  the  monitoring  wavelength  towards  200nm  would  improve  the 
sensitivity. 
3.2.2.3.  Conclusions 
Having  assessed  the  appropriate  wavelengths  for  the 
detection  of  the  local  anaesthetics  of  interest,  and  noted  the 
problems  associated  with  the  detection  of  bupivacaine, 
mepivacaine,  lignocaine  and  cinchocaine,  it  was  decided  also  to 
investigate  the  possibility  of  using  electrochemical  detection  to 
screen for  a  range  of local anaesthetics. 
3.2.3.  Electrochemical properties 
3.2.3.1.  Introduction 
The  use  of  electrochemical  detection  has  been  reported  for 
lignocaine,  bupivacaine  (Halbert  and  Baldwin,  1984;  Musch  et al., 
1985).  procaine,  amylocaine,  tetracaine  and  benzocaine  (Musch  et 
al.,  1985).  This  has  been  reviewed  earlier  (3.1.5.6.).  It  bas 
been  demonstrated  above  that  UV  detection,  whilst  suitable  for  the 
detection  of  all  the  local  anaesthetics,  did  not  have  a  COIllDOD 
wavelength  giving  good  response  to  all  the  drugs.  It was  decided 
therefore  to  examine,  by  the  use  of  cyclic  vo1tammetry  (CV),  tbe 
electrochemical  properties  of  some  of  the  local  aDaestheticl  to 
determine  if ED  would  be  suitable. 
-265-3.2.3.2.  Method 
Cyclic  voltammetry  was  performed  under  the  same  conditions 
as  described  for  morphine  (2.4.5.).  The  support  electrolyte 
KH2P04,  was  also  the  solution  (8'- acetonitrile  in  0.01M 
same.  The  pH  used  was  adjusted  to  3,  as  it has  been  demonstrated 
that  pH  in  this  range  was  required  to  give  acceptable 
chromatography for  basic  compounds. 
Samples  were  scanned  oxidation-reduction  with  a  switching 
potential  of  ±  1.5  volts. 
successive experiments. 
The  electrode  was  pol  i shed  between 
3.2.3.3.  Results  and  discussion 
The  compounds  examined  were  procaine,  bupivacaine  and 
cocaine.  The  results  are  shown  in  table  3.8 ..  Voltammagrams 
for  procaine  and  bupivacaine  are  shown  in  figure  3.5.  An 
electrochemical  response  for  bupi vacaine  was  observed  at  1. 25V, 
slightly  higher  than  reported  (Halbert  and  Baldwin,  (1984), 
Ep:1. 0) .  A  small  oxidative  wave  was  noted  for  procaine  at  0.65 
volts.  A wave  at 1.35 volts  was  noted  for  cocaine. 
The  proposed  reaction  mechanism  for  bupivacaine  and  procaine  is 
radical  formation  in  the  aniline  system  (see  3.2.3.3.  and 
3.1.5.6.). 
activity. 
It  is  assumed  that  mepivacaine  would  have  a  similar 
Cocaine  however  does  not  contain  an  aromatic  amine  and  the 
activity observed  here  was  assumed  to  result  from  reactionl  at  the 
benzoyl  ,roup.  Reactions  at  this  group  were  noted  earl  ier  wi tb 
80me  of the narcotic  analgesics  (2.4.7.). 
Inlufficient  material  was  available  to  permit  the  analysil  of 
-266-TABLE  3.8. 
Ep  VALUES  (Volts)  MEASURED  FOR  LOCAL  ANAESTHETICS 
compound 
bupivacaine 
cocaine 
procaine 
Ep 
+1.25 
+1.35 
+0.65 
-267-
Ep/2 
+1.05 
+1.10 
+0.55 Red. 
1.5  1.0  1.5 
Ox. 
pra:ai ne 
Red. 
1·5 
Ox. 
bupi vacaine 
FIGURE  3.S. 
OXIDATION-REDUCTION  CYCLIC  VOLTAMMOGRAMS 
RECORDED  FOR  PROCAINE  AND  BUPIVACAINE 
-268-benzoyl  ecgonine  which  could  have  tested this  theory. 
Further  examination  of  the  electrochemical  behaviour  of  procaine 
produced  the  voltammogram  shown  in  figure  3.6 .. 
Following  oxidation  reduction  cycling,  subsequent  oxidation 
produced  the  behaviour  shown. 
reduction-oxidation  cycling. 
The  same  pattern  was  observed  in 
This  implies  that  a  reductive 
product  of  procaine  (possibly  arising  from  the  wave  noted  at  -0.25 
volts  (figure  3.6.»  has  electrochemical  activity at  low  oxidative 
potentials.  This  behaviour  was  similarly  observed  for 
bupivacaine  and  xylidine· (2,6,dimethyl  aniline).  This  suggested 
the  involvement  of  the  aromatic  amine,  but  no  suitable  reaction 
scheme  is  apparent,  given  that  electron  rich  compounds  such  as 
aromatic  amines  are  not  expected  to  be  so  readily  reduced 
(Tomlinov,  1972). 
3.2.3.4.Conclusions 
The  EC  acti  vi  ty  of  local  anaesthetics  occurs  mostly  at 
high  potential.  These  are  at  the  upper  end  of  the  potential 
ranse  suitable  for  ED.  Further  cyclic  voltammetry  misht  be 
carried  out  to  investigate  the  cycl  ing  effect  noted  for 
bupivacaine  and  procaine.  The  use  of  multiple  electrode 
coulometric  detectors  misht  allow  the  detection  of  these  reduction 
products  at lower oxidative potentials  (Roston et al,  1984). 
3.2.4.  SUDlllary 
Both  UV  and  electrochemical  detectors  have  been  shown  to 
be  suitable  for  the  measurement  of  local  anaesthetics  by  HPLC. 
The  potentials  required  for  ED  are  hiSh,  which  might  lead  to  rapid 
-269-Red. 
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procai·ne 
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Ox. 
xyl1dine 
FIGURE  3.6. 
OXIDATION-REDUCTION-OXIDATION  CYCLIC  VOLTAMMOGRAMS 
RECORDED  FOR  PROCAINE  AND  XYLIDINE 
-270-electrode  fouling,  and  as  large  number  of  compounds  will  react  at 
this  potential,  some  of  the  selectivity of  the  detector  is  lost. 
There  is  an  additional  possibility  of  interference  from  the  other 
components  in  the mixture  and  a  larger  background  current  from  the 
mobile  phase  leading  to  greater  noise.  This  confirmed  the 
observation  by  Halbert  and  Baldwin,  that  local  anaesthetics  did 
not make  ideal candidates  for  electrochemical detection. 
For  these  reasons  it  was  decided  that  UV  monitoring  at  230nm 
should  be  used  as  the  method  of  detection  for  an  HPLC  assay  for 
local  anaesthetics.  The  sensitivity at  this  wavelength  is  poorer 
for  bupivacaine,  mepivacaine,  lignocaine  and  cinchocaine  but 
should  impart  some  degree  of selectivity to the  assay. 
The  usefulness  of  cyclic  voltammetry  in  assessing  the  suitability 
of  electrochemical  detection 
demonstrated.  In  addition, 
involved  in  the  reaction 
otherwise  for  compounds 
electrochemical detection. 
for  a  specific  compound  has  been 
an  understanding  of  the  mechanism 
might  suggest  the  suitability  or 
not  previously  considered  for 
-271-3.3.  CHROMATOGRAPHY 
3.3.1.  Introduction 
Bupivacaine  was  used  as  a  model  compound  in  an  attempt  to 
develop  an  HPLC  assay  su  i table  for  several  local  anaesthetics. 
It  was  chosen  for  two  reasons.  There  w~re  a  number  of  samples 
resulting  from  a  hospital  study  on  bupivacaine  in  abdominal 
surgery  which  required  analysis.  Secondly,  bupivacaine  is  a 
relatively  new  and  increasingly  popular  local  anaesthetic  and 
therefore  a  potential  doping  agent  in  sport.  No  rapid  screening 
method  for  the  drug  in urine  has  been  reported. 
On  the  basis  of  the  investigation  of  the  electrochemical  and  UV 
properties  of  these  compounds  (3.2.),  it had  been  decided  that  UV 
detection at 230nm  should  be  used  for monitoring  the eluent. 
The  behaviour  of  bupivacaine  in  binary  methanol/O.OlM  KH2PO. 
and  acetonitrile/O.01M  KH2P04  solvent  systems  was  investisated 
•  to  determine  if  these  would  provide  acceptable  chromatosrapby  and 
if  so,  whether  that  system  would  be  suitable  for  the  analysis  of 
other local anaesthetics. 
3.3.2.  THE  USE  OF  METHANOL  AS  ORGANIC  MODIFIER 
3.3.2.1.  Method 
Binary  methanol/O.01M  KH2PO.  mixtures  were  prepared 
and  the  chromatography  of  bupi  vacaine  was  examined.  The  HPLC 
IYltem  used  was  as  follows.  A  sinsle  piston  pump  (Gilson  302 
vi  th  802C  manometer)  operated  at  2  ml/mi n.  Sample  introduction 
val  throush  a  Rheodyne  7125  6-port  injection  valve  with  a  20ul 
-272-loop,  using  an  25ul  glass  syringe  (SGE). 
A  25cm  ODS  Hypersil  column  (Shandon  Southern,  packed  as  in 
appendix  B)  was  used.  The  detector  was  a  variable  wavelength  UV 
monitor  (Spectroflow  757  (Kratos)  or  PU4025  (Phillips»,  set  at 
230nm.  The  absorbance  and  chart  recorder  settings  were  adjusted 
as  neccessary.  High  pressure  fittings  were  stainless  steel,  low 
pressure fittings were  PTFE  or polyethylene .. 
A  25cm  ODS  Hypersil  column  was  used.  This  material  was  preferred 
for  reasons  given  .earlier.  Longer  columns  are  capable  of 
producing  longer  retention  times  and  greater  resolution  without  a 
drop  in  efficiency.  Once  the  best  binary  solvent  mixture  had 
been  found,  the  effect  of  adjusting  the  pH  was  also 
investigated.  This  had  been  shown  to  be  important  when 
chromatographing morphine  (2.5.3.). 
3.3.2.2.  Results  and  discussion 
The  retention  data  obtained  are  given  in  table  3.9 .. 
Increasing  the  methanol  content  of  the  mobile  phase  caused  a 
decrease  in  the  retention  time  of  bupivacaine.  At  a 
concentration of  100~ methanol  however,  the  drug  was  not eluted. 
It  was  noted  that  decreas ing  the  pH  of  the  mobile  phase  from  6.4 
to  3.0,  caused  a  reduction  in  retention  time,  but  also  gave  rise 
to  sharper  peaks.  This  was  also  noted  in  the  chromatography  of 
morphine  and  is  due  to  improved  solubility  of  the  analfte  in  the 
mobile  phase. 
The  optimum.  retention  behaviour  obtained  was  with  a  70/30  methanol 
O.OlM  mobile  phase,  adjusted  to  pH  2.5  with 
concentrated  orthopholphoric  acid  (K'=1.9;  Na123)  (figure  3.7.). 
-213-TABLE  3.9. 
EFFECT  OF  METHANOL  CONTENT  AND  pH 
ON  CHROMATOGRAPHY  OF  BUPIVACAINE 
\  Methanol 
20 
50 
70 
90 
100 
\  Methanol 
70 
70 
RT  K' 
not  eluted 
16.0 
9.5 
5.3 
not 
pH 
4.6 
3.0 
8.4 
4.6 
2.1 
eluted 
RT 
9.5 
5 
Pk  W 
K' 
4.6 
1.9 
16 
4 
2.8 
*  Chromatogram  shown  in figure  3.7. 
Pk  W 
4 
1.8 
N 
16 
94 
57 
N 
94 
123  * ,  , 
9  8  7  6  5  4  3  . 
mlns. 
FIGURE  3.7. 
2  1  o 
c 
< 
OJ 
0-
(/) 
CHROMATOGRAM  OF  BUPIVACAINE  USING  2S0mm  ODS  HYPERSIL 
COLUMN  WITH  70\  METHANOL  IN  O.OIM  KH2P04 
AT  pH  3.0  AT  2ml/min 
-275-The  peak  was  however  quite  broad  and  tailed  badly  (W=1.8mins; 
It  was  therefore  not  cons idered  acceptable  for 
analytical work. 
3.3.2.3.  Conclusions 
The  chromatography  achieved  with  methanol  as  the  or&anic 
modifier  was  not  satisfactory.  It  was  decided  that  a  solvent 
containing  acetonitrile  should  be  investigated,  as  its selectivity 
properties  are different from methanol. 
3.3.3.  USE  OF  ACETONITRILE  AS  THE  ORGANIC  MODIFIER 
3.3.3.1.  Introduction 
Solvents  with  the  same  polarity  have  similar  net  solvatin& 
properties,  but  may  have  different  selectivities  dependin&  on  the 
extent  of  their  proton  donating,  proton  accepting  and  dipolar 
interactions  (Snyder,  1974  and  1978). 
A  similar  capacity  factor  was  required,  therefore  the  O.OlH 
KH
2
P0
4
/acetonitrile  mixture  with  the  same  polarity  as  the 
above  O.OlM  KH2P04/methanol mixture was  used. 
3.3.3.2.  Method 
The  composition  of  an  acetonitrile  containin&  solvent with 
the  same  polarity  was  calculated  using  the  equation  discus.ed 
earlier  (1.3.4.2.)  and  was  found  to  be  81.~ acetonitrile.  The 
effect  of  using  lower  pH  was  also  investigated,  as  this  had  been 
-276-shown  to  improve  the  peak  shape  when  methanol  was  used  as  the 
modifier. 
other  HPLC  conditions  were  as  before  (3.3.2.1.). 
3.3.3.3.  Results  and  discussion 
The  results  are  shown  in  tabl1!  3.10 ..  The  81. ~ 
acetonitrile  solvent  gave  a  similar  retention  time  to  the  methanol 
solvent  for  bupivacaine,  but  also  gives  a  slightly  less  tailing 
peak.  The  peaks  were  still  broad  however,  so  the  acetonitrile 
content  was  increased  to  91.5~.  This  reduced  the  retention  time 
and  also  improved  the  efficiency.  Increasing  the  acetonitrile 
content  further  to  95~ resulted  in  the  non-elution  of  bupivacaine. 
The  effect  of  pH  on  the  chromatography  is  similar  to  that  of 
methanol  sovents.  The  retention  time  is  decreased  as  is  the  peak 
width.  In  this  case  however  there  is  a  net  fall  in  the 
efficiency. 
Optimum  chromatography  was  obtained  with  the  91.5~ solvent,  at  pH 
3.0 (figure 3.8.). 
3.3.3.4.  Conclusion 
The  solvent  giving  the  best  chromatography  so  far  (91.5" 
aeetonitrilel  buffer)  was  rejected  on  the  grounds  that  the 
effieiency  was  still  low  and  the  acetonitrile  content  was  very 
high.  Solvents  with  high  organic  modifier  content  should  be 
avoided  as  they  are  likely  to  elute  any  lipopbilic  material 
present  in  extracts,  causing  late  peaks  and  long  term  ba.eline 
fluetuation. 
Similar  problems  of  tailing  and  poor  efficiency  were  encountered 
-217-TABLE  3.10. 
EFFECT  OF  ACETONITRILE  CONTENT  AND  pH 
ON  CHROMATOGRAPHY  OF  BUPIVACAINE 
\  Acetonitrile  RT  K' 
81.2 
91.5 
95 
\  ACN 
91.5 
91.5 
10.3  5.1 
8.5  4 
not  eluted 
pH 
4.6 
3.0 
RT 
8.5 
6.3 
Pk  W 
3.4 
2.2 
K' 
4 
2.7 
·Chromatogram  shown  in figure  3.8. 
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CHROMATOGRAM  OF  BUPIVACAINE  USING  2S0mm  ODS  HYPERSIL 
COLUMN  WITH  91.5\  ACETONITRILE  IN  O.OlM  KH2P04 
AT  pH  3.0  AT  2ml/min 
-279-in  the  chromatography  of  morphine.  In  that  ease  tailing  was 
avoided  by  the  use  of  ion-paired  chromatography.  The  suitability 
of  that  technique  to  the  chromatography  of  bupivacaine  was 
therefore examined. 
3.3.4.  ION-PAIRED  CHROMATOGRAPHY  OF  BUPIVACAINE 
3.3.4.1.  Introduction 
Ion-paired  chromatography  is  a  popular  means  of  preventing 
peak  tailing  in  liquid  chromatography  (Gloor  and  Johnson,  1977). 
In  the  chromatography  of  morphine,  N-alkyl  sulphonic  ac ids  have 
been  shown  to  provide  a  suitable  ion-pair  (2.5.10).  Local 
anaesthetics  are  nitrogeneous  bases  and  have  similar  pla's  (table 
3.21.)  and  might  be  expected  to  form  similar  ion-pairs.  Pentane 
sulphonic  acid  (PSA)  was  chosen  for  this  study  as  it was  expected 
to  give  an  increase  in  retention  of  the  compounds,  which  could 
thereafter  be  further  increased  if  neccessary  by  replacinl  PSA 
with  a  sulphonic  acid with  a  longer alkyl  group. 
3.3.4.2.  Method 
A  9l.5~  acetonitrile/0.01M  KH2P04  solvent,  10-
2
M  iD 
pentane  sulphonic  acid  was  prepared  and  allowed  to  equilibrate  OD 
column  for  one  hour,  after  which  reproducible  chromatolraphy  was 
achieved.  Other  HPLC  conditions  were  as  described  in  3.3.2.1 .. 
The  acetonitrile content  of  the  mobile  phase  wal  then  adjulted  and 
the  effect  on  the  chromatolraphy  was  noted.  The  pH  was  kept  at 
pH3.0  as  thi.  had  been  shown  assist  ion-pair  formation  in  the cas. 
-280-of morphine  <2.5.10.2.). 
3.3.4.3.  Results  and  Discussion 
The  retention  behaviour  is  recorded  in  table  3.11..  A 
sample  chromatogram  is  shown  in  figure  3.9..  A  comparison  of 
these  results  with  the  results  obtained  without  ion-pairing  agents 
(tables  3.9.  and  3.10),  shows  that  even  with  solvents  containing  a 
relat  i vely  low  percentage  of  aceton  i tri  Ie  (eg  5~)  ,  short 
retention  times  are  achieved.  This  strongly  suggests  that 
ion-pairs  are  formed  and  their  solubility  in  the  mobile  phase  is 
greater  than  that  of  the  unpaired  drug.  This  is  the  opposite 
effect  to  that  observed  when  ion-paired  chromatography  was 
examined  for  morphine,  where  the  formation  of  ion  pairs  increased 
the  solubi  1 i ty  of  the  drug  in  the  stat  ionary  phase  and  suggests 
that  there  are  fundamental  di fferences  in  the  nature  of  the  ion 
pairs  formed  and  the mechanism of the  separation. 
Although  the  retention  time  is  decreased,  the  peak  width  is  still 
excessively  broad,  suggesting  that  the  ion-pairs  may  still  be 
interacting  with  the  silanol  sites  on  the  stationary  phase.  This 
implies  that  reducing  the  acetonitrile  content  further  would  only 
make  the  peak broader without  improving  its shape. 
The  retention  behaviour  of  some  other  local  anaesthetics  was 
examined  on  the  system  using  the  solvent  containing  S~ 
acetonitrile.  Their  retention  behaviour  is  noted  in  table 
3.12. .  The  results  show  that  most  compounds  elute  earl  ier  than 
bupivacaine  and  the  retention  times  were  very  short  (I'  It.  1). 
Increasing  the  chain  length  of  the  ion-pairing  agents  would 
ioerea.e  the  retention  time,  but  as  seen  with  morphine  this  doe. 
-281-\ 
TABLE  3.11. 
EFFECT  OF  ACETONITRILE  CONTENT  ON  ION  PAIRED 
CHROMATOGRAPHY*  OF  BUPIVACAINE 
Acetonitrile  RT  Pk  W  K'  N 
91  2.1  1.3  0.75  42 
81.4  2.8  1.4  1.33  64 
75  3.0  1.5  1.50  64 
70  3.0  1.6  1.50  S6 
SO  5.0  2.8  3.20  51 
*Concentration  of  pentane  sulphonic  acid  constant at 
10-2M 
-282-9  8  7  6  5  4  3  . 
mlns. 
FIGURE  3.9. 
2  1  o 
c 
< 
OJ 
0-
lI>  . 
CHROMATOGRAM  OF  BUPIVACAINE  USING  250mm  ODS  HYPERSIL 
COLUMN  WITH  50\  ACBTONITRILI  IN  O. OlM  KH2P04 
AT  pH  3.0,  ALSO  10-2M  PENTANE  SULPHONIC  ACID 
AT  2ml/min 
-283-TABLE  3.12. 
CHROMATOGRAPHY  OF  OTHER  LOCAL  ANAESTHETICS 
ON  AN  ION  PAIRED  SYSTEM  (SEE  3.3.4.). 
compound  Rt  W  K'  N 
Bupivacaine  5.0  2.8  3.20  51 
cocaine  2.8  1.2  1.33  87 
butacaine  1.9  0.8  0.58  90 
lignocaine  1.8  0.8  0.50  81 
procaine  1.6  0.8  0.33  64 
-284-not  significantly  alter  the  peak  shape  or  the  degree  of  tailing 
(2.5.11.). 
3.3.4.4.  Conclusions 
The  small  variability  in  retention  over  a  large  range  of 
acetonitrile  concentration  and  the  poor" efficiencies  achieved, 
suggested  that  ion-paired  chromatography might  not  be  suitable  for 
these  compounds.  For  this  reason  ion-paired  chromatography  was 
not  considered  further  and  other  techniques  were  therefore 
considered. 
3.3.5.  OTHER  TECHNIQUES  TO  REDUCE  PEAK  TAILING 
3.3.5.1.  Introduction 
A  recent  report  (Gill  et  al.,  1984)  reviewed  above 
(3.1.5.6.),  describes  the  use  of  liquid  chromatography  to  examine 
a  range  of  local  anaesthetics  in  street  drug  samples.  Thia  wal 
performed  on  a  C-18  column  (ODS  Hypersil),  modified  by  including 
hexylamine  in the mobile  phase. 
The  capacity  factors  for  lignocaine,  mepivacaine  and  procaine  are 
all  very  low  however  (table  3.13.),  and  this  solvent  is  therefore 
unlikely  to  be  sui table  for  the  analysis  of  these  compounds  in 
biological  extracts.  No  details  of  the  efficiency  of  the 
separation,  or  the  degree  of  peak  tailing  were  given  in  that 
report,  although  an  earlier  publication  (Gill  et  al.,  1982)  bad 
demonstrated  an  improvement  in  peak  shape  for  phenyletbylaminel 
uling  hexylamine  in  tbe mobile  phaae. 
-285-TABLE  3.13. 
RETENTION  DATA  FOR  LOCAL  ANAESTHETICS 
USING  MOBILE  PHASE  MODIFIED  WITH  HEXYLAMINE 
COMPARED  WITH  DATA  FROM  GILL  ET  AL.,  1984 
Gill 
experimental  results 
Compound  RT  W  N  K' 
amethocaine  25.5  4.2  589  16 
amylocaine  12.0  3.6  178  7 
benzocaine  30.0  3.3  1322  19 
benzoyl  ecgonine  10.5  3.3  162  6.0 
bupivacaine  12.6  3.3  282  7.4 
cocaine  7.2  3.6  64  3.8 
lignocaine  3.3  1.2  64  1.2 
procaine  1.5  0.9  44  0 
void  time  =  1.5minutes 
-286-
et al. 
1984 
K' 
16.25 
7.19 
20.06 
5.68 
7.19 
2.68 
0.79 
0 this  approach  was  investigated  to  assess  the  quality  of  the 
chromatography  for  bupivacaine  and  to  determine  if  alterations  to 
the  mobile  phase  might  make  the  method  su i table  for  the 
investigation of biological extracts. 
3.3.5.2.  Method 
the  mobile  phase  reported  by  Gill  et  ale  (1984)  was 
prepared.  this  was  methanol/water/aqueous  phosphoric  acid  (1~ 
v/v)/hexylamine;  30:70:100:1.4  v/v/v/v.  other  HPLC  conditions 
were  as  described  in  3.3.2.1 ..  A  range  of  local  anaesthetics 
were  examined  on  this  system  and  their  capacity  factors  are 
compared  with  those  reported  by  Gill  et  ale  (1984).  The 
calculated efficiencies are  also  given. 
3.3.5.3.  Results  and  discussion 
the  capacity  factors  achieved  for  the  same  mobile  phase 
(table  3.13.)  are  simi lar  to  those  reported,  given  that  a  2scm 
column  was  used  instead  of  16cm  as  described  by  Gi 11  et  al. 
(1984).  the  efficiencies  achieved  for  bupivacaine  did  represent 
a  significant  improvement  on  binary  mobile  phases  investigated 
earlier  (N  =  282  cf.  197).  the  peak  shape  achieved  for 
bupivacaine  was  much  more  symmetrical,  although  not  significantly 
sharper  (figure  3.10.).  the  capacity  factor  for  bupivacaine  wa. 
however  quite  large  (K'  = 7.4)  with  a  correspondingly  wider  peat 
(W  •  4mins).  It  was  felt  that  this  wider  peat  would  coaproai •• 
the  sensitivity of  the  chromatography  for  this  application,  and  .0 
the  methanol  content  was  increased  to  see  if  an  earlier  elution 
time  would  give  an  increase  in efficiency and  peat width. 
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FIGURE  3.10 
CHROMATOGRAM  OF  BUPIVACAINE  USING  2S0mm  ODS  HYPERSIL 
COLUMN  WITH  METHANOL/WATER/H3P04  (1\ v/v)/ 
/HEXYLAMINE;  30:70:100:1.4 v/v/v/v. 
-288-Increasing  the  methanol  content  of  the  mobile  phase  to  3~ (from 
15'-)  at  the  expense  of  water,  caused  a  decrease  in  the  retention 
time,  however  there  was  no  major  improvement  in  the  peak  width  or 
efficiency  (figure  3.11.)  and  the  peak  appeared  more  tailed. 
this  suggested  that  the  change  in  selectivity of  the  column  caused 
by  the  inclusion  of  hexylamine  was  not  co.mpatible  with  efficient 
chromatography of bupivacaine. 
3.3.5.4.  Conclusions 
the  use  of  hexylamine  in  the  mobile  phase  does  sive 
further  control  of  the  retention  properties  of  the  solvent  and  in 
this  case  does  extend  the  suitability of  a  simple  isocratic  mobile 
phase  to  a  large  number  of  local  anaesthetics.  the  peak  for 
bupivacaine  is  however  still  quite  broad  and  was  not  improved 
sufficiently  over  earlier  binary  mobile  phases  to  make  this  the 
method  of choice  for quantitative analysis  of  complex  samples. 
Having  examined  binary  mobile  phases  and  ion-paired 
chromatography,  other  approaches  which  might  be  considered  are  the 
use  of  ternary  mobile  phases,  elevated  column  temperatures  or  a 
change  of  the  stationary  phase.  the  use  of  gradient  elution  is 
another  possibility  but  it  is  outwith  the  scope  of  this  study  as 
it requires  the  use  of  more  complex  equipment  and  makes  the method 
no  more  convenient  than  temperature  programmed  GC. 
Of  these  alternatives,  ternary  mobile  phases,  as  discussed  in 
(1.3.5.).  were  considered  as  they  involved  no  alteration  to  the 
HPLC  hardware. 
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CHROMATOGRAM  OF  BUPIVACAINE  USING  2S0mm  ODS  HYPERSIL 
COLUMN  WITH  METHANOL/WATER/H3P04  (1\ v/v)/ 
/HEXYLAMINE:  60:70:70:1.4  v/v/v/v. 
-290-3.3.6.  A  SIMPLE  STRUCTURED  APPROACH  FOR  TERNA.RY  SOLVENT 
OPTIMISATION 
3.3.6.1.  Introduction 
On  consideration  of  the  complex  assumptions  required  for  a 
reliable  mathematical  optimisation  procedure,  it  was  decided  to 
use  the  concept  of  the  solvent  map,  but  to  assess  the 
chromatography  semi-intuitively,  based  on  the  efficiency,  capacity 
factor  and  peak  shape  achieved.  This  allowed  trends  in 
chromatographic  improvement  to  be  corelated  with  the  relative 
solvent  composition. 
3.3.6.2.  Method 
The  approach  adopted  was  as  follows.  Figure  3.12.  and 
table  3.14  show  the  solvents  selected  for  initial  investigation. 
These  were  chosen  to  represent  the  range  of  polari ties  5.1-10.2 
available  from  these  three  solvents.  The  table  also  demonstrates 
the  variation  in  Xe,  Xd  and  Xn  values  (Chi  values)  representing 
the  degree  of  proton  acceptor,  proton  dona tor  and  dipole 
interactions  respectively of  the  solvent mixtures. 
Fourteen  solvents  were  examined  in  all  and  the  retention  data  for 
bupivacaine  in each  is  noted  in table 3.14 .. 
Other  HPLC  conditions  were  as  noted  in 3.3.2.1. 
3.3.6.3.  Results  and  Discussion 
Of  the  fourteen  solvents  examined,  only  four  gave 
mealurable  retention  data  for  bupivacaine.  This  is  shown  in 
table  3.14 ..  This  would  be  insufficient  for  any  further 
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COMPOSITIONS  OF  FOURTEEN  SOLVENTS 
SELECTED  FOR  STRUCTURED  SOLVENT  OPTIMISATION 
WITH  THREE  SOLVENTS  (FOR  DETAILS  OF 
SOLVENT  STRENGTHS  SEE  TABLE  3.14.) 
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TABL§  3.14. 
SOLVENTS  SELECTED  TO  DETERMINE  OPTIMUM 
SOLVENT  FOR  BUPIVACAINE 
ACN  MeOH  Buffer  pI  Xe  Xn  Xd  Rt  W 
0  0  100  10.2  0.37  0.25  0.37  not  eluted 
40  0  60  8.44  0.35  0.32  0.33  not  eluted 
20  20  60  8.3  0.38  0.30  0.32  not  eluted 
0  40  60  8.2  0.41  0.27  0.31  not  eluted 
60  0  40  7.6  0.33  0.33  0.31  not  eluted 
30  30  40  7.4  0.39  0.32  0.30  6.6  1.8 
0  60  40  7.1  0.44  0.29  0.28  not  eluted 
80  0  20  6.7  0.32  0.39  0.29  10.4  3.6 
60  20  20  6.5  0.36  0.36  0.28  4.1  1.0 
20  60  20  6.3  0.42  0.32  0.26  10.8  3.9 
0  80  20  6.1  0.46  0.30  0.25  not  eluted 
100  0  0  ~.8  0.31  0.42  0.27  not  eluted 
SO  SO  0  ~.S  0.40  0.37  0.25  not  eluted 
0  100  0  S.l  0.48  0.31  0.22  not  eluted 
"  ~  number  in figure  3.12. 
KI  N 
4.5  215 
7.7  133 
2.4  269 
8.0  123 optimisation  under  the  scheme  described  by  Glajch  et  al,  1982, 
considered  above,  (1.3.5.)  and  illustrates  the  importance  of 
having  three  suitable  starting  solvents.  It  might  however 
provide  three  solvent mixtures  to  allow the  process  to  be  repeated 
with more  success. 
A few  qualitative observations  were  made  on- the results. 
The  optimum  solvent  for  bupivacaine  probably  lies  in  between 
points  6,9  and  8.  Of  these  three,  solvent  (number  9)  obtained  by 
the  method  described  above,  did  provide  a  more  effie  ient  example 
of  chromatography  than  achieved  by  the  use  of  binary  solvent 
mixtures  (K' =2.4,  N=269).  This  is  shown  in  figure  3.13 ..  The 
efficiency  is  similar  to  that  achieved  with  the  use  of  the 
hexylamine  containing  solvent  (3.3.5.),  however  the  capacity 
factor  is lower. 
As  demonstrated,  the  use  of  other  solvents  could  increase  the 
capacity  factor  only  at  the  expense  of  the  efficiency. 
not  acceptable. 
This  was 
In  summary,  the  degree  of  improvement  over  previous  solvents  was 
small  and  was  not  considered  sufficient  to  make  this 
chromatographic  system acceptable for  biological extracts. 
Increasing  the  methanol  content  of  the  mobile  phase  at  the  expense 
of  acetonitrile  increased  the  retention  time  (see  point  9  to  point 
10).  The  exact  identity  of  the  optimum  solvent  could  be 
calculated  by  the  use  of  an  iterative  procedure,  takins  the  three 
solvent.s  6,9  and  8  as  the  apices  for  a  second  run  of  fourteen 
lolvents  as  performed  above.  If  this  was  performed  until  the 
improvements  in  the  efficiency  were  negliSible,  this  should  give 
t.he  opt.imum  separation  of  bupivacaine  for  a  ternary  methanol, i 
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CHROMATOGRAM  OF  BUPIVACAINE  USING  250mm  ODS  HYPERSIL 
COLUMN  WITH  ACETONITRILE/METHANOL/BUFFER  60/20/20. 
AT  pH3  AND  2ml/min.  (SOLVENT  No.9.  TABLE  3.14. 
AND  FIGURE  3.12.) 
-295-acetonitrile,  water  solvent. 
This  is  obviously  a  long  and  tedious  process  with  several 
disadvantages.  The  most  notable  is  the  choice  of  the  three 
optimum  solvents  at  the  end  of  each  iterative  run  and  the 
diminishing  returns  in  improvement  of  efficiency  on  successive 
runs.  There  is  also  the  requirement  of  a-subjective  choice  about 
when  the  drop  in  capacity  factor  outweighs  any  improvement  in 
efficiency. 
3.3.6.4.  Conclusions 
Most  reports  in  the  1 i terature  avoid  the  use  of  ternary 
solvent  sytems  because  of  the  demonstrated  difficulties  in 
optimising  the  eluent.  Computer  assisted  optimisation  has  been 
reviewed  in  chapter  one  (1.3.5.).  Most  of  these  methods  require 
interacti  ve  computer  control  of  the  chromatograph  because  of  the 
solvent  changes  and  repeat  injections  required.  The  calculation 
of  the  response  surface  and  the  subsequent  simplex  search 
procedure  used  by  most  methods,  are  complex  and  best  handled  by  a 
computer.  The  initial  selection  of  three  suitable  starting 
solvent  mixtures  is  however  essential  to  the  success  of  any 
optimisation  method  and  the  approach  used  above  for  bupivacaine 
may  be  useful for this preliminary step. 
These  optimised  procedures  are  still in  the  development  stage  and 
until  agreement  is  reached  on  the  correct  algorithm  to  aSlesl  the 
chromatograms  in  terms  of  resolution,  retention  time  and 
efficiency,  the  optimisation  of  ternary  solvents  will  be  a  tedioul 
process. 
-296-the.examination  of  these  ternary  solvent  systems  has  demonstrated 
the  effect  of  changing  the  solvent  selectivity.  A  comparison 
with  the  optimisation  of  binary  solvent  mixtures  examined  earlier 
has  shown  that  the  chromatography  has  been  improved.  The 
capacity  factor  is  still quite  low  however  and  the  efficiency  is 
not  greatly  improved  on  previous  solvent  systems.  It  was 
considered  unlikely  that  the  variation  in  selectivity  afforded  by 
the  use  of  a  ternary  solvent  system  was  sufficient  alone  to 
improve  the  chromatography  of  bupivacaine  to  a  level  acceptable 
for  the  examination of biological extracts. 
No  further  work  was  done  on  ternary  solvent  systems  and  some  of 
the  other  alternatives  examined  in  section  3.3.5.  were 
considered.  The  improvement  in  efficiency  gained  by  the  greater 
range  of  selectivities  available  from  ternary  mixtures  is 
significant.  This  suggests  that  another  change  in  the 
selectivity  of  the  separation  might  improve  the  chromatography  by 
the  required degree. 
3.3.7.  REVIEW 
Several  approaches  for  the  optimisation  of  mobile  phases 
for  local  anaesthetics  have  been  considered,  however  none  has 
represented  a  significant  improvement  on  efficiency  or  peak 
shape.  Each  of  the  methods  was  assessed  for  the  degree  of 
tailing  and  assynlll\etry  of  the  peak  (table  3.15.).  Host  of  the 
methods  exhibit  this  to  a  greater  or  lesser  extent.  The  best 
results  were  obtained  with  a  mobile  phase  phase  containing 
bexylamine  ~hich  is  believed  to  modify  the  selectivity  of  tbe 
-297-stationary  phase  (Gill  et  al.,  1982)  and  a  ternary  solvent 
mixture,  which  was  directed  towards  changing  the  selectivity  of 
the  mobile  phase.  This  led  to  the  conclusion  that  the  ODS 
hypersil  column  used  for  all  the  above  chromatography  is  not 
ideally  suited  for  the  analysis  of  local  anaesthetics,  due  to  its 
particular  selectivity.  ODS  hypersil  was  chosen  as  the  standard 
reversed  phase  material  for  HPLC  assays  in  this  department, 
following  work  by  Eppel  (1980)  and  Smith  et al.,  1984),  showing  it 
• 
to  have  a  reliable  batch  to  batch  reproducibility  and  to  be 
sui table  for  a  wide  range  of  assays.  A  further  factor  was  the 
decision  by  the  Home  Office  to  use  this  material  in  all  their 
laboratories  (Gill,  1984),  in  an  attempt  to  standardise  their  HPLC 
assays.  It was  considered  convenient  to  follow this  decision,  in 
order  to  allow  the  direct  use  of  methods  suggested  or  reported  by 
Home  Office central Research  Establishment. 
Following  the  poor  results  produced  above,  it was  decided  that  the 
use  of  an  alternative  stationary  phase  might  be  neccessary  to 
achieve  the  aims  of  this  study,  n~ely  to  provide  efficient 
chromatography  for  a  range  of local anaesthetics. 
The  literature  survey  (3.1.5.6.  and  table  3.4.)  showed  that  a 
variety  of  stationary  phases  had  been  used  for  the  chromatography 
of  local  anaesthetics.  These  included  C-2  and  C-8  reversed 
phases,  as  well  as  polar phase materials  such  as  CN  and  silica. 
It  was  decided  that  another  reversed  phase  material  should  be 
examined,  as  these  are  reported  to  be  more  suited  to  the  analysis 
of  biological  extracts .  It  was  decided  to  examine  the 
• uitability  of  a  C-8  stationary  phase  to  determine  if  the  change 
in  .electivity of  the  column  would  make  any  significant  change  in 
the  chromatography. 
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TABLE  3.15. 
COMPARISON  OF  CHROMATOGRAPHIC  PARAMETERS  FOR 
SEVERAL  MOBILE  PHASES 
mobile  phase  K'  W  N 
methanol/buffer- 1.9  1.8  123 
70/30.  pH3 
acetonitrile/buffer  2.7  1.8  197 
91.5/8.5.  pH3 
acetonitrile/buffer  3.2  2.8  51 
SO/50 
lO-2M PSA,  pH) 
methanol/water/H3P04  (1%  v/v)  7.4  4.0  282 
/hexylamine;  30:70:100:1.4  v/v/v/v. 
acetonitrile/methanol/buffer  2.4  1.0  269 
60/20/20  pH) 
-buffer. O.OlM  KH2P04  solution. 
As  section 
3.75  3.3.2. 
3.5  3 . 3 .3. 
4.3  3.3.4. 
2.0  3.3.S. 
4.0  3.3.6. 3.3.S.  USE  OF  C-S  STATIONARY  PHASE. 
3.3.S.1.  Introduction 
The  HPLC  systems  examined  above  were  not  considered  to  be 
su i table  for  the  analys i s  of  biological  extracts  because  of  the 
peak  width  or  the  degree  of  tai  ling  of  th~  drug  peak.  The  HPLC 
system  described  for  bupivacaine  by  Lindberg  and  Pihlajamati, 
(19S4)  is  based  on  a  C-S  column  packed  with  Lichrosorb  RP-S.  As 
this  material  was  held  in  stock  in  the  department,  a  25cm  column 
was  prepared  using  the  packing  procedure  described  in  appendix  a, 
having first assessed  its ability to  form  a  slurry in  acetone. 
3.3.S.2.  Kethod 
Using  this  column  and  the  mobile  phase  recommended  (2S~ 
acetonitrile  in  0.05K  KH2P04,  Lindberg  and  Pihlajamaki,  19S4), 
the  chromatography  of  bupivacaine  was  examined.  Other  HPLC 
conditions  were  as  described  in  3.3.2.1..  The  retention 
behaviour  of  several  related  compounds  was  examined  on  the  same 
system. 
3.3.S.3.  Results  and  discussion 
The  chromatographic  data  are  shown  in  table  3.16..  A 
capacity  factor  for  bupivacaine  of  K'  = 3.5  and  an  efficiency of  N 
•  2916  were  noted.  It  was  also  noted  that  the  peak  width  was 
very  narrow  (W  = 0.4  mins),  and  it  proved  dififcult  to  accuratelr 
assess  the  assymmetry  of  the  peat.  The  efficiency  usina  this 
system  is  improved  by  an  order  of  ma&ni tude  over  the  effie  lency 
noted  with  any  of  the  other  mobile  phase  systems  considered 
-300-TABLE  3.16. 
CHROMATOGRAPHIC  BEHAVIOUR  OF  A RANGE  OF 
LOCAL  ANAESTHETICS  ON  THE  SYSTEM  DESCRIBED 
BY  LINDBERG  AND  PILAJAKAKI.  (1984) 
compound  Rt  W  K'  N 
procaine  2.2  0.2  0.83  1936 
lignocaine  2.5  0.4  1.1  625 
mepivacaine  2.6  0.4  1.16  676 
benzoyl  ecgonine  3.7  0.5  2.05  853 
cocaine  4.4  0.5  2.66  1239 
bupivacaine  5.4  0.4  3.5  2916 
cinchocaine  12.9  1.3  9.75  1575 
void  time  = 1.2 minutes 
-301-previously  (table  3.15. ) .  It  also  appears  to  provide  an 
efficient  separation  for  a  variety  of  other  local  anaesthetics 
including  cocaine  and  cinchocaine  (figure  3.14.).  The  other 
local  anaesthetics  investigated  elute  earlier.  This  implies  that 
the  selectivity  of  the  C-8  stationary  phase  is  more  suited  to 
these  compounds  than  the  ODS  material  ·used  in  all  previous 
chromatography.  There  is  very  little  tailing,  the  peaks  being 
almost  symmetrical. 
3.3.8.4.  Conclusions 
For  a  given  compound  in  solvents  of  different  strength, 
the  capac i ty  factor  may  vary,  but  the  peak  shape  and  effic  iency 
remain  more  or  less  constant.  This  implies  that  if  a  particular 
separation  is  tailing  badly,  this  will  not  be  solved  simply  by 
altering  the  organic  content  of  the  mobile  phase.  Th is  affords 
only  a  small  change  in  selectivity  and  whilst  the  solvent  strength 
(PI)  can  be  adjusted  to  control  the  degree  of  retention,  the 
subsequent  changes  in  the  indi  vidual  solvent  interac  t ions  (Xe,  Xe 
and  Xn)  are  not  generally  sufficient  to  improve  the  degree  of 
tailing.  Greater  control  of  these  individual  contributions  to  P' 
is  possible  with  the  use  of  ternary  solvent  systems,  but  these 
have  proved  difficult to  optimise. 
To  make  significant  changes  to  the  quality  of  the  chromatography 
(i.e.  efficiency,  capacity  factor  and  assymmetry),  alternatives 
such  as  ion-pairing  or  changes  to  the  stationary  phase  may  be 
required. 
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FIGURE  3.14. 
CHROMATOGRAM  OF  SEVEN  LOCAL  ANAESTHETICS  (1:  PROCAINE, 
2:  LIGNOCAINE,  3:  KEPIVACAINE,  4:  BENZOYL  ECGONINE, 
5:  COCAINE,  6:  BUPIVACAINE,  7:  CINCHOCAINE)  USING 
250mm  LICHROSORB  RP-8  COLUMN  WITH  28~ ACETONITRILE 
IN  0.05K  KH2P04  AT  pH3  AND  2m1/min. 
-303-3.3.9.  THE  EFFECT  OF  ACETONITRILE  CONTENT  ON  THE  CHROMATOGRAPHY  OF 
BUPIVACAINE  AND  RELATED  COMPOUNDS  USING  A C-8  COLUMN. 
3.3.9.1.  Introduction 
Having  established  that  the  use  of  a  stationary  phase  of 
lower  lipophilicity  gave  good  chromatography  of  bupivacaine  and 
some  other  compounds,  it  was  decided  to  investigate  whether 
altering  the  acetonitrile  content  might  allow  one  HPLC  system  for 
a  range  of local anaesthetics. 
3.3.9.2.  Method 
A  series  of  acetoni tri  le/O.  OSM  KH2PO 4  solvents  from 
SO~ to  1~) were  prepared  and  allowed  to  equilibrate  on  the  column 
for  one  hour,  after  which  time  reproducible  chromatography  was 
achieved.  Other  HPLC  conditions  were  as  in 3.3.2.1 .. 
-3  f  .  Standard  solutions  of  10  gIL  of  the  compounds  0  interest  were 
used  unless  otherwise  stated. 
3.3.9.3.  Results  and  discussion 
The  chromatographic  data  are  given  in  table  3.17.  (data 
for  28~ solvent  are  shown  in  table  3.14.)  and  shown  graphically  in 
figure  3.15 .. 
These  results  show  that  using  acetonitrile/O.OSK  KH2P04 
.olvents  on  a  C-8  column,  it is  not  possible  to  produce  one  system 
which  will  be  suitable  for  the  analysis  of  the  compounds  of 
interest. 
The  quality  of  the  chromatography  in  general  on  these  systems  wal 
lufficient  to  make  the  use  of  a  C-8  column  the  method  of  choice 
-304-TABLE  3.17. 
VARIATION  IN  CHROMATOGRAPHIC  BEHAVIOUR  OF  LOCAL  ANAESTHETICS 
WITH  ACETONITRILE  CONTENT 
10~ acetonitrile 
compound  Rt  W  K"  N 
procaine  5.4  0.8  3.5  729 
lignocaine  6.4  O. 7  4.3  1338 
mepivacaine  7.3  0.8  5.1  1332 
benzoyl  ecgonine  9.8  1.1  7.2  1270 
cocaine  NOT  ELUTED 
bupivacaine  NOT  ELUTED 
cinchocaine  NOT  ELUTED 
20~ acetonitrile 
compound  Rt  W  K'  N 
procaine  2.8  0.4  1.3  784 
lignocaine  3.4  0.4  1.83  1156 
mepivacaine  3.5  0.4  1.91  1225 
benzoyl  ecgonine  6.0  0.6  4.00  1600 
cocaine  8.0  0.9  5.7  1264 
bupivacaine  9.7  0.6  7.1  4181 
cinchocaine  38  2.5  31  369 
40'- acetonitrile 
compound  Rt  W  K'  N 
procaine  K'  LESS  THAN  1 
lignocaine  K'  LESS  THAN  1 
mepivacaine  K'  LESS  THAN  1 
benzoyl  ecgonine  K'  LESS  THAN  1 
cocaine  2.7  0.6  1.25  324 
bupivacaine  3.0  0.2  1.5  3600 
cinchocaine  4.6  0.8  2.8  529 
50'- acetonitrile 
compound  Rt  W  K'  N 
procaine  K'  LESS  THAN  1 
lignocaine  K'  LESS  THAN  1 
mepivacaine  K'  LESS  THAN  1 
benzoyl  ecgonine  K'  LESS  THAN  1 
cocaine  K'  LESS  THAN  1 
bupivacaine  2.3  0.2  0.9  2116 
cinchocaine  2.8  0.6  1.3  348 10 
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FIGURE  3.15 
VARIATION  IN  CAPACITY  FACTOR  FOR  SEVEN 
LOCAL  ANAESTHETICS  WITH  ACETONITRILE  CONTENT 
OF  THE  MOBILE  PHASE for  the  analysis  of  these  compounds. 
From  the  above  experiment  three  solvent  systems  were  chosen,  for 
three  groups  of compounds.  These  are  as  follows: 
SYSTEM  1:- For  bupivacaine  and  cinchocaine,  the  system  described 
by  Lindberg  and  Pihlajamaki,  (1984),  28~  acetonitrile  in  0.05K 
KH2P04  adjusted  to  pH3. 
SYSTEM  2:- For  cocaine,  bupivacaine  and  benzoyl  ecgonine,  20~ 
acetonitrile  in  0.05K  KH2P04  adjusted to pH3. 
SYSTEM  3:- For  procaine,  mepivacaine  and  lignocaine,  1()4£. 
acetonitrile  in  0.05K  KH2P04  adjusted to  pH3. 
other  HPLC  conditions  were  as  described  in 3.3.2.1 .. 
Sample  chromatograms  from  each  system are  shown  in  figure  3.16 .. 
3.3.9.4.  Conclusions 
Although  a  single  system  for  a  wide  range  of  local 
anaesthetics  has  not  been  found,  suitable  chromatography  OD 
similar  systems  has  been  achieved  for  the  compounds  of  interest. 
Not  considered  in  this  study  was  the  use  of  elevated  column 
temperature,  which  is  known  to  allow earlier  elution  of  compounds 
with  high  capacity factors  (Gant  et al.,  1979). 
The  process  of  changing  to  methanol  based  solvents,  the  use  of 
ion-pairing  agents,  ternary  solvent  systems  etc.  with  this  C-8 
column  could  now  be  investigated  in  an  attempt  to  provide  one  HPLC 1: 
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CHROMATOGRAMS  FOR  SEVEN  LOCAL  ANAESTHETICS 
IN  SOLVENTS  WITH  VARYING  ACETONITRILE  CONTENT 
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'" system  suitable  for  a  larger  range  of  local  anaesthetics. 
Similarly,  the  fact  that  the  compounds  of  interest  elute  in 
different  strengths  of  the  same  solvent  mixture  suggest  that  it 
would  convert  readily to  a  gradient  system. 
The  chromatography  achieved  was  however  efficient  and  the 
compounds  of  interest  displayed  very  little  tailing  or 
assymmetry.  The  1 ineari  ty  of  the  response  to  the  compounds  of 
interest  was  examined  and  possible  interference  in  the  assay  from 
other  common  drugs  was  assessed,  before  suitable  extraction 
procedures  for  each were  investigated 
3.3.10.  LINEARITY  OF  DETECTOR  RESPONSE 
3.3.10.1.  Introduction 
The  linearity  of  the  detector  response  to  increasing 
amounts  of  drug,  is  essentially  a  property  of  the  detector,  up  to 
the  point  at  which  the  HPLC  column  becomes  overloaded  with  sample 
(Snyder  and  Kirkland,  1978).  For  this  reason  only  one  of  the 
detectors  used 
(Phillips),  was 
previously,  the  PU4025  UV 
selected  for  further  work. 
spectrophotometer 
Its  1 ineari  ty  was 
investigated  for  cocaine,  procaine,  bupivacaine  and  benzoyl 
ecgonine  using  one  of  the  HPLC  systems  described  above  which  was 
known  to  separate  all  these  compounds  (system  2,  (3.3.9.3.)  and 
table 3.17.>. 
-309-3.3.10.2.  Method 
The  HPLC  system  used  was  as  follows.  A  single  piston 
pump  (Gilson  302  operated  at  2  mllmin,  with  S02C  manometer). 
sample  introduction  was  through  a  Rheodyne  7125  6-port  injection 
valve  with  a  20ul  loop,  using  an  25ul  glass  syringe  (SGE).  A 
25cm  Lichrosorb  RP-S  column  (Merck,  Darmstadt)  packed  as  in 
appendix  B.  The  detector  was  a  variable  wavelength  UV  moni tor 
PU4025  (Phillips),  set  at  230nm.  The  absorbance  and  chart 
recorder  settings  were  adjusted  as  neccessary.  High  pressure 
fittings  were  stainless steel,  low  pressure fittings  were  PTFE. 
Drug  standards  were  prepared  by  serial dilution  and  the  absorbance 
was  calculated  from  the  peak  heights.  The  absorbances  are  given 
in table 3.1S.  and  linearity plots  are  shown  in  figure  3.17 .. 
3.3.10.3.  Results  and  discussion 
All  the  drugs  gave  linear  calibration  over  the  region  of 
interest,  however  that  noted  for  procaine  was  poorer  than  for  the 
other  compounds  examined.  Deviations  from  linearity  arise  froll 
stray light,  which  in  turn  is  a  measure  of  the  instruments optical 
quality. 
The  absorbance  is  determined  by  the  concentration  of  the  drug,  and 
the  value  for  the 
1  equation,  Absorbance  = A1Cl. 
compound,  as  in  the  Beer-Lambert 
Samples  containing  concentrations  above  the  upper  boundary  of  thil 
region  would  probably  require  to  be  diluted  and  reanalYled.  The 
ablolute  detection  limits  were  calculated  as  2ng  olc  (20ul  of 
lO-4g/L)  for  procaine,  cocaine  and  benzoyl  ecgonine.  and  10ns 
ole  (20ul  of  Sx10-1a  giL)  for  bupivaeaine.  This  il due  to  tbe 
-310-TABLE  3.18. 
ABSORBANCE  DATA  FOR  ASSESSING  LINEARITY  OF 
OF  HPLC  METHODS 
compound  amount  olc  absorbance 
cocaine  2ng  1.6x10~4 
lOng  6.4x10-4 
20ng  1.3x10-3 
100ng  6.6x10-3 
200ng  0.013 
lug  0.060 
benzoyl  ecgonine  2ng  2.4x10-4 
lOng  7.2x10-4 
20ng  1.4x10-3 
100ng  7.4x10-3 
200ng  0.015 
lug  0.075 
procaine  2ng  1.2x10-4 
lOng  8.0x10-4 
20ng  1.6x10-3 
100ng  8.8x10-3 
200ng  0.015 
bupivacaine  2ng  2.4x10-5 
lOng  1.6x10-4 
20ng  2.8x10-4 
100ng  1.3x10-3 
200ng  2.6x10-3 
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LINEARITY  OF  UV  ABSORBANCE  DETECTOR  FOR  FOUR  LOCAL  ANAESTHETICS poorer  absorbance  of  bupivacaine  at  230nm  (see  2.3.2.).  Assuming 
lO~ extraction  efficiency  from  biological  samples,  this  is  within 
the  range  of  sensitivity  required  for  the  analysis  of  biological 
samples  for  therapeutic  to fatal levels  (3.1.4.  and  table 3.2.) 
3.3.10.4.  Conclusions 
It  has  been  shown  that  the  linearity  of  the  detector 
response  within  the  region  of  interest  is  good  for  the  particular 
detector  examined.  It  was  therefore  dec ided  that  thi  s  detector 
should  be  used  exclusively for  further work  in this  study. 
3.3.11.  EXAMINATION  OF  OTHER  COMPOUNDS  FOR  INTERFERENCE 
3.3.11.1.  Introduction 
A  selection  of  drugs  commonly  encountered  in  forensic 
toxicological  analysis  were  examined  to  determine  their  elution 
behaviour  on  the  HPLC  systems  developed  for  the local  anaesthetics. 
3.3.11.2.  Method 
Standard  solutions  of  the  drugs  (10-2g/L)  were  prepared 
and  examined  on  HPLC  systems  consisting  of  the  pump  and  detector 
a.  described  in  3.3.2.1.,  and  the  Lichrosorb  RP-8  column  with 
mobile  phase  ranging  from  1~  to  40'- acetonitrile.  The 
chromatographic  behaviour  of  a  series  of  local  anaesthetici  and 
narcotic  analsesics,  benzodiazepines  and  acidic  anti-depressant 
druss  was  examined.  The  retention  data were  recorded  for  tho  •• 
-313-compounds  which  eluted  in  less  than  30  minutes. 
in table 3.19  (I - IV). 
These  are  &i ven 
3.3.11.3.  Results  and  discussion 
As  the  retention  data  for  bupivacaine,  cocaine,  benzoyl 
ec&onine  and  procaine  (table  3.16.)  were  not  recorded  at  the  same 
time  as  these  other  drugs,  there  is  a  slight  difference  in  the 
capacity  factors  as  demonstrated  by  the  position  of  bupivacaine 
which  was  included  in the  present study. 
This  data  can  therefore  only  be  used  to  indicate  compounds  elutin& 
in  the  same  region of  the  chromatogram  as  the  compound  of  interest. 
In  summary,  on  the  10~  system,  procaine  had  a  similar  K'  to 
prilocaine.  And  if the  identification of  an  unknown  compound  was 
required,  prilocaine  should  be  compared  for  interference. 
Also  included  in  table  3.19  (I),  is  a  list of  GC  retention  indices 
on  a  non-polar  SE-30  or  OV-l  type  column  for  the  compounds 
examined  (from  Ardrey  and  Moffat,  1981).  A  comparison  of  the  GC 
retention  indices  shows  that  these  compounds  could  be 
discriminated  against  by  GC  however  (procaine  RI  ;I;  2018, 
prilocaine II = 1825. 
This  indicates  that  the  selectivity  of  the  GC  separation  of  the 
drugs  is  different  from  the  selectivity  of  the  HPLC  method. 
Which  would  &ive  added  specificity  to  a  cross-check  method 
incorporating  GC  and  HPLC. 
Similar  comparisons  can  be  made  for  other compounds. 
From  the  capacity  factors  recorded  in  table  3.19.(1  -IV).  and  the 
chromatograms  in  figure  3.18.  it  can  be  seen  that  all  tbe  dru&s 
examined  were  separated  in at least one  of  the  solvents  examined. 
Benzocaine  (peak  13)  is  unusual  in  that  it  demonstrate.  tbe TABLE  3.19. 
COMPARISON  OF  CHROMATOGRAPHIC  PERFORMANCE  OF  SOME  COKMON  DRUGS 
ON  SOLVENT  SYSTEMS  USED  FOR  LOCAL  ANAESTHETICS 
Solvent: 
·flow rate 
Column: 
Wavelength: 
Dead  Time: 
compound 
I 
4~ acetonitrile  in 0.05MKH2P04  at  pH  3 
2 
25cm  Lichrosorb  RP-B 
210nm 
13 
Rt  W  K'  N  RI 
GENERAL  BASIC  DRUGS 
1  morphine  15  2454 
2  nalorphine  16  2517 
3  codeine  19  4  0.5  361  2316 
4  oxycodone  19  3  0.5  641  2524 
5  prilocaine  22  2  0.7  1936  1B25 
6  levorphanol  23  3  O.B  940  2234 
7  diamorphine  24  3  0.9  1024  2614 
B  amylocaine  29  3  1.2  1495  1600 
9  bupivacaine  33  3  1.5  1936  2273 
10  pentazocine  34  3  1.6  2055  2275 
11  papaverine  33  5  1.5  670  2825 
12  amethocaine  34  4  1.6  1156  2219 
13  benzocaine  36  3  1.8  2304  1555 
14  butacaine  43  4  2.3  1849  2457 
15  cinchocaine  48  5  3.0  1475  2701 
16  dextromoramide  55  5  3.2  1936  2940 
17  dipipanone  94  7  6.2  2885  1474 
BENZODIAZEPINES 
nitrazepam  24  2  0.7  2304 
lorazepam  37  2  1.6  5476 
chlordiazepoxide  40  2  1.9  6400 
desmethyldiazepam  118  3  2.4  4096 
diazepam  62  3  3.4  7260 
ACIDIC  DRUGS 
prillidone  21  1  0.6  7056 
methyprylone  25  1  0.9  10000 
phenobarbitone  27  2  1.1  2916 
butobarbitone  32  2  1.5  4096 
but.albital  34  2  1.6  11624 
amylobarbitone  34  2  1.6  4624 
,lutet.himide  36  2  1.8  5184 
quinalbarbit.one  49  5  2.8  1536 
-315-TABLE  3.19.  contd. 
COKPARISON  OF  CHROMATOGRAPHIC  PERFORMANCE  OF  SOKE  COKMON  DRUGS 
ON  SOLVENT  SYSTEMS  USED  FOR  LOCAL  ANAESTHETICS 
Solvent: 
flow rate 
column: 
Wavelength: 
Dead  Time: 
compound 
II 
30~ acetonitrile  in  0.OSKKH2PO~ at  pH  3 
2 
25cm  Lichrosorb  RP-8 
210nm 
13 
Rt  W  K'  N 
GENERAL  BASIC  DRUGS 
1  morphine  19  o.~ 
2  nalorphine  20  o.~ 
3  codeine  22  4  0.7  ~8~ 
4  oxycodone  22  5  0.7  310 
5  prilocaine  27  4  0.9  729 
6  levorphanol  29  3  1.1  1~95 
7  diamorphine  38  3  1.7  2567 
8  amylocaine  40  5  1.9  102~ 
9  bupivacaine  46  5  22.3  135~ 
10  pentazocine  48  5  2.4  1475 
11  papaverine  50  8  2.6  625 
12  amethocaine  62  5  3.~  2460 
13  benzocaine  54  5  2.9  1866 
14  butacaine  71  5  ~.1  3226 
15  cinchocaine  95  9  5.8  1782 
16dextromoramide  114  9  7.2  2567 
17dipipanone  227  18  15.2  2544 
BENZODIAZEPINES 
nitrazepam  35  4  1.7  1225 
lorazepam  71  8  4.~  1260 
chlordiazepoxide  81  9  5.2  1296 
desmethyldiazepam  105  11  7.1  1~58 
diazepam  131  9  9.1  3390 
ACIDIC  DRUGS 
priaidone  26  3  1.0  1202 
methyprylone  35  3  1.69  2177 
phenobarbitone  38  ~  1.71  14~~ 
butobarbitone  49  5  2.77  1537 
butalbital  58  5  3.46  2153 
amylobarbitone  60  6  3.61  1600 
slutethimide  61  6  3.69  1653 
quinalbarbitone  92  10  5.57  1354 
-316-TABLE  3.19.  contd. 
COMPARISON  OF  CHROMATOGRAPHIC  PERFORMANCE  OF  SOME  COMMON  DRUGS 
ON  SOLVENT  SYSTEMS  USED  FOR  LOCAL  ANAESTHETICS 
Solvent: 
flow rate 
Column: 
Wavelength: 
Dead  Time: 
compound 
2~ acetonitrile  in 0.05MKH2P04  at  pH  3 
2 
25cm  Lichrosorb  RP-8 
210nm 
13 
Rt  W  K'  N 
GENERAL  BASIC  DRUGS 
1  morphine  21  2  0.61  1164 
2  nalorphine  25  3  0.92  1111 
3  codeine  28  5  1.15  502 
4  oxycodone  32  6  1.46  455 
5  pt"ilocaine  31  5  1.85  816 
6  levorphanol  53  5  3.01  1198 
1  diamorphine  59  1  3.53  1131 
8  amylocaine  80  8  5.15  1600 
9  bupivacaine  95  9  6.31  1183 
10  pentazocine  101  10  1.23  1832 
11  papaverine  131  15  9.54  1334 
12  amethocaine  165  15  11.69  1936 
13  benzocaine  99  9  6.62  1936 
14  butacaine  180  15  12.9  2304 
13  cinchocaine  NOT  ELUTED  IN  UNDER  30  MINUTES 
14  dextt"omoramide  NOT  ELUTED  IN  UNDER  30  MINUTES 
15  dipipanone  NOT  ELUTED  IN  UNDER  30  MINUTES 
BENZODIAZEPINES 
nitt"azepam  14  1  6.98  1188 
lorazepam  184  19  13.1  1500 
chlordiazepoxide  229  19  16.6  2324 
desmethyldiazepam  347  31  25.1  1407 
diazepam  430  35  32.1  2415 
ACIDIC  DRUGS 
priaidone  40  5  2.07  1024 
methyprylone  51  6  3.38  1444 
phenobarbitone  64  5  3.92  2621 
butobarbitone  98  6  1.46  4268 
butalbital  124  10  8.31  2460 
lJIlylobarbitone  130  10  9.00  2704 
,lutethimide  143  13  10.0  1936 
quinalbarbitone  240  20  11.46  2304 
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COMPARISON  OF  CHROMATOGRAPHIC  PERFORMANCE  OF  SOME  COMMON  DRUGS 
ON  SOLVENT  SYSTEMS  USED  FOR  LOCAL  ANAESTHETICS 
Solvent: 
flow rate 
Column: 
Wavelength: 
Dead  Time: 
compound 
GENERAL  BASIC 
1  morphine 
2  nalorphine 
3  codeine 
4  oxycodone 
5  prilocaine 
6  levorphanol 
7  d i anlorph i ne 
8  anlylocaine 
9  bupivacaine 
10  papaverine 
11  amethocaine 
12  pentazocine 
13  benzocaine 
14  butacaine 
15  cinchocaine 
DRUGS 
16  dextromoramide 
17  dipipanone 
BENZODIAZEPINES 
nitrazepam 
lorazepam 
chlordiazepoxide 
desmethyldiazepam 
diazepam 
ACIDIC  DRUGS 
priaidone 
methyprylone 
phenobarbitone 
butobarbitone 
butalbital 
amylobarbltone 
glutethimide 
quinalbarbltone 
10~ acetonitrile  in  0.05MKH2P04  at  pH  3 
2 
25cm  Lichrosorb  RP-8 
2l0nm 
13 
Rt  W  K'  N 
27  6  1.07  324 
37  6  1.85  608 
45  7  2.46  661 
51  11  2.88  344 
56  7  3.31  1024 
117  9  8.00  866 
155  14  10.9  1961 
180  17  12.8  1793 
205  24  14.8  1167 
305  34  22.5  1287 
NOT  ELUTED  IN  UNDER  30  MINUTES 
NOT  ELUTED  IN  UNDER  30  MINUTES 
173  12  12.3  3325 
NOT  ELUTED  IN  UNDER  30  MINUTES 
NOT  ELUTED  IN  UNDER  30  MINUTES 
NOT  ELUTED  IN  UNDER  30  MINUTES 
NOT  ELUTED  IN  UNDER  30  MINUTES 
NO  DATA  COLLECTED 
65  9  4.0  834 
100  13  6.7  946 
119  14  8.2  1156 
210  22  15.2  1457 
296  35  21.8  1144 
NOT  ELUTED  IN  UNDER  30  MINUTES 
NOT  ELUTED  IN  UNDER  30  MINUTES 
NOT  ELUTED  IN  UNDER  30  MINUTES 
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CHROMATOGRAMS  OF  SEVENTEEN  COMMONLY  OCCURING  BASIC  DRUCS 
ON  THE  CHROMATOGRAPHIC  SYSTEMS  DESCRIBED  IN  TABLE  3.19 .. 
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FIGURE  3.18.  contd. 
CHROMATOGRAMS  OF  SEVENTEEN  COMMONLY  OCCURINC  BASIC  DRUGS 
ON  THE  CHROMATOGRAPHIC  SYSTEMS  DESCRIBED  IN  TABLE  3.19 .. 
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Y' phenomenon  of  peak  cross-over,  its  position  relative  to  the  other 
compounds  changing  throughout  the  series of  solvents  examined. 
The  separation  achieved  for  the  acidic  drugs  and  the 
benzodiazepines  was  not  as  good  has  been  achieved  elsewhere  (see 
Eppel,  1980  and  2.5.15.  respectively),  illustrating  the  effect 
that  changing  the  selectivity  of  the  stationary  phase  can  have  on 
the  chromatography of  a  group of  similar  compounds. 
Also  noted  was  the  lower  efficiencies  obtained  for  the  narcotic 
analgesics  compared  to  the  local  anaesthetics.  Of  these 
compounds  the  best  efficiency  achieved  was  for  papaverine  whicb 
implicates  the  involvement  of  the  free  hydroxyl  groups  in  codeine, 
morphine  and  nalorphine  in  the  phenomenon  of  peak  tailing,  as  in 
papaverine,  the  hydroxyl  groups  are  in  the  form  of  methyl 
ethers.  The  fundamental  differences  between  the  chromatographic 
behaviour  of morphine  and  the  local  anaesthetics  was  noted  earlier 
(2.3.4.) 
Overall  the  conclusion  drawn  from  this  experiment  was  that  the 
less  lipophilic  C-S  phase  is  less  selective  than  the  C-1S  phase  as 
it  allows  a  wider  range  of  compounds  to  be  chromatographed  wi tb 
the  same  solvent  system.  This  should  be  compared  with  the 
examination  of  potential  interferants  in  the  study  of  morphine 
where  very  few  compound  would  chromatograph  on  the  same  system 
(2.5.15.). 
This  has  both  advantages  and  disadvantage  •.  It suggests  that  a 
C-S  stationary  phase  might  provide  a  suitable  chromatograpbic 
system  for  screening  samples  for  the  presence  of  a  wide  range  of 
drugs.  It  also  suggests  that  more  compounds  might  elute  in  the 
lame  area  of  the  chromatogram  and  greater  care  sbould  be  taken  to 
-321-ensure  the  identity  of  the  peaks.  This  is  analogous  to  the  use 
of  an  OV-17  type  column  for  screening  samples  by  gas 
chromatography  (Ardrey  and  Moffat,  1981).  A number  of  different 
compounds  might  have  the  same  retention  index,  and  an  independent 
analytical  technique  may  be  required  for  confirmatory  analysis. 
For  a  routine  confirmatory  method,  shorter  chromatographic  run 
times  are  preferred. 
3.3.11.4.  Conclusion 
It has  been  shown  that  the  lower  selectivity obtained  froa 
a  C-8  column  allows  a  large  number  of  compounds  to  be  identified 
on  one  system  over  a  longer  period  of  time.  A comparison with  GC 
retention  indices  reported  suggests  that  the  use  of  a  C-8  column 
might  provide  a  complimentary  screening  procedure  for  unknown 
drugs.  This  might  be  investigated further. 
The  possibility  of  interference  makes  this  method  less  selective 
than  (say)  the  system  developed  for  morphine  (2.5.5.)  but  the 
increase  in  the  number  of  compounds  which  can  be  analysed  on  one 
system must  be  considered against  this. 
-322-3.3.  12 •  CONCLUSIONS  ON  DEVELOPMENT  OF  CHROMATOGRAPHY  FOR  LOCAL 
ANAESTHETICS 
The  above  study  has  shown  the  evolution  of  suitable 
chromatographic  systems  for  the  measurement  of  the  compounds  of 
interest  (bupivacaine,  procaine,  cocaine  a~d benzoyl  ecgonine)  and 
others.  In  the  course  of  this  development  it  proved  neccessary 
to  change  to  use  a  stationary  phase  of  different  selectivity. 
The  resulting  improvement  in  the  quality  of  the  peak  shape  and  the 
chromatography made  this  the method  of choice. 
These  systems  were  then  ready  to  be  applied  to  the  analysis of  the 
compounds  of  interest  in  suitable extracts  from  biological fluids. 
-323-3.4.  EXAMINATION  OF  DRUG  SCREENING  PROCEDURES  FOR  LOCAL 
ANAESTHETICS  IN  GREYHOUND  URINE 
3.4.1.  Introduction 
General  screening  procedures  have  been  reviewed  above 
(3.1.7.2.).  The  applicability  of  the  method  which  is  in  general 
use  (Bogan  and  Smith,  1968)  has  not  been  ex~ined specifically for 
its  ability  to  detect  local  anaesthetics.  It  is  generally 
accepted  that  an  important  part  of  an  effective  doping  control 
programme  must  include  checking  and  updating  of  the  methods  used 
(Smith,  1972). 
It was  therefore  decided  to  examine  this  method  and  an  alternative 
procedure  also  reviewed  earlier,  to  assess  the  suitability of  both 
for  this application. 
3.4.2.  SUITABILITY  OF  THE  TLC  SYSTEM  FOR  THE  CHROMATOGRAPHY  OF 
LOCAL  ANAESTHEtICS. 
3.4.2.1.  Introduction 
The  Rf  values  of  several  local  anaesthetics  on  the  TLC 
system  recommended  by  Bogan  and  Smi th  (1968),  (Rentoul  and  SlIli th. 
1971)  were  examined  and  compared  with  data  tabulated  therein. 
The  suitability  of  the  locating  procedures  recoaaended  was  a110 
examined. 3.4.2.2.  Method 
Using  stock  solutions  (made  up  in  ethanol)  of  IglL  and 
O.lg/L  of  the  drugs  indicated  in  table  3.20.,  lug  and  10ug  spots 
were  applied,  lcm  from  the  bottom  of  a  10cm  silica  TLC  plate. 
The  plates  were  then  developed  in  a  chloroform:methanol  (3:1) 
solvent  system  in  a  paper  lined  tank  for  a  distance  of  6-8clD. 
The  plates  were  removed  and  air dried  for  2-5  minutes  before  being 
subjected to the  following  locating tests. 
1.  Examination  under  UV  light  to  show  the  position  of 
fluorescing  material.  Non-flourescing  material  was  also 
visible  on  these  TLC  plates  as  they  contained  a 
fluorescent  indicator which  was  quenched where  this 
material was  present 
2.  The  plates  were  sprayed  with  concentrated  HCI,  under  which 
phenothiazine  type  drugs  show  up  as  pink  spots  (Oliver, 
1971). 
3.  They  were  finally  oversprayed  with  acidified  potalsium 
iodoplatinate  solution  (PIP)  (prepared  as  in  appendix  D) 
to  show  the  position  of  any  basic  nitrogen-containing  or 
alkaloidal material. 
-325-3.4.2.3.  Results 
The  response  of  the  drugs  to  these  detect  ion  systems  is 
shown  in  table  3.20..  The  Rf  values  obtained  were  compared  with 
those  reported  elsewhere  for  this  system  (Rentoul  and  Smith, 
1973).  Most  were  found  to  compare  well. 
It was  noted  that  when  the  plates  were  sprayed  with  iodoplatinate 
following  spraying  with  HCl,  the  response  was  notably  poorer  than 
if only acidified  iodoplatinate  spray had  been  used. 
No  reaction was  noted  for  some  of  the  lug or 10ug  spots. 
Thi s  was  contrary  to  the  react  ion  reported  in  Rentoul  and  Smi th, 
(1973)  and  elsewhere  (Oliver,  1971).  It was  also  noted  that  the 
intensity  of  the  spots  would  develop  slowly  over  a  period  of  2-8 
hours. 
If  ·the  ac id  pre-spraying  step  was  ommi tted,  10ug  and  lug  spots 
could all be  clearly seen  immediately after spraying. 
It was  found  that  this  developing  process  could  be  accelerated  by 
warming  the  TLC  plates  over  a  hot  plate for  a  few  minutes. 
It  was  therefore  concluded  that  the  acid  was  responsible  for 
inhibiting  the  developement  of  these  spots,  and  that  heating  or 
leaving  the  plates  for  a  period  of  time  would  allow  the 
evaporation of  HCl  as  vapour. 
After  the  full  intensity  of  the  spots  had  developed  it was  noted 
that  response  of  bupivacaine  was  poorest,  giving  a  faint  brown 
spot,  compared  to  the  darker  blue/purple  spots  for  other compound •. 
All drugs  were  visible at levels  of  lug on  the  TLC  plate. 
Subsequent  overspraying  wi th  concentrated  HCL  caused  the  spot  to 
fade.  On  warming,  the  spots  would  re-appear.  Using  procaine  a. 
an  elample,  as  much  as  40ug  on  the  plate  remained  undetected  if it 
VI.  presprlyed with  acid. 
-326-TABLE  3.20. 
TLC  OF  VARIOUS  LOCAL  ANAESTHETICS 
compound  Rf  Rf lle  UV  KPtI04  HCl  later 
amethocaine  0.52  0.72  +  ++  +-
benzocaine  0.79  0.66  + 
bupivacaine  0.73  $  +  +  +  + 
butacaine  0.60  0.55  +  ++  +-- +-
cinchocaine  0.45  0.53  +  +  +  + 
cocaine  0.54  0.68  +  ++  ++  ++ 
lignocaine  0.84  0.7  +- +  + 
metycaine  0.48  $  +  +  +  + 
prilocaine  0.67  $  +  +-
procainamide  0.1  0.22  +  +  +--
procaine  0.39  0.40  +  ++  +-
lie  data for  same  solvent  system,  Oliver,  1971 
key:-
++  strong positive 
+ 
+- positive 
+--
negative 
$  No  data given 
-327-3.4.2.4.  Discussion 
The  minor  differences  observed  in  the  Rf  values  between 
this  and  other  studies  can  be  attributed  to  differences  in  the 
silica  used  on  the  plates,  and  minor  changes  in  the  solvent 
composition. 
Acidified  potassium  iodoplatinate  spray  is  used  to  detect 
alkaloids,  amines  and  organic  nitrogen  compounds  including 
quaternary  ammonium  compounds.  The  various  colours  reactions 
produced  have  been  discussed  by  Stead  et  ale  (1982).  It is  known 
that  factors  such  as  the  amount  of  drug,  pH  and  amount  of  locating 
reagent  sprayed  onto  the  plate may  affect  the  hue  and  intensity of 
the  spot. 
The  exact  mechanism  of  the  reaction  is  not  known,  but  it is likely 
that  it  involves  complex  formation  involving  iodide,  the  platinum 
ion  and  the electrons  on  the  basic nitrogen. 
Several  possible  causes  of  the  acid  masking  of  certain  compounds 
were  considered.  Several  properties  of  the  compounds  are  siven 
in  table  3.21  (the  properties  of  caffeine  are  siven  for 
comparison). 
A comparison  of the  pKa  values  showed  no  consistent relationship 
An  examination  of  the  structures  showed  that  there  was  no 
relationship  between  the  degree  of  substitution  on  the  basic 
nitrosen  and  acid  masking.  It  had  been  thought  that  the  ule  of 
concentrated  acid  on  an  ester  might  cause  hydrolysis  of  lhe 
peptide  bond,  however,  no  consistent  relationship  val  found 
between  acid  masking  and  the  type  of  linkase  (i.e.  e.ter  or 
amide).  In  addition  this  would  be  irreversible  and  the  colour 
reaction would  not  be  expected  to  return. 
-328-TABLE  3.21. 
COMPARISON  OF  PROPERTIES  OF  LOCAL  ANAESTHETIC  DRUGS 
IN  RELATION  TO  ACID  MASKING  WITH  TLC  SPRAYS. 
compound  masking  pKa 
amine 
substitution  linkage 
amine 
coordination 
benzocaine  2.8  no  amine  ester  no  amine 
amethocaine  Y  8.S  3ry  ester  chain 
butacaine  Y  9.0  3ry  ester  chain 
lignocaine  Y  7.9  3ry  amide  chain 
prilocaine  Y  7.9  2ry  amide  chain 
procainamide  y  9.2  3ry  ester  chain 
procaine  Y  9.0  3ry  ester  chain 
bupivacaine  N  8.1  3ry  amide  piperidine 
cinchocaine  N  7.S  3ry  amide  pyridine 
cocaine  N  8.6  3ry  ester  piperidine 
metycaine  N  3ry  ester  piperidine 
caffeine  N  14  4  x  3ry  pyrimidine 
-329-the  only  consistent  factor  in  those  drugs  examined  which  did  not 
.how  acid masking  was  the  incorporation of  the  basic  nitrogen  in  a 
ring  system  (e.g.  cocaine,  bupivacacine,  caffeine).  This  aight 
iaplicate  some  steric  effect  in  the  reaction  causing  the  colour 
chance.  This  point was  not developed  any  further. 
3.4.2.5.  Conclusions 
tbe  tLC  system  investigated  has  been  shown  to  produce 
acceptable  Rf  values  for  the  compounds  investigated. 
The  practice  of  acid  pre-spraying  TLC  plates  prior  to  the  use  of 
acidified  iodoplatinate  can  however,  maslc  even  large  amounts  of 
sOlDe  compounds.  On  the  other  hand,  acid  spraying  enhances  the 
intenlity  of  the  spot  with  some  ring  nitrogen  compounds,  e.g. 
bupivacaine  and  caffeine,  and  allows  the  identification  of 
phenothiazines.  the  compromise  settled  upon  was  to  continue 
pre-Ipraying  the  plates  with  acid,  mark  the  position  of  any  spots 
indicating  phenothiazines,  and  then  spray with  acidified  potassiwa 
iodoplatinate.  Any  spots  which  immediately  developed  were  noted 
and  the  plates  were  gently warmed  over  a  hotplate  for  two  to three 
minutes  to  allow the  development  of  any  spots  which  were  inhibited 
by  acid prespraying. 
On  the  basis  of  this  study  the  TLC  syst..  described  above 
incorporating  these  chances  was  retained  for  the  examination  of 
extracts  obtained  from  screening  procedures  for  these  drug.  in 
urine. 
-330-3.4.3.  EXTRACTION  PROCEDURES  (I)  - Bogan  and  saith,  (1968) 
3.4.3.1.  Introduction 
. 
The  extraction  procedure  in  routine  use  for  urinary  drus 
screening  in  the  racing  greyhound  is  based  closely  on  that 
described  by  Bogan  and  Smith,  (1968).  This  was  used  to  extract 
several  urine  samples  which  had  been  spiked  with  known 
concentrations  of  bupivacaine,  procaine  and  cocaine  and  its 
metabolite  benzoyl  ecgonine. 
3.4.3.2.  Method 
A  bulk  urine  sample  (lL)  was  collected  from  a  drus-free 
sreyhound  and  the  pH  measured.  This  was  then  divided  into 
aliquots  of  SOmI  and  spiked  wi th  known  concentrations  (lO-3g/L) 
of  the  drugs  of  interest.  Each  of  these  spiked  samples  were 
extracted as  below.  A drug-free  sample  was  also extracted. 
The  routine extraction procedure  in its current form  is  as  follows: 
Urine  (2Oml)  and  20~ ammonia  solution  (lOml)  were  added  to  a  100m! 
separating  funnel.  Ethyl  acetate  (SOml)  was  added  and  the  flask 
was  shaken  thoroughly.  The  aqueous  layer  was  removed  and  kept 
for  subsequent  analysis  for  acidic  drugs. 
was  added  to  the  ethyl  acetate  and  shaken  thoroughly.  The  pH  of 
the  aqueous  layer  was  checked  wi th  pH  paper,  to  ensure  it  was 
acidic  (below·  4).  The  acid  layer  was  transfered  to  a  second 
'.parating  funnel  and  ethyl  acetate  (SOml)  added .  This  va. 
• haken  thoroughly  and  made  alkaline  by  the  addition  of  2~ ~nia 
.olution  (about  20m!).  The  pH  of  the  aqueous  layer  was  checked 
-331-to  ensure  that  it  was  alkaline  (above  pHS).  This  layer  was 
discarded  and  the  ethyl  acetate  was  filtered  throu&h  anhydrous 
sodium  sulphate  to  remove  any  residual  water,  collected  in  an 
evaporatin&  basin  and  evaporated  to  dryness  on  a  steam  bath.  A 
few  drops  of  254£  HCl  were  added  to  the  final  or&anic  extract  to 
prevent  the  evaporation  of  volatile  bases  (if  present)  by  the 
for.mation  of the  HCl  salt. 
The  residue  was  reconstituted  in  ethyl  acetate  (5ml).  Half 
(2.5ml)  was  removed  and  kept  for  confirmatory  anlysis  by  CC  or 
GCMS. 
The  remainder  of  the  extract  was  evaporated  to  a  small  volume  and 
spotted  onto  a  TLC  plate.  The  appropriate  dru&  was  spotted 
alon&side  as  a  standard.  The  plate  was  developed  in  the  solvent 
system  described  above  (3.2.2.1.)  and  examined  under  UV  licht, 
sprayed  first  with  concentrated  HCl  and  then  with  potas.ium 
iodoplatinate.  The  plates  were  warmed  &ently  over  a  hotplate  and 
the  Rf  values  were  noted  as  the  spots  appeared. 
3.4.3.3.  Results  and  discussion 
The  results  of  the  TLC  analysis  of  each  of  the  extract. 
are  shown  in  table  3.22 ..  The  TLC  plates  showed  the  presence  of 
• pots  correspondin&  to  the  dru&s  added,  at  a  concentration  of 
10-3,/1.  The  response  of  bupi  vacaine  and  benzoyl  ec&onine  wa. 
poor,  sussestin&  that  they  mi&ht  have  a  lower  recovery  frOil  the 
• ample.  The  recovery was  not measured . 
The  extracts  were  relatively  clean.  Other  stainins  wal  noted  at 
tbe  foot  of  the  plates  (If It.  0.2),  but  no  distinct dark .pot  •. 
The  ana1Jsis  time  for  this  extraction  procedure  (includin,  the 
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TABLE  3.22. 
RESULTS  OF  URINARY  DRUG  SCREEN  PERFORMED  BY 
THE  METHOD  DESCRIBED  BY  BOGAN  AND  SMITH,  1968 
compound  TLC  screen  GC  (EtOAc)  GC(MeOH) 
procaine  ++  +  ++ 
cocaine  ++  +  - ++ 
bupivacaine  +- +  ++ 
benzoyl  ecgonine  +-acidic  extraction)  was  about  one  hour  and  four  samples  could  be 
extracted,  conveniently,  at the  same  time. 
Confirmatory  analysis  was  carried  out  by  gas  chrOlll8.tographf  as 
described  below.  (3.4.5.) 
3.4.3.4.  Conclusions 
The  ,creening  procedure  currently  in  use  for  the  detection 
of  drugs  in  the  urine  of  racing  greyhounds  has  been  shown  to  be 
capable  of  detecting  those  local  anaesthetics  examined,  at 
concentrations of 1ug/ml  in  a  urine  sample. 
3.4.4.  EXTRACTION  PROCEDURES  (II)  - Hill et al .•  (1982) 
3.4.4.1.  Introduction 
An  alternative  urinary  screening  method  developed 
specifically  for  the  identification  of  acidic,  basic  and  n.utral 
drugs  in  greyhound  urine  was  examined  in  order  to  a.....  it. 
efficiency  and  to  compare  it  with  the  method  currently  in  u.e, 
.xamined  above.  This  procedure  i.  based  on  a  single  .tep 
extraction  procedure  using  ion-pair  formation.  It i. perfot"'Md 
at  pH7  where  it  is  assumed  that  basic  compound.  will  be 
sufficiently  protonated  to  form  ion-pairs,  and  that  weaklf  acidic 
and  neutral  drugs  will  be  unionised.  Both  neutral  specie ••  hould 
tben partition into the organic  solvent. 3.4.4.2.  Method 
In  addition  to  the  spiked  samples _prepared ·previously,  two 
barbiturate  drugs,  phenobarbitone  and  pentobarbitone, 
extracted from  spiked urine  samples  as  follows. 
were 
Urine  (9ml),  1.25mM  dioctyl  sulphosuccinate  (!sa)  and 
chloroform/isopropanol  3:1  (Sml)  were  added  to  a  15ml  screwcap 
test  tube.  This  was  capped  and  mixed  on  a  rocking/rolling  mixer 
for  10 minutes. 
Tbe  tube  was  centrifuged at 3000rpm  for  approximately  five .inute. 
or  until  the  layers  were  separated.  Tbe  upper  aqueous  layer  was 
aspirated  and  discarded.  The  organic  solvent  was  passed  through 
a  ,lass  pasteur  pipette  containing  some  ,lass  wool,  to  remove 
particulate  matter.  This  was  collected  in  a  ,las.  centrifuge 
tube  and  evaporated  to  dryness  under  a  stream  of  oxygen-free 
nitrogen. 
Tbe  residue  was  reconstituted  in  30ul  of  ethyl  acetate.  AI  thi. 
extract  would  normally  contain  acidic,  neutral  and  ba.ic  drug., 
10ul  were  spotted  onto  two  10cm  TLC  plate. ,  u.  ing  a 
micropipette.  One  plate  was  developed  in  tbe  .olvent  sy.tea 
examined  above  for  basic  drugs  (3.4.2.),  and  the  otber  in  a 
chloroform/acetone,  9/1  solvent  system  (Rentoul  and  Smith,  1971. 
Oliver,  1971)  sui  table  for  a  range  of  acidic  drug..  Tbe  plate. 
were  sprayed  with  saturated  mercurous  nitrate  solution  which  will 
indicate  the  presence  of  barbiturates  and  phenylbutazone 
metabolite.  (Oliver,  1971). 
The  remaining 10ul was  retained for  confirmatory  GC  ana1y.i •. 
-335-3.4.4.3 Results  and  Discussion 
A summary  of the results  is  shown  in table 3.23 .. 
All  the  local  anaesthetics  examined  were  detected  on  the  TLC 
plates  at concentrations  of  lug/ml.  The  poorest  response  was  for 
bupivacaine  and  benzoyl  ecgonine  which  were  just visible.  their 
visualisation  was  made  easier  by  the  presence  of  a  drug  standard 
run  alongside  the extract on  the  same  plate. 
The  extracts  did  contain  interfering  material  and  produced  long 
yellow  or  whi te  "candle  flame"  streaks  on  the  TLC  plates.  Tbe 
blank  however  did  not  eontain distinet dark  spots  which .ight bave 
been  eonfused  for drugs. 
The  proeedure  was  very  rapid  and  as  many  as  20  samples  were 
extraeted  and  the  TLC  analysis  completed  in  one  hour.  It  sbould 
also  be  not.ed  from  t.he  data  in  t.able  3.23.  tbat  this  single  .tep 
ext.raetion  procedure  was  effeet.ive  in  extraeting  two 
barbit.urates.  Both  gave  posit.ive  results  at  lug/ml.  No  further 
analysis  of  acidie  or  neutral  drugs  was  considered  as  part of thi  • 
• tudy. 
The  extraets  were  readily  reeonst.it.uted  in  ethyl  aeetate  or 
methanol. 
3.4.4.4.  Cone1usions 
This  alternative  extraction  proeedure  has  been  shown  to  be 
effeetive  in  extraeting  t.he  local  anaesthetic  drugs  of  intere.t 
fro.  a  .piked  urine  sample.  It  apppears  to  be  as  effecti  ve  a. 
the  other  proeedure  examined  in  spite  of  the  faet  that  a  ...  ller 
urine  sample  was  u.ed. 
In  addition  thi.  proeedure  bas  been  sbown  to  be  effective  in 
-336-TABLE  3.23. 
RESULTS  OF  URINARY  DRUG  SCREEN  PERFORMED  BY 
THE  METHOD  DESCRIBED  BY  HILL  ET  AL.c  1982. 
compound  TLC 
procaine 
cocaine 
bupivacaine 
benzoyl  ecgonine 
phenobarbitone 
pentobaritone 
screen 
++ 
++ 
+-
*  ++ 
*  ++ 
GC  (EtOAc) 
+ 
+ 
+ 
+ 
+ 
*  developed  in chloroform/acetone.  9/1 solvent 
system  and  sprayed with saturated aqueous 
mercurous  nitrate.  (Rentoul  and  Smith.  1971: 
Oliver,  1971) 
-337-estracting  two  barbiturates  in  the  same  fraction  as  the  basic 
drugs.  Whilst  this  makes  the  estraction  less  specific,  it ..  t.s 
it easier  to  perfo~.  A full  comparison  of  both  methods  follows 
in section 3.4.6 .. 
3.4.5.  THE  USE  OF  GAS  CHROMATOGRAPHY  AS  A CONFIRMATORY  TECHNIQUE 
3.4.5.1.  Introduction 
The  use  of  gas  chromatography  for  the measurement  of  local 
anaesthetics  was  reviewed  earlier  (3.1.2.5.).  It  is  however  the 
method  currently  used  for  the  confirmatory  analysis  of  dru,.  in 
urine  extracts,  although  its  suitability  has  not  been  examined 
specifically for  this application. 
For  this  reason  the  extracts  obtained  by  both  extraction 
procedures  described  above  were  examined  by  this technique. 
3.4.5.2.  Method 
Gas  chromatography  was  performed  on  a  capillary  ,a. 
chromatograph  (Packard  Instruments,  model  427).  The  cola.D 
eluent  was  split  and  the  instrument  was  equipped  with  a  fl  ... 
ioni.ation  detector  and  a  nitrogen/phosphorus  detector  (.od.l 
612).  The  injection  system  used  was  a  Grob  type  splltle  •• 
lnj.ctor.  The  column  was  a  CP-Sil  5  fu.ed  .lllca  capillary 
column  (SGI).  The  extracts  were  analy.ed  on  a  teaperature 
at  1100C  after  which  the  purse  pro&r ....  d  run.  Two  minutes 
o  0 
then  a  teaperature  ris.  froa  110  to  300  C  valv.  was  opened, 
There  was  a  final  plateau  of  flve  .inut  ••  at 
-338-Tbe  injector and  detector temperatures  used  were  both  2500C. 
Standard  solutions  of  the  drug  were  analysed  to  dete~ine  the 
retention  index.  The  remainder  of  the  residue  was  evaporated  to 
dryness  and  reconstituted  in  ethyl  acetate  (SOul).  lul  wa. 
injected into the  injection port of the  gas  chromatograph. 
The  results  obtained  from  both  extracts  a~e  considered  seperatel, 
below.  The  run  time  inluding  thermal  re-equilibration  of  the 
system took about  forty minutes. 
3.4.5.3.  Results  and  discussion 
Bogan  and  Smith.  1968 
The  presence  of  procaine,  bupiYacaine  and  cocaine 
were  all  confirmed  in  the  releyant  extracts  (table  3.22.)  bJ  the 
use  of  retention  indices  and  subsequent  camparilon  with 
unextracted drug  standards. 
Benzoyl  ecgonine  was  not  detected,  but  it  is  known  not  to 
chromatograph  under  these  conditions  without  deriYati.ation 
(Lindgren,  1981). 
It  wal  noted  that  the  peaks  obtained  for  the  drugs  vere  quite 
.mall  on  both  NPD  and  FlO.  It  also  appeared  that  the  dried 
extract  did  not  reconstitute  very  well  in  the  SOul  of  ethJl 
acetate uled  as  the  GC  injection solvent. 
A  more  suitable  solvent  was  therefore  sousht.  Hethano1  va. 
conlidered  al  an  alternatiYe.  The  extract  appeared  to  di ••  olye 
IDOre  readily  and  the  peak  heishts  illproved  significantl,  (bJ  a 
factor of 3  or 4). 
It  wal  thousht  that  this  phen~non  Ilisbt  be  cau.ed  bJ  the 
-339-practice  of  converting  any  free  base  in  the  extract  to  the 
hydrochloride  salt  in  the  last  step  of  the  extraction.  Hel  salts 
have  a  poor  solubility  in  ethyl  acetate  (Albert,  1976).  Methanol 
is  a  more  readily  ionised  solvent  and  therefore  a  better  solvent 
for  these  ionisable  species.  Methanol  can  contain  a  relatively 
large  proportion  of  water  however  which  ~s  not  &ood  for  the  GC 
column,  and  may  lead  to  a  decrease  in  column  lifetime  and 
performance.  This  problem  could  be  avoided  by  reconstitutin&  the 
extract  in  alkali  and  back-extracting  the  free  base  into  ethyl 
acetate  or  some  other  organic  solvent.  This  however  will  add  an 
additional  step to  the  s~ple preparation  procedure  for  Ge. 
Hydrochlorides  can  be  readliy  dissolved  in  water  or  dilute  acid, 
and  in  aqueous  form  can  conveniently  be  analysed  by  reversed  phase 
liquid chromatography. 
Aqueous  samples  cannot  be  analysed directly by  GC. 
Hill et al.,  1982 
The  gas  chromatograms  obtained  from  these  extracts 
contained  a  number  of  addi tional  peaks  on  both  the  FlO  and  NPO 
traces.  The  presence  of  the  drugs  of  interest  were  confirmed  in 
the  relevant  extracts  (table  3.23.).  This  applied  also  to 
pentobarbitone  and  phenobarbitone. 
The  residue  appeared  to  reconstitute  readily  in  ethyl  acetate: 
There  was  no  apparent  improvement  in  peak  hei&ht  if  methanol  was 
used  to reconstitute. 
.  ff"  cy  of  thi.  No  attempt  was  made  to  measure  the  extract  10n  e  lC len 
procedure. 
-340-3.4.5.4.  Conclusions 
Confirmation  of  positive  results  is  possible  with  Ge,  but 
care  must  be  taken  that  the  sample  is  not  lost throush  the  use  of 
an  inappropriate  solvent  for  reconstitution,  if  the  druS  is 
extracted  as  the  hydrochloride  salt.  This  factor  IDay  lover  the 
detection limit of the assay as  a  whole,  both  by  TLC  and  Ge. 
A  detailed  study  of  solubility  of  these  salts  in  different 
solvents  would  be  useful. 
In this  case  it was  not  possible to directly analyse  for  the __ jor 
metabolite  of  cocaine,  benzoyl  ecgonine  by  GC  under  the  conditions 
described,  derivatisation being required. 
This  illustrates  an  additional  advantase  that  a  seneral  HPLC 
method  for  these  local  anaesthetics  would  have  over  GC,  al  no 
derivatisation  is required. 
3.4.6.  COMPARISON  OF  EXTRACTION  PROCEDURES 
3.4.6.1.  Discussion 
Both  extraction  procedures  have  been  shown  to  extract  a 
range  of  local  anaesthetics  from  urine  saaples.  The  extraction 
efficiencies  were  not  calculated.  A possible  area  of ...  ple  lOll 
in  the  method  described  by  Bosan  and  Smith.  (1968)  il  the  poor 
101ubilty  of  bydrochloride  .alta  in  ethyl  acetate,  d..aoltrated 
above.  The  fo~ation  of  lipophilic  ion-pairl  involvinl 
dioctylsulpbosuccinate avoida  this complication. 
The  ti  thod  vas  verv  much  quicker  and  ion-pair  extrac  on  me  ~ 
-341-convenient,  being  a  sin·le  step  ewtr  t'  o  ..  ac  lone  It  was  IlOre 
economical  also,  requiring  only  Sml  of  solVent,  compared  to  200al 
in the other method. 
The  sensitivity of  the  ion-pair  method  is  probably  lower,  as  only 
1/6  of  all  the  basic  material  in  the  extract  is  applied  to  the 
basic  TLC  plate.  One  half of  the  basic  e~tract is  applied  in  the 
method  described  by  Bogan  and  Smith.  Hills  method  uses  9ml.  of 
urine,  however  this  could  be  scaled  up  to  20m}  relatively 
easily.  No  quantitative measure  of  the  extraction efficiencJ val 
made  for either process. 
The  extracts  from  the  ion-pair  method  were  less  clean  and 
contained  more  interfering  material.  Spots  resulting  fro. drugl 
were  more  clearly visible if 20cm  TLC  plates were  used. 
3.4.6.2.  Conclusions 
The  method  described  by  Bogan  and  Smith  was  preferred  on 
grounds  of  quality  of  the  extract  for  TLC.  It  va.  al.o 
conlidered  to  be  more  suitable  for  racetrack  testing,  al  the 
interpretation  of  the  TLC  plates  was  more  straightforward.  Tbi. 
il a  major  factor  in  testing  procedures,  as  the  personnel  aaploJed 
at  the  racetrack  are  not  always  technicall,  qualified.  Both 
procedures  could  detect  all  three  local  anaesthetici  and  benzoyl 
ecgonine when  present  in urine at concentrations of  1u&/~. 
ror  convenience  and  rapid  extraction of  acidic  or  basic  compound., 
a  .caled-up version  of Hills  method  was  preferred  for  confi~atory 
anal,lis.  Thil  liDgle  Itep  procedure  wal  rapid  and  hal  been 
Ihown  to  extract  basic  and  acidic  drug.  at  level.  of  lug/at  in  a 
9al.  urine  I ..  ple.  It  also  avoidl  subjecting  the  analfte.  to 
-342-extremes  of  pH.  The  rate of hydrolysis  of  cocaine  has  been  shown 
to  be  silnificant at hilh  pH  even  over  periods  of  seyeral .inute. 
(Fletcher  and  Hancock,  1981;  Baselt,  1983). 
The  GC  method  described  above  was  capable  of  detectinl  all  the 
compounds  of  interest except  benzoyl  eClonine  and  the  existence  of 
possible  problems  invo1vinl  the  reconsti  tution  of  the  suple  va. 
demonstrated. 
For  the  reasons  outlined  earlier  (3.1.5.7),  the  suitability of  an 
HPLC  method  was  to  be  cons idered  .  A  su i table  HPLC  method  could 
also  be  used  to  confi~ the  identity of  a  drul  sUIsested  by  its CC 
retention  index. 
Both  urine  extracts  were  examined  for  their compatibility with  the 
HPLC  methods  developed  earlier,  before  consideration  was  made  of 
extraction procedures  for other samples. 
3.4.7.  SUITABILITY  OF  URINARY  DRUG  SCREEN  EXTRACTS  rOR 
CONFIRMATORY  HPLC  ANALYSIS 
3.4.7.1.  Introduction 
In  previous  sections  (3.3.)  HPLC  methods  vere  deyeloped 
for  the  analysis  of  bupivacaine,  mepiYacaine,  lisnocaine,  cocaine, 
benzoyl  eClonine,  cinchocaine  and  procaine. 
Extracts  obtained  by  the  extraction  procedures  examined  aboye 
(BOlan  and  Smith,  1968;  Hill  et  al.,  1982)  were  analy.ed  to 
determine if the extracts  could  be  applied directly to HPLC. 
-343-3.4.7.2.  Itethod 
A  urine  sample  was  obtained  and  spiked  with  a  known 
concentration  (lug/ml)  of  bupivacaine.  Thi s  was  extracted  by 
both  the  procedures  described  above.  The  residues  were 
reconstituted  in  the  respective  mobile  phases  (200ul)  prior  to 
injection  into  the  HPLC  system.  The  HPLC  conditions  were  as 
de.cribed  in System One,  section 3.3.9.3 .. 
3.4.7.3.  Results  and  discussion 
Both  extracts  gave  very  dirty  chromatograms.  There  were 
peaks  present  in  the  region  where  the  drugs  were  expected,  but 
there  were  also  other  smaller  peaks  and  shoulders  on  the  peak.  of 
interest. 
The  extracts  from  Hi Ils  method,  was  cons iderably  more  dirty  and 
peaks  continued  to  elute  for  up  to  40  minutes  after  injection. 
The  urine  extracts  are  known  from  TLC  screening  to  contain  the 
drugs  of  interest.  The  HPLC  method  directly  applied  to  these 
extracts  was  able  to  confirm  a  peak  in  the  region  of intere.t,  but 
other  extraneous  material  interfered  wi th  this  and  it  took  some 
time  for  all  the  extract  to  elute  from  the  column.  To  eliminate 
this  interference  it was  concluded  that  further  clean-up  would  b. 
required.  Alternatively,  another  extraction  procedure  for  urine 
could  be  found. 
3.4.7.4.  Conclusions 
Although  the  extracts  produced  from  the  drug  .cr  ••  nln, 
proc.dures  have  been  shown  to  be  suitable  for  local  ana  ••  th.tic. 
br  ac,  neither  of  the  extracts  were  suitable  to  be  directly applied  to  HPLC  analysis.  It  was  concluded  that  further  sample 
clean  up  would  be  required,  if  HPLC  was  to  remain  the  method  of 
choice. 
3.S.  EXTRACTION  PROCEDURES  FOR  THE  ISOLATION  OF  LOCAL  ANAESTHETICS 
II PLASMA 
3.S.1.  LIQUID/LIQUID  EXTRACTION  OF  BUPIVACAINE  FROM  PLASMA 
3.S.1.1.  Introduction 
The  HPLC  system  (System  One,  3.3.9.3.>  selected  for 
bupivacaine  was  that  described  by  Lindber&  and  Pihlajamaki, 
(1984).  The  extract  from  the  urinary  screenin&  procedure  hal 
been  shown  to  be  unsuitable  for  direct  anal,sil  by  HPLC 
(3.4.7.).  An  alternative  extraction  procedure  applicable  to 
blood,  plasma  and  urine was  sousht. 
The  extraction  procedure  described  in  Lindber&  and  Pihlajamaki. 
(1984),  for  the  extraction of  bupivacaine  from  plasma  was  reviewed 
earlier  (3.1.7.2.).  It  had  a  reported  extraction  efficiency  of 
9~ and  the  extract  had  been  shown  to  be  suitable  for  anal,lil b, 
HPLC. 
which 
This  therefore  seemed  to  provide  appropriate  conditionl  OD 
to  base  a  general  method  for  local  anaesthetici  in 
biological fluids. 
Por  practical  reasons  several  modifications  were  made  to  the 
delcribed  procedure .  Dichloromethane  was  used  as  the  extractinl 
• olvent  a.  it  was  easier  to  evaporate  than  helane-containlnl 
.olyent.,  and  wa.  also  expected  to  have  a  good  lolubilit, for .o.t of  the  drugs  of  interest  as  it  has  a  low  polarity  (P'  =  3.1, 
Snyder,  1974)  which  is  compatible  with  the  extraction  of  the 
unionised  lipophilic  drugs.  Its selectivity is  also  litely to  be 
good  as  it has  a  low  solubility for  water  (0.17~ weight).  1JDl  of 
plasma,  instead  of  0.5ml,  was  used.  This  was  done  because  larger 
volumes  of  plasma  were  available,  and  also  to  enhance  the 
sensitivity of the  assay. 
Extraction  efficiency  was  calculated  by  comparison  of  peak  heigbts 
in  the  extracted  standard  with  an  unextracted  standard  of  the 
appropriate  strength.  To  show  the  improvement  in  precision 
achieved  by  the  use  of  an  internal  standard,  the  ratio of  internal 
standard to drug  is also given  in  terms  of extraction efficiencies. 
3.5.1.2.  Method 
A  plasma  sample  spiked  with  bupivacaine  was  prepared 
(10-3g/L).  Plasma  (1ml)  was  placed  in  a  15ml  screwcap  telt 
O.lM  NaOH  (1ml)  and  lug  of  cinchocaine  (0.1m!  of 
as  internal  standard  were  added.  The  extraction 
lolvent,  dichloromethane  (10m!)  was  added  and  the  mixture  vaa 
abaken  thoroughly  on  a  vortex  mixer  for  approximately  30  secondl, 
then  placed  on  a  rocking-rolling  mixer  for  10  minutes.  Thil  val 
then  centrifuged  to  separate  the  layers.  The  organic  layer  val 
removed  and  filtered  through  phase  separating  paper  (Wba~an PS-1) 
before  being  evaporated to dryness  at 50
0C under OFI. 
The  residue  was  reconstituted  in  100ul  of  IDObile  phale  and  20ul 
injected  into the  HPLC. 3.5.1.3.  Results  and  discussion 
This  extraction  procedure  was  easy  to  perform  and  provided 
a  clean  extract  sui  table  for  HPLC.  No  emuls ion  formed.  AD 
extraction  efficiency  of  76.8~  ±  8.8  (o-S)  was  achieved  for 
bupivacaine  and  53.4~  ±  6.6  for  cinchocaine.  The  ratio  of 
cinchocaine to bupivacaine was  0.69  ±  0.017  (~oV-2.4~). 
The  recovery  is  less  than  that  reported  by  Lindberg  and 
Pihlajamaki  (1984),  (91~>,  but  the  small  error  relative  to  the 
internal  standard,  is  comparable.  Extracts  from  blank  plasma 
samples  showed  no  interference  and  no  peaks  eluted  after 
cinchocaine. 
The  removal  of  the  upper  aqueous  phase  occasionally  left  a 
semi-solid  residue  requiring  the  use  of  the  phase  separating 
paper.  It  was  decided  to  investigate  the  possibility  of 
tt"ansfering  this  procedure  to  a  solid  phase  method  as  this  could 
remove  the  requirement  for  the  filtering  step,  and  eliminate  the 
pt"oblem  of  phase  separation which  might  be  a  source  of  sample  lOll 
(see  section 2.7.5.>. 
3.5.2.  THE  USE  OF  ABSORPTION/ELUTION  EXTRACTION  TECHNIQUES 
3.5.2.1.  Introduction 
The  advantages  of  solid  phase  extraction methods  have  been 
conlidered  earlier  for  local  anaesthetics  (3.1.7.3>  and  the 
adaptation  of  liquid/liquid  extraction  methods  to  lolid  pha •• 
• xtt"action  techniques  can  often  be  frui tful  in  teras  of  ea  ••  of 
.aapl.  handling,  prevention  of  emulsion  formation,  pha •• .eparation  problems  and  time  required  for  the  analysis.  A 
limited  degree  of  success  had  been  experienced  with  solid  phase 
extraction  techniques  for  morphine  from  plasma  (see  2.8.".).  It 
was  decided  to  investigate  whether  the  most  promising  of  the.e, 
namely  absorbent  extraction  on  diatomaceous  earth,  would  be 
suitable  for  the  extraction  of  local  anaesthetics  from  biological 
fluids. 
3.S.2.2.  Method 
Sml  glass  syringes  were  prepared  as  described  earlier 
(2.8.4.)  and  filled with  6  to  7ml  of extrelut material.  A  pla.ma 
sample  spiked  with  bupivacaine  (10-3g/L)  was  used.  Pla.ma 
(lml) , 
(O.lml 
O.lM  NaOH  (lml)  and  cinchocaine  internal  standard  ,lug 
of  10-2g/L  solution)  were  added  to  a  2ml  disposable 
syringe  and  mixed  thoroughly  by  inversion.  This  mixture  was 
applied  to  the  extrelut  column  and  allowed  to  absorb  for  3-S 
minutes.  The  drug  was  then  eluted with  dichloromethane.  leal  of 
the  eluent  was  collected  in  a  glass  sample  tube  (8ml)  and 
evaporated  to dryness.  The  residue  was  reconstituted  in  100ul  of 
the mobile  phase  and  20ul  were  injected into the  HPLC. 
HPLC  conditions  were  as  in  System  One,  section  3.3.9.3..  The 
mobile  phase  was  28'- acetonitrile  in  0.05K  KH2PO",  adjusted  to 
pH  3. 
3.5.2.3.  Results  and  discussion 
The  chromatograms  produced  from  these  plasma  extract. vere 
of  an  acceptable  quality.  An  example  i. shown  in  figure  3.19 .. 
the  procedure  was  easy  to  perform  and  no  proble..  vere Ci 
B 
20  18  16  14  12  10  8  6  4  2  0  . 
mlnS. 
FIGURE  3.19. 
c 
< 
~ 
0-
til  . 
CHROMATOGRAM  OF  EXTRELUTe- PLASMA  EXTRACT  CONTAINING 
BUPIVACAINE  AND  CINCHOCAINE TABLI  3.24. 
EXTRACTION  EFFICIENCY  OF  BUPtvACAINE  FRO!! 
PLASMA  USING  EXTRELUT  EXTRACTION  KEnlOD 
Bupivacaine  Eff. 
85 
70 
83 
100 
X  84.5 
SD  12.3 
CoV(~)  14.6 
Cinchocaine Iff. 
55 
42 
55 
60 
53.0 
7.7 
14.5 
-350-
Ceff/Beff 
0.65 
0.62 
0.66 
0.60 
0.63 
0.024 
4.3 encountered.  Sample  preparation  took  approximatelJ  10  to  15 
minutes,  an  improvement  over  the  20  to  25  required  for 
liquid/liquid  extraction,  most  of  the  time  beins  saved  bJ  the 
oaission of the centrifugation step. 
The  chromatographic  run  time  was  up  to  21  minutes  and  no  peaks 
eluted  after  the  internal  standard.  The  exbraction  was  perfor.ed 
four  times  and  the  results  are  given  in  table  3.24.  and  discussed 
below.  The  absolute  recovery  of  bupivacaine  was  found  to  be 
84.5'- :!:  12.3.  This  compares  well  with  the  previous  procedure 
(3.5.1.)  where  the  absolute  recovery was  76.8'- :!:  8.8  (n-5). 
The  CoY  is  14.6'-,  which  is  hiSh.  The  recoverJ  of  the  internal 
.tandard  (cincocaine)  was  53.Of.  :!:  7.7,  and  the  ratio  of  drus  to 
internal  standard  is  0.63  :!:  0.024  (CoV.4.3'-).  Thi.  illu.trate. 
the  improvement  in  precision  obtained  with  the  use  of  an  internal 
.tandard  in this  assay. 
3.5.2.4.  Conclusions 
This  simple,  one  step,  extraction  procedure  is  .ultable 
for  extracting  bupivacaine  from  plasma  quicklJ  and  efficientl" 
with  reproducible  recovery.  The  use  of  an  internal  standard  ba. 
been  shown  to  give  a  relative  error  of  4.3'-,  an  improvement  over 
the  absolute  error  of  12.31..  It  was  dec ided  to  investisate  the 
elution  volume  of  the  drug  from  the  extrelut  COlWDD  to  determine 
the suitability of the arbitrary volume  (4ml)  used  initiall,. 
-351-3.5.3.  EFFECT  OF  SOLVENT  VOLUME  ON  EXTRACTION  PROCEDURE 
3.5.3.1.  Introduction 
The  elution  volume  of  the  drug  and  internal  standard  vas 
investigated  by  collecting  the  eluent  in  small  fractions  and 
analysing  each  separately. 
3.5.3.2.  Method 
An  extrelut  column  vas  packed  and  the  sample  prepared  and 
applied  as  before.  An  aqueous  standard  of  bupi  vacaine.  luS/1lll 
vas  used.  Dichloromethane  was  applied  to  the  top  of  the  colWID 
and  collected  in  400ul  fractions.  These  were  evaporated  to 
dryness  and  the  residues  reconstituted  in  100ul  of  the  IDObile 
phase.  These  were  analysed  in  turn  on  the  HPLC  system  described 
above  and  the recoveries  in each fraction were  calculated. 
3.5.3.3.  Results  and  discussion 
The  recoveries  are  shown  in  table  3.25 ..  All  the 
detectable  drug  and  internal  standard  were  eluted  in  the  first 
four  fractions.  The  cumulative  recoveries  (66~  and  49~  for 
bupivacaine  and  cinchocaine  respectively)  were  lower  than  that 
calculated  in 
respectively), 
reconstitution 
the  previous 
indicating  that 
step.  It  has 
experiment  (84.5~  and  53" 
sample  loss  may  occur  in  the 
been  reported  that  the  elution 
pattern  from  extrelut  columns  can  vary  dependins  on  the  rate  of 
elution  (Christiansen,  1984).  The  percentage  of  the  coapound  not 
recovered  may  be  bound  to  pla ..  a  proteins  and  not  recoverable 
limpl, b, solvent extraction. 
-352-TABLE  3.25. 
EFFECT  OF  ELUTION  VOLUME  ON  THE  RECOVERY 
OF  DRUG  AND  INTERNAL  STANDARD 
fraction 
II 
1 
2 
3 
4 
5 
6 
Cumulative 
volume  (ml) 
0.4 
0.8 
1.2 
1.6 
2.2 
2.6 
Recovery  (7.) 
bupivacaine  cinchocaine 
-353-
34  24 
24  19 
8  5 
trace  1 
none  detected 
none  detected 
667. 3.5.3.4.  Conclusions 
Both  bupivacaine  and  cinchocaine  were  eluted  in  the  first 
1.6ml,  but  it was  decided  that  in  future  4ml  of  the  eluate  would 
be  collected  to  ensure  maximum  absolute  and  relative  recoverJ. 
This  volume  had  proved  convenient  to  collect  and  evaporate  to 
dryness. 
3.6.  EXTRACTION  PROCEDURES  FOR  BUPIVACAINE  IN  OTHER  BIOLOGICAL 
FLUIDS 
3.6.1.  Introduction 
Plasma  samples  are  easier  to  handle  and  to  extract  than 
whole  blood  as  they  are  less  prone  to  putrefaction  or  chanses  in 
consistency  than  is  whole  blood.  Problems  associated  with  these 
changes  have  been  reviewed  and  were  investisated  in  the  case  of 
morphine  (see  2.9.3.).  Plasma  is  generally  available  onlJ  frOll 
clinical  samples  where  there  is  ready  access  to  a  centrifus.· 
Other  sample  types  have  been  discussed  above,  but  normal  post 
mortem  samples  include  blood  and  occas ionally  urine.  For  drus 
testin&  in'  sport,  whether  human  or  animal,  urine  is  invariablJ 
supplied.  The  extrelut  extraction  procedure  developed  above  was 
examined  for  compatability witb  tbese otber sample  tJpes. 3.6.2.  WHOLE  BLOOD 
3.6.2.1.  Introduction 
Blood  samples  are  generally  in  various  states  of 
putrefaction  or  decomposi tion  when  presented  for  analysis.  Por 
the  purposes  of  this  study  only  fresh  blood  samples  were 
examined.  Based  on  previous  experience  (2.9.3.),  extractioD 
efficiencies  for  older  samples  might  be  expected  to  be  lower,  and 
the  extracts  may  contain  other  interfering  material.  As  the 
object  of  this  study  was  to  extend  the  applications  of  the 
extrelut  method  rather  than  assess  its  limits,  aged  blood  was  Dot 
investigated  initially.  Before  this  method  is  applied  to  post 
mortem  blood  however,  these effects  should  be  investigated. 
3.6.2.2.  Method 
Expired  transfusion  blood  was  spiked  with  a  known 
concentration  of  bupivacaine  (10-3  gIL  unless  otherwi •• 
Itated) . 
disposable 
Blood  (~l)  was  mixed  with  0.1"  NaOH  in  a  2al 
syringe.  Cinchocaine 
.olution)  was  added  as  an  internal  standard.  This  was  thoroulbly 
mixed  and  applied  to  the  top  of  an  extrelut  column  prepared  a. 
described  earlier  (2.8.4.2.).  This  was  allowed  to  equilibrate 
for  3-5  minutes.  and  then  the  eluted  with  dichloromethane.  4al 
were  collected.  The  solvent  was  evaporated  to  dryness  under 
oxygen  free  nitrogen  (OFN)  and  reconstituted  in  100ul  of  .,bile 
phase.  20ul  were  injected  into  the  HPLC.  HPLC  conditions  were 
.s de.crlbed  in 3.3.2.1 .. 
-355-3.6.2.3.  Results  and  Discussion 
The  chromatograms  produced  from  these  extracts  were  of  an 
acceptable  quality.  An  example  is  shown  in  fi&ure  3.20..  The 
use  of  blood  on  the  extrelut extraction  columns  increased  the ti  .. 
required  for  absorption  of  the  sample.  In  some  cases  the  sample 
would  not  absorb  and  the  extraction  had  to  be  repeated.  It vas 
found  that  the  sample  would  absorb  more  readily  if  the  extrelut 
column  was  loosely packed. 
The  use  of  blood  also  made  the  rate  of  elution  from  the  co1WID 
slower.  4m1  were  collected  in  approximately  25  minutes,  &etting 
slower  towards  the  end.  The  speed  of  elution  allo  depended  to  a 
large  extent  on  the  dens i ty  of  packing  of  the  columns.  Reports 
in  the  literature  suggest  that  elution  from  the  sample  can  be  made 
easier  and  the  efficiencies  improved  if the  blood  is  diluted prior 
to  application  to  the  column  (Breiter et al.,  1978;  Christianlen, 
1984) .  The  chromatographic  run  time  was  16  minutes  althoulh  lome 
peakl  eluted  after  the  internal  standard.  The  extraction  val 
performed  four  times  and  the  results  are  &iven  in  table  3.26.  and 
discussed  below.  The  absolute  recovery  of  bupivacaine  wa.  found 
to  be  63.8"  ±  7.3.  This  is  lower  than  from  plasma,  where  the 
absolute  recovery  was  84.5".  The  CoY  is  11.4",  which  is  lower 
than  for  plasma  (14.6").  The  recovery  of  the  internal  standard 
cinchocaine  vas  42.0"  ±  4.5  (CoY.10.8"> ,  and  the  ratio  of 
internal standard to drug  is 0.66  ±  0.04  (CoY.5.5~). 
The  fact  that  the  relative  recovery  is  .imilar  to  that  noted  for 
plalma  (0.63)  would  suggest  that  the  drop  in  ablolute  recover, aa, 
b.  due  to  matrix  effects  rather  than  bindin&  or  decomposition  of 
the  drug  in  the  lample. 
-356-Ci  B 
20  18  16  14  12  10  8  6  4  2  0 
. 
mlnS. 
FIGURE  3.20. 
c 
< 
~ 
0-
(J)  . 
CHROMATOGRAM  OF  EXTRELUTe  BLOOD  EXTRACT  CONTAINING 
BUPIVACAINE  AND  CINCHOCAINE 
-357-TABLE  3.26. 
RECOVERY  OF  BUPIVACAINE  AHD  CINCHOCAINE  FROtI 
BLOOD  USING  EXTRELUT  EXTRACTION  KETHOD 
Bupivacaine  Eff.(~)  Cinchocaine  Eff.(~)  C/B 
X 
SD 
CoV(~) 
54 
67 
71 
63 . 
63.8 
7.3 
11.4 
38 
43 
48 
39 
42.0 
4.5 
10.8 
-358-
0.66 
0.64 
0.68 
0.62 
0.66 
0.04 
5.5 10  interference was  found  in the blank  sample. 
3.6.2.4.  Conclusions 
The  extrelut  extraction  method  has  been  shown  to  be 
suitable  for  extracting  bupivacaine  and  cinchocaine  from  an 
alkaline  blood  sample.  Further  examination  of  the  extraction 
procedure  with  respect  to  sample  age,  speed  of elution,  densitJ of 
packing  and  absorption  time  might  give  greater  control  over  the 
recoveries,  and  improve  on  the  variation  observed  in  extraction 
efficiency. 
3.6.3.  URINE 
3.6.3.1.  Introduction 
Urine  samples  are  occas ionally  obtained  at  post  mortem  in 
addi tion  to  other  samples.  In  drug  testing  in  sport  (human  or 
animal)  the  sample  supplied  is  invariably urine.  Two  metbod.  for 
Icreening  urine  samples  for  basic  drugs  using  TLC  bave  been 
examined  above  (sections  3.4.3.  and  3.4.4.).  Both  were  .hOWD  to 
be  lui  table  for  t.he  extraction  of  a  range  of  local  anaestheticl, 
including  bupivacaine,  from  urine.  The  ext.racts  were  however 
found  to be  unsuitable for direct.  analysis  by  HPLC  (3.6.7.>. 
-359-3.6.4.  THE  USE  OF  EXTRELUT  EXTRACTION  PROCEDURE  AS  A CLEAN  UP  STEP 
FOR  EXTRACTS  OBTAINED  FROM  THE  ROUTINE  DRUG  SCREEN 
3.6.4.1.  Introduction 
The  extracts  from  both  screening  procedures  were  shown  to 
be  unsuitable  for  direct  analysis  by  HPLC  (3.4.7.).  The  use  of 
extrelut to  remove  the  interfering material was  investi&ated. 
3.6.4.2.  Method 
A  urine  sample  spiked  with  bupivacaine  -3  (10  giL),  was 
extracted  by  the  procedures  described  by  Hill  et  ale  (1982)  and 
Bogan  and  Smi th  ( 1968) .  The  extracts  were  then  reconstituted  in 
1ml  of water.  This  was  treated  in  the  same  way  as  plasma  samplel 
in  the  above  section.  It  was  mixed  with  O.lK  NaOH  (1ml)  and 
applied  to  the  top  of  a  6ml  extrelut  column  prepared  as  delcribed 
earlier  (2.8.4.2.),  then  allowed  to  absorb  for  2-3  minutes.  No 
internal  standard  was  used.  The  column  was  eluted  through  wi th 
dichloromethane  and  4ml  were  collected.  The  eluate  wal 
evaporated  to  dryness  at  40°C  under  OFN  and  the  relidue 
reconstituted  in  100ul  of  the  mobile  phase.  20ul  were  injected 
into  the  HPLC.  HPLC  conditions  were  as  described  in  Syst .. One, 
section 3.3.9.3 .. 
3.6.4.3.  Results  and  discussion 
The  chromatogram  produced  by  this  procedure  was  lei. clean 
than  that  resulting  from  the  extraction  of  blood  or  pla ... 
'''ples.  This  may  be  because  the  initial  extraction  procedure 
ba.  the  effect  of  concentrating  the  interfering  materlal  in  tbe extract  as  well  as  the  analyte,  from  10  or  20  ml  of urine  into  lml 
of material  to  be  analysed.  Consequently  both  the  drug  peaks  and 
the  interference  peaks  were  larger.  This  was  avoided  to  some 
extent  by  diluting  the  residue  by  a  greater  factor,  adjusting  the 
absorbance  setting  on  the  UV  detector  or  by  using  only  a  small 
fraction  of  the  initial  extract  for  ext~elut  clean-up.  The 
extracts  still  contained  a  number  of  other  peaks,  although  no 
interference  was  found  in  the  region  of  the  drug  peak  in  the  blank 
samples  examined. 
3.6.4.4.  Conclusions 
The  HPLC  system  described  for  bupivacaine  has  been  .hown 
to  be  suitable  for  the  analysis  of  extracts  from  blood  and  pla~a 
prepared  by  the  extrelut  procedure.  It has  also  been  shown  that 
the  presence  of  bupi  vacaine  in  an  extract  from  a  general  drug 
screen  can  be  confirmed  by  this  procedure.  The  extract was  found 
to  be  dirty  and  to  take  a  long  time  for  all the  co-extractants  to 
elute  (run  time  up  to  40  minutes).  In  addition,  as  the 
extraction  efficiency  of  the  screening  procedure  was  not  measured, 
the  overall  extraction  efficiency  for  the  procedure  was  not 
known.  For  this  reason  it was  decided  to  determine  whether  the 
extrelut  procedure  used  above  for  plasma  and  whole  blood  could  be 
applied  to  a  small  volume  of  urine  (1ml)  to  give  a  clean  extract 
suitable for  HPLC. 
-361-3.6.5.  EXTRELUT  EXTRACTION  PROCEDURE  APPLIED  TO  A  SMALL  VOLUIII 
URINE  SAllPLE. 
3.6.5.1.  Introduction 
A  urine  sample  spiked  with  a  known  concentration  of 
bupivacaine  (10-3g/L)  was  analysed  in  tandem  with  a  blank 
sample.  to  determine  if  the  extrelut  procedure  would  provide  a 
suitable extract for  bupivacaine  in urine  samples. 
3.6.5.2.  Method 
Greyhound  urine  was  obtained  and  spiked  with  a  knoWD 
concentration  of  bupivacaine  (10-3  gIL).  This  sample  and  a 
blank  sample  were  treated  as  follows.  Urine  (~l)  and  O.lM  NaOH 
(lml)  were  added  to  a  2ml  disposable  syringe.  Cinchocaine  (lUI) 
was  added  as  an  internal  standard.  This  was  mixed  thoroughl,  and 
applied  to  the  top  of  a  6ml  extrelut  column  prepared  as  described 
earlier  (2.8.4.2.).  The  sample  was  allowed  to  absorb  for  2-3 
minutes  and  then  eluted  through  wi th  dichloromethane  (4ml).  The 
eluate  was  evaporated  .to  dryness  at  40
0C  under  OFN  and  the 
residue  reconstituted  in  100ul  of  the  mobile  phase.  An  aliquot 
of  20ul  were  injected  into  the  HPLC.  HPLC  condi tions  were  as 
delcribed  in 3.3.2.1 .. 
3.6.5.3.  Results  and  discussion 
The  chromatograms  produced  from  these  extract.  were  of  an 
acceptable  quality.  An  example  is  shown  in  figure  3.21..  The 
urine  lamples  adsorbed  readily  and  the  solvent  eluted  throulb 
rapidl,.  4ml  being  collected  in  2-3  minutes.  The  cbromatographic 
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-363-TABLE  3.27. 
RECOVERY  OF  BUPrvACAINE  AND  CINCHOCAINE  FROH 
URINE  USING  EXTRELUT  EXTRACTION  KETHOD 
Bupivacaine  Eff.  Cincbocaine  Eff.  CIS 
X 
SD 
CoV(t,) 
80 
95 
102 
75 
88.0 
12.6 
1 •.  3 
52 
56 
59 
.8 
53.8 
•.  8 
8.9 
0.65 
0.59 
0.57 
0.64 
0.61 
0.0  • 
6.3 run  time  was  up  to  20  minutes,  althoush  one  small  peat  eluted 
after  the  internal  standard.  The  extraction  was  performed  four 
times  and  the  results  are  tiven  in  table  3.27.  and  discussed 
below.  The  absolute  recovery  of  bupi  vacaine  was  found  to  be 
88.~ ±  12.6.  This  is  comparable  to  the  efficiency  for  plas  .. 
and  is  better  than  for  whole  blood. 
rather high. 
The  CoY  is  14.3~,  which  is 
The  recovery  of  the  internal  standard  was  53.8~  :!;  4.8,  and  the 
ratio  of  internal  standard  to  druS  is  0.61  ±  0.04  (CoV-6.3t.). 
This  illustrates  the  improvement  in  precision  achieved  by  the  use 
of  an  internal standard  in this assay. 
3.6.5.4.  Conclusions 
The  extrelut  extraction  method  provides  a  lui  table 
procedure  for  the  analysis  of  bupivacaine  in  lIIll  urine  lamples. 
This  could  be  used  to  confirm  the  identity  of  bupivacaine  in  a 
Imall  urine  sample,  if  its  presence  had  been  suspected  in  the 
extract  from  the drug  screen. 
3.6.6.  APPLICATION  OF  THE  METHOD  TO  DOPING  CONTROL  IN  THE  RACING 
GREYHOUND 
3.6.6.1.  Introduction 
Havins  established  that  levell  of  bupivacalne  ID 
biological  samples  as  low  as  2ng  on  column  can  be  detected 
(3.3.10.),  it  wal  decided  to  apply  this  _thod  to  autbeDtlc 
I.ples  obtained  from  a  dog  to  which  bupivacalne  had  been 
aclminilt.ered. 
-365-The  metabolism  and  elimination  of  bUP1' vacal' ne  .  ln  man  has  been 
examined  and  has  been  studied.  It  has  been  shown  that  up  to  6~ 
of  the  drug  is  excreted  unchanged  (Reynolds,  1971)  and  various 
metabolites  have  also  been  identified.  The  excretion  of  the  drug 
in the racing  greyhound  has  not been  examined. 
3.6.6.2.  Method 
A 40Kg  male  greyhound  retired  from  racing  was  given  a  deep 
intramuscular  injection  of  bupivacaine  HCl  (Marcain),  250ms  in  the 
hind  quart.ers.  Over  t.he  following  24  hours  it was  placed  in  a 
me.h  bot.t.omed  metabolic  cage  and  the  urine  was  collect.ed. 
Thereaft.er  urine  was  collected  for  the  next  24  hours  when 
po.sible.  The  samples  were  pooled  in  two  12  hour  fraction  •. 
The  dogs  response  to  t.he  injection  was  also  noted.  The  urine 
samples  were  analysed  by  the  method  described  by  Bogan  and  Salth, 
and  1ml  was  extracted  separat.ely  by  the  extrelut  procedure 
de.cribed  in 3.5.2.2.  for  confirmatory  HPLC  analJsi •. 
3.6.6.3.  Results  and  discussion 
The  dog  accepted  the  injection  without  anJ  complaint, 
either  from  t.he  injection  or  the  loss  of  feeling  induced  bJ  t.he 
drug.  The  muscle  tissue  in  the  hind  quarters  is  quite  den.e  and 
not  beavily  enervated.  Tbe  dogs  behaviour  as  reported  bJ  the 
kennel  staff  was  not  noticabl)'  different,  and  no  impairment  in 
walking  or  whilst  exercising  was  not.ed.  The  belt  ..  t.hod  of 
a ••  e ••  inl  the  effect of  a  drul  on  the  dogs  performance  would  be  to 
race  it.  over  a  timed  dist.ance.  This  was  not  polsible  wit.hin  the 
conltralnt,  of  the  animal  licence,  and  was  againlt  the  policJ  of 
-366-the  institute  where  the  dogs  were  kenneled.  the  dogs  were 
unwilling  to urinate  in  the  metabolic  cages  and  generally onlJ did 
so  when  allowed  out  for  exerc  i se. 
collection  was  not  always  possible. 
For  this  reason  total  urine 
This  in  turn  meant  that  the 
absolute  excretion  rates  could  not  be  measured,  and  any 
quantitative assessment was  impossible. 
the  results  of  the  analysis  were  as  follows.  the  tLC  screen 
indicated  the  presence  of  bupivacaine  in  the  0  to  12  hour  sample, 
after its administration to the  animal. 
the  TLC  plate  for  the  12-24  hour  sample  indicated  the  presence  of 
some  material,  but  this  did  not  correspond  to  the  if  value  for 
bupi vacaine  and  probably  represents  the  presence  ofsoae 
metabolites.  These  were  not  identified.  The  presence  of  these 
spots  in  the  TLC  screen  would  however  have  been  sufficient  to 
require  further  investigation,  resulting  in  the  dOl  beinl 
withdrawn  from  racing. 
Bupivacaine  was  identified  by  HPLC  in  the  0-12  hour  sample  at  a 
concentration  of  1.4ug/ml,  and  in  the  12-24  hour  sample  at  a 
concentration  of  0.3ug/ml.  The  presence  of  the  drug  wa. 
confirmed  by  GCKS.  The  concentrations  found  were  significant, 
but  the  total  eKcretion  cannot  be  assessed  wi thout  knowinl  t.he 
t.ot.al  urinary  volume.  Relating  the  concentrations  to  creat.inine 
levels  was  not  considered  for  the  reasons  discussed  earlier 
(3.1.6.3.). 
3.6.6.4.  Conclusions 
Tbe  result.  of  greatest  importance  in  the  above  eKperiMnt 
i. the  detection  of  bupivacaine  in  the  12  and  24  hour  sample.  frca 
-367-the  greyhound.  Bupivacaine  was  identified  by  HPLC  and  further 
the  presence  of  the  drug.  The  analysis  by  GCKS  confirmed 
therapeutic  duration  of  the  drug  for  muscular  anaesthesia  is 
around  12  hours,  so  wi thin  the  period  in  which  it was  effective  , 
the  drug  would  be  detected.  This  is  of  special  importance  as  the 
administration  of  a  therapeutic  dose  to  the  ~og made  no  noticeable 
difference  to  its  gait  and  the  dog  may  have  passed  a  veterinary 
inspection.  The  effect  of  the  local  anaesthetic  may  only  become 
apparent  at racing  speed,  and  as  there  are  only  tenths  of  a  second 
difference  between  placings,  this  would  be  significant.  In 
addition  to  the  effects  on  the  dogs  speed,  any  loss  of  sensation 
in  one  of  the  limbs  might  lead  to  imbalance  and  to  the  dog 
injuring itself by  falling or stumbling. 
Further  work  might  be  done  to  identify  the  other  metaboli tes  of 
the  drug.  More  rigourous  control  of  the  dogs,  eg  immobilisation 
and  bladder  catheterisation,  would  be  required  for  a  full 
investigation  into  metabolism  and  excretion  patterns,  and  an 
as.esment  of  how  soon  after  administration  detectable  drug  was 
identified  in the urine. 
Creatinine  excretion,  and  its  application  to  the  normalisation  of 
drug  levels  in  the  racing  greyhound  is  currently  under 
inve.tigation  in this department. 
-368-3.6.7.  PLASMA  BUPIVACAINE  LEVELS  IN  PATIENTS  RECEIVING  BUPIVACAINE 
DURING  SURGERY 
3.6.7.1.  Introduction 
Bupivacaine  is  popular  as  a  local  anaesthetic  in  general 
surgery  because  because  of  its  persistance.  (being  an  amide). 
This  section  illustrates  the  use  of  the  method  established  above 
for  the  detection  of  bupi  vacaine  in  plasma  samples  obtained  from 
hospital patients receiving  the  drug  for post operative pain. 
The  route  of  administration  is  important  as  it may  affect  the  rate 
of  absorption  of  the  drug.  Fast  absorption  from  the  site. of 
administration,  coupled  with  the  persistance  of  the  drug  may  lead 
to high  plasma  levels,  perhaps  in  the toxic  range  (3.1 .•. ). 
Th.  aim  of  the  following  study  was  to  assess  the  degree  of 
absorption  of  the  drug  into  the  systemic  circulation  following  one 
particular route  of administration. 
3.6.7.2.  Method 
A  double  blind  study  was  conducted  involving  a  number  of 
patients  in  a  west  coast  Scottish  hospital  who  were  receiving 
general  peri  toneal  surgery.  The  site  of  the  surgery  was  wasbed 
with  bupivacaine  solution  (2Oml  0.5",  Marcain  plain)  before  the 
peritoneum was  closed. 
A control  group  had  the wound  washed  with saline. 
Blood  samples  were  taken  from  the  patients  at  intervals  of  10,  30 
and  60  minutes  following  administration. 
Thel.  were  centrifuged  immediately  to  obtain  plasma,  which  wal 
Itored frozen  (-20°)  until the  analysis  was  performed. 
-369-TABLE  3.28. 
BUPIVACAINE  LEVELS  IN  HOSPITAL  PATIENTS 
blood  concentration  (uqlal) 
patient  no.  lOmins  30mins  60mins 
1  1.3  2.0  2.8 
2  7.7  8.7  9.6 
3  5.6  5.2  4.8 
4  2.2  2.5  4.2 
5  1.5  2.6  2.9 
-370-Tbe  extraction  procedure  used  was  that  described  in  sectioD 
3.5.2.,  and  the  HPLC  conditions  were  as  described  in  Systea  One, 
.ection 3.3.9. 
Plasma  concentrations  were  calculated  by  comparison  of  peak 
heights with  an  extracted standard. 
3.6.7.3.  Results  and  discussion 
The  extracts  provided  good  chromatograms  (see  figure 
3.19.)  and  the calculated levels  are  shown  in table 3.28 .. 
All  patients  who  received  bupivacaine  were  given  the  same  do ••. 
The  plasma  concentrations  were  at  the  top  end  of  the  therapeutic 
levels  quoted  in  Moffatt  (1986),  1-2ug/ml,  with  toxic  reaction. 
including  muscular  rigidi  ty  and  convulsions  being  noted  at 
/aug/ml.  Additionally,  in  four  of  the  five  cases  reported,  the 
plasma  concentrations  had  not  peaked  by  the  time  the  60  minute 
.ample  was  taken.  As  no  later  samples  were  taken,  the  peak 
concentration  is  not  known,  but  the  results  indicate  that  a 
significant  amount  of  the  drug  is  being  absorbed  into  the  syst ..  ic 
circulation. 
A full  assessment  of  the  clinical  findings  is  not  yet  available, 
but  initial  results  (Blythe  et  al.,  1985)  have  shown  that  there 
va.  no  significant  correlation  between  the  administration  of 
bupivacaine  or  placebo,  and  the  amount  of  analgesic  required  by 
the patient to relieve POlt-operative pain. 
The  findings  above  suggest  that  the  bupivacaine  is  being  di.per  ••  d 
from  the site of pain,  and  is therefore not  acting  locally. 
-371-3.6.7.4.  Conclusions 
The  use  of  bupi  vacaine  doucbe  to  1·  re  leve  post  operative 
pain  has  been  shown  to  be  ineffectl·ve·  t·  t  In  pa  len  s  receiving 
peritoneal  surgery. 
The  measurement  of  plasma  levels  of  the  drug  are  important  as  the, 
indicate  that  a  significant  amount  of  the  ~rug  is  absorbed  into 
the  general  circulation from  the  site of  the  surger"  at  levels  in 
the toxic  range  in  some  cases. 
The  degree  of absorption of the drug  is  however  not predictible. 
If  future  studies  of  this  nature  were  performed,  blood  samples 
should  be  taken  for  a  longer  time  period  to  establish  the  peat 
concentration following  this route of administration. 
3. 7  .  THE  ISOLATION  OF  OTHER  LOCAL  ANAESTHETIC  COMPOUNDS  FROM 
BIOLOGICAL  FLUIDS. 
3.7.1.  Introduction 
The  success  of  the  extrelut  extraction  procedures  for 
rapid  extraction  of  bupi  vacaine  from  small  volumes  of  biological 
fluids  prompted  the  investigation of this  procedure  for  SODe  other 
local  anaesthetics  for  which  HPLC  methods  bad  been  developed 
• arlier.  The  compounds  cons idered  were  proca  i ne  becau.e  of  it  • 
popularity  as  a  doping  agent  in  greyhound  racing  (Sund1of  et  a1., 
1982;  Hartford  Courant,  1985),  and  cocaine  because  of  it. 
incr.ased  availability and  its potential  for  use  as  a  doping  a,ent 
(L  • .,is,  1982). 
-372-3.1.2.  PROCAINE 
3.1.2.1.  Introduction 
Procaine  is  a  short  acting  local  anaesthetic  which  il 
rapidly  broken  down  in  most  mammals  by  serum  and  liver 
cbolinesterases  (Goodman  and  Gilman,  1980) .  The  sreyhound 
bowever  possesses  very  little  serum  cholinesterase  and  therefore 
most  of  the  drug  is  excreted  unchanged  in  tbe  urine.  Tbia  of 
course  aids  in  detection,  as  urinary  concentrations  are 
consequently  qu i te  bigh.  Procaine  is  occasionally  used  on  ita 
own  as  a  sbort  acting  local  anaesthetic  but  more  often  as  procaine 
penicillin G. 
This  is  a  popular  veterinary  and  medical  preparation  used  as  a 
topical  anti-infective.  The  procaine  salt  is  lipophilic  and 
hence  less  water  soluble.  This  localises  the  counterion, 
penicillin  G,  in  the  area  surrounding  a  wound  where  infection  ia 
likely to set in. 
Anaesthesia  resulting  from  the  procaine  may  reduce  the  runnins 
performance  of  the  dog,  or  make  it  more  susceptible  to  accident 
and  injury  as  discussed  above  for  bupivacaine.  Procaine  has  allo 
been  reported  as  having  CNS  stimulating  activity  in  some  m 81111\.la 
(Dunlop,  1935;  Sundlof et al., 1983). 
The  effectiveness  of  the  screening  procedures  for  procaine  and  the 
ule of extrelut extraction prior to HPLC  was  examined. 
3.1.2.2.  Method 
Aa  the  HPLC  analysis  waa  perforeed  on  •  different  solvent 
I,ate.,  an  alternative  internal  standard  "i  th  a  ,ui  t.able 
-313-capacity.  As  shown  earlier  (3.3.9.)  lignocaine  and  mepivacaine 
chromatographed  well  on  the  same  system  as  procaine  (lot. 
acetonitrile  .  O.OSH  Di2P04'  adjusted  1n  to  pH3) .  Both 
meplvacaine  and  lignocaine  have  similar  230
Al  to  procaine  1 
(lee  table  3.7.).  Hepivacaine  however  has  a  higher  capacity 
factor  (see  table 3.17.)  and  was  selected as  .n internal standard. 
Blood,  plasma  and  urine  samples  were  spiked  with  a  known 
.  f  •  -3  concentrat10n  0  proca1ne  (10  gIL,  unless  otherwise  stated). 
Thele  samples  were  extracted as  for  bupivacaine. 
Sample  (lml)  and  O.lM  NaOH  (lml)  were  added  to  a  2m!  dispo.able 
.yringe  with  lug  of  mepi vacaine.  This  was  mixed  thoroughly  by 
inversion  and  applied  to  the  top  of  a  6ml  extrelut column  prepared 
as  described  earlier  (2.8.4.2.).  The  sample  was  allowed  to 
ablorb  for  2-3  minutes  before  being  eluted with  dichloromethane. 
4ml  of  eluate  were  collected  and  evaporated  to  dryness  at  40°C 
under  OFN. 
The  residue  was  reconstituted  in  200ul  of  mobile  pha.e  and  20ul 
injected  into  the  HPLC.  HPLC  conditions  were  as  described  in 
system three,  section 3.3.9.3 .. 
3.7.2.3.  Relults  and  discussion 
The  chromatograms  produced  from  the  blood  and  pl  .... 
• amples  were  similar  and  of  good  quality.  An  example,  th.t  for 
i  f ·  3  22  Determination  of  the  the  plasma  sample,  is  shown  n  19ure  .  . 
extraction  efficiencies  was  possible.  Similar  probleas  .s before 
were  encountered  wi th  the  extraction  procedure  for  whole  blood. 
n ...  1,  the  increased  elution  time.  For  plalma  and  whole  blood 
the  cbromatolraphic  run  time  was  up  to  twenty minut..  and  no  peat. 
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-375-eluted  after  the  internal  standard.  More  peaks  were  present  than 
had  been  observed  in the  analysis  of  bupivacaine extracts. 
The  extracts  from  the  urine  sample  contained  a  peak  corresponding 
to  procaine  (see  figure  3.23  (a».  The  blank  samples  extracted 
in  tandem  however  contained  a  number  of  large  peaks  eluting  in the 
same  region  as  procaine. 
This  made  any  unequivocal  identification of procaine  impossible. 
These  additional  peaks  were  thought  to  appear  as  a  result  of  the 
lower  concentration  of  acetonitrile  in  the  mobile  phase.  With 
the  previous  mobile  phase  described  for  bupivacaine.  these  peats 
would  have  eluted  in  the  same  region  as  procaine  (ie  "  It.  1)  and 
did not  interfere with  bupivacaine. 
The  extraction  was  performed  four  times  and  the  results  for 
plasma,  urine  and  whole  blood  are  given  in  table  3.29.  and 
discussed  below. 
In  plasma,  the  absolute  recovery  of  procaine  was  found  to  be 
a~ost  complete,  9S.S~  ±  4.4.  The  CoY  was  4.6~,  which  is 
good.  the  recovery  of  the  internal  standard  (mepivacaine)  wa. 
79.3~  ±  7.3  and  the  ratio  of  internal  standard  to  drug  was 
0.83  ±  0.07  (CoV=8.1~).  this  suggests  that  the  use  of  an 
internal  standard  in  this  assay  would  actually  reduce  its 
precision,  as  the  drug  of  interest was  almost  completely  recovered 
whilst the  internal standard was  not. 
Por  whole  blood,  the  absolute  recovery  of  procaine  wa.  lower, 
76.  3~  ±  7.6.  the  CoY  was  10.  at..  The  recovery  of  the  internal 
S•  10  7  and  the  ratio  of  .tandard  (meplvacaine)  was  64.  - ~  .• 
internal  standard  to drug  was  0.84  ±  0.06  (CoV.7.4~). 
i  the  whole  blood  wa.  le  •• ea.,  A.  with  the  analysis  of  bupivaca  ne, 
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CHROMATOGRAM  OF  EXTRELUTe  URINE  EXTRACT  CONTAINING  PROCAINE  AND  MEPIVACAINE. 
MONITORED  AT  (a)  230n. AND  (b)  280n. TABLE  3.29. 
RECOVERY  OF  KEPrvACAINE  AND  PROCAINE 
FROM  PLASMA  AND  BLOOD  WITH  DICHLOROKETHANE 
plasma 
recovery of 
procaine  mepivacaine 
92 
94 
102 
94 
X  95.5 
SO  4.4 
CoV(~) 4.6 
blood 
recovery of 
84 
76 
87 
71 
79.3 
7.3 
9.2 
procaine  mepivacaine 
83  71 
75  63 
81  74 
66  50 
X  76.3 
SO  7.6 
CoV(~) 10.0 
urine 
recovery of 
64.5 
10.7 
16.6 
procaine  mepivacaine 
98 
103 
93 
93 
X  96.8 
SO  4.8 
CoV(f.)  4.9 
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1ftepivacaine 
procaine 
0.91 
0.81 
0.85 
0.75 
0.83 
0.07 
8.1 
1ftepivacaine 
procaine 
0.86 
0.84 
0.91 
0.76 
0.84 
0.06 
7.4 
1ftepivacaine 
procaine to extract on  the extrelut columns. 
Thl ·S  suggests  tbat  for  whole  blood,  tb  e  use  of  an  internal 
standard  improves  the  precision  and  should  be  used. 
Examination  of  tbe  UV  spectrum  of  procaine  showed  a  significant 
absorbance  maximum  at  280nm  (table  3.7.).  The  urinary  extract. 
were  re-analysed  under  tbe  same  conditions  but  monitoring  tbe 
eluent at 280nm  (figure 3.23  (b». 
Whilst  tbis  added  selectivity  to  the  metbod  in  tbat  tbe  procaine 
was  identified  in  the  spiked  samples,  and  no  interference  vas 
noted  in  the  blank,  it was  also  noted  tbat  the  internal  standard 
did  not  absorb  at  tbis  wavelengtb.  The  absolute  recovery  of 
procaine  from  tbe  urine  samples  was  96.8'- +  4.8  (CoVcr4.91.)  (table 
3.29.),  tbis  is  comparable  to  tbe  recovery  from  plasma.  It vas 
concluded  tberefore  tbat  tbe  measurement  of  procaine  in  urine 
could  be  performed  wi tbout  the  use  of  an  internal  standard,  and 
still bave  an  acceptable level of precision  and  accuracy. 
3.7.2.4.  Conclusions 
Tbe  extrelut  extraction  procedure  bas  been  sbown  to 
extract  procaine  almost  completely  from  plasma  and  urine 
I ..  ples.  Tbe  recovery  from  wbole  blood  was  lower.  probabll  due 
to matrix effectl. 
Interference  in  tbe  urine  extract  prevented  tbe  use  of  tbe 
internal  standard  but  it vas  decided  tbat  this  was  not  e ••  ential 
for  the  accurate  measurement  of  procaine  in  tbese  sampl ••  ,  and  for 
tbe  further  analysis  of  plasma  and  urine  samples.  the  extraction 
efficiency  was  assumed  to  be  97'- (~  4~),  and  no  internal 
.tandard vas  uled. 
-379-It is  recOlllllended  that  the  internal  standard  be  retained  for  the 
analysis of whole  blood. 
3.7.3.  STABILITY  OF  PROCAINE  IN  STORED  URINE  SAMPLES 
3.7.3.1.  Introduction 
It had  been  suggested  that  procaine,  being  an  ester, ai,ht 
undergo  auto-hydrolysis  in  urine  samples  if  stored  for  any  length 
of  time.  The  rate of this  hydrolysis  may  increase  if the storage 
media  was  alkaline.  This  auto-hydrolysis  has  been  widely 
reported  for  cocaine  (Fletcher  and  Hancock,  1981;  Balelt,  1983; 
Garrett  and  Seyda,  1983).  The  aim  of  this  experiment  vas  to 
determine  the  rate  of  hydrolysis  of  procaine  in  a  stored  urine 
sample. 
3.7.3.2.  Method 
A  survey  of  some  23  urine  samples  recieved  in  the 
department  was  conducted  to  determine  the  mean  pH  of  a  greyhound 
urine  sample.  this  was  found  to  be  9.1.  A urine  sample  at  tbll 
mean  pH  was  spiked  wi th  procaine  (lug/all).  This  was  stored  at 
room  temperature  and  analysed  at  intervals  for  tvo  weeks.  The 
samples  were  analysed  by  HPLC  as  described  above  without  tbe  ule 
of  an  internal  standard  and  moni tored  at  280nm  (3.7.2.2.).  The 
procaine  concentration  was  calculated  against  a  frelhlJ  prepared 
extracted standard  on  each  occasion. 
-380-3.7.3.3.  Results  and  discussion 
Alkaline  conditions  are  known  to  increase  the  rate  of 
hydrolysis  of  cocaine  in  stored  samples  (Fletcher  and 
Hancock,198l;  Baselt,  1983;  Garrett  and  Se,da,  1983). 
The  calculated  concentrations  for  the  spiked  sample  are  shown  in 
table  3.30.  This  shows  that  the  concentration  of  procaine  fall. 
significantly  over  the  first  three  days  to  481.  of  its  original 
concentration,  and  that  after  7  days  less  than  2OY.  remained. 
This  drop  in  the  level  of  the  drug  in  the  sample  may  be  due  to  a 
combination  of  hydrolysis  of  the  drug  due  to  the  pH  and  to  the 
action of bacteria in the  sample. 
This  however  implies  that  after  being  stored  for  one  week  the 
amount  of  procaine  in  the  sample  could  have  fallen  by  greater than 
8OY..  Th i sIeve  1  may  be  be  low  the  detec  t ion  1 imi t ,  and  .0  a 
confirmatory  analysis  might  be  negative.  Against  this,  it  va. 
noted  that  the  levels  found  in  urine  samples  were  rather  high  due 
to  the  low  metabolism  of  the  compound,  and  that  even  a  9OY. 
reduction  in  the  level  found  in  an  authentic  sample  (see  3.7.4.) 
vould still leave  a  level of 1ug/ml or greater. 
3.7.3.4.  Conclusions 
Samples  being  analysed  at  the  racetrack  are  talten  le  •• 
than  30  minutes  before  extraction,  therefore  no  significant 
hydrolysis  will  take  place.  Samples  sent  to  this  department  for 
analysis  are  generally  analysed  within  a  weelt  of  being  taken. 
Although  the  concentration  might  drop  in  this  period  a.  .hown 
above,  that  drop  should  not  be  sufficient  to  prevent  the detection 
of  the  drug  in  most  cases.  This  might  be  prevented  bJ  the 
-381-TABLE  3.30. 
STABILITY  OF  PROCAINE  IN  A  STORED  URINE  SAMPLE 
Day  pH  concentration  (ug/ml) 
0  7.9  0.94 
1  7.6  0.80 
2  7.4  0.62 
3  0.48 
5  8.1  0.41 
7  8.5  0.19 
9  9.0  0.17 
-382-inclusion  of  a  preservative  (eg  sodium  fluoride)  0  b  ff  .  r  a  u  er  In 
the  sample  collection  bottles.  It  would  also  be  useful  if  the 
original  positive  extract  obtained  at  the  racetrack  was  available 
for  confirmatory analysis. 
3. 7 .4 .  APPLICATION  OF  THE  METHOD  TO  DOPING  CONTROL  IN  THE  RACINe 
GREYHOUND 
3.7.4.1.  Introduction 
Procaine  is  one  of  the  drugs  most  often  detected  in 
greyhound  screening  overseas  (3.1.3.2.).  Info~ation  on  the 
incidence  in  this  country  is  not  available.  However.  in  most 
incidences  where  this  compound  is  found  it  is  argued  either  that 
procaine  levels  arose  as  a  result  of  therapeutic  treatment  of  the 
animal  with  procaine  penicillin  G  for  a  bite  or  scratch.  or  that 
procaine  came  from  contaminated  food  (NGRC,  1986).  Greyhounds 
are  often  fed  on  meat  rejected  as  unfit  for  human  consuaptioa. 
This  may  be  because  the  animal  was  diseased  prior  to  death,  or 
because  it was  treated  with  drugs  before  its  death.  These  drug. 
may  include  procaine  penicillin  G  .  A  study  in  the  united  State. 
• howed  that  because  procaine  is  only  slightly metabolised  bl  tbe 
dog,  even  small  amounts  of  the  drug  ingested  in  tbe  food  M, 
appear  in detectable  levels  in  the  urine  (Dunlop,  1935;  Sundiof et 
al..  1978).  To  ensure  that  the  method  developed  above  would 
detect  procaine  satisfactorily  in  urine  from  a  dog  whicb  bad  been 
a.iailtered  with  the  drug,  the  following  experi_at  was  carried 
out. 
-383-3.7.4.2.  Method 
A  38Kg  greyhound  bitch  was  administered  with  84011&  (2.8al 
of  30Omg/al  suspension)  of  procaine  penicillin  G.  Tbil 
corresponds  to  337ms  of  procaine.  This  was  given  as  a  deep 
intra-muscular  injection  into  the  hind  quarters  of  tbe  ani ..  l. 
OVer  the  following  24  hours  it was  placed  in a  mesb  bottomed  case 
and  the  urine  was  collected.  Thereafter  urine  was  collected  for 
a  further  24  hours  when  possible.  The  samples  were  collected  in 
twelve-hourly  fractions.  The  dogs  response  to  the  injection  vas 
also  noted.  The  urine  samples  were  analysed  by  the  screenins 
method  described  by  Bogan  and  Smith,  (1968),  and  by  the  screenins 
method  described  by  Hill  et  al,  (1982).  lml  was  extracted 
separately  by  the  extrelut  procedure  for  confinaatory  analYlil  by 
HPLC. 
3.7.4.3.  Results  and  discussion 
The  results  were  as  follows  All  samples  up  to  24-36 
hours  were  positive  for  the  presence  of  procaine  by  TLC  follovin, 
both  screening procedures. 
This  was  confirmed  by  HPLC  in all cases. 
Levels  of  24,  11,  2  and  O. 2ug/al  were  found  in  the  0-12,  12-2", 
24-36  and  36-48  hour  samples  respectively. 
Tbe  concentrations  are  of  interest  from  the  point of  view  of  their 
bi,b  levell.  No  quantitative  assessment  of  tbe  fraction  excreted 
uncbansed  was  possible  as  a  total  urine  collection  was  not ..  de, 
and  tbe  volume  was  not  known.  The  samples  were  analy.ed  wi tb  iD 
one  day  of  beins  collected,  so  the  extent  of  any  bydroly.i ...  y  be 
betveen  0  and  201.,  dependins  on  whether  the  decompo.itlon  i. due 
-384-to alkaline conditions or microbial action. 
10  noticeable  deterioration  in  the  greyhounds  condition  was  noted 
by  the  kennel  staff,  and  the  dog  may  have  passed  a  veterinarr 
inspection.  As  noted  with  bupivacaine,  this  indicates  the 
importance  of  detecting  these  drugs  in  the  pre-race  chromatographJ 
testing,  as  any  incapacity  caused  by  the  d~ug  might  onlJ  becOM 
visible  at  racing  speed.  It is  considered  that  the  injection  of 
this  drug  would  have  to  be  repeated  every  twelve  to  fifteen  hours 
to maintain  any  therapeutic effect. 
3.7.4.5.  Conclusions 
It  has  been  demonstrated  that  the  adminstration  of 
procaine  to  a  greyhound  would  be  detected  by  the  TLC  screen  eyen 
in the  36  hour  period following  any  therapeutic effect. 
It  was  also  shown  that  the  HPLC  system  is  capable  of  confirming 
the  presence  of  the  drug  in  the  urine.  The  findings  in  section 
3.1.3.  however  indicate  that  the  sample  should  be  analysed  as  soon 
as  possible  after  collection,  otherwise  the  drug  level  in  the 
sample  may  fall. 
-385-3.7.5.  COCAINE 
3.7.5.1.  Introduction 
Cocaine  is  a  CNS  stimulant  which  also  has  local 
anaesthetic  properties.  It  is  seldom  used  medically  and  is  not 
included  in  MIKS.  It  is  taken  as  a·  euphoriant  and  is 
psychologically  addictive. 
death  through  cardiac  or 
Overdose  of  this  compound  ma,  caule 
respiratory  depression.  Toxic, 
therapeutic  and  fatal  levels  in  biological  fluids  have  been 
discussed  in section 3.1.4 .. 
The  incidence  of  cocaine  use  in  the  UK  is  believed  to  be 
increasing,  and  its use  as  a  stimulant makes  it a  likely candidate 
for  doping  of  greyhounds  (Lewis,  1982),  although  to  date  no 
positive cases  have  been  identified. 
An  HPLC  method  developed  above  has  been  shown  to  provide  suitable 
chromatography  for 
metabolite  in  man, 
the  measurement  of  cocaine  and  its  ..  jor 
benzoyl  ecgonine  (System  Two,  3.3.9.3.).  The 
applicability  of  the  extrelut  extraction  procedure  was  therefore 
examined  for  these  compounds. 
3.7.5.2.  Method 
As  shown  earlier  (3.3.9.)  bupivacaine  chromatographed  well 
On  the  same  system  as  cocaine  and  benzoyl  ecgonine  and  .0  " •• 
• elected  as  the  internal  standard.  Its  absorbance  at  230na  va. 
le..  than  for  cocaine  and  the  reported  absorbance  for  benzoyl 
eClonine  (3.2.2.).  In  addition,  the  peat  eluted  later  than 
cocalne,  so  band  broadening  may  lead  to  reduced  .ensitivity.  It 
wa.  found  neccessary to use  a  2ug  internal standard. 
-386-Plasma  samples  were  spiked  wi th  a  known  concentration  of  cocaine 
and  benzoyl  ecgonine  (10- 3  IL  1  g  ,  un  ess  otherwise  stated). 
These  samples  were  extracted as  for  bupivacaine. 
Plasma  (lml)  and  O.lM  NaOH  (1ml)  were  added  to  a  2ml  dispo.able 
.yringe  with  2ug  of  bupivacaine  (O.lml  of  2xlO-2g/L  solution). 
Thi.  was  mixed  thoroughly  by  inversion  and  applied  to  the  top of a 
6ml  extrelut  column  prepared  as  described  earl  ier  (2.8.4.2.). 
The  sample  was  allowed  to  absorb  for  2-3  minutes  before  beinS 
eluted  with  dichloromethane.  4ml  of  eluate  were  collected  and 
evaporated to dryness  at 40
0C under  OFN. 
The  residue  was  reconstituted  in  200ul  of  mobile  phase  and  20ul 
injected  into  the  HPLC.  HPLC  condi tions  were  as  described  in 
System One,  3.3.9. 
3.7.5.3.  Results  and  discussion 
The  ini tial  extracts  obtained  did  not  appear  to  contain 
measurable  quantities  of  cocaine  or  benzoyl  ecsonine.  The 
elution  volume  was  therefore  increased  from  4  to  8al.  The 
extracts  obtained  gave  acceptable  chromatography.  The  extraction 
efficiencies  were  calculated  and  are  shown  in  table  3.31..  The 
recovery  of  bupivacaine  was  high  75.3~  ±  5.8  (CoY.7.71.)  and  va. 
.imilar  to  that  found  earlier  (3.5.2.).  The  recovery  for  cocaine 
va.  381.  ±  10.8  (CoV=28. 41.)'  and  for  benzoyl  ecgonine,  20.31.  ± 
5.7  (CoY.281.). 
Tbe.e  recoveries  were  poor  and  there  was  a  larse  error  in  the 
ab.olute  recovery  of  both  compounds.  The  relative  extraction 
efficiency  of  each  compound  to  the  other.  is  .how  (table  3.31), 
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TABLE  3.31. 
RECOVERY  OF  BUPIVACAINE I  COCAINE  AND 
BENZOYL  ECGONINE  FROM  PLASMA  WITH  DICHLOROKETHANE 
recovery of  bup.  bup.  ~ 
bup.  coc.  b.e.  coco  b .•.  b ••. 
SO  50  24  1.60  3.33  2.08 
SO  44  26  1.S2  3.07  1.69 
73  27  17  2.70  4.29  1.58 
68  31  14  2.19  4.86  2.21 
75.3  3S  20.3  2.0S  3.S8  1.90 
5.8  10.S  5.7  0.48  0.81  0.29 
CoY  7.7  2S.4  28  23  20.9  15.4 
-388-bowever  tbe  degree  of  correlation  between  any  of  these  i8  poor, 
the  CoY  being  large in eacb case. 
WI • tb  liquid/liquid  extractl·  on,  th  d  e  egree  of  partition  i8 
determined  by  an  equilibrium  based  on  the  polarity  of  the  two 
.olvents  and  tbe solubility of the analyte  in each. 
With  solid  pbase  absorption/elution  extraction  the  solvent  is 
continually  being  replaced,  and  the  extraction  procedure  i8 
non-equilibrium.  The  degree  of  partition will  be  determined  by 
tbe  polarity  of  the  two  solvents,  the  solubi li  ty  in  each  of  the 
analyte  and  the  volume  of  the  eluting  solvent  used.  In  theory 
tbis  should  enable  the  elution  of  all  analytes  and  tbe  internal 
.tandard  in  some  finite volume  of an  appropriate eluting 8olvent. 
3.7.5.4.  Conclusions 
Increas  ing  the  volume  of  the  eluate  has  been  shown  to  be 
ineffective  in  producing  an  acceptable  extraction  procedure  for 
tbese  compounds. 
For  tbis  reason  it was  decided  to  investigate  the  use  of  another 
.olvent for extracting bupivacaine,  cocaine  and  benzoyl  ecgonine. 
3.7.6.  THE  USE  OF  ANOTHER  SOLVENT  FOR  THE  EXTRACTION  OF  COCAIIiI. 
BENZOYL  ECGONINE  AND  BUPIVACAINE  FROM  BIOLOGICAL  FLUIDS. 
3.7.6.1.  Introduction 
Extraction  procedures  for  cocaine  and  benzoyl  ecgooine 
frca  biological  fluids  bave  been  reviewed  earlier  (3.1.7.2.).  It 
va.  noted  that mixed  solvents  or  the  use  of  8alting out  procedure. 
-389-bad  been  shown  to  be  sui table  but  th  t  b  a  oth  had  their 
disadvantages. 
Several  reports  of  the  isolation  of  cocaine  and  benzoyl  ecgonine 
from  biological  fluids  use  the  solvent  system  described  by  Wallace 
et  a1.,  1975,  (von  Minden  and  D'Amato,  1977'  J  tl  t  1  ,  a  ow  ea., 
1978) .  It  was  decided  to  investigate  the  application  of  this 
solvent  (20~ ethanol  in  chloroform)  to the extrelut procedure. 
3. 7 .6. 2.  Method 
Samples  of  blood,  plasma  and  urine  were  spiked  wi th  equal 
concentrations  (10-3g/L)  of  cocaine  and  benzoyl  ecgonine. 
Sample  (lml)  and  O.lM  NaOH  (lml)  were  added  to  a  2ml  disposable 
• yringe.  Bupivacaine  (2ug)  was  added  as  an  internal  standard . 
This  was  mixed  thoroughly  by  inversion  and  applied  to  the  top of  a 
6ml  extrelut  column  prepared  as  described  earlier  (2.8.4.2.>. 
The  sample  was  allowed  to  absorb  for  2-3  minutes  and  then  eluted 
through  with  ethanol/chloroform  (20:80).  The  first  6ml  of  the 
eluate  were  collected.  The  eluate  was  evaporated  to  dryness  at 
40°C  under  OFN  and  the  residue  reconstituted  in  100ul  of  the 
mobile  phase.  20ul  were  injected  into  the  HPLC.  HPLC 
conditions  were  as  described  in  System Two,  3.3.9.3 .. 
Appropriate  blanks  were  extracted  in  tandem  with  the  spiked 
samples. 
3.7.6.3.  Results' and  discussion 
The  chromatograms  produced  from  these  extracts  were  of  an 
acceptable  quality.  An  example  of  an  extract  from  a  plasma 
lample  is  shown  in  figure  3.24 ..  No  problems  were  clper  icnced 
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FIG  URE  3. 24 . 
CHROMATOGRAM  OF  EXTRELUTe  PLASMA  EXTRACT  CONTAINING 
BUPIVACAINE,  COCAINE  AND  BENZOYL  ECGONINE 
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Yl with  the extraction of  plasma  or urine  samples. 
As  experienced  previously  wi th  blood  samples,  the  sample  took  a 
cons iderable  time  to  absorb  onto  the  column.  When  the  elutin& 
solvent  was  added  to  the  columns,  the  blood  turned  to  a  brownish 
colour  suggesting  that  the  blood  proteins  were  being  denatured 
probably  by  the  presence  of  the  alcohol  in  the  extracting  solvent 
and  becoming  coagulated.  This  change  in  the  blood  sample 
prevented  the  solvent  from  eluting,  and  so  analysis  of  whole  blood 
by  this  procedure  proved  impossible. 
For  plasma  and  urine  samples  the  extract  ion  was  performed  four 
times  and  the  results  are  given  in  table  3.32.  and  3.33.,  and 
discussed  below. 
The  chromatographic  run  time  was  up  to  25  minutes. 
Plasma 
For  plasma  samples  the  absolute  recovery  of  bupivacaine 
was  found  to  be  80.3"  ±  8.8  (CoV=ll.O").  This  compares  well 
with  the  efficiency  achieved  when  dichloromethane  was  used  as  the 
extracting solvent  (15.3"  ±  5.8,  CoV;1.1~). 
The  recovery  of  cocaine  was  14.3~  ±  5.9  (CoV=8.~),  and  the 
ratio  of  internal  standard  to  drug  was  1.08  ±  0.06  (CoV~5.3~). 
Both  the  relat  i ve  and  absolute  recoveries  were  improved  wi th  the 
ule  of this eluting solvent. 
The  recovery  of  benzoyl  ecgonine  was  55.8"  ±  5.9  (CoV.10.5~). 
and  the  ratio  of  internal  standard  to  drug  was  1.66  ±  0.14 
(CoV.IO.~).  The  coefficient  of  variation  is  quite  hiSh  for  both 
these  compounds.  As  with  cocaine,  both  the  relative  and  absolute 
recoveries  were  improved  with  the  use  of this elutins  solvent. 
-392-TABLE  3.32. 
RECOVERY  OF  BUPIVACAINE,  COCAINE  AND 
BENZOYL  ECGONINE  FROM  PLASMA  WITH  CHLOROFORM/ETHANOL 
recovery of  ~  ~  ~ 
bup.  coco  b.e.  coco  b.e.  b.e. 
80  72  49  1.11  1.63  1.47 
88  82  62  1.07  1.42  1.32 
68  68  53  1.00  1.28  1.28 
85  75  59  1.13  1.44  1.27 
X  80.3  74.3  55.8  1.08  1.44  1.34 
SO  8.8  5.9  5.9  0.06  0.14  0.09 
CoY  11.0  8.0  10.5  5.3  10.0  6.9 
-393-These  results  indicate  that  a  precise  measurement  of  cocaine  and 
benzoyl  ecgonine  in  plasma  and  urine  samples  can  be  obtained  using 
this  method.  The  use  of  an  internal  standard  did  improve  the 
precision of the procedure. 
Urine 
The  recoveries  from  the  urine  samples  were  similar  but 
slightly  lower  (table  3.33.).  An  example  of  the  chromatogram  is 
given  in  figure  3.25 ..  The  absolute  recovery  of  bupivacaine  was 
found  to  be  78.3~ ±  9.8. 
The  recovery  of  cocaine  was  64.3~  ~  10.2,  and  the  ratio  of 
internal  standard  to drug  was  1.22  ±  0.04  (CoV=3.6~). 
Whilst  the  recovery  was  slightly  lower  than  obtained  for  plasma 
(64.3~  cf.  74.3~)  and  the  error  on  the  absolute  recovery  was 
greater  (CoV=15.9~  cf.  8.0~),  the  error  relative  to  the  internal 
standard  was  similar  (CoV=3.6~ cf.  5.3~).  This  illustrates  the 
improvement  in  precision  obtained  by  the  use  of  an  internal 
standard  in this  assay. 
The  recovery  of  benzoyl  ecgonine  was  42.3~  ~  6.9,  and  the  ratio 
of  internal standard to drug  was  1.86  ±  0.10  (CoV=S.z\). 
As  with  cocaine  the  recovery  was  slightly  lower  than  for  plasma 
(42.3~  cf.  SS.8~)  and  the  error  on  the  absolute  recovery  was 
greater  (CoV=16.0~  cf.  10.S~).  The  error  relative  to  the 
internal  standard was  however  improved  (CoV=5.Z\ cf.  10.01). 
These  differences  between  the  recoveries  from  plasma  and  urine 
f  h  fact  that  the  rate  of  elution  from  samples  probably  arise  rom  t  e 
the  extrelut  columns  was  much  greater  with  the  urine  samples  than 
wi th  plasma  samples.  The  lower  error  noted  in  the  mcasut"ements 
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FIGURE  3.25. 
CHROMATOGRAM  OF  EXTRELUT®  URINE  EXTRACT  CONTAINING 
BUPIVACAINE.  COCAINE  AND  BENZOYL  ECGONINE 
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TABLE  3.33. 
RECOVERY  OF  BUPIVACAINE,  COCAINE  AND 
BENZOYL  ECGONINE  FROM  URINE  WITH  CHLOROFORM/ETHANOL 
recovery of  ~  bup.  ~ 
bup.  coco  b.e.  coco  b.e.  b .•. 
84  72  44  1.17  1.91  1.63 
89  74  51  1.20  1.75  1.45 
71  57  39  1.24  1.82  1.46 
69  54  35  1.27  1.97  1.38 
78.3  64.3  42.3  1.22  1.86  1.48 
9.78  10.2  6.9  0.04  0.10  0.11 
CoV  12.5  15.9  16.0  3.6  5.2  7.2 
-396-on  the  urine  samples  and  the  fact  that  lh  .  e  Internal  standard  to 
drug  ratio  is  higher  in  the  urine  sample  than  in  the  plasma  sa.ple 
may  suggest  that  lhere  is  differential  binding  of  the  cocaine  to 
the  plasma  proteins  in  the  plasma  sample. 
3.7.6.4.  Conclusions 
In  summary,  lhe  use  of  bupivacaine  as  an  internal  standard 
was  shown  lo  improve  the  precision  of  the  assay  for  cocaine  and 
benzoyl  ecgonine  in  plasma  and  urine. 
It  was  decided  that  this  method  was  sufficient  to  provide  a 
precise  estimation  (within  lhe  limits  shown  above)  of  the 
concentration  of  cocaine  and  benzoyl  ecgonine  in  plasma  and  urine 
samples.  The  method  was  however  not  su i table  for  whole  blood 
samples. 
The  use  of  lhe  appropriate  solvent  demonstrates  how  the  extraction 
efficiency  can  be  improved.  It  was  also  shown  that  the  HPLC 
method  developed  above  was  su i lable  for  the  detect ion  of  small 
amounts  of  cocaine  and  benzoyl  ecgonine  in  plasma  and  urine 
exlracts. 
3.7.7.  APPLICATION  OF  THE  METHOD  TO  DOPING  CONTROL  IN  THE  RACING 
GREYHOUND  - COCAINE 
3.7.7.1.  Introduction 
Cocaine  as  a  popular  stimulant  drug  is  an  obvious  choice 
to  altempt  to  enhance  a  greyhounds  performance  (Lewis.  1980). 
the  effect  that  th  i s  has  on  the  dog  has  not  been  noted.  but  i. 
-397-likely  to  be  in  the  form  of  eNS  and  cerebral  stimulate  lon,  leadin& 
to  excitability.  A  study  has  been  made  of  the  excretion  pattern 
of  orally  administered  cocaine  l' n  th  h  e  grey  ound,  and  this 
concluded  that  no  unchanged  cocaine  was  excreted  (Lewis,  1980). 
The  extraction  procedures  used  in  that  report  were  performed  at 
notably  low  pH,  and  it  was  thought  that  the  administration  of 
cocaine  to the  greyhound might merit  further  investigation. 
3.7.7.2.  Method 
A  36Kg  greyhound  bi  tch  was  fasted  overnight  prior  to  the 
oral  administration  of  ~Omg  of  cocaine  Hel  in  a  gelatine 
capsule.  This  was  chosen  as  it  was  the  least  toxic  route,  and 
absorpt ion  of  the  drug  wi 11  be  slower.  Assuming  the  lack  of 
plasma  esterases  to  be  significant,  rapid  absorption  such  as 
occurs  following  intravenous  injection  or  absorption  through  the 
mucous  membranes,  might  cause  an  accumulation  of  toxic  levels  of 
cocaine  in the  blood. 
The  animal  was  kept  in  a  metabolic  cage  for  24  hours  and  urine  was 
collected  at  0.3. 7 •  2~  and  30  hours.  The  dog  did  not  urinate  in 
the  cage  and  urine  was  collected  by  allowing  the  animal  out  and 
collect  ing  urine  by  the  "free-catch" method.  This  resulted  in  an 
incomplete  urine  collection.  Blood  samples  were  taken  frOID  the 
1c  t  0  1  2  3  4  6  and  2
1.  hours  and  collected  in  heparini.ed  nec  a  ••••••  .. 
tubes. 
All  samples  were  stored  under  refrigeration  and  analysed  within  8 
hours  of  collection.  Blood  was  centrifuged  at  3000rpm  to  obtain 
plasma.  The  extraction  procedure  used  on  all  samples  wa.  that 
de.cribed  in  section  3.7.6 ..  The  samples  were  also  extracted  bJ 
-398-the  routine  screening  procedure  (Bogan  and  Smith,  1968)  and  that 
described  by  Hill  et  aI,  (1982)  and  analysed  by  TLC.  Furtber 
confirmatory analysis was  done  by  GCKS. 
3.7.7.3.  Results  and  discussion 
The  results  of  the  analyses  of  the  urine  samples  were  as 
follows.  Both  screening  procedures  gave  positive  results  by  TLC 
for  the  first  three  urine  samples  (3,  7  and  24  hours).  There 
were  also  other  spots,  one  corresponding  to  benzoyl  ecgonine  witb 
Rf  =  0.12.  The  confirmatory  HPLC  procedure  gave  the  following 
concentrations.  The  3,  7  and  24  hour  urine  samples  bad 
concentrations  of  0.9,  1.5,  and  2.6  ug/ml  respectively.  Peaks 
corresponding  to  benzoyl  ecgonine  were  noted  in  all  four  sample •• 
but  the  presence  of  other  peaks  in  the  same  region  made 
quantitation  difficult  (see  figure  3.25.).  The  levels  calculated 
were  1.2,  1.5,  1.5  and  0.3 ug/ml  respectively. 
No  cocaine  was  found  in  the  30  hour  urine  sample  by  TLC  or  HPLC. 
HPLC  did  show  a  small  peak  corresponding  to  benzoyl  ecgonine. 
The  presence  of  cocaine  in  the  3,  7  and  24  hour  samples  was 
confirmed  by  GCMS.  GCMS  also  showed  the  presence  of  the  cocaine 
metabolite,  methyl  ecgonine,  in  the  samples.  This  has  been 
reported  as  a  major  metabolite  in  dog  urine  elsewhere  (Matsubara. 
1984).  No  benzoyl  ecgonine  was  available  as  a  standard  during 
the  course  of  the  study  however,  so  its  behaviour  on  the  HPLC 
.ystem is not  known. 
The  plasma  samples  were  extracted  by  the  same  method  and  .bowed 
some  evidence  for  the  presence  of  cocaine  and  benzoyl  ecgonine  at 
concentrations  below  O.Olug/ml.  No  atteapt  was  made  to  quantif, 
this. 
-399-these  results  illustrate  one  of  lhe  adv  l  an  ases  of  urine  analysis 
over  other  body  flu ids,  namely  its  tendency  to  concentrate  drugs 
and  metabolites.  The  urinary  be  concenlrations  cannot 
realistically interpreted without  knowin.  the  tot  1  . 
o  a  urlnary volu.e. 
The  finding  of  cocaine  in  the  urine  directly  conlradicts  the 
report  by  Lewis,  (1980).  In  that  reporl  8~ of  cocaine 
administered  orally  gave  rl·se  to  det  t bIll  ec  a  e  eve  s  of  benzoJl 
ecgonine  up  to  eight  hours  post  administration,  but  no  cocaine  "as 
found  in  the extract. 
This  is  attributed  to  the  use  of  innappropriate  conditions  for  the 
extraction  of  cocaine  in  that  report.  The  author  statel  that  an 
extraction  at  pH  3-4  into  chloroform  should  remove  any  cocaine  in 
the  sample.  Wallace  et  al.,  (1975)  concluded  that  cocaine  would 
be  extracted  efficiently  only  at  pH  between  7  and  10.  The  basic 
extraction  used  by  Lewis  to  isolate  benzoyl  ecgonine  would  be  more 
likely  to  extract  the  cocaine.  The  subsequent  derlvatisation  of 
the  benzoyl  ecgonine  back  to  cocaine  for  purposes  of  GC  analysis, 
would  mask  the  presence of  any  cocaine originally  in  that extract. 
The  third  sample  which  contains  the  highest  concentration  of  the 
drus  was  darker  in  appearance  and  was  probably  a  lot  more 
concentrated  than  those  samples  collected  during  the  day.  This 
is  due  to  the  fact  that  the  sample  was  collecled  In  lhe  morning 
following  a  period  of  18  hours  in  the  metabolic  cage.  The 
greyhound  would  not  urinate  in  the  cage  and  thil  sample  reprelentl 
the metabolic  waste  from  that  l8hour  period.  AI  lhe  lamples  were 
refrigerated  afler  collect  ion  (fa °C)  and  analYled  wi th  i n  leveral 
hours  of  collect  ion  it  is  proposed  lha  t  the  degr~e  of  converllon 
of  cocaine  to  benzoyl  ecgonine  will  be  small.  This  Iltuation .aJ differ  in  the  case  of  samples  sent  for  confirmatory  analysis  wber 
the  degree  of  hydrolysis  may  be  significant.  The  ability  of  the 
TLC  analysis  to  detect  benzoyl  ecgonine  and  the  HPLC  analys i 5  to 
confirm its presence  is therefore  important. 
3.7.7.4.  Conclusions 
The  HPLC  experiment  described  above,  by  avoiding 
derivatisation,  simplifies  the  measurement  of  cocaine  and  its 
metaboli te  benzoyl  ecgonine  in  biological  extracts.  Although  no 
quanti tati  ve  assesment  of  the  percentage  of  the  drug  excreted 
unchanged  has  been  made,  it  is  evident  that  a  significant 
proportion  of  the  drug  is  excreted  unchanged  as  cocaine,  probably 
due  to  the  dogs  lack  of  plasma  cholinesterase.  This  i. 
sufficient  to  allow,  in  this  case,  the  detection  of  the  parent 
drug  in  the  urine  for  up  to  24  hours  post  administration.  This 
is well  after the  time  of  any  likely stimulating effect. 
-.01-3.8.  CONCLUSIONS  ON  THE  ANALYSIS  OF  LOCAL  ANAESTHETICS  IN 
BIOLOGICAL  FLUIDS  BY  HPLC 
In  this  study  local  anaesthetics  were  considered  to  be 
suitable  candidates  for  analysis  by  HPLC.  Several  HPLC  lIethods 
were  examined  in  turn,  and  it was  shown  ultimately  that  suitable 
chromatography  could  be  achieved  for  a  range  of  these  compounds 
using  a  reversed  phase  of  intermediate lipophilicity. 
The  procedure  developed  for  the  extraction  of  these  drugs  froll 
biological  fluids,  namely  solvent  extraction  on  an  absorbent 
phase,  has  been  shown  to  be  rapid  and  convenient  and  to  give  clean 
extracts.  It  is  applicable  to  plasma,  blood  and  urine,  giving 
extracts  suitable  for  analysis  on  the  chromatographic  systems 
described.  The  methods  were  applied  to  authentic  samples 
obtained  from  clinical  studies  and  from  doping  studies  and  were 
shown  to  be  suitable for  both  applications. 
The  results  from  the  clinical  study  indicated  that  bupivacaine  va. 
being  rapidly  and  extens  i vely  absorbed  from  the  site  of 
application,  wi th  important  consequences  for  further  stUdies  of 
this  nature. 
The  presence  of  unchanged  bupivacaine,  procaine  and  cocaine  in  the 
urine  of  greyhounds  administered  with  these  drugs  confirms  that 
the  administration  of  these  drugs  to  the  racing  greyhound  would 
not  only  be  detected  in  the  screening  procedures  currently  in  use, 
but  showed  that  trace  amounts  (below  the  sens it  i vi ty  of  the  TLC 
Icreen)  could  be  confirmed  at  low levels  in  small  samples. 
Further  development  of  these  solid  phase  extraction  procedure. 
aisht  improve  recoveries  and  allow  the  extension  of  the  method  to 
COver  a  wider  range  of drugs. 
-402-APPENDIX  A 
PACKING  PROCEDURE  RECOMMENDED  BY  EPPEL
e  1980 
NOTE:  MASK  AND  GLOVES  SHOULD  BE  WORN. 
1  A  25cm  column  requl" res  4  Og  of  ODS  H  i  .  ypers  1  pactio, 
material.  Weigh  out  packing  material  into  a  20ml  glasl 
vial.  Add  15m1  of  O.l~  sodium  acetatelmethanol  20/80, 
stopper  and  shake  thoroughly  for  2  minutes. 
2  Place  in  an  ultrasonic  bath  for  5  minutes. 
3  Place  the  column  in  5K  nitric  acid,  and  place  in  the 
ultrasonic  bath  for  15  minutes.  Remove  and  wash  with 
distilled water,  then with methanol. 
Prime  packing  pump  wi th  O. l~  sodium  acetatelmethanol  50/50, 
Attach  bottom  end  fi ttings  to  column  and  attach  to  reservoir 
and  packing  pump. 
s  Bring  up  to  pressure  and  check  for  leaks.  Remove  froID  pump 
and drain. 
.  bath  and  .hate  S  Remove  packing  material  from  ultrasonlc 
thoroughly.  Add  qu i ckly  to  the  reservo  i r  and  at  tach  to  the 
packing  pump. 
-403-6  Bring  up  to  pressure  (4-5Kpsi)  and  allow  500ml.  of  pactio, 
solvent to  flow througb  column. 
7  Remove  from  the  packing  pump  and  attach  top  fittin,s.  attach 
to  HPLC  pump  and  pump  through  150ml  methanol/water  SO/SO 
conditioning  solvent. 
methanol. 
Follow this  with  100ml  water  and  100m! 
-.0.-APPENDIX  B 
PACKING  PROCEDURE  RECOHHENDED  BY  SHANDON  SOUTHERN 
PRODUCTS  ltd,  1984 
NOTE:  MASK  AND  GLOVES  SHOULD  BE  WORN. 
1  A  25cm  column  requl' res  4  Og  of  ODS  H  il  .  ypers  packing  . 
material.  Weigh  out  packing  material  into  a  20ml  glass 
Add  15ml  of  acetone,  stopper  and  shake  thoroughly  for  vial. 
2 minutes. 
2  Place  in  an  ultrasonic  bath  for  5 minutes. 
3  Place  the  column  in  5K  nitric  acid,  and  place  in  the 
5 
5 
ultrasonic  bath  for  15  minutes.  Remove  and  wash  with 
distilled water,  then  with methanol. 
Prime  packing  pump  with  acetone,  attach  bottom  end  fittings  to 
column  and  attach  to  reservoir  and  packing  pump.  ENSURE 
PACKING  PUKP  IS  FITTED  WITH  KEL-F  SEALS  AND  WASHERS 
Bring  up  to  pressure  and  check  for  leaks.  Remove  column  froa 
pump  and  drain. 
R  i  .  1  from  ultrasonl'  c  bath  and  shake  emove  pack  ng  materla 
thoroughly.  Add  qu ickly  to  the  reservoir  and  attach  to  the 
packing  pump.  The  column  should  be  inverted  illll.diatel,  and 
remain  that way  during  packing. 
-405-6  Bring  up  to  pressure  (5-6Kpsi)  and  allow  5oo.l  of  pactins 
solvent  to  flow  through  column.  (This  tates  about  half  as  lon, 
as  with  procedure  A.) 
7  Remove  from  the  packing  pump  and  attach  top fittin,s.  attach 
to  HPLC  pump  and  pump  through  15Om1  methanol/water  50/50 
conditioning  solvent. 
methanol. 
Follow this  with  100m}  water  and  100m! 
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APPENDIX  C 
DETAILS  ABSTRACTED  FROM  PATIENTS  CHARTS 
IN  HOSPITAL  MORPHINE  STUDY  (2.10.4.) 
Infusion  sickness  sedation  blood morphine 
rate  score  score  level 
0  17  6.1  0.016 
0  17  6.4  0.005 
0  19  7.1  0.007 
0  19  5.5  0.008 
1  13  3.7  0.015 
1  IS  3.5  0.011 
2  19  4.5  0.039 
2  15  3.3  0.039 
2  IS  4.5  0.028 
2  17  4  0.031 
2  19  3  0.024 
2  19  3.7  0.033 
2  17  4  0.006 
2  15  3.7  0.029 
2  17  3.5  0.028 
5  20  5  0.102 
5 
lit  4.1  0.047 
5 
lit  lit  0.108 
0  24  6.5  0.005 
2  20  6.5  0.023 
3  25  7.5  0.032 
3  22  5  0.023 
5  20  6  0.078 
5  20  4.5  0.031 
5  19  0.5  0.056 
5  20  2  0.050 
3 
lit  4  0.011 
3 
lit  3  0.015 
0  9  6.4  0 
0  8  5.8  0 
3  3  9.2  0.030 
5  7  4.2  0.081 
7.5  9  5  0.077 
7.5  5  4.5  0.079 
7.5  7  4.9  0.118 
6  5.5  0.120 
7.5  0.135 
7.5  7  4.4 
-407-patient  Infusion  sickness  sedation  blood IBOrpbiDe  number  rate  score  score  level 
6  0  11  4.6  0.005 
3  8  4.5  0.056 
3  8  6.5  0.050 
4  10  5.8  0.064 
4  9  3  0.015 
4  13  2.2  0.062 
4  12  2  0.069 
4  12  2  0.054 
5  1  3.5  0.093 
5  11  5.2  0.093 
7  0  2  10  0.004 
0  0  8.6  0 
3  2  10  0.029 
3  0  9  0.034 
3  4  8.5  0.037 
3  7  7.5  0.033 
3  7  7.6  0.035 
3  7  7.4  0.045 
4  'Ie  lit  0.057 
5  lit  'Ie  0.082 
5  'Ie  'Ie  0.058 
5  lit  lit  0.055 
8  3  5  10  0.027 
3  6  9  0.039 
3  2  8.2  0.046 
3  4  8.5  0.025 
3  8  8.5  0.023 
9  5  'Ie  'Ie  0:071 
5  'Ie  lit  0.100 
5  'Ie  'Ie  0.105 
8  'Ie  'Ie  0.143 
8  'Ie  'Ie  0.124 
10  lit  'Ie  0.112 
10  'Ie  'Ie  0.095 
10  'Ie  'Ie  0.145 
10  'Ie  :It  0.169 
10  lit  :It  0.248 
10  :It  'Ie  0.239 
10  'Ie  'Ie  0.211 
10  :It  :It  0.222 
15  :It  'Ie  0.322 
15  :It  :It  0.299 
15  :It  lit  0.280 
15  :It  :It  0.349 
-408-~ 
patient  Infusion  sickness  sedation  blood IDOrpbine 
number  rate  score  score  level 
10  5  *  *  0.018 
5  *  *  0.119 
5  *  4.4  0.128 
5  10  5.2  0.132 
10  *  *  0.162 
10  *  *  0.138 
10  *  *  0.109 
10  *  *  0.154 
10  *  *  0.180 
10  *  *  0.230 
15  *  *  0.253 
15  * 
:III:  0.312 
15  * 
:III:  0.388 
15 
:III:  *  0.358 
11  1  10  1  0.032 
1  10  1  0.032 
1  14  2  0.042 
4  10  2  0.011 APPENDIX  D 
PREPARATION  OF  ACIDIFIED  IODOPLATINATE  SPRAY  FOR  TLC 
Chloroplatinic  acid  (lgram)  was  dissolved  in  water  (10s1).  A 
solution  of  potassium  iodide  (10grams)  in  water  (35Om1)  was  then 
added.  The  final  volume  was  made  up  to  500ml  wi th  a  solution  of 
hydrochloric  acid:water,  3:2. APPENDIX  g 
SUPPLIERS  OF  CHEMICALS  AND  EQUIPMENT  USED  IN  THE  STUDY 
solvents:  ethyl  acetate"  dichloromethane,  chloroform,  methanol  and 
isopropyl  alcohol,  (all HPLC  grade),  and  acetonitrile  (HPLC  srade  S), 
Rathburn  solvents ltd., Walkerburn,  Scotland. 
water  was  singly distilled in the department. 
Pentane,  heptane  and  octane  sulphonic  acids,  dioctyl  sulphosuccinate 
and  para-amino  benzoic  acid  were  supplied  by  Sigma  chemicals,  Poole, 
Dorset,  UK. 
All  drug  standards  were  supplied  gratis  to  the  Department  of 
,orensic  Medicine  and  Science  courtesy  of  the  relevant  druS 
companies,  and  benzoyl  ecgonine  was  supplied  courtesy  of  Strathclyde 
police  forensic  science  laboratory,  Pitt Street,  Glasgow. 
Thin  layer  chromatography  plates  (5  and  10cm)  with  background 
fluorescence  (Merck),  Extrelut  diatomaceous  earth  (Merck),  Whatman 
PS-l  phase-separating  filter  paper  and  ammonium  carbonate  (rock 
form)  (BDH)  were  obtained  from  Macfarlane  Robson,  Ltd,  Glasgow. 
All  other  reagents  were  Analar  grade  by  Koch  Light  Chemicals  or  80H 
and  were  obtained  from  the  Chemical  Store,  Glasgow University. 
Sep  Pak  C-18  cartridges  were  obtained  from  Waters  inc.,  Edinburgh, 
UK. 
Bond  elut  C-18  cartridges  were  supplied  by  Crawford  Scientific, 
Strathaven,  Scotland,  UK. 
uv  spectra were  recorded  on  a  Hewlett  Packard  HP8451A  scanning  diode 
array  spectrophotometer,  supplied by  Hewlett  Packard,  Edinburgh,  UK. 
The  Bioanalytical  Sysyems  CV-IA  cyclic  voltammeter  was  loaned  by  the 
department  of  Chemistry,  Glasgow  University  and  was  supplied  by 
Anachem  ltd,  Luton,  UK. 
The  Gilson  302  single  piston  pump  and  802C  manometer,  the 
Bioanalytical  Systems  (BAS)  LC-48  electrochemical  detector  and 
various  HPLC  fittings  and  accessories  were  supplied  by  Scotlab 
Instrument  Sales ltd., Bellshill,  Glasgow,  UK. 
The  Spectroflow  757  (Kratos)  UV  monitor  was  supplied  by  Severn 
Analytical,  Bristol,  UK. 
The  Phillips  PU4025  UV  monitor  was  supplied  by  pye  Unicam, 
Cambridge,  UK. 
Servoscribe  flat  bed  chart  recorders  were  supplied  and  serviced  by 
Burke  Electronics  ltd,  Glasgow,  UK. 
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